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ABSTRACT  
 
Background: Every year 287,000 women die from pregnancy related complications.  
Methods: Systematic reviews of interventions to reduce maternal mortality in developing 
countries with meta-analysis or meta-synthesis where appropriate. 
Results: Participatory learning and actions cycles with women’s groups significantly reduce 
maternal and neonatal mortality, training and supporting TBAs also reduces perinatal 
mortality. Clinical officers performing caesareans section do not seem to cause any more 
maternal or perinatal mortalities than doctors. Prophylactic antibiotics reduce infectious 
morbidity in surgical abortion, yet the effect on miscarriage surgery is unclear. Cell salvage in 
ectopic pregnancy and caesarean section appear to be a safe and effective alternative in the 
absence of homologous transfusion. Motivational interviews may have potential to improve 
contraceptive use short term. Symphysiotomy may be a safe alternative to caesarean 
section. The anti-shock garment may improve outcomes when used in addition to standard 
obstetric haemorrhage management. Potential solutions to emergency transport for pregnant 
women include motorcycle ambulance programmes, collaboration with local minibus taxis 
services, and community education and insurance schemes. 
Conclusion: Several interventions reviewed in this thesis can be utilised to aid reduction in 
maternal mortality, however the level of evidence available within each review varies, some 
allowing firm inferences with others more tentative. 
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CHAPTER 1: INTRODUCTION 
In 2010 it was estimated that 278 000 women died from pregnancy related 
complications (1). The enormity of the matter was brought into focus with the launch of 
the MDGs in September 2000  (2, 3) (table 1) when the maternal mortality rate was 
529,000. World leaders committed to reduce poverty, hunger, disease, illiteracy, 
environmental degradation, and discrimination against women (3). Improving maternal 
health and reducing maternal mortality rates featured amongst these goals (MDG5). 
MDG 5 endeavours to improve maternal health by reducing maternal mortality by three 
quarters and achieve universal access to reproductive health services by 2015.  
 
Since conscious efforts have been made to reduce maternal mortality, improvements 
have occurred. However substantial improvements were not seen until 2010. In 1990 
the number of maternal deaths was 543,000, in 2000 this toll was 529,000 and in 2005 
the total was 536,000, almost double the 2010 figures (278,000). Between 1990 and 
2010 global maternal death decreased by 47% and many countries in sub-Saharan 
Africa experienced reductions of up to half. Despite this progress, the targeted 5.5% 
annual reduction set by the MDGs in 2000 is not yet being achieved globally.  Between 
1990 and 2010 the global annual reduction was just 3.1%.  Ten countries however 
including Estonia, Romania, and the Islamic Republic of Iran have already achieved the 
targeted 5.5% annual reduction in maternal mortality rates, and a further nine more 
countries are on track to achieve this goal by 2015 (1). Yet twenty five countries have 
made less progress (classed as insufficient progress or no progress) in reducing 
maternal mortality and are not on track towards achieving MDG five, with some 
achieving less than 1% reduction (1).  
 
 
 
 
2 
 
There is great disparity in maternal mortality across the globe: in 2010 99% of maternal 
deaths occurred in developing countries. Half of all global maternal deaths occurred in 
Sub-Saharan Africa and a third in South Asia alone. Comparatively, developed 
countries attain just 1% of all maternal deaths (1). This is demonstrated in Figure 1 and 
equates to a ratio of 240 maternal deaths per 100,000 live births for developing 
countries, and 16 per 100,000 live births for developed countries. The disproportion in 
maternal deaths globally is not only evident between developing and developed 
regions; it also exists between urban and rural areas particularly within developing 
regions.  
 
There are notable variations both historically and geographically with maternal mortality 
trends. Figure 1 also demonstrate the geographical variation in maternal mortality, it 
gives a global picture of maternal mortality in 2010, providing the maternal mortality 
ratios across countries. The map demonstrates the marked differences within 
continents such as Africa. For example, sub-Saharan countries such as Chad and the 
Central African Republic (MMR 1100 and 890 per 100, 000 live births respectively) 
have an MMR ten times that of Northern countries such as Algeria (97 per 100,000 live 
births). Even in continents where MMR is low, such as Europe, there is still some 
variation, for example the MMR in Belarus is 4 per 100,000 live births, and in the 
Republic of Moldova this statistic is 41 per 100,000 live births. There is however much 
greater variation between continents, which is demonstrated clearly in Figure 2. Figure 
3 illustrates the annual rate of decline in maternal mortality per country between 1990 
and 2008, thus showing the variable geographical progression towards achieving 
millennium development goal 5.  The variability in maternal mortality rate within urban 
and rural regions is shown in Figure 4; this shows the difference in maternal mortality 
rates between rural and urban areas of countries in sub-Saharan Africa. This is 
suggested to be due to issues relating to obstetric care access or the poor quality of 
emergency obstetric care in hospitals or clinics (4). 
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The high rates of maternal mortality in developing regions often reflect the inequality in 
healthcare services and access to healthcare provisions. As most maternal deaths are 
preventable with good quality obstetric care, it is comprehensible that most maternal 
deaths occur in regions where women are less likely to receive this care. For example 
in developed countries where maternal mortality rates are low almost all births are 
attended by skilled birth attendants, and almost all women receive at least the four 
antenatal visits advised by the WHO. For example in Ireland (2010) 99.8% of births are 
attended by skilled birth attendants, with the same amount receiving the recommended 
antenatal care, the maternal mortality ratio was 4 per 100,000 live births. 
Comparatively in developing countries where maternal mortality rates are high, less 
than half of women receive skilled birth attendance, and one third receive the advised 
minimum of four antenatal visits. For example in Afghanistan the MMR is 460 per 
100,000 live births, 36.3% of births are attended by skilled birth attendants, and 14.6% 
receive the recommended antenatal care. 
 
The historical variation in maternal mortality is demonstrated in Figure 2, this shows the 
trends in maternal mortality over the twenty years from 1990 to 2010 by WHO region. 
Globally there was a 47% decline during these two decades, with Europe and the 
Americas even though low still showing some decline, but Africa and South East Asia 
showing the greatest reductions in maternal mortality between that period. Maternal 
mortality rates have not always been low developed countries: in 1800s and 1900s in 
England and Wales for example maternal mortality rates were much higher. It was not 
until the 1930s that maternal mortality rates began to fall, however a substantial 
reduction in rates was not seen until the 1950s (Figure 6). The reduction in maternal 
deaths from 1930s, with a steeper reduction in the 1950s may be due to the 
introduction, followed by the wider use, of antibiotics and blood transfusion. It is also 
suggested that some of the substantial reduction may be due to the change in the 
measurement of maternal mortality, for example measuring maternal death in the 
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population at risk, only those of childbearing age, usually defined as women aged 15–
44, rather than the whole female population, or the classification of ‘true’ maternal 
deaths and how this changed in 1933 to include only ‘diseases of pregnancy, childbirth 
and the puerperal state’ (4). Furthermore after 1927, with the registration of stillbirths, 
the denominator that was used was total births (live and stillbirths), rather than just live 
births, and the gestational age in the classification of stillbirths was increased from 20 
weeks to 28 weeks gestation in 1930. 
 
Not only is there variation in maternal mortality rates historically and geographically, the 
leading causes of maternal mortality also fluctuate between time periods and 
geographical locations. Figure 5 demonstrates the geographical variation in distribution 
of causes of maternal deaths in Africa, Asia, Latin American and Developed countries. 
A systematic review conducted by the World Health Organisation (5) found that 
Haemorrhage was the leading cause of death in Africa and in Asia, representing 30% 
of all maternal deaths. Hypertensive disorders caused most deaths in Latin America 
and the Caribbean. Abortion related deaths were the highest in Latin America and the 
Caribbean. Deaths due to sepsis were lower in developed countries than in Africa, 
Asia, Latin America and the Caribbean. Ectopic pregnancy was reported as the cause 
of death in 1% of deaths in developing countries but nearly 5% in developed countries.  
 
The varying rates of maternal mortality, and the main causes of maternal death in 
specific regions, are often a reflection on the quality of healthcare services available, as 
well as access and to healthcare provisions (6, 7) although, the social status of women 
is often connected.  Although Figure 5 provides information of the clinical causes of 
death, it does not account for the underlying causes that may lead to maternal 
mortality. Gender inequality, lack of education or lack of autonomy in decision making 
are key factors reported in the literature (8, 9). Poverty is another factor that is 
suggested to be closely linked to maternal death (9, 10). A models that examines the 
 
 
5 
 
societal causes of maternal death is the three delays model (7). This model focuses on 
access to care and how it is impeded. These three steps are not independent and are 
linked closely to one another; a delay in one stage of the woman’s journey can often 
result in subsequent delays. 
 
The three delays model describes the three different types of delay in care access 
(Figure 7)(7);  
Delay 1: A delay in making the decision to seek care (e.g. in the case of an obstetric 
emergency); this may due to a lack of awareness of the need to seek care, often due to 
lack of education or low social status of women. 
Delay 2: A delay in reaching care (e.g. an appropriate obstetric facility that can perform 
caesarean section); this may be due to poverty, not being able to afford the transport 
required to reach the facility, or the cost of the treatment; or a lack of autonomy, the 
woman not being allowed to seek care or make the decisions to seek care.   
Delay 3: A delay in receiving care (e.g. receiving the caesarean section that is needed); 
this may be due to poverty and gender inequality, with maternity care being poorly 
supported with staff and resources. It may also be due to a lack of education and 
empowerment, with the women not asserting a right to safe, effective care. 
 
This model (7) emphasis the need for comprehensive consideration of the problem of 
maternal mortality, and can be used to guide our understanding of the way in which the 
problem should be addressed. 
 
Another structure that can guide our understanding is the structure for analysing the 
determinants of maternal mortality (11). This places the pregnant woman at the crux of 
the structure and considers the three stages that contribute to maternal death. The first 
set of components are the immediate determinants of maternal health; these are the 
complications associated with pregnancy. This includes haemorrhage, infection, 
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obstructed labour, hypertension, and unsafe abortion (Figure 8), the most common 
causes accounting for 80% of all maternal deaths (1). Interventions that target the 
immediate determinants of maternal health focus on improving the outcome for women 
who develop such complications.  
 
The second set of components in the framework, intermediate determinants of 
maternal health, are the health status of the woman, access to and the use of health 
services, and healthcare seeking behaviour. This includes diseases and conditions that 
affect the health of the woman and her ability to cope with the immediate determinants 
(complications of pregnancy), for example HIV/AIDS, malaria, malnutrition and 
anaemia (MDG 6). It also includes the concepts that affect the care received, such as a 
lack of available, acceptable or accessible care, or the quality of the care received. 
Interventions that target the intermediate determinants focus on reducing the likelihood 
of a woman experiencing a serious complication.  
 
The third set of components; the distant determinants are more complex and affect the 
family and community in addition to the individual woman. This includes, but is not 
restricted to gender inequalities, female autonomy and advocacy (MDG 3), poverty 
(MDG 1), and education (MDG 2). Interventions that target these determinants focus 
on reducing the likelihood of unplanned or unwanted pregnancy. 
 
Despite maternal mortality being halved globally, progress towards achieving MDG 5 is 
still inadequate, with some regions showing more progress than others. It has been 
acknowledged that improvements in maternal mortality rates have been seen in some 
developing countries. Countries such as Bangladesh, Sri Lanka and Nepal (1) share a 
number of common features; increased contraceptive use, delaying or limiting 
childbearing, enhanced access to high quality healthcare, and improvements in 
education and social status of women. Many developing countries however, are yet to 
 
 
7 
 
accomplish these standards. Instead poor political will, inadequate governance, and 
minimal economical input into healthcare are suggested to hinder improvements in 
maternal health (12-14). Inequality (15), conflict, and famine, as well as poor quality 
care or a lack of available obstetric care due to various barriers (16) may impede 
improvement further.  
 
Poor maternal health and maternal mortality greatly influence perinatal, neonatal and 
infant health and mortality rates, as they are inextricably linked (MDG 4). Infants of 
mothers that die are between three and ten times more likely to die within two years of 
their mothers deaths (12).  For this reason perinatal and neonatal mortality rates are 
also examined within this thesis. These rates can be useful when examining 
interventions to reduce maternal mortality, as greater improvements are often seen in 
these outcomes first, due to the sample size needed to show an effect in maternal 
mortality.   
 
High maternal mortality rates profoundly influence the wider community. Poor health 
among women and children can gravely impede economic growth, with an estimated 
£9.4 billion being lost in potential productivity annually (13, 17-19). The WHO 
advocates the global importance of maternal and neonatal health, stating the central 
roles they encompass in global well-being. The effect of affordable interventions on 
neonatal health has been demonstrated, even in the poorest countries it is suggested 
that between 41% and 72% of neonatal deaths could be prevented if simple, evidence-
based, cost effective interventions were implemented (20). Has the same effect been 
shown with interventions to reduce maternal mortality rates?  
 
The effect of interventions on maternal mortality in developing countries is more difficult 
to measure. It is complicated by a lack of reliable data, incomplete and sporadic 
reporting of individual deaths, as well as the difficulty with assessing the true causality 
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of each death (1) (21). Despite this, many interventions have aimed to reduce maternal 
mortality, and improve maternal health, but some have neglected the economic, 
geographic and social constraints of developing countries. Without such consideration, 
interventions can be targeted incorrectly, thus not able to demonstrate the largest 
possible effect. One example of this is focusing efforts on skilled birth attendants only, 
or providing interventions only within health facilities. This does not take into account 
the global deficit of skilled birth attendants, and that most women in developing 
countries receive care from a lay-provider at home, or outside of health facilities. 
Targeting interventions that utilise available resources and comply with the current 
infrastructure may prove more successful in implementation, size of effect, 
generalisabilty to population, as well as overall outcome. An example of targeting 
interventions is training and supporting TBAs or participatory learning and action cycles 
with women’s groups (chapter 3 and 4).  
 
Not only can complexities arise with measuring maternal mortality, and assessing 
progress toward achieving MDG5, it is often difficult to assess the impact of  
interventions within a specific setting, or single interventions within complex packages. 
The design and implementation of interventions and projects to reduce maternal 
mortality can be poorly documented or reported, often lacking sufficient detail for direct 
inferences to be made.  Therefore assessing the impact of interventions too can also 
be problematic, particularly if they have been evaluated in a non-systematic and non-
rigorous manner (13).  Good quality data from well designed and well executed 
systematic reviews and meta-analyses, are the ideal source of evidence to guide 
clinical practice and projects.  In the absence of these, well designed and well executed 
RCTs are the next best form of evidence.  RCTs however are not always feasible or 
ethical, thus the next best available evidence should be assessed as per the hierarchy 
of evidence. It is however important to consider the strength of the evidence from which 
inferences are made.  
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This thesis aims to systematically synthesise, review and assess the evidence on 
interventions proposed to reduce maternal deaths in developing countries, thus 
enabling interventions to be classed accordingly: 
a) Beneficial (suitable for implementation; no further research required) 
b) Likely to be beneficial (may be suitable for implementation with close monitoring 
of outcomes; further research may be required) 
c) Trade off between benefits and harm (may be suitable for implementation 
according to local circumstances and priorities. Implementation ideally carried 
out in the context of research; further research required 
d) Unknown effectiveness (not for implementation; may be suitable for research if 
existing data indicative of benefits) 
e) Unlikely to be beneficial, or likely to be harmful (not for implementation; not for 
research) 
 
Due to the scale of existing interventions that have been conducted in developing 
countries to reduce maternal mortality, only those that were deemed to be the most 
promising were focused on. Ten interventions and clinical situations have been 
reviewed. The selection of the interventions to be reviewed in this thesis were not pre-
defined when the thesis commenced. Alternatively the interventions evolved through 
discussions with experts and clinicians with experience in maternal health in 
developing countries, in conjunction with publication of new evidence, and revelation of 
new information on maternal health.   
 
Initially a scoping literature search was performed within the following databases 
MEDLINE, EMBASE, Reproductive Health Library and The Cochrane library. Experts 
were contacted to discuss the various interventions identified that aimed to reduce 
maternal mortality in developing countries. The types of interventions identified were 
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initially planned to be grouped in the following categories. As there is no universally 
recognised classification of interventions, the classifications that were used were 
developed following consultation with a range of stakeholders; including obstetricians, 
midwives, researchers and experts in the area. The purpose of the classifications was 
to group the intervention into meaningful categories to aid the reader. 
 
A Single interventions 
B Packages or strategies 
C Behavioural or educational interventions 
D Organisational interventions 
E Policy and programmatic interventions 
 
This is shown in Table 2 (Examples of Interventions from Research Proposal) 
 
The best possible evidence available is included in the systematic reviews to evaluate 
the interventions. Where possible, level one evidence, data from RCTs are used in the 
reviews. In the absence of sufficient data from such trials, data from quasi-experimental 
and observational studies will be included. For example where RCTs are not available, 
the next level of available evidence was included. This hierarchy of evidence will be 
followed (22) to ensure the inclusion of the highest level of evidence available is 
included within the reviews. 
 
 
This provisional list was subject to development and change as the reviews were 
conducted. The initial categories given in the provisional list above evolved as part of 
the iterative review process, giving the list that features in Table 3 (Interventions 
reviewed in the thesis). Many of the interventions reviewed spanned more than one 
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category in the provisional list, but fit the new classifications more appropriately. The 
new classifications are as follows:  
a) Community based interventions 
b) Task-sharing / Task-shifting interventions 
c) Clinical interventions 
In the absence of a universally recognised intervention classification scheme, the 
above classifications were used to group the interventions into meaningful categories 
to aid the reader. 
The aim of this thesis was to systematically review the evidence on interventions to 
reduce maternal mortality in developing countries. The aim was achieved through the 
following objectives: 
a) Review, synthesise and assess the literature on community based interventions 
b) Review, synthesise and assess the literature on task-sharing interventions 
c) Review, synthesise and assess the literature on clinical interventions 
d) Make recommendations for practice 
e) Make recommendations for research 
 
The questions addressed in the thesis and the interventions that have been 
systematically reviewed in this thesis are shown in Table 3. A cost effectiveness 
assessment of the interventions reviewed was not formally considered in the thesis, 
however it is recognised that the cost of interventions does need consideration, 
particularly when considering implementation. Cost effectiveness of various 
interventions to reduce maternal mortality is available in the literature 
(23-25). 
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Figure 1 Maternal mortality ratio (per 100,000 live births) in 2010, as per WHO 
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Figure 2 Maternal mortality ratio per 100,000 live births by region (1990-2010) 
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Figure 3 Yearly rate of decline in maternal mortality ratio, 1990–2008 
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Figure 4 Maternal mortality ratios in urban and rural sites in sub-Saharan Africa (26) 
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Figure 5 Geographical variation in distribution of causes of maternal deaths *Represents HIV/AIDS. †Represents embolism. ‡Represents ectopic pregnancy. 
§Represents anaemia
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Figure 6 Maternal mortality rates in England and Wales 1850-1980 (five year averages
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Figure 7  Three delays model
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Figure 8 Immediate, intermediate and distant determinants of maternal health
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Table 1 Millennium Development Goals 
 
Millennium Development Goals 
 
Eradicating extreme 
poverty and hunger 
 
 
Improving maternal health 
 
 
Achieving 
universal primary 
education 
  
Combating HIV/AIDS, malaria, 
and other diseases 
 
 
Promoting gender 
equality and  
empowering women 
  
Ensuring 
environmental sustainability 
 
 
Reducing child 
mortality rates 
 
 
Developing a global partnership 
for development 
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Single Interventions 
Problem 
Population 
Intervention Outcome Examples of Existing Research 
A1. Obstructed Labour. 
Labouring women. 
Healthcare professionals 
caring for labouring 
women 
Partograph 
 
Correctly completed 
documentation, referral 
rate,  Vaginal exams, 
oxytocin use, c/s, 
prolonged labour, 
complications, correctly 
completed documentation 
Fahdhy, 2005 (27) (Indonesia) Assessing effectiveness of promoting WHO 
partograph by midwives. RCT (i) trained in Partograph (ii) normal care. 
Comparing birth outcomes, health centres referral, prolonged labour, c/s. 
Fawole, 2007 (28) (Africa) Retrospective review of 445 patient records. Audit 
use of partograph and how influences decision making 
A2.  Eclampsia. 
Pregnant women with 
pre-eclampsia 
Anticonvulsant therapies 
(Magnesium sulphate, 
diazepam etc) 
MMR, occurrence of 
convulsions 
The eclampsia collaborative group 1995 (29) (India, Sub-Sahara Africa, Latin 
America) Multicentre (25) RCT sample: 198 women, comparing magnesium 
sulphate with diazepam or phenytoin or lytic cocktail 
A3.  Sepsis. 
Labouring and Postnatal 
Women 
Vaginal chlorhexidine during 
labour 
MMR,  peri-partum 
infection 
Lumbiganon, 2004 (30) (Pakistan, Zimbabwe, South Africa) Cochrane 
review. 3 RCT’s placebo controlled. Assessing if vaginal chlorhexidine 
washes during labour prevents maternal and neonatal infections excluding 
Group B Streptococcal and HIV 
A4. Hypertensive 
Disorders. Pregnant 
women <34/40 gestation 
Calcium supplementation 
 
MMR, pre-eclampsia,  
raised blood pressure, 
serious morbidity 
Hofmeyr , 2006 (31): Cochrane review, 12 RCT’s: 15,206 women. Calcium 
supplementation >1g prevent hypertensive disorders & associated problems 
A5.  Syphilis. 
Antenatal women 
Benzyl-penicillin 
 
Cases of active syphilis, 
female education, 
abortion, MMR 
Hira, 1990 (32) (Zambia) Comparing pre/post intervention. 3 centres 
involved. 491 women from study centres. 434 from control. Syphilis 
intervention project: (i) implement screening, (ii) treating active cases, (iii) 
demonstrate improvements in outcomes. 
Guinness, 1988 (33) (Swaziland). Survey 283 deliveries. Examining 
influence of syphilis screening on perinatal mortality 
A6. Malnutrition 
also see A7 C3. 
Pregnant women and 
Postpartum women up to 
12 weeks  
Vitamin A supplements MMR, anaemia, vitamin A 
deficiency, maternal 
sepsis, night blindness, 
maternal infection 
markers 
Van den Broek, 2010 (34) (Nepal, Indonesia, Malawi). Cochrane review. 5 
randomised/quasi randomised trials. 23,426 women. Effectiveness of vitamin 
A supplementation during pregnancy, alone or in combination with 
supplements on maternal, newborn clinical, laboratory outcomes 
A7.  Anaemia 
also see A6. 
Iron supplementation +/- 
Folic acid 
Hb concentration Pena-rosas, 2006 (35). Cochrane review, RCT/quasi randomised trials (i) 
Iron alone 29 trials (ii) Iron with folic acid. 8 trials (iii) intermittent iron 
Table 2 Examples of Interventions from Research Proposal 
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Pregnant women   supplementation vs. daily iron.  2 trials (iv) intermittent iron with folic acid vs. 
daily iron with folic acid 7 trials. Assessed  (i) use of daily iron supplements 
(+/- folic acid)  vs. placebo  (ii) intermittent use of iron supplements (+/- folic 
acid) with daily supplements   (iii) intermittent use of iron supplements (+/- 
folic acid) with placebo 
A8.  Postpartum 
haemorrhage prophylaxis 
Syntometrine 
Syntocinon 
Misoprostol 
Carbetocin 
Risk of severe PPH, use 
of additional uterotonics, 
blood transfusion,  
need for uterine massage 
following both caesarean 
delivery,  blood loss, need 
for therapeutic uterotonic 
agents, adverse effects, 
hypertension 
Tuncalp, 2012 (36) 72 trials (52,678 women). Oral or sublingual misoprostol 
vs. placebo. Compared conventional injectable uterotonics and oral 
misoprostol. Measured risk of severe PPH, use of additional uterotonics, 
blood transfusions, shivering, temperature above 38º.  
Su, 2012 (37)11 studies (2635 women) Carbetocin vs. oxytocin. Outcomes 
were blood loss, need for therapeutic uterotonic agents, risk of adverse 
effects such as nausea and vomiting, incidence of postpartum hypertension, 
cost-effectiveness  
Strategies or Packages 
B1. Unsafe Abortion.   
Women requiring abortion 
Safe surgical procedures to 
complete abortion 
Efficacy of procedure, 
procedure duration, EBL, 
analgesia, MMR 
Kestler, 2002 (38)(South Africa , Zimbabwe) RHL Commentary. 25 studies 
identified. 2 studies meeting criteria – most not randomised. Comparing 
safety and efficacy of surgical methods for incomplete abortion 
B2. Inaccessible Health 
Care and Drugs. also see 
D1 Childbearing women  
Health facility strengthening. 
Improved drug provision via 
antenatal care and CHWs. 
Improved community drug 
based provisions via female 
volunteers in villages. 
Financial reimbursement for 
eligible women and health 
care professional. 
MMR, skilled birth 
attendance, 
haemorrhage, sepsis, 
referral of high risk cases, 
number of vouchers 
distributed and used.             
Pagel, 2009 (39) (Malawi, Sub Sahara Africa). Mathematical model applied 
comparing 3 packages: combat key events to maternal mortality and 
effectiveness of drugs within model in 3 packages (i) ensuring health 
facilities supplied with oxytocin and antibiotics (ii) package (i) plus 
misoprostol and antibiotic distribution to CHWs (iii) package (i) plus (ii) plus 
misoprostol and antibiotics and advice via female volunteer outreach 
workers. 
Ir, 2010 (40) (Cambodia) Assessing effectiveness improving access to 
skilled birth attendants for poor women using targeted vouchers and health 
equity funds. 5,611 deliveries, 3 Operational health districts. Qualitative data 
collected through focus groups, discussions, in-depth interviews with key 
informants of users/non users of the scheme quantitative data collected from 
health information system on deliveries, contraception prevalence 
B3. Poor Maternal Health. 
Women of reproductive 
age 
Women’s groups MMR, women 
participating in women’s 
organisations, antenatal 
care, skilled birth 
attendance.  
O’Rouke, 1998 (41) (Bolivia).Before and after intervention initiated. 
Questionnaires. Included 50 communities total population 15,000. Evaluating 
impact of organising women’s groups on PMR. Included interventions 
focused on (i) strengthening women’s organisations, (ii) developing skills in 
problem identification and prioritisation (iii) training community members in 
2
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safe birth techniques 
B4. Poor Quality 
Maternity Care 
also see C2 D1.      
Pregnant women and lay 
health workers 
 
Training of lay health 
workers. Disposable 
delivery kits. Links with 
established health services 
and professionals. SBA. 
Training TBAs 
MMR, place of delivery, 
complications, referral to 
health centres, skilled 
birth attendance, use of 
safe delivery kits, 
antenatal care uptake  
Jokhio, 2005 (42) (Pakistan). Cluster RCT, 7 sub-districts, 3 assigned to 
intervention, 4 to usual care. 10,114 women in intervention, 9443 women in 
control. Assess impact of intervention on PMR/MMR. Intervention is training 
TBAs, issuing disposable delivery kits, linking TBAs with establishes 
services, documenting processes/outcomes. Outreach clinics by obstetric 
teams. 
 
B5. Postpartum 
Haemorrhage 
also see A8 
Pharmacological: 
Misoprostol, Ergometrine, 
Syntometrine,  Carbetocin, 
oxytocin  Surgical: Uterine 
packing, trans-cervical 
catheter, ligation of uterine 
arteries, uterine tamponade  
MMR, EBL, continued 
bleeding and 
unsatisfactory response, 
maternal Hb 
concentration, serious 
maternal morbidity, 
hysterectomy,  need for 
therapeutic uterotonic 
agents, risk of adverse 
effects such as nausea 
and vomiting, incidence of 
postpartum hypertension, 
cost-effectiveness 
Mousa, 2007 (43) (South Africa) Cochrane review. 3 studies, 462 
participants, 2 RCT compared misoprostol with placebo. Assess 
efficacy/safety of pharmacological, surgical/radiological interventions used 
for treatment of PPH 
Su, 2012 (37)11 studies (2635 women) Carbetocin vs. oxytocin. Outcomes 
were blood loss, need for therapeutic uterotonic agents, risk of adverse 
effects such as nausea and vomiting, incidence of postpartum hypertension, 
cost-effectiveness 
B6. Unsafe Birthing 
Practices. also see C1. 
Pregnant women of 
varying educational and  
economic status 
Antenatal care Skilled birth attendance 
incidence, uptake 
antenatal care 
 
WHO, 2005 (12) (India) WHO report. Household surveys, 
demographic/health surveys, Survey & interviews using Delphi method 
Socio-demographic data collected. Skilled attendant at birth estimates.  
Bloom, 1999 (44) Cohort study. Association between antenatal care/safe 
delivery; care utilisation & visit frequency 
Behavioural or Educational Interventions 
C1. Unsafe Birthing 
Practices. also see B6. 
Pregnant Women, 
Members of Community, 
TBA 
Training TBA. Encouraging 
links with health care 
facilities. Education, 
information on safe 
childbirth. Focus group 
discussions. 
 
 
 
Referral to health centres, 
complications (sepsis, 
haemorrhage, prolonged 
labour), antenatal care, 
iron supplementation, 
location birth, skilled birth 
attendance,  hygienic 
practices employed, TBAs 
supporting monitoring 
Smith, 2000 (45) (Ghana) Multi-component design, qualitative & quantitative 
methods, cross sectional surveys, questionnaire, interviews. Random 
sample survey of 1961 clients TBAs. Outcome evaluation TBA Training, 
specifically maternal/neonatal morbidity and mortality. 
Barnett, 2006 (46) (Bangladesh) Retrospective cross sectional survey 
collected data about pregnancy, childbirth, postnatal period via interviews; 
socio-demographic, economic data. 6,875 women interviewed. Examine 
prevalence maternal, newborn care practices among women who gave birth  
Sibley, 2007 (47) Cochrane review.  Training TBAs for improving health 
2
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standards, maternal 
mortality, vitamin A 
supplements, malaria & 
tetanus prophylaxis, 
contraceptive use.  
behaviours and pregnancy outcomes. Assess effects TBA training on health 
behaviours and pregnancy outcomes. Published, unpublished randomised 
control trials. Controlled before/after and interrupted time series studies 
comparing trained/untrained TBAs for women cared for/living in areas served 
by TBAs. Four studies. 2000 TBAs. 27,000 women 
C2. Inadequate 
Knowledge/Training/Skills 
for Health Care 
Professionals 
also see B4 D1 
Health care workers 
Life saving skills training.  
Strengthening links between 
major health care facilities. 
Assessment of training. 
Creating links between  
major health care facilities, 
educating importance 
Perceptions/attitudes to 
healthcare, referrals to 
appropriate health 
services, awareness of 
signs/symptoms of 
pregnancy complication, 
knowledge of cause/ 
treatment, life saving skills 
training, knowledge 
counselling, knowledge 
emergency care, 
knowledge partogram use 
knowledge contraception  
Okafor, 1994 (48)(Nigeria) Report of safe motherhood programme. Focus 
group discussions. Interviews. Examining pregnancy related knowledge, 
attitudes, and practices of community members, and women’s use of 
community maternal health services. 
Ijadunola, 2010 (49)(Nigeria) 152 health workers; doctors, nurses, midwives, 
community health extension workers. Self administered semi structured 
questionnaires. Non participant observation checklist. Assessment of 
knowledge maternity unit operators at primary and secondary levels of care 
about concept of emergency obstetric care and contents of antenatal care  
C3. Poor Nutrition 
also see A6.  
Pregnant women 
Members of the 
community 
Food supplementation. 
Dietary advice. Addressing 
cultural taboos.   Pregnancy 
nutrition education  
MMR with maternal 
anaemia prevalence, 
maternal deaths due to 
anaemia, causes of 
anaemia associated with 
maternal mortality, weight 
improvement, 
improvement in health 
outcome. 
Lindmark, 2003 (50) Dietary interventions assessed for benefit to the infant 
or the mother. Reproductive health library commentary of Cochrane review 
(i) nutritional advice (ii) balanced energy/protein supplementation (iii) high 
protein supplementation (iv) isocaloric protein supplementation (v) energy/ 
protein restriction in overweight or high weight gain women 
C4. High Fertility Rates. 
Women of childbearing 
age. Postnatal women 
Family planning education. 
Education on postponing 
early marriage.  Readily 
available family planning 
Incidence contraceptive 
use, knowledge 
contraception, incidence 
unplanned pregnancies, 
attendance family 
planning clinic, literacy of 
women, access and 
acceptability family 
planning 
Hiller, 2002 (51) (Lebanon, Peru, Nepal) Cochrane review. RCT/quasi-
randomised trials. 5438 women giving birth more than 20 weeks gestation. 
Assess effects of education about contraceptive use to postpartum mothers 
(i) unplanned pregnancy (ii) attendance at family planning clinics (iii) use of 
contraception (iv) knowledge of contraception (v) breast feeding (vi) 
satisfaction with postnatal care. 
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C5. Inappropriate health 
services for service 
users, Village 
development committees 
Women’s group meetings. 
Discussion of problems, 
possible strategies. 
Prioritise strategies. 
Assessment of factors 
relating to performance of 
health services 
MMR, women assessing 
antenatal/ delivery care, 
skilled birth attendance, 
assessment current 
health facilities 
Manandhar, 2004 (52) (Nepal) Cluster RCT. 28,931 births.  
42 village development committees matched pairs. Questionnaires. 
Interviews. Assess effect of participant intervention of women’s groups on 
birth outcome 
Organisational Interventions 
D1. Poor Quality Health 
Care.  Poor delivery of 
care.  
Barriers to accessing 
healthcare 
also see A2 E4 
Childbearing women.  
Service users.    
Service providers.  
Wider community 
Employ effective strategies 
to prioritise maternal health. 
Employ strategies to 
coordinate levels in delivery 
and fragmentation of care. 
Skilled birth attendance 
MMR, utilisation of 
services,  efficacy of 
health care strategies in 
targeting service users, 
deaths due to illegally 
induced abortion, literacy 
rate, skilled birth 
attendance 
Prakash, 1991 (53) (India) Professional opinion of retrospective data 
collected. Incidence deaths linked to direct causes. Incidence preventable 
deaths. Status, strategies for maternal mortality reduction: (i) Prioritise 
maternal, child health services, integrate vertical problems (ii) attention to 
labour/ delivery care (iii) community based delivery huts and maternity 
waiting homes (iv) improve quality of maternal/child health care at rural 
community level (v)improve quality of care at primary health care level (vi) 
include postpartum programme maternal child health, family planning 
services (vii) examine feasibility of blood transfusion network (viii) improve 
transportation (ix) educate girls on heath/sex (x) informally educate masses 
on maternal, child health (xi) focus obstetrics and gynaecology training in 
practical skills management (xii) research reproductive behaviour (xiii) 
ensure women right to safe motherhood. 
D2. Poverty-deficient 
maternal health 
infrastructure budget. 
Healthcare providers. 
Financial personnel in the 
health facility 
Assessment effective 
interventions. Evaluate new 
interventions, technologies 
Improvement in maternal 
health, acceptability and 
cost of interventions to 
reduce MMR, intervention 
success, intervention 
feasibility, near misses of 
interventions or lack of 
resources 
Filippi, 2006 (54): Professional report reviewing progress of MDGs. Broader 
context of maternal mortality, Economic, social vulnerability of pregnant 
women, importance of concomitant strategies. 
D3. Ineffective 
interventions. Ineffective 
addressing of 
interventions. Ineffective 
deployment of 
interventions 
Childbearing women 
Assessment of interventions 
 
 
Interventions success, 
economic viability of 
intervention, correct  
intervention deployment, 
MMR, MMR improvement, 
time of death, timing of 
effective interventions, 
Tsu, 2004 (55): Report from maternal health experts, organisations from 
Bellagio workshop. Evaluation of utilising and developing new and 
underutilised technologies to reduce MMR. Developing a set of priority 
actions for reducing MMR (i) obstacles to the successful use of health 
technologies (ii) accelerating the use of high priority technologies (iii)beyond 
technology (iv)recommendations. 
Ronsmans et al, 2006 (26): Examining maternal mortality: (i) who dies, 
2
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place of deaths, 
correcting placing of 
interventions,  health 
inequalities 
 
comparing women from developed and developing countries (ii) when, at 
what point in pregnancy and childbirth (iii) where, comparing developed and 
developing world (iv) why, causes of death. Literature review on maternal 
death and life time mortality risk comparing women in developed and 
developing countries.   
D4. Isolated healthcare 
facilities. Healthcare 
professionals 
Links with other healthcare 
facilities. Communication 
Improvement in services 
offered 
 
JHPIEGO 2005 (56): Save the Children professional report. WHO evidence 
based. Development of a household to hospital continuum of care – utilising 
the gap tool analysis to bring care closer to mothers and newborns in rural 
communities. Examining different levels of care 
Programmatic and Policy Level Interventions 
E1. Social vulnerability of 
women- breach in 
women’s human rights.  
Women.  
Wider community. 
Government bodies 
 
Verbal autopsy interviews.  
Education. Women’s 
groups. Advocacy. 
Governmental 
accountability. Legal support 
MMR, reporting and 
documentation  accuracy 
of maternal mortality, 
maternal death 
investigation, 
complications, women’s 
health improvement, 
human rights recognition 
Hoj, 1999 (57) (Guinea-Bissau) Structured interviews. Data collected from 
pregnancies - cohort of 100 clusters of 100 women of fertile age over a 6 
year period (15,832). Examined use of verbal autopsy reported in multi-
ethnic population. Interviews with filter questions to close female family 
members who experienced maternal mortality about cause of death, relation 
to childbirth. 
Gruskin, 2008 (58) WHO bulletin. A proposed practical approach to improve 
maternal health using human rights. Development of maternal mortality as 
public health concern including history and connections with human rights 
and MMR 
E2. Early age pregnancy  
Wider community 
Prohibiting early marriage MMR, age at the first 
pregnancy, obstructed 
labour 
World Health Organisation, 2004 (59): Systematic review randomised/non 
randomised control trials. Examines incidence of adolescent pregnancies, 
social background, possible health problems, clinical management. 
Recommendations for practice. 
E3. Female Genital 
Mutilation Wider 
community 
Prohibiting Female 
Gestation Mutilation 
Education 
 
Female Genital Mutilation 
Attitudes.  Female Genital 
Mutilation Incidence.                            
obstructed labour 
Banks, 2006 (60): (Burkina, Faso, Ghana, Kenya, Nigeria, Senegal, Sudan) 
Prospective study 28,393 women attending 28 obstetric units. Follow up 
information gathered until discharge, interviews performed. Comparison of 
female genital mutilation with obstetric outcome, included:  (i) operative 
delivery (ii) episiotomy (iii) perineal damage (iv) birth weight (v) apgar score  
(vi) NMR and MMR (vii) extended hospital stay 
E4. Poor organisation of 
health facilities. Barriers 
to healthcare assess.                
Delays in care. 
Inaccurate/Out dated 
policies.  Lack of policies.   
Interaction between care 
providers and patients.                 
Engage multiple practice 
organisations. 
Communication between 
private/public services and 
Services offered, delivery 
of services, utilisation of 
services, staff recruitment/ 
retention, MMR, changes 
in care delivery, 
improvements in health 
Ronsmans, 1997 (61) (Bangladesh) Analysis of demographic surveillance 
data of MMR. Comparing before and after intervention implementation. Data 
between 1976-1993. Incidence and causes examined related to intervention 
of maternal and child health programme. Comparisons made with trends of 
MMR in presence or absence of project. Services included: Trained TBAs, 
essential obstetric emergency care from government district hospital and 
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Lack of professional 
and/or government 
support. also see D1.  
Healthcare providers.  
Senior healthcare staff.             
Community.  
Governmental bodies 
organisation Implementation 
of guidelines/policies. 
Implementation of support 
mechanisms for staff.  
Employing accountable 
personnel.   interaction 
between care providers and 
patients 
 
outcomes, policy 
changes,  improvement of 
services offered, 
improvement in antenatal 
care 
 
private clinics, tetanus immunisation, contraception access and advice. 
Kidney, 2009 (62) Systematic review of effect of community level 
interventions. 5 cluster RCTs. 8 cohort studies. Review effectiveness of 
community level based interventions to reduce MMR. Community level 
intervention, intervention locally accessed at woman’s home, village, school 
or local clinic to be delivered by any person within the community.  
E5. Poor maternal and 
female health. 
Malnutrition 
also se A7 C3 
Females 
Female nutrition 
programmes.           Health 
education programmes.          
Greater financial input into 
maternal health 
improvements.  Community 
health and nutrition 
programmes. Policies 
prioritising female health 
MMR, health of female 
population, anaemia in 
childbearing women, 
accuracy of cause of 
mortality 
Rush, 2000 (63)  Literature review relating nutritional status to pregnancy 
related deaths in developing countries. Examines maternal mortality links 
with: (i) historical trends (ii) social status (iii) antisepsis (iv) other causes. 
Explores common problems with MMR: (i) underestimation of problem (ii) 
national, social, environmental. Association with anaemia and effects. 
Association with obstructed labour 
2
7
 
 
 
28 
 
Table 3: Interventions reviewed in the thesis 
Question Population Intervention Comparison Outcome 
Community Based Interventions 
Does training and supporting TBAs 
reduce maternal, neonatal and 
perinatal mortality in developing 
countries? 
Pregnant women seeking 
labour care in developing 
countries 
Training, supporting and 
linking TBAs 
Standard care plus 
additional 
enhancements (vary 
between studies) 
Maternal, perinatal and 
neonatal mortality 
Do women’s groups practising 
participatory learning and action 
cycles improve maternal and 
neonatal outcomes in developing 
countries? 
Women of reproductive age 
in developing countries 
Participatory learning 
and action cycles with 
women’s groups 
Standard care plus 
enhancements (vary 
between studies) 
Maternal, neonatal 
mortality and stillbirth 
What are the barriers and 
facilitators of emergency 
transportation for pregnant women 
in developing countries? 
Pregnant women in 
developing countries seeking 
emergency transportation to 
access emergency obstetric 
care 
Emergency transport None Experiences and opinions 
of pregnant women or 
stake holders. Barriers 
and facilitators of 
emergency transport for 
pregnant women. 
Can motivational interviews reduce 
the unmet need for contraception in 
developing countries? 
Women of reproductive age  Motivational interviews Standard care Effective contraceptive 
use, subsequent 
pregnancy or birth  
Task Sharing Interventions 
Are clinical officers as safe and 
effective as medical doctors at 
performing caesarean section? 
Pregnant women in 
developing countries 
requiring caesarean section 
Clinical officers 
performing the 
caesarean section 
Medical doctors 
performing 
caesarean section 
Maternal and neonatal 
mortality, wound infection 
and dehiscence 
Clinical Interventions 
Do prophylactic antibiotics reduce 
infectious morbidity in surgical 
abortion and miscarriage surgery? 
Women having surgical 
abortion and women having 
miscarriage surgery 
Antibiotics Placebo or no drug Infectious morbidity 
Is cell salvage a safe alternative to 
homologous blood transfusion in 
caesarean section 
Women having caesarean 
section and blood transfusion 
Cell salvage homologous blood 
transfusion 
Pre and post operative 
haemoglobin, blood loss, 
use of additional 
homologous blood, length 
of hospital stay, serious 
2
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adverse effects 
Is cell salvage a safe alternative to 
homologous blood transfusion in 
surgery for ruptured ectopic 
pregnancy 
Women having surgery for 
ruptured ectopic pregnancy 
and blood transfusion 
Cell salvage Homologous blood 
transfusion 
Pre and post operative 
haemoglobin, blood loss, 
use of additional 
homologous blood, length 
of hospital stay, serious 
adverse effects 
Is symphysiotomy a safe 
alternative to caesarean section in 
developing countries 
Women with obstructed 
labour in  
Symphysiotomy Caesarean Section Maternal mortality, 
neonatal mortality, pain, 
infection, haemorrhage, 
incontinence, pyrexia 
Can the anti-shock garment, 
improve outcomes for women with 
postpartum haemorrhage in 
developing countries 
Women with post-partum 
haemorrhage  
Anti-shock garment Standard care Blood Loss,  
blood transfusion, 
maternal morbidity and 
mortality 
2
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CHAPTER 2:  METHODS FOR SYSTEMATIC REVIEWS, 
META-ANALYSIS AND META-SYNTHESIS 
 
Systematic reviews are vital in healthcare and clinical practice; they can assist 
clinicians with decision making and guide policy makers. A systematic review is a 
research article that identifies relevant evidence, appraises the quality of the evidence 
and summarises the results of the evidence included to draw conclusions and explore 
new findings using a rigorous, systematic methodology. Systematic reviews provide the 
reader with an up to date, comprehensive, balanced summary of the literature on a 
particular topic. Systematic reviews are preferred to traditional literature reviews as 
they are not biased by the author’s opinion. Systematic reviews are based on balanced 
inferences generated from the evidence collated through the steps that are undertaken 
in the review process. 
 
A systematic review involves five key steps in the identification, appraisal and 
application of the evidence, which consist of the following: 
1. Framing the question 
2. Identifying the relevant literature 
3. Assessing the quality of the literature 
4. Summarising the evidence 
5. Interpreting the findings 
All of these steps will be discussed in the context of this thesis. 
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Step 1: Framing the question 
This is an important part of the review, as consideration of the components within the 
question are required to perfect what is it that the review is aiming to address. Each of 
the subsequent steps in the review will flow more efficiently and effectively if the 
question is framed accurately.  The four components that should be included when 
framing the question are the population, intervention, comparison, outcomes and study 
design. The benefit of the question containing the prescribed components is that this 
structured approach is more clear and explicit than a free form question. The question 
should be formulated prior to the search. It is important to consider how the following 
components may vary among the existing literature (22). 
 
The population that is to be studied is the group of patients or participants with the 
specific health problem or requirement in the healthcare setting, about whom the 
evidence is being sought. In this thesis the population is generally pregnant women or 
women of reproductive age (64) or health care providers (65).  
 
The intervention (or the exposure) that is to be examined is the main action that is 
being considered in the population; in this thesis there are ten interventions that have 
been considered, for example women’s groups practising participatory action and 
learning cycles.  
 
The comparison (if applicable) of the intervention examined; this is often the standard 
care provided which the intervention is compared to; in this thesis an example of this is 
the standard care that women receive, or the standard behaviour in the absence of 
women’s groups practising participatory learning and action cycles.  
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The outcomes that are to be examined are the measures of what the population wishes 
to achieve, such as the changes in health that a woman experiences; in this thesis the 
key clinical outcomes were selected, predominately maternal mortality. In some 
reviews in the thesis where the key clinical outcomes were less apparent, an initial 
scoping search was conducted to examine the reported outcomes. These were 
determined by reviewing the articles obtained, and if outcomes were repeated and 
measured in a similar manner, they were selected as key outcomes for the review and 
used within the review protocol.  
 
The design of the studies that are to be included in the review to answer the question 
posed is an important consideration. An example from this thesis is the randomised 
trials included in the review that examined women’s groups’ practising participatory 
action and learning cycles. In this thesis the highest level of evidence was used in the 
reviews, where possible data from RCTs. In the absence of sufficient data from RCTs, 
data from lower levels was included. For example in the case where RCTs were not 
available, the next level of available evidence was included in the review in the order as 
follows, quasi-randomised studies, non-randomised controlled studies, before and 
after, cohort studies, case-control studies, case series, case reports and expert 
opinions. This hierarchy of evidence was followed to ensure the inclusion of the highest 
level of evidence available within the reviews.  For example there were no randomised 
controlled trials comparing clinical officers and medical doctors performing caesarean 
section, so the highest level of evidence available was used. In this review it was 
comparative cohort studies. Another example of this is demonstrated in the anti-shock 
review. As there was an absence of randomised data and sufficient data from cohort 
studies, all available studies were included (quasi-experimental studies, case series 
case and reports) as there. 
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Step 2: Identifying the relevant literature 
This step is often an iterative process of many stages. The aim is to capture the 
maximum number of relevant studies possible from electronic and manual searches in 
a quantitative systematic review.  Firstly the search terms were defined; this was often 
guided by an initial scoping search to explore the terms used in the current literature. 
Previously conducted systematic reviews were explored for search terms utilised. The 
breadth of search terms used within the reviews differed with each topic. A wide variety 
of search terms were used in some reviews, such as strategies incorporating the 
training and support of traditional birth attendants. In this case numerous search terms 
used were necessary to capture all of the studies that included traditional birth 
attendants, as the name of this cadre varies widely across cultures and countries. 
Some of the reviews used minimal search terms, because there was little diversity in 
the terms used for the intervention being examined, for example symphysiotomy.  
 
The aim in this thesis was always to conduct the most comprehensive search possible, 
and therefore include as many relevant studies as possible. Some reviews did not 
include a pregnancy specific search term (as in the clinical officer systematic review), in 
order to increase the sensitivity of the search, and to ensure all relevant studies were 
identified. By not including a pregnancy related search term, a study would be identified 
even if the title or keywords were not pregnancy related. Pregnancy related data may 
be contained in the main body of the paper and this study may have been missed in 
the search. Most of the reviews however had pregnancy specific search terms, for 
example symphysiotomy, traditional birth attendant, miscarriage and abortion.  
 
The search process differed in the systematic review of qualitative studies, where the 
search terms were selected iteratively through scoping searches. The aim here was to 
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conduct a comprehensive search, and to obtain a purposive sample of studies for 
interpretive explanation (66). 
 
No language restrictions were applied to any of the searches. Articles that were not in 
English were translated into English. 
 
Multiple databases were searched in all reviews in this thesis to ensure all relevant 
studies were obtained. The popular databases that were used for each review were 
decided on by the type of journals that they included. All searches involved the use 
MEDLINE, as this is a generic database containing biomedical literature. However the 
database psycInfo was used in the search of the review on motivational interviews, but 
not the antishock garment. This was because this database contains records of 
literature on psychology and related behavioural and social sciences, thus not relevant 
to interventions such as anti-shock garment. Different databases were used in the 
emergency transport review, compared to the other reviews, as this review included 
only qualitative literature, therefore databases with a qualitative focus, such a 
QUALIDATA were utilised in addition to generic databases such as MEDLINE. 
 
In keeping with good practice the electronic search results were scrutinised by multiple 
reviewers for each of the systematic reviews in this thesis. The titles and abstracts 
were initially reviewed for inclusion by each reviewer against the inclusion and 
exclusion criteria developed when defining the question. Full manuscripts of relevant 
studies were then acquired and scrutinised against the criteria. Final decisions on 
inclusion or exclusion of the articles were made after inspection of these manuscripts 
by the reviewers, with the addition of another reviewer if necessary to resolve any 
disagreement. Reasons for the exclusion of studies were noted on a database by the 
reviewer. All of the reviews apart from the qualitative review included only studies with 
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quantitative data. The qualitative review included studies that contained qualitative data 
alone or both qualitative and quantitative data.  
 
In conjunction to searching databases, reference lists and grey literature were 
searched to increase the scope of the search, and to search for articles that may not 
have been indexed or have been indexed inaccurately. Discussions with experts in the 
field were also undertaken at this stage to explore possible studies that had not yet 
been published. Review of the grey literature and reference lists was more extensive in 
the qualitative review. 
 
Step 3: Assessing the quality of the literature 
This step appraises the aspects of the study design, conduct and analysis. The quality 
of a study can be defined as the degree to which it aims to minimise bias and error.     
Standardised tools have been developed to aid the quality assessment of studies, 
which are reporting checklists or criteria and risk of bias assessment tools. These tools 
can help guide the reviewer with making a judgement on the internal validity of a study, 
thus the degree to which the results of the study are likely to be free of bias. There are 
several key forms of bias that the tools consider; selection bias (whether the study 
participants were randomly allocated, and was the allocation concealed); performance 
bias (was the care for both intervention and control group standardised, and was it 
blinded to the patient and provider); measurement bias (were the outcome assessors 
blinded); attrition bias (was a description of the patient that withdrew provided, was an 
intention to treat analysis conducted).   
 
The tools that have been used in this thesis are ones commonly used in the quality 
assessment of systematic reviews previously by credible groups such as Cochrane 
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(67). The quality assessment tool that were used, were specific for the study design of 
each article. The tools were completed independently by multiple reviewers.  
 
Reporting checklists: Independent assessment of the reporting checklist criteria was 
performed by multiple reviewers in accordance with good practice. The checklist 
specific to the study design of the articles was used. Randomised controlled trials were 
assessed for methodological quality using the CONSORT checklist, with the extension 
statement added to account for the cluster effect if required (68). These studies were 
assessed for randomisation and sequence generation, baseline comparability, blinding, 
appropriate statistical analysis and accounting for cluster effect if necessary. Cohort 
studies were assessed for adequacy of reporting using the STROBE checklist (69). 
The STROBE statement is a checklist of 22 items considered essential for sound 
reporting of observational studies. The items included relate to the article’s title and 
abstract, the introduction, the methods, the results of the study and the   discussion 
section. Other information such as funding is also featured. The checklist differs slightly 
for reporting case-control studies, cohort studies and cross sectional studies. The 
STROBE statement assesses adequacy for reporting on setting, participants, variables, 
bias, quantitative variables, statistical methods and generalisability. Case series were 
assessed using the MINORS checklist (70), this assesses for reliability, consistency 
and validity. The items are scored between 0 and 2 for the adequacy of the reporting, 
with the ideal score being 16. 
  
Risk of bias: There are two risk of bias assessment tools that are designed for 
randomised and non-randomised studies that have been used in this thesis.  RCTs 
were assessed for risk of bias using the Cochrane Collaboration’s tool, which assesses 
the risk of bias through examining the following items: random sequence generation, 
allocation concealment, blinding of participants, personnel, and of the outcome 
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assessment, completeness of outcome data, selective reporting and any other bias 
within the studies. Non-randomised studies were assessed for methodological quality 
using the Newcastle Ottawa Scale (71). The studies were evaluated for 
representativeness of the cohorts, selection of the cohorts, ascertainment of the 
intervention and the outcome, comparability of the cohorts, as well as the length and 
adequacy of follow-up. The risk of bias within a study  was deemed low if a study 
obtained four stars for selection, two stars for comparability and three stars for 
ascertainment of exposure (71). Medium risk of bias was suggested to exist in studies 
with two or three stars for selection, one for comparability and two for exposure. Any 
study scoring one or zero stars for selection, comparability or exposure was classed as 
having high risk of bias. Qualitative studies were assessed using the COREQ 
framework for reporting qualitative research.  This framework aims to assess the 
trustworthiness and transparency of studies within their settings, by focusing on the 
research team and reflexivity, study design, and data analysis and reporting (72). 
 
Step 4: Summarising the evidence 
This step involves collating the findings of the individual studies included in the review. 
It is however more than a summary of the studies included. It involves deeper 
exploration of the pooled evidence in the review to generate a greater level of 
understanding and insight than what was obtained from the primary studies alone in 
both quantitative and qualitative studies. In the reviews in this thesis, the information on 
the characteristics from included studies was extracted by two reviewers 
independently. It was then presented in a table of study characteristics (this is included 
in each review) and contained details on the population that has been studied, the 
interventions and the outcomes, and details on the designs of the studies. Tabulating 
the characteristics of the studies enables the reviewer to identify similarities and 
differences across the studies, thus identify the presence of any clinical heterogeneity. 
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If substantial heterogeneity is not identified from the narrative summary of the studies, 
then it could be decided if a meta-analysis is suitable, however a meta-analysis or 
meta-synthesis is not always deemed appropriate.  Numerical data was also extracted 
by two reviewers and tabulated in each systematic review. 
 
Tabulating and examining the study characteristics was essential for evaluating and 
explaining the presence of heterogeneity in the systematic reviews. In the thesis this 
was particularly useful when examining the differences in effect size between the trials 
included in the women’s groups’ systematic review. From examining the characteristics 
of each study, it was apparent that studies conducted in a rural location with more than 
30% of pregnant women participating in the group had a great effect.  It was also useful 
when trying to understand the presence of statistical heterogeneity. 
 
This thesis examined complex interventions as well as discrete interventions. Complex 
interventions are often associated with greater heterogeneity when compared to 
discrete interventions. They have multiple components that are often highly context 
specific. Complex interventions cannot be treated in the same way as discrete 
interventions when considering heterogeneity, as what is considered as significant 
heterogeneity varies with the complexity of the intervention. Furthermore, what 
constitutes reasonable heterogeneity is always a judgement. This judgement was 
made by multiple reviewers in each of the systematic reviews in this thesis. 
 
Quantitative synthesis of findings 
Determining if a meta-analysis was suitable was an iterative process. The decision to 
pool effect measures was widely discussed within the research team. However the 
general principle was that the level of clinical and statistical heterogeneity was 
considered in depth before the decision of pooling was made. When the value of 
pooling was suspect, disaggregated data were made available in the reviews, so that 
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interpretation could be made without reference to the pooled findings.  If a meta-
analysis was deemed appropriate in cases where substantial heterogeneity was 
present, the relevant model was chosen to account for this. The addition of sub-group 
analysis was used if deemed appropriate. An example of this from the thesis is the 
systematic review on strategies incorporating training and support of traditional birth 
attendants. There was substantial clinical heterogeneity in the interventions of the 
studies, as each contained multiple components that were highly specific to the context 
of the study setting. The random effects model was used in this case to account for the 
variability within the intervention, and the characteristics examined to explain the 
differences and similarities between the interventions. If sufficient numbers of studies 
were included in the systematic reviews, formal exploration of heterogeneity would be 
conducted, in the form of a meta-regression (22) or other methods, however this was 
not possible with any of the reviews due to the limited number of studies included. A 
sub-group analysis was performed to examine the effect in studies that had the 
greatest difference in training and support between the intervention and control group. 
 
Meta-analyses were appropriate to be conducted for the majority of the systematic 
reviews in the thesis. These analyses involved pooling the risk ratios or odds ratios that 
were reported in the primary studies, and using the appropriate model to pool the data. 
In reviews that reported data from both randomised and non-randomised studies, these 
were pooled separately. In the absence of heterogeneity the fixed effects model was 
used. This model was used once in this thesis due to the level of heterogeneity 
involved in many of the reviews.The random effects model was most commonly used in 
this thesis to pool the risk ratios or odds rations from individual studies. The random 
effects model was used to account for the clinical heterogeneity within the studies. The 
fixed effects model was not deemed suitable in most reviews as this model is only 
suitable when there is a single source of variability within the included studies (73).  
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In the meta-analyses of cluster randomised controlled trials, data were pooled 
differently. Data for effect estimates and corresponding 95% confidence interval were 
extracted directly from cluster RCT reports after assuring that the analyses performed 
had taken into account the cluster nature of the trial design. If the intra-cluster 
correlation coefficient was reported this figure was used in the analysis. In the case of a 
trial reporting the effect estimate without accounting for cluster design, the standard 
error of the effect estimate from the analysis without clustering was inflated by 
multiplying by the square root of the estimated cluster effect (73). These effect 
estimates and their 95% CI were then meta-analysed using the generic inverse-
variance method using a random effect model. This type of analysis was used to 
account for the cluster effect within the trials, to allow for the variability of responses in 
the sample, and to detect the true differences between the intervention and control 
arms. Account for the cluster effect allows a comparison within-group variance and 
between-group variance. 
 
Statistical tests were used to measure the heterogeneity of treatment effects using 
forest plots, chi square tests and its magnitude determined by computing I2 statistic. 
The I2 statistic measures the variation between the studies; therefore heterogeneity 
was assessed to be low if the I2 statistic was equal to or less than 25%, moderate if the 
I2 statistic was less than 25% and equal to or less than 50%, and high if the I2 statistic 
was equal to or above 75% (74). 
 
Qualitative synthesis of findings:   
Methods for the synthesis of qualitative literature in the form for a meta-synthesis are 
much less well developed than the synthesis of quantitative data (meta-analysis). The 
findings of qualitative research studies are intended to be applicable to specific setting 
in which it was conducted, thus not generalisable. However when a meta-synthesis is 
conducted in addition to a systematic review, it can offer more insight on a variety of 
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settings, contexts and participants. It can explore concepts not reported in primary 
studies.   
  
Meta-synthesis is based on the qualitative methodology meta-ethnography (75) and 
involves identifying key concepts from studies and translating them into each other 
(76). This process involves recognising key concepts within a single study and 
identifying similar concepts in other studies, even though the expression of the concept 
may be not reported identically. In the meta-synthesis in this thesis, thematic synthesis 
was used for analysis through examination and translation of common elements across 
the studies that explored transport in emergency obstetric care, as this is the 
suggested method of analysis in systematic reviews (77-79).  
 
The first and second stages of the thematic synthesis is to code the text and develop 
descriptive themes (76). This was developed by identifying quotes from respondents 
and relevant texts in all studies. Extracted data were then labelled to develop a code 
(80). Initial codes closely reflected the quotes from the manuscript. Codes were 
continuously refined and altered as more quotes were added. Codes then lead to the 
development of themes and a thematic framework was constructed. In the third stage 
(76) the thematic framework was developed and implored to develop a ‘line of 
argument’, that concepts could be tested against (81). Having applied the thematic 
framework to individual manuscripts, in order to build up a picture of the data as a 
whole and to consider the range of each theme, the data was charted. Charts were 
developed using themes against individual manuscripts. This method sought to 
develop an analytical framework, ensuring that the themes built up were cross-checked 
with other data within and then between studies, so that the validity of emerging 
explanations was tested and improved. The third stage is suggested to be the most 
controversial stage in thematic synthesis as it is subject to the reviewer’s judgments 
and insights (76). Multiple reviewers were involved in this stage to reduce the likelihood 
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of this. Furthermore, the development of themes was presented in a tabulated form, in 
addition to a discussion in the text, to demonstrate how the themes were developed in 
a more transparent manner. 
 
Step 5: Interpreting the findings 
Systematic reviews aim to guide practice and policy, therefore this step is important 
when considering how to translate the findings obtained from the systematic review into 
meaningful conclusions about the question addressed. This step aims to determine the 
strength of the review findings. It involves consideration of the reviews strengths and 
weaknesses. The key points that should be considered are the adequacy of the 
searches, the presence of bias (publication or other), the quality of the studies, and the 
significance of the effects (22).  
 
One of the most relevant points for this thesis is the quality of the included studies. 
Although it is preferable to draw inferences on good quality experimental data, such as 
double blind randomised controlled trials, this is not always available. However, it may 
still be important to assess the body of evidence that is available as this too can guide 
practice, policy and further research funding. The evidence, taking account of the level 
of study design, must be assessed for credibility and trustworthiness. The applicability 
and transferability of clinical practice should also be assessed.  
 
In this step conclusions on sub-groups of the population compared to the total 
population examined can also be drawn. An example of this in this thesis is 
demonstrated in chapter four (women’s groups practicing participatory action and 
learning cycles). Further exploration of a sub group analysis discovered that where 
groups contained more than 30% of pregnant women (per group), living in a rural 
location, and a greater reduction in maternal mortality was seen. 
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There are several factors that need to be taken into consideration with the reviews in 
this thesis. The main factor is the quality of the available studies for the particular 
reviews. Chapter 3 (strategies incorporating the training and support of TBAs) and 
chapter 4 (women’s groups practising participatory action and learning cycles) both 
draw inferences from reviews involving large cluster randomised controlled trials. 
However most of the other reviews contained studies providing much lower levels of 
evidence, thus the inferences drawn from these reviews will be subject to greater bias. 
It is important to take this into consideration when this evidence is used to guide policy 
and practice. 
 
The second significant factor in this thesis is the level heterogeneity in some if the 
reviews. This is particularly applicable to the review on strategies that incorporate 
traditional birth attendants. The interventions varied within the complex package of 
care. However despite the variation, almost all studies suggested a benefit, providing a 
consistent message that regardless of the exact approach to involving TBA’s, 
strategies that incorporate TBA’s were effective. However, such heterogeneity in the 
intervention means it is difficult to provide one clear approach for programme 
development. The specific approach for programmes will need to be considered within 
the local context and constraints.  
 
The third pertinent factor in this thesis is the limited number of events that are 
contained in the outcomes of some of the meta-analyses. In chapter 11 
(symphysiotomy for obstructed labour) the tentative conclusions on outcomes such as 
fistulae, haemorrhage and infection, were based on a limited number of events. With 
small numbers it is difficult to make firm inferences on the likelihood of the outcome 
developing in a larger population, than those included in the review. 
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The fourth important factor considered in this thesis was the origins of the data. Most of 
the reviews contained data from studies originating from developing countries only, but 
some contained data from only developed countries, since this was all that was 
available. In the case where all of the included studies in the review were from 
developed countries, the transferability of the intervention obviously had to be 
considered. An example of this is chapter 10 (cell salvage in caesarean section), where 
due to the complexities and costs associated with the training and resources required 
for this procedure, the applicability of this type of cell salvage in a low resource setting 
would need careful consideration. 
 
The interpretation of the systematic reviews findings have been discussed in each 
chapter. Recommendations for further research and recommendations for policy and 
practice have also been provided. There is however a formal process for grading 
evidence to make recommendations for practice. The GRADE approach classifies 
evidence to the extent to which it can be applied to clinical practice. This classification 
involves consideration of the bias present within the study. The GRADE approach also 
considers the directness of evidence, the variability (heterogeneity) within the evidence, 
the precision of effect estimate, and the risk of biases such as publication bias. The 
GRADE approach allows the recommendation to be downgraded or up graded as a 
result of these criteria.  The GRADE approach was not applied to the interventions 
reviewed in this thesis (82).   
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COMMUNITY BASED 
INTERVENTIONS 
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CHAPTER 3.  EFFECTIVENESS OF STRATEGIES INCORPORATING 
TRAINING AND SUPPORT OF TRADITIONAL BIRTH ATTENDANTS ON 
PERINATAL AND MATERNAL MORTALITY: META-ANALYSIS  
ABSTRACT 
Background: Despite the drive to increase skilled birth attendance in the developing 
world, more than 50% of births are attended by TBAs (TBA). However, there is 
uncertainty about the effectiveness of including TBAs in strategies to improve perinatal 
and maternal health. We have therefore systematically reviewed and meta-analysed 
the effectiveness of strategies incorporating TBAs.  
Methods: A systematic review with meta-analysis was conducted. MEDLINE, 
EMBASE, AMED, BNI, Cochrane library, CINAHL, BIOMED Central, PsycINFO, 
LILACS, African Index Medicus, Web of Science, the Reproductive Health Library, and 
the Science Citation Index (inception-2011) were searched without language 
restriction. Studies of randomised and non-randomised controlled design were 
selected, with the outcomes of perinatal, neonatal and maternal mortality. Studies were 
assessed for risk of bias and adequacy of reporting.  Relative risks (RR) from the 
individual studies were pooled separately for the randomised and non-randomised 
controlled studies, using random effects model. 
Results: Six cluster RCTs (n=138,549), and seven non-randomised controlled studies 
(n=72 225) were identified.  All six randomised trials found a reduction in adverse 
perinatal outcomes; meta-analysis of the randomised trials showed significant 
reductions in perinatal death (RR 0.76, 95% CI 0.64, 0.88; p<0.001) and neonatal 
death (RR 0.79, 95% CI 0.69, 0.88; p<0.001) with strategies incorporating TBAs. The 
findings of the non-randomised studies were consistent with the above findings. Six 
studies reported on maternal mortality, and five found no significant difference with 
strategies incorporating TBAs; meta-analysis of three cluster randomised trials found a 
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relative risk of 0.79 (95% CI 0.53, 1.05; p 0.12) and three non-randomised studies a 
relative risk of 0·80 (95% CI 0.44, 1.15; p 0.26) for maternal mortality. 
Conclusion: Perinatal and neonatal deaths are significantly reduced with strategies 
incorporating TBAs. 
 
Impact of review: Publication in BMJ, presentation at international conference (FIGO) 
 
Citation of published work on which this chapter is based 
Amie Wilson, Ioannis D Gallos, Nieves Plana, David Lissauer, Khalid S Khan, Javier 
Zamora, Christine MacArthur, Arri Coomarasamy. Effectiveness of strategies 
incorporating training and support of traditional birth attendants on perinatal and 
maternal mortality: meta-analysis. BMJ 2011;343:d7102 
 
3.1 BACKGROUND 
It is estimated that around 60 million births occur outside healthcare facilities in 
developing countries (83), with 52 million births occurring without the assistance of a 
Skilled Birth Attendant (SBA)(83). According to the WHO, an SBA is an accredited 
health professional (midwife, doctor or nurse), which has been educated and trained in 
the skills needed to competently manage uncomplicated pregnancies, childbirth and 
the immediate postnatal period. An SBA is also trained to identify, manage and refer 
women and newborns if complications arise.  
 
Many interventions have been implemented with the aim of reducing perinatal and 
maternal mortality, yet these have often focused on skilled birth attendants, or been 
targeted at health facilities. However, there is a global deficit of skilled birth attendants, 
particularly within developing countries (21), so many women do not receive skilled 
birth attendance. Furthermore, there are also limited healthcare resources in the 
 
 
48 
 
majority of many developing countries, so the ideal prospect of all births taking place 
within a health facility, with skilled birth attendance, is yet to materialise.  
 
At present it is estimated that more than 50% of births within developing countries are 
attended by TBAs (TBA), with incidence being as high as 90% in some countries (2). A 
TBA is a person who assists the mother during childbirth; their roles vary accordingly to 
local customs, interests, and expertise. The tasks TBAs conduct range from provision 
of intrapartum and postnatal care, to domestic chores. TBAs acquire their skills by 
delivering many babies or through an apprenticeship with other TBAs. In many regions 
they are known and respected for their knowledge and experience, they are not usually 
salaried, but paid in-kind. 
 
There are many reasons for women not having an institutional birth with skilled birth 
attendance. Women give birth outside of health facilities with the help of a TBA for 
financial reasons because they are unable to afford the care, or the transport to access 
the care; for geographical reasons, because the health centre maybe difficult to reach, 
or too great a distance to travel. Instead many women utilise the services of TBAs for a 
more accessible, more culturally sensitive approach. 
 
TBAs were previously supported, and training programmes began over 60 years ago in 
regions where maternal mortality rates were high. In 1994 it was estimated that over 
85% of developing countries had some form of TBA training (84). However support for 
training TBAs diminished due to the lack of evidence of effect on perinatal and 
maternal health. In 2009 a Cochrane review described the potential of TBA training in 
reducing perinatal and maternal mortality as ‘promising’ (47), yet the analysis contained 
only a single cluster randomised trial, as no further randomised trials had been 
conducted at this time.  
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In response to the International Safe Motherhood Initiative, TBA training was adopted 
as part of the maternal health policy in many developing countries in the 1970s and 
1980s (85). However, it is suggested within the literature that traditional birth attendants 
should have never been expected to reduce maternal and perinatal deaths directly, for 
example in cases of obstetric emergency. Yet they could be utilised in weak health 
systems, often where literacy levels among women are low, and have insufficient 
schooling to be trained as midwives, to prevent complications through using safe birth 
kits, and preventing sepsis, and referring women to a higher level of care when 
complications arise (86, 87). However, it was not only due to lack of evidence on the 
effect on traditional birth attendant training as to why the support for training traditional 
birth attendants was withdrawn in the late 1990’s, it was also due to an ongoing debate 
of cost effectiveness of this cadre, and whether resources could be utilised with in a 
more effective manner elsewhere (88-93). It was suggested that training TBAs would 
have limited benefit as they often worked in poor resource settings, where availability 
and access to quality obstetric services was restricted (47, 88). Therefore with a lack of 
systematic evaluation and rigours cost effectiveness analysis, cumulatively these 
factors contributed to the removal of TBA training from the safe motherhood project.  
 
Given the uncertainty about the effectiveness of TBAs on perinatal and maternal 
outcomes, we have systematically reviewed and meta-analysed the effectiveness of 
strategies incorporating TBAs. 
 
3.2 METHODS 
Data sources and searches 
The databases that were searched were MEDLINE, EMBASE, AMED, BNI, Cochrane 
library, CINAHL, BIOMED Central, PsycINFO, LILACS, African Index Medicus, Web of 
Science, the Reproductive Health Library, and the Science Citation Index (from 
database inception to April 2011). Databases were searched for literature evaluating 
 
 
50 
 
strategies that incorporated TBAs in developing countries. Electronic searches were 
complimented with hand searching, and reference lists were checked. The search 
terms that were used were ‘Birth attend*’, ‘traditional midwife’,’ lay birth attendant’, as 
well as ‘Dais’ and ‘Comadronas’.  No language restrictions were applied to the search. 
 
Study selection and data extraction 
RCTs and non-randomised controlled studies were selected.  Primarily the electronic 
searches were scrutinised and full manuscripts of relevant studies were acquired. Final 
decisions on inclusion or exclusion of manuscripts were made after inspection of these 
manuscripts by the author and another reviewer (AW and AC). Information was 
extracted from each article independently on study characteristics, quality and outcome 
data by the author and multiple reviewers (AW, CM, IG, NP, JZ).  The outcomes 
deemed most clinically relevant were focussed on, the objective outcomes of perinatal, 
neonatal and maternal mortality. Morbidity outcomes such as postpartum 
haemorrhage, obstructed labour and neonatal apnoea were not extracted, as they were 
subjectively assessed, in a non-standardised manner, between the two study groups. 
For example post-partum haemorrhage was described as “bleeding”(94) 
”haemorrhage”(42) “heavy bleeding”(95) “significant bleeding that soaked more than 
two kangas”(96), and was assessed by TBAs, SBAs or by women themselves. The 
outcomes that were selected were the key clinical outcomes. These were decided by 
reviewing the articles obtained from an initial scoping search. This was used to 
examine the reported outcomes. If outcomes were repeated and measured in the same 
manner, they were selected as key outcomes for the review and used within the review 
protocol. The systematic search for the review was then conducted. The outcomes in 
the individual studies were then synthesised from the included studies. 
 
 
 
 
 
51 
 
Methodological quality assessment 
The cluster randomised studies were assessed for methodological quality using the 
CONSORT statement extension (68), to accommodate for the cluster effect within the 
data. These studies were assessed for randomisation and sequence generation, 
baseline comparability, accounting for cluster effect, blinding and appropriate statistical 
analysis. Risk of bias was assessed using the Cochrane collaboration’s tool, which 
assesses the risk of bias through examining  the following items, random sequence 
generation, allocation concealment, blinding of participants, personnel, and of the 
outcome assessment, completeness of outcome data, selective reporting and any 
other bias within the studies.  
 
The non-randomised studies were assessed for methodological quality using the 
Newcastle Ottawa Scale(71). The studies were evaluated for representativeness of the 
cohorts, selection of the cohorts, ascertainment of the intervention and the outcome, 
comparability of the cohorts, as well as the length and adequacy of follow-up. The risk 
of bias within a study  was deemed low if a study obtained four stars for selection, two 
stars for comparability and three stars for ascertainment of exposure (71). Medium risk 
of bias was suggested to exist in studies with two or three stars for selection, one for 
comparability and two for exposure. Any study scoring one or zero stars for selection, 
comparability or exposure was classed as having high risk of bias.  
 
Statistical Analysis 
The data from randomised and non-randomised studies were pooled separately to 
reduce methodological heterogeneity. Non-randomised studies were included to 
examine the overall effect of strategies incorporating training and support of TBAs on 
perinatal and maternal outcomes, to see if there was any difference between the 
randomised and non randomised data. Data for effect estimates (Risk Ratios) and 
corresponding 95% confidence interval were extracted directly from cluster RCT 
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reports after assuring that the analyses performed had taken into account the cluster 
nature of the trial design. If the intra-cluster correlation coefficient was reported this 
figure was used in the analysis. In the case of a trial reporting the effect estimate 
without accounting for cluster design, the standard error of the effect estimate from the 
analysis without clustering was inflated by multiplying by the square root of the 
estimated cluster effect. These effect estimates and their 95% CI were then meta-
analysed using the generic inverse-variance method using a random effect model. This 
type of analysis was used to account for the cluster effect within the trials, to allow for 
the variability of responses in the sample, and to detect the true differences between 
the intervention and control arms. Accounting for the cluster effect allows a comparison 
within-group variance and between-group variance. Heterogeneity of treatment effects 
was evaluated using forest plots, chi square tests and its magnitude determined by 
computing I2 statistic. The I2 statistic measures the variation between the studies, 
therefore heterogeneity was assessed to be low if the I2 statistic was equal to or less 
than 25%, moderate if the I2 statistic was less than 25% and equal to or less than 50%, 
and high if the I2 statistic was equal to or above 75%.(74) Analyses were performed 
using STATA 11.0 statistical software.  
 
3.3 RESULTS 
The process of literature search conducted, and the study selection process is given in 
Figure 9. Six cluster RCTs, with a total of 138,549 participants, were included in the 
review. Seven non-randomised controlled studies, with a total of 72,225 participants, 
were also identified. The characteristics of the included studies are shown in Table 4, 
and the details of the care package in the intervention and control clusters are reported 
in greater detail in Table 5.  
 
Study Characteristics 
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All six cluster RCTs included women of child bearing age, one trial by Jokhio et al 
included pregnant women specifically (42), whereas all of the other trials included 
newly delivered mothers. All trials included women from rural regions: Jokhio et al 
excluded city residents where healthcare access was better (42), Azad et al excluded 
temporary residents (97) and Carlo et al trials excluded infants and still births with a 
birth weight under 1500kg (98) and Jokhio et al excluded maternal deaths due to injury 
or accident (42). All of the trials included women from communities with poor health 
systems with a high proportion of home births. In the trials that reported the age of the 
women, the mean age was 26.7 and 26.6 years old in Jokhio et al (42), and 25.3 years 
old in Gill et al (99), with the majority of women aged between 20-19 years in Azad et 
all (97). The majority of women in the trials by Jokhio et al, Azad et al, Gill et al and 
Bhutta et al had limited or no education (42, 97, 99, 100).  
 
All of the included trials examined the effect of TBAs on perinatal and maternal 
mortality; however the TBAs encompassed a variety roles, and were incorporated 
within wider interventional strategies with a multitude of components (e.g. neonatal 
resuscitation, umbilical cord care). For example, the trials by Jokhio et al and Carlo et 
al incorporated a three days training course for TBAs in the intervention arm, in which 
they were trained in neonatal resuscitation (42, 98) and clean delivery techniques (42). 
Other trials did not report the length of the training, but reported that the training 
consisted of similar components, such as neonatal resuscitation (97, 99, 100), 
recognising danger signs in mothers and babies (97, 99, 101), and clean delivery (97, 
101).  The trials by Jokhio et al and Midhet et al did not provide any TBA training in the 
control arm (42, 101), but trials by Azad et al, Carlo et al, Gill et al and Bhutta et al 
included minimal TBA training in the control arm (97-100). In all of the included trials 
TBAs in the intervention arm were supported by staff; however the type of support staff 
varied in the trials. In the trials by Jokhio et al and Bhutta et al TBAs were supported by 
lady health workers (42, 100), in the other trials they were supported by female peer 
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facilitators (97, 101), health management staff (99) and community leaders (98). Clean 
delivery kits were supplied to both arms in all trials except in the trial by Jokhio et al, 
where clean birth kits were only supplied in the intervention arm (42). 
 
Study quality 
The six cluster randomised trials were assessed using the consort extension 
statement, and the majority of trials adequately reported on the appropriateness of 
randomisation, cluster comparability, accounting for the cluster effect within the data, 
and that no clusters were lost to follow up (Table 6). The cluster randomised trials 
when assessed using the Cochrane collaboration tool (102) were found to have low 
risk of bias in random sequence generation, allocation concealment, incomplete 
outcome data, selective reporting and other bias in most studies. There was high risk of 
bias in blinding of participants and personnel and blinding of outcome assessment in 
most studies (Table 7) The seven non-randomised studies were assessed to have low 
to medium risk of bias for selection, low risk of bias for comparability and low risk of 
bias for outcome assessment on the Newcastle Ottawa scale (Table 7)(71).  
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Figure 9 Flowchart of study selection in strategies incorporating TBAs for maternal and perinatal health outcomes 
5
5 
 
 
 
56 
 
Table 4 study characteristics of included studies in strategies incorporating TBAs for maternal and perinatal health outcomes 
 
Study population &method of allocation Intervention (n= number of 
clusters) 
Control(n= number of 
clusters) 
Outcome 
Cluster RCTs (3) Mean age 26.7 years, 
mean parity 3.5, mean 
years education 1.1. Mean 
distance 2.7 km from health 
centres.  
(4) Mean age 26.6 years, 
mean parity 3.7, mean 
years education 1.4, 2.5 
km mean distance from 
health centres. 
PMR, 
NMR, 
MMR 
Jokhio: 2005 (42) 
19,557 pregnant women in rural Pakistan: Excluded: City residents, multiple pregnancies 
excluded from perinatal outcome. Maternal deaths due to injury or accident. Cluster 
randomisation, computer generated. 
Carlo: 2010 (98) (43) characteristics not 
provided. 83.5% of 
neonates weighed at birth 
>2500g, 5% suffered birth 
apnoea.  
(45) characteristics not 
provided.  85.2% of 
neonates weighed at birth 
>2500g, 5.2% suffered 
apnoea at birth.  
PMR & 
NMR 63,324 mothers, 63,729 infants > 28 weeks of gestation delivered in rural sites, Congo, 
Guatemala, India, Pakistan, Zambia. Excluded: infants & stillbirths with birth weight <1500 
grams. Poor health systems & high rate of home births assisted by TBAs. Birth attendants 
in birth clusters randomly assigned to neonatal resuscitation program. 
Azad:2010 (97) (9) 65% 20-29 years, 50% 
no education.  
(9) 60% 20-29 years, 48% 
no education.  
NMR 
25,714 home births of women aged 15-49 in rural districts Bangladesh. Excluded: 
Temporary residents. Each district constituted a stratum & each union a cluster. 18 unions 
selected. Unions randomly allocated to either intervention or control groups via names 
written on pieces of paper, folded & placed in a bottle. The randomised clusters were then 
further randomly assigned by same method to TBA  intervention or control clusters  
Midhet: 2010 (101)  (8)(8 couples clusters 
excluded in analysis to 
avoid heterogeneity).  
Socioeconomic & 
demographic 
characteristics similar age, 
parity & education, higher 
proportion with electricity & 
telephone.  
(16) socioeconomic 
&demographic 
characteristics similar 
age, parity & education 
(couples could not be 
removed from control arm 
in analysis). 
PMR, 
NMR  2,561 women in 32 village clusters in Khuzar rural district in Pakistan. Each cluster 
contained 5-15 villages with an average population of 2000, all within 80mk from a central 
town where a district hospital was located (8 clusters containing couples excluded in our 
analysis to reduce heterogeneity within the intervention arm). Randomisation separately 
within each of 3 zones, equal number of village clusters randomly allocated to intervention 
or control sites. 
Bhutta: 2011 (100) (8) 83% illiterate. Lady 
Health Worker programme 
is National program 
introduced 1994 to 
strengthen primary care & 
preventative services 
(8) clusters. 80% illiterate. 
Lady Health Worker 
programme is National 
program introduced 1994 
to strengthen primary care 
& preventative services.  
MMR, 
NMR, 
PMR 
23,834 births Hala & Matiari subdistricts, Pakistan 16 clusters  23,834 births. Restricted, 
stratified randomisation. 3 strata on basis of size & number of LHW per 1000 population, 
126 random allocations resulted in similar population sizes in two groups, similar numbers 
of live birth and NMRs, similar ratios of LHW to population, similar proportions of women 
delivering in hospital. From list of balanced allocations, one scheme selected using random 
5
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number.   (including family planning).  
Gill: 2011 (99) (60) Mean age 25.3. 68.9% 
some primary education, 
89% married.  
(67) Mean age 25.3. 
69.3% some primary 
education, 90.1% married.  
MMR, 
NMR, 
PMR 
3559 newborns, mothers attended by 127 TBAs in Zambia. Randomisation by compiling 
120 allocation slips, 60 control & 60 intervention, selected by participants.  
Non- Randomised Controlled Studies 
Janowitz:1988 (103) 69.2% aged 20-34, 49.6% 
parity 1-4, 54% 1-3 years of 
education.  
61.9% aged 20-34, 50.0% 
parity 1-4, 54.2% 1-3 
years education.  
PMR 
1160 Women delivered in Brazil. Included deliveries by TBAs, family or neighbours, & 
deliveries that took place in hospital 
Greenwood: 1990 (104) Other changes in study area were increase in town size, 
transport networks improved, increased number of taxis 
& frequency of buses. New health centre opened 1983, 
staffed with 2-4 doctors, increased visits to local 
dispensaries. No blood transfusion or major surgery 
services.  
MMR, 
PMR, 
NMR  
2738 women aged 15-44 in 41 villages & hamlets in Gambia. Villages selected if population 
>400. Villages where primary health care programme was not introduced were control 
group. Participants were women who resided within villages that were selected. 
Alisjahbana: 1995 (94) 27.1% aged <20 or >35. 
83.4% mothers <6 years 
education. 6.5% had > 5 
children.  
26.8% aged <20 or >35. 
11.7% had > 5 children. 
82.9% mothers < 6 years 
education. 
PMR 
3275 pregnant women in West Java, intervening distance 60km to reduce possible 
contamination.  Data collected on women who were pregnant, parturient or postpartum 
during 12 month period 
Ronsmans: 1997 (61) Main income sources are rice growing or fishing. Low 
literacy rates. Geographical ease to access services 
varies across area: Access most difficult in north of 
control area (>4hrs travel). Access most simple in south 
of control area (<2hrs) Extensive services in health & 
family planning since 1977 with government TBA 
training  
MMR, 
PMR, 
NMR 
24,059 births of pregnant women in Bangladesh. Intervention area had received extensive 
family planning & health services previously), comparison area received no intensive health 
inputs.   
Bang 1999 (92) 37.9% female literacy rate, 
35.6% lowest caste.  
33.0% female literacy 
rate, 41.2% lowest caste.  
NMR, 
PMR 2264 births in 86/100 villages in India. 14 villages excluded due to small population size and 
lack of suitable female worker to assist with study. 100 villages, births & child deaths 
recorded in 39/53 villages in intervention area (14 villages not included due to population 
size of <300, or inability to identify a suitable woman to be trained), 47 villages in control. 
Gloyd: 2001 (105) Mean age 26.6 yrs.  
32% completed 4
th
 grade 
education.  
Mean age 27.3.  
31% of women completed 
4
th
 grade education.  
NMR 
4169 Pregnant women, 3616 completed pregnancies from 65 rural zones of Mozambique 
(612 women who delivered at health post by midwife were excluded from our analysis to 
reduce heterogeneity). 40 rural zones where trained TBAs resided, 25 zones were randomly 
selected proportional to population size from census estimates. further comparison group 
comprised of 9 villages/ town in study area served by health facilities with trained 
5
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nurses/midwives 
Bhutta: 2008 (106) (4) No information on age, 
education or parity.  
86.3% home owners, 
86.7% electricity, 56.9% 
functioning dry toilet, 66.6% 
water pump in village.  
(4) No information on age, 
education or parity.  
79.2% home owners, 
69.5% electricity, 67.5% 
functioning dry toilet,  
55.9% water pump in 
village.  
MMR, 
NMR, 
PMR 
34,560 women of reproductive age, 5,134 birth from subdistricts in Pakistan. 24 village 
clusters identified, each cluster contained basic health centre. 8 clusters randomly selected 
for pilot 
  
5
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Table 5 Details of Intervention 
Component Intervention  
Control 
Jokhio: 2005 (42) 
TBA strategy 3 day training course by obstetricians and paramedics.  Involved picture cards containing advice on 
antenatal, intra-partum & postpartum care, clean delivery, care of newborn including basis 
resuscitation. TBAs visit each woman >3 times in pregnancy (3/6/9mths) to check danger signs. 
Register all pregnant women.  
None specified 
Support 
workers 
LHW trained to support TBAs & record data. Obstetric teams offered outreach clinics. LHW followed 
all pregnant women in catchment area with normal monthly visits to women & children 
LHW followed up all pregnant women in catchment area by 
normal monthly visits to women & children. No outreach 
clinics. 
Resource 
support 
Disposable delivery kit: sterilised disposable gloves, soap, gauze, cotton balls, antiseptic solution, 
umbilical cord clamp, surgical blade. 
No delivery kits. 
Referral 
support 
Trained to refer a woman for emergency obstetric care & recognition of danger signs. Links with 
primary care facilities. Improved contact with LHW &primary care centres 
No links facilitated. 
Carlo: 2010 (98) 
TBA strategy 3 day course, included routine neonatal care, initiation of breathing & resuscitation (bag and-mask 
ventilation), thermoregulation, breast-feeding, kangaroo (skin-to-skin) care, care of small babies, 
recognition of danger signs & initial management of complications. Modified for illiterate participants. 
Also received neonatal resuscitation program, 3-day course, refresher course given 6 months. 
Hands-on training in basic knowledge & skills of resuscitation, resuscitation & bag-and-mask 
ventilation, not chest compressions, endotracheal intubation, administration of medications 
3 day course, included routine neonatal care, initiation of 
breathing &resuscitation (bag and-mask ventilation), 
thermoregulation, breast-feeding, kangaroo (skin-to-skin) 
care, care of small babies, recognition of danger signs & 
initial management of complications. Course modified for 
illiterate participants.  
Support 
workers 
Government officials & community leaders facilitated training & collection of data. Government officials & community leaders facilitated training 
& collection of data 
Resource 
support 
Ventilation bags & masks, spring scales, &clean delivery kits were distributed after training Ventilation bags & masks, spring scales, clean delivery kits 
distributed after training 
Referral 
support 
No information is provided No information is provided. 
Azad:2010 (97) 
TBA strategy Basic training in undertaking clean & safe deliveries, recognising danger signs in mothers & infants, 
making emergency preparations, mouth to mouth resuscitation.  Additional training in neonatal 
resuscitation with bag & mask valve. 
Basic training in clean & safe deliveries, recognising danger 
signs in mothers & infants, making emergency preparations 
& mouth to mouth resuscitation.  No additional training in 
neonatal resuscitation with bag & mask valve.  
Support 
workers 
Female peer facilitator to act as a catalyst for community mobilisation in random half of clusters Female peer facilitator to act as a catalyst for community 
mobilisation in random half of clusters  
Resource 
support 
Safe delivery kits & information on efficient use of available resources were provided Safe delivery kits, information on efficient use of available 
resources were provided 
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Referral 
support. 
Received health services strengthening. Referral support Improving referral systems & links 
between the community & health service & between different levels of health service. TBAs 
accompany women to facilities. 
Received health services strengthening. Improving referral 
systems & links between the community & health service & 
different levels of health service. TBAs accompany women to 
facilities. 
Midhet: 2010 (101) 
TBA strategy Trained in clean delivery, recognising common obstetric & neonatal emergencies. TBAs introduced 
to medical staff 
None specified 
Support 
workers 
Support workers leading support groups for women on family planning, nutrition, danger signs in 
pregnancy & labour. Six sessions. Facilitators encouraged to hold sessions in villages not directly 
trained by project staff. Advance training given to obstetricians, paediatricians & anaesthetists in 
district hospital. Training for health care providers in primary healthcare settings on clinical skills for 
neonatal & obstetric care 
Training health care providers in primary healthcare settings 
on clinical skills for neonatal & obstetric care 
Resource 
support 
Pictorial booklets, audio cassettes None specified 
Referral 
support 
Facilitated timely referral, transportation of obstetric & newborn emergencies to district hospital, 
Local transport owners & public transport drivers trained in stretcher use, orientation to hospital, 
introducing doctors & medical staff. Wireless telecommunication used. TBAs & drivers linked with 
healthcare facilities 
None specified 
Bhutta: 2011 (100) 
TBA strategy Lady health worker programme continued to function as usual included regular refresher training 
according to standard national lady health worker programme curriculum & monthly debriefing 
sessions in public sector health facilities. Extra 6 days to lady health worker training. Encouraged 
LHW to identify pregnant women, provide basic antenatal care, work with TBAs. LHW trained in 
mouth-to-mouth resuscitation. LHW encouraged to visit mothers in pregnancy & after birth. 
Additional visits encouraged after birth.  LHW performed group education sessions. 3 day training 
programme for TBAs in basic newborn care including basic resuscitation. Attendance voluntary, 
TBAs informed about training sessions through LHW & community health committees encouraged to 
attend lady health worker. Led community education sessions. 
Lady health worker programme continued to function as 
usual included regular refresher training according to 
standard national LHW programme curriculum & monthly 
debriefing sessions in public sector health facilities. Basic 
training on promotion of antenatal care, iron folate use in 
pregnancy, immediate newborn care, cord care, 
breastfeeding. No extra training sessions  
Support 
workers 
Promotion of liaison & linkage between TBA with LHW. Each provides antenatal care, contraceptive 
advice, growth monitoring, &immunisation. Village health committees linked with LHW &TBAs 
No attempt made to link TBAs with lady health worker or 
communities or change usual lady health worker activity 
Resource 
support 
Clean delivery kits provided to LHW, no resuscitation equipment or injectable antibiotics provided Clean delivery kits provided to LHW. No resuscitation 
equipment or injectable antibiotics provided 
Referral 
support 
Emergency transport fund, use of vehicles using local resources Emphasis on recognition &referral 
rather than home-based management.  Links facilitated with community health committees to 
promote maternal &newborn care 
Emphasis on recognition & referral rather than home-based 
management. 
Gill: 2011 (99) 
TBA strategy Training received in basic obstetric & newborn care (including mouth to mouth assisted breathing). 
Training on record keeping & importance of regular contact with mother & infant post delivery. 
Training workshop, modified from neonatal resuscitation protocol. Various techniques used to teach 
Training received in basic obstetric & newborn care 
(including mouth to mouth assisted breathing). Training given 
on record keeping, importance of regular contact with mother 
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required skills, drying & warming baby, ensuring clear open airways & evaluating respiration on 
manikins. TBAs trained to recognise signs & symptoms of possible sepsis. Drugs &chest 
compressions not taught. Assessment took place following the course. TBAs took part in refresher 
courses.  
& infant post delivery. TBAs took part in refresher courses 
Support 
workers 
Lufwanyama district health management team Lufwanyama district health management team 
Resource 
support 
Clean delivery kits for each birth. single dose of amoxicillin. intervention supplied with resuscitator 
mask, bottle with chlorinated water, absorbent blankets, soft rubber bulb syringe, equipment to 
administer antibiotics to infant. Received reference cards summarising neonatal resuscitation 
protocol, trigger conditions for antibiotics with facilitated referral. 
Clean delivery kits for each birth 
Referral 
support 
Refer all high risk pregnancies for delivery at health centres. Formal link with health sector 
maintained & facilitated referral of infants to health centre. 
Required to refer all high risk pregnancies for delivery at 
health centres. Formal link with health sector maintained. 
Non- Randomised Controlled Studies 
Janowitz:1988 (103) 
TBA strategy TBAs with 5 meetings & practical experience at mini-maternity unit. training orientation & supervision 
in prenatal care identification of high-risk pregnancies, assistance in normal deliveries postpartum 
care, identification of complications & hospital referrals 
No TBA training 
Support 
workers 
None specified None specified 
Resource 
support 
Health program including setting up of mini-maternity units  No health program set up 
Referral 
support 
None specified None specified 
Greenwood: 1990 (104) 
TBA strategy Instructed to administer malaria prophylaxis. Selected women received 10 week training course & 
support & supervision from government employed community health nurses. 
None specified 
Support 
workers 
Village health workers selected to be trained No added support although have access to health centres & 
hospitals, subject to constraints of transport 
Resource 
support 
Obstetric pack containing clean dressings, scissors, string, oral ergometrine, disinfectant, colour 
coded spring balance for weighing newborn babies.  Given chemoprophylaxis 
None specified 
Referral 
support 
No added support although have access to health centres & hospitals, subject to constraints of 
transport 
None specified 
Alisjahbana: 1995 (94) 
TBA strategy 8 month of preparation & training to improve knowledge, skills & practices of TBAs & health 
personnel in facilities for preparing birthing homes. Trained in detection of pregnancy complications 
& making referrals. 
None specified 
Support 
workers 
None specified None specified 
Resource 
support 
None specified. Area without maternal &neonatal health program. 
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Referral 
support  
None specified None specified 
Ronsmans: 1997 (61) 
TBA strategy government training of TBAs No TBA training 
Support 
workers 
None specified None specified 
resource 
support  
Extensive services in health & family planning since 1977 No such services 
Referral 
support  
None specified None specified 
Bang 1999 (92) 
TBA strategy Trained & supported TBAs in distribution of iron & calcium, clean delivery, treat reproductive tract 
infections. 
Not given in control area. 
Support 
workers 
Trained & supported male & female village health workers trained in neonatal care &illness, 
managing birth asphyxia, premature birth, low birth weight, hypothermia & breast feeding problems. 
Diagnosed & treated neonatal sepsis. Case management of children with pneumonia & neonatal 
sepsis  
Management of pneumonia in children not given by study 
health workers in control area, done by government health 
services 
Resource 
support 
Distribute iron & calcium tablets & treatment for reproductive tract infections. Reproductive health 
education program for adolescents, management by village health workers for minor health 
problems such as malaria, scabies. Prenatal care at referral clinic. Village health worker provided 
with neonatal care kit containing, flip chart for health education, nail brush, torch, wristwatch, mucus 
sucker, tube & mask for resuscitation, spring balance for weighing, thermometer, photo album with 
reference points, baby clothes & head cover, blanket, sleeping bag, breast pump for inverted 
nipples, spoon, record & files, soap, cotton, spirit, sodium hypochlorite solution, gentian violet, 
disposable syringes & needles, gentamicin vials, co-trimoxazole syrup, paracetamol tablets, vitamin 
k ampoules. No evidence of resources for TBAs 
Reproductive health education program for adolescents, 
management by village health workers for minor health 
problems & prenatal care at the referral clinic. 
Referral 
support 
No added referral care than what already present at government health facilities. No added referral care than what already present at 
government health facilities. 
Gloyd: 2001 (105) 
TBA strategy Access to trained TBA with 3 week training program, promoted pre-natal care, family planning, 
immunisation, hygienic management of birth, risk recognition. 
No access to TBA 
Support 
workers  
None specified Not given in control area. 
Resource 
support  
Clean birth kits. None specified 
Referral 
support  
None specified. None specified 
Bhutta: 2008 (106) 
TBA &lady 
health worker 
 3 day voluntary training programme in basic newborn care including basic resuscitation & 
immediate newborn care. Encouraged to attend LHW led community education sessions. Special 
Not offered to TBAs, however special training in basic & 
intermediate newborn care to all public-sector rural health 
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strategy training in basic & intermediate newborn care offered to public-sector rural health centre &hospital-
based medical &nursing staff.  
 
centre & hospital-based medical &nursing staff. Referral 
support 
Support 
workers 
Community health committees set up support from two community mobilisers  No attempt to link LHW with TBAs or to set-up community 
health committees. 
Resource 
support 
All health-care facilities provided basic & intermediate newborn care equipment. Enhanced 6 day 
module of LHW training programme, covering community mobilisation, basic newborn care, group 
counselling. LHW encouraged to work with TBAs to identify when births would occur, visit mothers 
twice during pregnancy & following birth. No resuscitation equipment or injectable antibiotics were 
provided to the LHW or TBAs. 
LHW training programme continued as usual, regular 
refresher sessions. All health-care facilities provided with 
basic &intermediate newborn care equipment. No 
resuscitation equipment or injectable antibiotics provided to 
the LHW or TBAs. 
Referral 
support 
Assistance to establish emergency transport funds for mothers &newborns None specified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6
3 
 
 
 
64 
 
Table 6 Consort extension statement reporting checklist for cluster randomised trials in strategies incorporating TBAs for maternal and perinatal health outcomes
Item Checklist item Jokhio Carlo Azad Midhet Bhutta Gill 
Title and abstract 
 Identification as  RCT  in title N N Y Y Y Y 
Structured summary of design, methods, results, 
conclusions  
Y Y Y Y Y Y 
Introduction 
Background 
objectives 
Scientific background and explanation of rationale  Y Y Y Y Y Y 
Specific objectives or hypotheses  Y Y Y Y Y Y 
Methods 
Trial design Description of design including allocation ratio Y Y Y Y Y Y 
Changes after trial commencement with reasons n/a n/a n/a n/a n/a n/a 
Participants Eligibility criteria for participants  Y Y Y Y Y Y 
Settings and locations where data collected Y Y Y Y Y Y 
Interventions Interventions per group with details  Y Y Y Y Y Y 
Outcomes Pre-specified primary and secondary outcome 
measures  
Y Y Y Y Y Y 
Changes to outcomes after commenced n/a n/a n/a n/a n/a n/a 
Sample size Sample size determined: Method of calculation, 
number of clusters(s) cluster size, coefficient of 
intracluster correlation, indication of uncertainty 
Y Y Y Y Y Y 
When applicable, explanation of interim analyses 
and stopping guidelines 
n/a n/a n/a n/a n/a n/a 
Randomisation: 
 Sequence 
generation 
Method to generate random allocation sequence Y Y Y Y Y Y 
Randomisation; details of any restriction  Y Y Y Y Y Y 
 Allocation 
concealment 
mechanism 
Random allocation sequence, steps taken to 
conceal sequence until interventions assigned  
Y Y Y Y Y Y 
Implementation 
 
Random allocation sequence and enrolled 
participants enrolment 
Y Y Y Y Y Y 
Who generated random allocation sequence, 
enrolled clusters, assigned clusters to interventions 
Y Y Y Y Y Y 
Mechanism by which individual participants were 
included in clusters for purposes of trial  
Y Y Y Y Y Y 
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where consent was sought and whether consent 
was sought before or after randomisation 
N N N N N N 
Blinding who blinded after assignment to interventions, how N N N N N N 
description of similarity of interventions N N N N N N 
Statistical 
methods 
Statistical methods to compare groups 
primary/secondary outcomes  
Y N Y Y Y Y 
additional analyses Y Y Y Y Y Y 
Results 
Participant flow  numbers randomly assigned, received intended 
treatment, analysed for primary outcome 
Y Y Y Y Y Y 
losses and exclusions after randomisation, reasons N N N N N N 
Recruitment Dates of recruitment and follow-up Y Y Y Y Y Y 
Why trial ended or was stopped N N N N N N 
Baseline data table baseline demographic, clinical characteristics  Y Y Y Y Y Y 
Numbers 
analysed 
participants included in each analysis and whether 
analysis was by original assigned groups 
Y Y Y Y Y Y 
Outcomes and 
estimation 
primary and secondary outcome, results and the 
estimated effect size and its precision  
Y Y Y Y Y Y 
binary outcomes, presentation of both absolute and 
relative effect sizes is recommended 
Y Y Y Y Y Y 
Ancillary 
analyses 
Results of other analyses performed, including 
subgroup analyses, adjusted analyses, 
distinguishing pre-specified from exploratory 
Y Y Y Y Y Y 
Harms important harms or unintended effects in group  X X X X X X 
Discussion 
Limitations Trial limitations, addressing sources of potential 
bias, imprecision, if relevant, multiplicity of analyses 
Y Y Y Y Y Y 
Generalisability Generalisability of trial findings Y Y Y Y Y Y 
Interpretation Interpretation consistent with results, balancing 
benefits and harms, considering relevant evidence 
Y Y Y Y Y Y 
Other information 
Registration Registration number and name of trial registry N N N N N N 
Protocol full trial protocol can be accessed, if available N N N N N N 
Funding funding and other support role of funders Y Y Y Y Y Y 
Y = Reported N = Not Reported N/A = Not Applicable 
6
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Table 7 Newcastle Ottawa Scale for assessing risk of bias in non-randomised studies 
Cohort Studies Janowitz 
1998 
Greenwood 
1990 
Alisjahbana 
1995 
Ronsmans 
1997 
Bang 
1999 
Gloyd 
2001 
Bhutta 
2008 
Selection Representativeness Y Y Y Y Y N Y 
Selection on comparison Y Y Y Y Y Y Y 
Ascertainment of exposure Y Y N Y Y N Y 
Demonstration of outcomes Y Y Y Y Y Y Y 
Comparability 
(maximum of 
two is 
available) 
Comparability YY N YY N N YY YY 
Outcome 
 
Outcome assessment Y Y Y Y Y Y Y 
Follow up length Y Y Y Y Y Y Y 
Adequacy of follow up Y Y Y Y Y Y Y 
 
Y = Reported N = Not Reported 
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Table 8 Risk of Bias assessment of randomised studies in strategies incorporating the training and support of TBAs 
Random sequence 
generation 
Allocation concealment Blinding of 
participants and 
personnel 
Blinding of outcome 
assessment 
Incomplete 
outcome data 
Selective 
reporting 
Other bias 
Jokhio 
LOW: Page 
2092:simple cluster 
randomisation  
computer generated 
LOW: Page 2092: 
computer generated 
UNCLEAR: Not 
reported 
UNCLEAR: Page 2094: LHW 
recorded outcomes could not 
be blinded to intervention but 
were not aware of study 
objective or outcome 
measures. 
LOW: Figure 
1: all 
accounted for 
LOW: Table 
3 & 4: all 
outcomes 
reported 
LOW: no other 
sources of bias 
Carlo 
UNCLEAR: Page 
616: randomly 
assigned, no further 
details  
UNCLEAR: Not reported UNCLEAR: Not 
reported 
UNCLEAR: Page 617: The 
birth attendants/community 
coordinators obtained written 
informed consent from 
mothers and collected data 
on standardized data forms. 
 LOW: Figure 
1: all 
accounted for 
LOW: Table 
1 & 2: 
outcomes 
reported 
LOW: no other 
sources of bias 
Azad 
LOW: Page 1194: 
Unions randomly 
allocated to 
intervention or 
control groups by 
district in presence of 
project staff and 
external individuals. 
Randomisation 
process done before 
collection and 
analysis of baseline 
data. 
LOW: Page 1194: Cluster 
names written on pieces 
of paper, folded and 
placed in bottle. Project 
manager drew papers 
from bottle. allocation 
sequence decided upon 
by project team before 
drawing papers and 
based on clusters not 
individuals. Clusters had 
been pre-identified by 
team on basis of 
previously mentioned 
criteria. 
HIGH: Page 1195: 
None of staff 
attending 
randomisation 
process had 
previous knowledge 
of health and 
socioeconomic 
status of chosen 
union clusters. 
Neither study 
investigators nor 
participants 
masked to group 
allocation. 
HIGH: Page 1195: Neither 
study investigators nor 
participants were masked to 
group allocation. No details 
given for analysts 
LOW: Page 
1198:Interview
s completed 
for 84% and 
82% of births 
in intervention 
and control 
arm 
LOW: Page 
1199: 
outcomes 
reported; 
table 2 & 3 
HIGH: Page 
1194: control 
clusters included 
3 areas 
worse health & 
socioeconomic 
indicators than 
rest of area. In 
these areas, 
surveillance 
started late due to 
entry restrictions.  
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Midhet 
 UNCLEAR: Page 
1183: external 
observer drew folded 
papers with numbers 
corresponding to 
clusters with existing 
groups from basket.  
LOW: Page 1183: first 
four clusters drawn from 
basket allocated to 
intervention group, rest to 
control group.  
HIGH: Page 1183: 
Because of nature 
of intervention, 
neither team nor 
participants were 
masked to group 
assignment. 
HIGH: Page 1183: Because 
of nature of intervention, 
neither intervention team nor 
participants were masked to 
group assignment. No details 
on blinding of analysts 
LOW: Page 
1187: Loss to 
follow up was 
<1% and 2% 
in intervention 
and control 
clusters. 
LOW: Page 
1187: 
outcomes 
reported: 
table 2 & 3  
LOW: Page 1191: 
No incentives or 
disincentives for 
under or over 
reporting deaths 
and births, 
several 
mechanism in 
place to detect 
errors 
Bhutta 
LOW: Page 6: 
clusters allocated to 
both or no 
intervention with 
random number 
sequence generated.  
LOW: Page 6: 
concealment of 
intervention allocation, 
identification numbers 
assigned for each cluster 
and random number 
generated for each. 
Sequence used to 
allocate to each of four 
intervention groups. 
Sequence concealed until 
interventions assigned.  
HIGH: Page 6: 
Neither participants 
nor those 
administering 
interventions 
blinded to group 
assignment. 
HIGH: Page 6: Those 
assessing outcomes not 
blinded to group assignment 
UNCLEAR: 
Page 10: 29% 
lost to follow 
up, observed 
birth rates in 
study matched 
expected 
crude birth 
rate within 3%, 
little difference 
in loss-to-
follow-up 
between arms.  
LOW: Page 
10: outcome 
reported, 
table 2-6 
LOW: None 
reported 
Gill 
LOW: Page 8: 
random number 
sequence  
LOW: Page 8: 
Randomization done after 
collection, before entry 
and analysis, of baseline 
data. Study personnel 
allocated clusters to 
intervention groups. 
HIGH: Page 8: 
nature of 
interventions made 
masking of 
allocation 
impossible at 
participant level. 
LOW: Page 8: Masking at 
level of analysis and trial 
monitors. Data collected 
independently of programme 
implementation, no results 
were back to inform 
interventions 
LOW: Figure 
4: Participants 
lost to follow 
up accounted  
for  
LOW: Page 
17: outcomes 
reported, 
table 3-6 
LOW: None 
reported 
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Perinatal mortality: 
Five cluster randomised trials reported on the outcome perinatal mortality. All individual 
studies showed a reduction in perinatal mortality, with three studies (42, 100, 101) showing a 
statistically significant reduction with strategies that incorporate the training and support of 
TBAs. Study level meta-analysis of the five cluster randomised trials showed a significant 
reduction in perinatal death (RR 0.76, 95% CI 0.64, 0.88, p<0.001, Figure 10). There was 
statistical heterogeneity between the studies, that was assessed to be moderate (I2 = 65.7%). 
Non-randomised studies also demonstrated a very similar reduction in perinatal death with 
strategies that incorporate the training and support of TBAs (RR 0.70, 95% CI 0.57, 0.84, 
p<0.001, Figure 10). There was evidence also of moderate heterogeneity within this analysis 
(I2 = 40.2%). 
 
Neonatal death:  
All six cluster randomised trials individually showed a reduction in neonatal mortality, with 
three studies (42, 99, 100) showing a statistically significant reduction. Meta-analysis of the 
six studies showed a significant reduction in neonatal death with strategies that incorporate 
the training and support of TBAs (RR 0.79, 95% CI 0.69, 0.88, p<0.001, Figure 11). There 
was moderate level of heterogeneity between the studies (I2 = 40.5%). Non-randomised 
studies also showed a reduction in neonatal mortality (RR 0.61, 95% CI 0.48, 0.75, p<0.001, 
Figure 11). There was evidence of low heterogeneity within this analysis (I2 = 19.3%). 
 
Maternal mortality:   
Three cluster RCTs (42, 99, 100) reported on this outcome and found no significant 
difference in maternal mortality with strategies incorporating TBAs (RR 0.79; 95% CI 0.53, 
1.05, p=0.12, Figure 12).  There was no evidence of heterogeneity within this analysis 
(I2=0%). Three non-randomised controlled studies (61, 106, 107) also showed no significant 
difference (RR 0.80, 95% CI 0.44, 1.15, p=0.26: Figure 12), there was no evidence of 
heterogeneity in the analysis (I2=0%).  
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Figure 10 Perinatal mortality in areas that incorporated the training and support of TBAs compared to the control
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Figure 11 Neonatal mortality in areas that incorporated the training and support of TBAs compared to the control
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Figure 12 Maternal mortality in areas that incorporated the training and support of TBAs compared to the control
7
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3.4 DISCUSSION  
Findings 
The meta-analysis of cluster RCTs showed that perinatal and neonatal deaths were 
significantly reduced with interventions incorporating the training and support of TBAs.  The 
findings from non-randomised studies were entirely consistent with the findings of the cluster 
randomised trials. There was statistical heterogeneity in the analysis for perinatal death and 
neonatal death; however, all cluster randomised trials and all non-randomised studies 
showed a reduction in these two outcomes.  The heterogeneity thus represents differences in 
the magnitude of the favourable effect found across all studies, rather than suggesting 
opposing effects. The estimated effect is large enough to contribute to a substantial 
improvement in perinatal and neonatal outcomes in the developing world.  
 
Meta-analysis of the cluster RCTs showed no significant difference in maternal mortality, with 
the non-randomised studies following a similar trend. There was no evidence of 
heterogeneity identified for this outcome within the studies. 
 
Limitations 
All trials included within the systematic review evaluated highly complex interventions with a 
range of components.  There was substantial variation in the role of the TBAs, the support 
staff involved, the resources that they were provided with, and the referral pathways that 
were incorporated (Figure 13).  None of the trials included provided a direct comparison 
between trials that involved TBAs versus trials that did not include TBAs, rather it included 
trials that provided a comparison of strategies that incorporated additional support of TBAs, 
against strategies that did not. Some trials supported TBAs in both intervention and control 
arms, but the level of support was enhanced within the intervention group; for instance, Gill 
et al (99) supplied clean delivery kits to all TBAs, in conjunction with providing basic training 
on newborn care and resuscitation. Their addition for the intervention arm was providing 
training and protocols on higher level resuscitation and recognition of signs of neonatal 
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sepsis.  In the study by Carlo et al (98), the there was limited difference in the TBA 
involvement between the two trial arms; interestingly, this was also the study that showed the 
smallest difference in perinatal death.  In contrast, Jokhio et al (42) and Midhet and Becker 
(101) trials had the largest difference in TBA involvement between the trial arms, and these 
trials showed the largest improvement in perinatal mortality with the intervention. However, 
one cannot infer that the greater the support for TBAs, the better the perinatal outcomes, as 
within a complex package of interventions, it is not possible to separate out the role played 
by enhanced TBA support against other components in achieving the observed 
improvements.  
 
Notwithstanding, the primary question in the included trials, and for our review, was whether 
the complex interventions incorporating TBAs, as a whole, resulted in an improvement in 
outcomes. The consistency in the findings, despite the heterogeneity in the populations, 
settings (countries), health systems, interventions and comparisons, contributes to the 
generalisability of the findings. This is likely to be important for policy making.  
 
Existing evidence 
The effect of incorporating TBAs into perinatal and maternal mortality reduction programmes 
was examined in a Cochrane review (47) in 2009. As there was only one cluster randomised 
trial at the time of the review, firm inferences could not be drawn resulting in the suggestion 
that “TBA training had promising potential to reduce perinatal and neonatal mortality when 
combined with health services; however the limited number of studies included did not 
provide the evidence needed”.  Our meta-analysis, consisting of six cluster randomised trials 
and seven non-randomised studies, allows firm inferences to be drawn.  Another Cochrane 
review (108) evaluated the full range of ‘community based intervention packages’ which 
included strategies as wide as nurse-led nutrition counselling, stimulation exercises to 
improve psychomotor development in infants (109), distributing supplementary foods to poor 
families (110), and providing preschool education. This review identified 11 cluster 
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randomised and 8 quasi-randomised trials or controlled studies; however, only one RCT 
incorporated TBAs as an interventional strategy, a further two trials involved TBAs as the 
type of health worker involved for delivery of the intervention.  Darmstadt et al (83) reviewed 
the evidence for community based skilled and TBAs, as well as CHWs in improving perinatal 
and intrapartum related outcomes.  This review included a single cluster randomised trial 
with TBAs as the intervention, as this is all that existed at the time of the review (42). Their 
findings on TBAs were consistent with our review findings.   
 
Practice and policy implication 
Deployment of TBAs without an appropriate package of training, support and resources is 
unlikely to be effective.  Potentially important components that support strategies 
incorporating TBAs include support from health care professionals, continued skill 
development, access to resources such as clean birth kits, and effective referral pathways.   
Although the optimal intervention to improve perinatal and maternal outcomes is to increase 
the proportion of births attended by skilled birth attendants, the economical, geographical, 
political and social realities have limited the ability of national and international efforts for all 
births to be attended by SBAs.  This has therefore resulted in critical coverage gaps, and 52 
million women give birth without skilled birth attendance (83). Therefore, other cadres of 
health workers may need to be considered to extend the coverage of maternal and neonatal 
care to help improve outcomes.  TBAs are on location, culturally acceptable, and can 
improve care coverage, and evidence from this meta-analysis suggests that TBAs can be a 
component of strategies to improve perinatal outcomes.  TBAs often represent a more 
feasible, culturally acceptable and an accessible option for women in developing countries 
(95).   
 
Unanswered questions and future research 
It is suggested that the incorporation of TBAs in the absence of an appropriate training 
package, or without appropriate and adequate support and resources is likely be ineffective. 
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As this intervention is a complex intervention package that has several interacting 
components, it is important to understand the processes involved as well as evaluating the 
outcome. Evaluating complex interventions can be problematic due to the practical and 
methodological difficulties that arise with complex intervention packages. The Medical 
Research Council framework can be used to offer guidance with evaluation, however it is 
suggested that it is necessary to understand the change process, as well as the evidence 
base and the developing theory (111). Currently however, detail lacks on the exact effect of 
the components of each of these elements. Therefore further research is needed to examine 
the components in greater detail, and attempt to establish an understanding of which 
components contribute to more successful incorporation of TBAs, and maternal and newborn 
health outcomes. A qualitative synthesis of existing studies may offer greater insight into the 
practical and methodological challenges of implementing complex interventions, as well as 
the possible barriers and facilitators of this process. However, as complex interventions are 
suggested to be most effective when they are tailored to local circumstances, rather than 
being completely standardised, it may be more effective to conduct this research in a variety 
of settings, to develop a firm theoretical understanding of how the intervention causes 
change, so fragile links in the causal chain can be identified and strengthened (111). Further 
primary research may also provide greater insight (112, 113).  
 
3.5 CONCLUSION 
Our systematic review and meta-analysis provides good quality evidence showing a 24% 
reduction in perinatal death rates with strategies incorporating TBAs. Enhancing access to 
care during pregnancy and labour, in areas where coverage by skilled birth attendants is 
poor, can form part of the solution to meet MDGs 4 (reducing child mortality) and 5 
(improving maternal health). 
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Figure 13 Optimal support for TBAs as suggested in primary studies 
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CHAPTER 4:  WOMEN’S GROUPS PRACTISING PARTICIPATORY 
LEARNING AND ACTION TO IMPROVE MATERNAL AND NEWBORN HEALTH 
IN LOW-RESOURCESETTINGS: A SYSTEMATIC REVIEW AND META-
ANALYSIS 
ABSTRACT 
Background: Participatory action research has attempted to address the impact of women’s 
participatory action groups on maternal and neonatal health outcomes, yet results have 
shown conflicting findings. Therefore a systematic review and meta-analysis was performed 
on the impact of women’s participatory action groups on maternal and neonatal health 
outcomes in low income settings 
Methods: MEDLINE, EMBASE, Cochrane library, CINAHL, African Index Medicos, Web of 
Science, the Reproductive Health Library, and the Science Citation Index were searched 
(inception- November 2012) without language restriction. Studies of randomised controlled 
design were selected, with the primary outcomes of still birth, neonatal and maternal 
mortality. Relative risks (RR) were pooled using random effects model. A sub-group analysis 
was performed on groups from trials where at least 30% of pregnant women participated in 
the women’s groups. This figure was selected as previous studies have suggested that this 
coverage is a key determinant of impact.  
Results: Seven cluster RCTs (n= 119,443 births) were identified.  Meta-analysis of the 
randomised trials showed a reduction in maternal mortality (OR 0.66, 95%CI: 0.33-0.99), a 
reduction in neonatal mortality (OR 0.77, 95% CI 0.65-0.89) and a non-significant reduction 
in stillbirth (OR 0.91, 95%CI: 0.79-1.03) with women’s participatory action groups. Women’s 
groups where at least 30% of pregnant women participated showed more marked effects on 
outcomes. Maternal and perinatal mortality were reduced further (OR 0.45, 95% CI: 0.17-
0.73 and OR 0.67, 95% CI: 0.59-0.74 respectively)  
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Conclusion: Maternal and neonatal deaths are significantly reduced with women’s 
participatory action and learning groups. Women’s groups with at least 30% of pregnant 
women participating show greater reductions on neonatal and maternal mortality. 
 
Impact of review: Published in Lancet, Presented at the Houses of Parliament 
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4.1 BACKGROUND 
Community-based interventions are suggested as being critical to improving maternal as well 
as newborn health (20) in low income settings, however packages of these interventions 
have demonstrated various levels of effect on maternal and neonatal mortality (108, 110, 
114-117). Research suggests that increasing community participation in maternal and 
newborn health projects improves health outcomes and care seeking behaviours (41, 118).  
A systematic review of randomised trials of various community based intervention packages 
published in 2010 (108) demonstrated significant reductions in neonatal mortality, but there 
was inconclusive evidence on the effect of maternal mortality. The interventions included 
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were heterogeneous, some involved home counselling visits to mothers, some enhanced 
referral pathways and some provided home-based care to newborns. Other intervention 
packages included community-level activities to strengthen newborn care practices, and 
women’s groups using a four phase, participatory learning and action cycle.  
Participatory action and learning cycles are a rigorously examined community based 
intervention that aims to explore and understand local health problems, possible causes and 
solutions (119, 120).  Participatory action and learning cycles with women’s groups involves 
identifying and prioritising problems in pregnancy, delivery and the postpartum period; 
planning how to address these problems through locally feasible strategies; implementing the 
chosen strategies; and evaluating their activities. These cycles are a form of community 
mobilisation that involves a group of local community members, meeting in the presence of 
group facilitators, often in the presence of key stake holders, to identify and discuss problems 
within the local community. Through this problems are addressed, the group then plan how 
to implement strategies to instigate change through an action plan. Once action has been 
taken to address the problems, the group then assess the effect of the actions, and reassess 
the problems initially identified, with the addition of any newly arising problems (121) (119, 
122). 
The concept of working with women’s groups arose after the Alma Ata Declaration in a 
commitment to supporting the participation of local people in healthcare planning and 
implementation. This idea stems from the work of Pedagogue Paulo Freire. When translated 
into healthcare it focuses on three main notions: firstly that many health problems are rooted 
in powerlessness, thus social and political empowerment can therefore improve health; 
secondly that health education is more empowering if it is a dialogue-based process of co-
learning and problem-solving rather than as ‘message-giving’; and thirdly that communities 
can develop ‘critical consciousness’ to recognize and address the underlying social and 
political determinants of health, as well as the immediate determinants of health (123). 
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Figure 14 Process of women’s participatory action and learning cycle 
8
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Participatory action is suggested to empower groups, as well as the wider community (124, 
125)  and encourage them to assess their own environmental situation and health needs 
(122). The effects of participatory learning and action with women’s groups, has been 
assessed on maternal and neonatal health outcomes in low income settings (121, 126). 
Other studies have measured the impact of women’s groups on behavioural change (127).  
Results have been conflicting (52, 97, 128), with some studies showing a reduction in 
neonatal death (52, 129), and others showing no effect (97).  Most studies were not 
individually powered to show an effect in maternal mortality.  
The various types of community-based interventions to improve maternal and newborn 
health have different ideological, organisational and economic implications. Therefore 
pooling their results may not be as informative for policy recommendations as analysing their 
impact separately, and reflecting on factors that affect their effectiveness. By conducting a 
systematic review of RCTs the impact of women’s groups practising participatory learning 
and action on maternal and neonatal mortality and stillbirth could be assessed. The aims of 
this review were to determine the impact of women’s groups on maternal mortality, neonatal 
mortality and stillbirths with women of reproductive age in low resource settings.  
 
4.2 METHODS 
Data sources and searches 
Databases were searched for literature on women’s participatory action groups in developing 
countries. We searched PUBMED, EMBASE, Cochrane library, CINAHL, African Index 
Medicus, Web of Science, the Reproductive Health Library, and the Science Citation Index 
(from database inception to November 2012). Hand searching complemented electronic 
searches, and reference lists were checked. The search terms were a combination of 
‘community mobilisation’, ‘community participation’, ‘participatory action’, ‘participatory action 
group*’,‘women* group*’ and ‘women’.  No language restrictions were applied to the search. 
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Study selection and data extraction 
RCTs only were selected.  Initially the electronic searches were scrutinised and full 
manuscripts of relevant studies were acquired. Final decisions on inclusion or exclusion of 
manuscripts were made after inspection of these manuscripts by the author and another 
reviewer (AW and CM). Information was extracted from each article on study characteristics, 
study quality and outcome data by the author and three other reviewers (AW, CM, NS, AP).  
Studies were excluded if they did not contain all of the stages used within a participatory 
action and learning cycle, if the majority of the participants were not women of reproductive 
age, and the study outcomes did not include maternal mortality, neonatal mortality or 
stillbirth.  The outcomes for the systematic review were stillbirth, neonatal mortality and 
maternal mortality.  
Methodological quality assessment 
The RCT were assessed for methodological reporting using the CONSORT statement and its 
extension (68) as appropriate for cluster trials. These studies were assessed for 
randomisation and sequence generation, baseline comparability, accounting for cluster 
effect, blinding and appropriate statistical analysis (68). Risk of bias within individual studies 
was assessed using the Cochrane collaboration’s tool (130). 
 
Statistical Analysis 
Odds or risk ratios were extracted from each study for each outcome using the main 
estimates reported in the trials. The ratios accounted for stratification and clustering, and 
where appropriate adjustments for other covariates reported were made. When an outcome 
was required for the analysis, but not reported in the outcome data, the identical methods 
reported as used in the original study were used to calculate an effect size from the trial 
datasets. Meta-analysis of the study-level data was conducted with the metan command in 
Stata (version 12.1) using random-effects model, this was because the effects seen in each 
trial were assumed to be taken from an underlying distribution. A-priori meta-analyses to 
ascertain the effect of women’s groups on maternal mortality, neonatal mortality, and 
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stillbirths with all trials were performed. Subgroup analyses were then performed to identify 
population-level predictors of effect, as it was postulated that these may include the 
population coverage of women’s groups, proportion of pregnant women within the groups, 
and background mortality and institutional birth rates as measured in the control areas during 
the trials. In previous studies, the hypothesis was that having one women’s group per 450–
750 population and between 30% and 50% of pregnant women attending groups would be 
key determinants of effect. Meta-regression analysis was used to assess whether each of the 
predictors was associated with intervention effects. If there was evidence of statistical 
heterogeneity (I2>50%, p<0.05), the trials were separated into groups according to the 
results of the meta-regression analyses. Potential publication bias and small-study effects 
were assessed using funnel plots and Egger tests (TC, A.Cop) 
 
4.3 RESULTS 
The process of literature search and selection is given in Figure 15. Seven RCTs were 
included all of which were cluster randomised (52, 97, 120, 128, 130) with a total of 119,443 
births. Characteristics of the included studies are shown in Table 9, and characteristics of the 
clusters are shown in Table 10.  The studies examined the effect of women’s participatory 
action and learning cycles on stillbirth, neonatal and maternal mortality. Four studies used 
these groups within a wider interventional strategy with a multitude of components, however 
these other components were introduced in both the control and intervention arms. Most 
studies effectively reported on sequence generation, randomisation, baseline comparability, 
accounting for cluster effect, blinding and appropriate statistical analysis (Table 11). Four 
studies did not adequately report the reason for a cluster design within the background of the 
manuscript, and five studies lack reporting on adverse outcomes. Most studies were 
assessed as having low risk of bias for random sequence generation (6/7), incomplete 
outcome data (5/7), or selective reporting (5/7). All studies had low risk of bias for allocation 
concealment (7/7), but high risk of bias for blinding of participants and personnel (7/7). Half 
 
 
85 
 
of the studies had high risk of bias in blinding of outcome assessment, and one study was 
assessed as high risk for other sources of bias (Table 11). 
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Figure 15 Results of search strategy and identification of literature included in the review
Total citations identified from electronic searches n= 2226
Citations excluded after screening title and/or abstracts: n = 2161
Primary articles fulfilling inclusion criteria for systematic review: n = 7
Articles excluded after review of full text with reasons
Incorrect intervention n =15
Incorrect study design n =18
Incorrect outcome n =13
Protocol n =13
No primary data n =1
No control n =1
Total excluded n = 61
Full manuscripts retrieved for detailed evaluation: n = 65
Unpublished articles: n = 3
8
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Maternal mortality 
Seven cluster RCTs (n= 119,443) reported on the effect on maternal mortality.  Meta-
analysis of RCTs demonstrated a significant reduction of 34% in the odds of maternal 
mortality (OR 0.66,95%CI: 0.33-0.99: Figure 16). There was evidence of moderate and 
significant heterogeneity within the analysis (I2=58.8%, p=0.015).  
 
Neonatal mortality 
Seven cluster RCTs (52, 97, 120, 128, 131) (n=119,443) reported on neonatal 
mortality. Meta-analysis showed a significant reduction of 23% in the odds of neonatal 
mortality with women’s participatory action and learning cycles (OR 0.77, 95% CI 0.65-
0.89: Figure 17). There was high heterogeneity noted within the analyses (I2=64.7%, 
p=0.009). 
 
Stillbirth 
Seven RCTs reported on this outcome. There was no evidence of reduction in stillbirths 
(OR 0.91, 95% CI 0.79–1.03, I2=37.7%: p=0.141: Figure 18). 
 
Sub-group analysis 
Maternal mortality: More than 30% pregnant women participating in groups 
Four cluster RCTs (n=49,703 births) where at least 30% of pregnant women 
participated in the women’s groups showed a significant reduction of 55% in the odds 
of maternal mortality (OR 0.45, 95% CI: 0.17-0.73: Figure 19). There was evidence of 
low heterogeneity within this analyses that was not statistically significant (I2 = 51.3%, p 
= 0.104). 
Neonatal mortality: More than 30% pregnant women participating in groups  
Four cluster RCTs (n=49,703 births) where at least 30% of pregnant women 
participated in the women’s groups showed a significant reduction of 33% in the odds 
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of neonatal mortality (OR 0.67, 95% CI: 0.59-0.74: Figure 20). There was evidence of 
moderate heterogeneity within this analyses that was not statistically significant (I2=0%, 
p=0.844). 
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Figure 16 Maternal mortality in clusters where women’s groups’ practised participatory action and learning cycles compared to the control 
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Figure 17 Neonatal mortality in clusters where women’s groups’ practised participatory action and learning cycles compared to the control
9
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Figure 18: Stillbirth in clusters where women’s groups practised participatory action and learning cycles compared to the control 
9
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Figure 19 Maternal mortality by % of women participating in groups 
9
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Figure 20 Neonatal mortality by % of women participating in groups 
9
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4.4 DISCUSSION  
Principal findings of the study 
This meta-analysis of cluster RCTs showed a significant and substantial reduction in 
neonatal and maternal mortality with women’s participatory action groups.  There was 
moderate heterogeneity, but not statistically significant for both outcomes in the sub-
group analysis. Participatory action and learning cycles that were conducted within a 
rural setting, and had a group density of more than 30% or pregnant women attending 
the groups showed the most marked reductions in the odds of mortality, these are 
demonstrated in Figure 21. 
 
Strengths and limitations of the study 
There was considerable heterogeneity within the analyses that included both rural and 
urban settings, with various concentrations of pregnant women attending the groups. 
However this heterogeneity was reduced and the effect on maternal and neonatal 
mortality more pronounced when data was pooled and analysed where groups from 
trials contained more than 30% of pregnant women. This figure was selected upon the 
guidance of previous studies that had hypothesised that population coverage was a 
key determinant of impact. Studies have suggested that the order of one group per 
450–750 population, and between 30% and 50% of pregnant women attending groups, 
are key for impact (97, 132). 
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Figure 21 Map of settings of where the research on women's groups was conducted 
Lewycka, 2013
51% pregnant 
women 
440 per group
Colbourn, 2013
10% pregnant 
women 
1200 per group
Manandhar, 
2004
37% pregnant 
women 
756 per group
Azad, 2010
3% pregnant 
women 
1414 per 
group
Tripathy, 2010
37% pregnant 
women 
468 per group
More, 2012
2% pregnant 
women 
788 per 
group
Fottrell, 2012
36% pregnant 
women 
309 per group
9
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Comparison with other studies 
To date no systematic reviews have evaluated the impact of women’s groups practising 
participatory learning and action cycles on maternal and neonatal mortality. However 
two reviews (62, 108) have evaluated the effect of community based intervention 
packages on maternal and perinatal mortality: these assessed the full range of 
community interventions which included diverse strategies such as TBA training, 
antenatal care, nurse led nutrition counselling, distributing supplementary foods to poor 
families, and providing preschool education. Limited information was provided on the 
effects of women’s participatory learning and action cycle on maternal and newborn 
health within these reviews. 
 
A more recent review (133) found a significant decrease in neonatal mortality rates with 
community based newborn care: this systematic review contained 13 controlled trials 
(randomised, quasi-randomised and non-randomised) of a variety of community based 
neonatal care packages. Three studies from this review examined the effect of 
participatory women’s groups, and meta-analysis found a reduction in the risk of 
neonatal mortality by 23% (RR 0.77 95% CI 0.61, 0.96; I2 78.2%, p=0.010), however 
one randomised trial that was included was omitted from our analyses as it was not 
conducted in a developing country. Furthermore the effects on maternal outcomes 
were not examined within this review. 
 
Policy implications 
Women’s participatory groups have been used to assess perceptions of maternal 
health issues within communities (134), as well as to measure objective quantitative 
outcomes such as death and disability. Women involved within participatory action 
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groups have shown an enhanced awareness of maternal health problems, as well as 
the desire and motivation to address them.  It is however suggested that the process of 
identifying problems and implementing strategies to address the problems, may be 
more beneficial to the group than the strategy itself, as research suggests that 
interaction with the wider community may encourage greater interest and involvement 
of the community with perinatal health issues (121).   
 
Activities between women’s groups can vary, some studies suggest that there is no 
‘magic bullet’ for successful community mobilisation, whereas participatory learning 
and action cycles often follow a ‘formula’ for an active women’s group (121). For 
example it is suggested that working closely with communities and consulting them at 
stages in the design, planning and implementation of the participatory action group is 
critical for achieving favourable outcomes (135). A participatory approach is thought to 
have the potential to develop knowledge, skills and critical consciousness, as well as 
enhance community involvement beyond the women’s group itself. It can target and 
actively recruit marginalised communities and vulnerable groups such as newly 
pregnant women, and achieve high population coverage (119).  
 
Research suggests that several interrelated factors influence the interventions impact 
on health and care-seeking behaviour outcomes. Pregnancy and childbirth are often 
culturally viewed as ‘women’s problems’, therefore the responsibility often falls with 
women themselves (136, 137), therefore the acceptability and feasibility of this 
methodology within the region should be assessed prior to implementation, especially if 
marginalised and vulnerable communities are being targeted.  It is suggested that a 
detailed understanding of the context in which the participatory action group will take 
place is necessary to ensure successful delivery of the intervention.  A planned yet 
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flexible approach to key implementation features, and a strong support for participatory 
methods from implementing agencies are recommended for scaling-up this intervention 
(119). 
In regions where improvements in maternal health and maternal mortality are inhibited 
by gender inequity, empowered women’s groups could give individuals the support and 
confidence to strive for a healthy pregnancy, and be involved with decisions about their 
care. 
 
Unanswered questions and future research 
As this review addressed only the objective outcomes of mortality, associated effects 
on morbidity or improvements in health seeking behaviours could be examined. 
Communications with the WHO have occurred since publication of this review to 
examine the effect of this intervention on such outcomes. 
 
4.5 CONCLUSION 
This systematic review and meta-analysis demonstrates the effect of women’s groups 
practicing learning and action cycles, and provides good quality evidence showing a 
significant reduction in maternal and neonatal mortality. Empowering women and 
encouraging support for improvements in care seeking behaviours to enhance 
maternal and perinatal health can form part of the solution to meet MDGs 4 (reducing 
child mortality) and 5 (improving maternal health). 
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Study population, setting Intervention Control Outcomes 
Tripathy: 2010  18 clusters (9770 births): Monthly women’s group 
meetings facilitated by local woman (20 meetings 
per cluster). Facilitators had 7 day residential 
training course. Groups followed four-phase 
participatory learning & action cycle. community 
members encouraged to participate. Strategy 
implementation was discussed to assess results. 
Information on clean delivery & care-seeking 
behaviour shared through stories & games. 
Stories, participatory games & picture cards to 
facilitate discussions on prevention & care-
seeking in pregnancy, birth & postnatal period. 
Health committees formed – as control. 
18 clusters (9260 births): Health 
committees formed, community 
members discuss & express 
opinions about design & 
management of local health 
services. Meetings held two 
months & structured action 
cycles, to discuss maternal & 
newborn health entitlement 
issues. Workshops provided for 
appreciative inquiry with frontline 
government health staff. 
Primary: NMR, 
maternal depression 
scores. Secondary: 
Stillbirths, MMR, PMR, 
uptake of 
antenatal/delivery 
services, home-care 
practices, health-care-
seeking behaviour. 
Open cohort women 15-49 in 
rural India, gave birth Jul 05-
Jul 08. 6 clusters (average 
population 6338 per cluster). 
Manandhar: 2004  12 clusters (2972 births):  Each cluster had local 
literate female facilitator, Facilitators given training 
in perinatal health issues. Facilitators had manual 
on ‘Warmi project methodology’. Facilitators 
supported groups with meetings x10. Women’s 
groups implemented & assessed strategies. 
Information through iterative design & picture card 
games. Health service strengthening – as control. 
12 clusters (3303 births): Health 
service strengthening undertaken; 
primary health centres equipped 
with resuscitares, phototherapy 
units, warm cots, neonatal 
resuscitation equipment. 
Remedied short falls & discussed 
strategies for resupplies of 
neonatal drugs. Essential 
newborn care training health staff 
& TBAs. Community based 
workers received newborn care 
kits containing suction, 
resuscitation equipment, iodine 
gauze, wrapping cloth, pictorial 
manual. 
Primary NMR 
Secondary: Stillbirths, 
MMR, uptake of 
antenatal/delivery 
services, homecare 
practices, infant 
morbidity, health-care 
seeking. 
Closed cohort married women 
15-49 Jun 2000, living rural 
Nepal. Pregnancies registered 
Nov 2001 – Oct 2003. Women 
included: married with 
potential to become pregnant. 
Excluded separated or 
widowed women. 24 clusters 
(average population 7000 per 
cluster). 
Table 9 Study characteristics of included studies in the review 
9
9 
 
 
100 
 
Azad: 2010  9 clusters (15695 births): Women’s group 
facilitators visited every tenth household in 
intervention clusters & invited married women of 
reproductive age to join. Mothers-in-law, 
adolescents, other women joined later. Groups 
facilitated by local female peer facilitator. 
Facilitators 5 training sessions that covered 
communication, maternal & neonatal health 
issues. Health service strengthening and basic 
training of TBAs – as control. 
9 clusters (15257 births): Health 
service strengthening, basic TBA 
training, included improving 
referral systems & links with 
health services, between different 
levels health services. Resources 
& refresher clinical training 
maternal & neonatal care, 
information, education & 
communication materials. 
Training refreshing knowledge 
pregnancy & birth care, 
recognition of danger signs in 
mother & baby, essential newborn 
care, clean birth kits. 
Primary: NMR 
Secondary: MMR, 
stillbirths, uptake of 
antenatal and delivery 
services, home-care 
practices during and 
after delivery, infant 
morbidity, health-care 
seeking behaviour, 
PMR, early NMR, late 
NMR 
Open cohort women 15-49 in 
rural Bangladesh giving birth 
Feb 05 – Dec 07.18 clusters 
(average population 27953 per 
cluster).  
 
More: 2012  24 clusters (9155 births): Women’s groups full-
time facilitator in each (1000 households). 
facilitator was local woman with secondary 
education & leadership skills married with 
children. regular training on healthcare topics. 
Over six months each facilitator set up 10 groups. 
Groups met fortnightly, & facilitator weekly with 
other facilitators & supervisor. Women’s groups 
followed 36 meeting cycle, attended by women, 
pregnant & non-pregnant.  
24 clusters (9042 births):No 
details for control clusters 
Primary: Stillbirth, 
NMR, PMR, perinatal 
care, maternal 
morbidity. Secondary: 
MMR, Antenatal care, 
iron supplementation, 
nutrition and rest, 
institutional delivery, 
breastfeeding, 
newborn care seeking  
Women recruited Oct 06 -Sept 
09  urban Mumbai slums. 
Excluded women from 
transient communities & areas 
of resettlement. 48 clusters 
(average cluster population 
5865).  
 
Lewycka: 2013  24 clusters (9374 births): Women’s group 
intervention supported by female facilitator, (20 
meetings). Meetings facilitated by local literate 
woman aged 20-49, at least one child. trained 11 
days, refresher 4 months. Strategies evaluated & 
plans made for future meetings. Groups restricted 
to females, expanded to men later.  Health service 
strengthening – as control. 
 
24 clusters (9749 births) 
strengthening of health services. 
Health workers from facilities had 
theory & practical training in 
essential newborn care, life-
saving skills, safe motherhood, 
orientated two interventions. 
Neonatal resuscitation equipment 
donated to facilities. Prevention of 
mother to child transmission of 
HIV (PMTCT) project introduced  
Primary: MMR, PMR, 
IMR. Secondary: 
Maternal, infant 
morbidity, use of SBA, 
postnatal services, 
tetanus toxoid 
immunization, malaria 
prophylaxis, 
insecticide-treated 
nets, PMTCT services, 
infant immunizations, 
Open cohort of women 10-49. 
Women with permanent family 
planning excluded. 48 clusters 
(average cluster population of 
8000).  
1
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2005, scaled  to all facilities 2008 breastfeeding. 
Colbourn: 2013 15 clusters (10331 births): Participatory women’s 
groups to mobilise communities around maternal 
and newborn health, using volunteer facilitators. 
Facilitators formed 9 women’s groups. In 2009 
women’s groups chose maternal & neonatal 
health as a strategy to focus on (50%) had 
maternal & neonatal health task forces added to 
enhance antenatal coverage, maternal, neonatal 
health knowledge, facility delivery.  . 
17 clusters (10260 births): No 
details reported. 
Primary: MMR, NMR, 
PMR. Secondary: 
Deliveries at health 
facility; percentage of 
maternal deaths 
subjected to maternal 
death audit, case 
fatality rates, practice 
of signal obstetric care 
functions. 
open cohort pregnant women 
from rural Malawi Oct 2008-
Dec 2010. 32 clusters 
(average cluster population 
4000 people).  Cluster was 
catchment population of a 
health centre. Areas excluded 
if health facilities provided 
comprehensive emergency 
obstetric care or were non–
functioning. Urban facilities 
were also excluded due to 
transient nature of urban 
communities. 
Fottrell: 2013 9 cluster (9107 births): In addition to 162 women’s 
groups already set up (Azad, 2010) 648 new 
groups formed by newly recruited facilitators to 
increase population coverage. Original groups 
continued to meet on monthly basis from late 
2004-Jun 2011, focus expanded beyond maternal 
& newborn health to include women’s health & 
health of under-fives. From Jan 2009 new groups 
had cycle of monthly meeting on maternal & 
newborn health.  Health system strengthening 
initiatives – as control  
 
9 clusters (8835 births): 
Health system strengthening 
initiatives including provision of 
basic medical equipment, TBA 
training of essential newborn 
care, refresher training for 
physicians & establishing links 
between communities & health 
services   
Primary: NMR,  
Secondary: Stillbirth, 
NMR PMR, pregnancy 
related mortality. 
Facility delivery, home 
delivery, clean birth 
practice, thermal care 
of newborn, infant 
feeding, health service 
utilisation 
 
Open cohort of women rural 
Bangladesh, permanent 
residents, delivered Jan 2009-
Jun 2011. Temporary 
residents excluded.  N.B. 
clusters same as Azad 2010. 
1
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Study Pregnant 
women 
per group 
% 
Coverage 
group 
Allocation Area  Facilitators per  
cluster 
Meeting 
frequency 
Existing cluster activities  Education level/literacy of 
cluster 
Manandhar 
2004 
 37 756 Pair 
matched 
60 km
2 
1 per cluster Monthly 
per ward 
Some groups set up by 
local female community 
health volunteers already 
existed but activities were 
sporadic 
none: 82% primary: 12% 
secondary or higher: 7% 
illiterate: 66% 
Azad      
2010 
3 1414 stratified NR Each facilitator 
18 groups 
Month NR none: 50% primary: 32% 
secondary or higher: 18% 
Tripathy 
2010 
37 468 stratified NR Each facilitator 
13 groups per 
month 
Monthly 18 clusters-172 existing 
women’s groups involved 
in savings & credit 
activities. 
none: 78% primary:6 % 
secondary or higher: 16% 
More      
2012 
2 788 NR NR 1 per cluster fortnightly slum women’s groups 
existed in some clusters, 
focus on single issues  
none:23.7 % primary: 5.2% 
secondary or higher:71.1% 
Colburn  
2013 
10 1200 stratified NR Each 
facilitator:9 
women’s 
groups 
NR NR NR 
Fottrell   
2013 
36 309 Stratified NR NR Monthly 162 women’s groups 
already set up continued 
monthly meetings until 
June 2011 
none: 25.2% primary: 36% 
secondary or higher:38.8% 
illiterate: 29.8% 
Lewycka 
2013 
51 440 NR NR 1 per cluster NR NR none: 20% primary:73% 
secondary or higher: 7% 
Table 10 Characteristics of clusters in interventions groups of included studies 
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Table 11 CONSORT Checklist – Assessment of reporting in the included studies  
Item Checklist item (with extension for cluster) Manandhar 
2004 
Azad 
2010 
Tripathy 
2010 
More 
2012 
Colburn 
2013 
Fottrell 
2013 
Lewycka 
2013 
Title and abstract 
 Identification as RCT in title Y Y Y Y Y Y Y 
Structured summary design, methods, results, 
conclusions  
Y Y Y Y Y Y Y 
Introduction 
Background & 
objectives 
Scientific background & explanation of rationale  Y Y N N N N Y 
Specific objectives or hypotheses  N N N N N N N 
Methods 
Trial design Description of design including allocation ratio  N N N N N N N 
Changes after trial commencement with reasons n/a n/a n/a n/a n/a n/a n/a 
Participants Eligibility criteria for participants  Y Y Y Y Y Y Y 
Settings & locations where data collected Y Y Y Y Y Y Y 
Interventions Interventions per group with details  Y Y Y Y Y Y Y 
Outcomes Pre-specified outcome measures  Y Y Y Y Y Y Y 
Changes to outcomes after commenced n/a n/a n/a n/a n/a n/a n/a 
Sample size Sample size determined: Method of calculation, 
number of clusters(s) size, coefficient intracluster 
correlation, uncertainty 
Y Y Y Y Y Y Y 
explanation of interim analyses & stopping guidelines n/a n/a n/a n/a n/a n/a n/a 
Randomisation: 
 Sequence 
generation 
Method to generate random allocation sequence Y Y Y Y Y Y Y 
Randomisation; details of any restriction  Y Y Y Y Y N Y 
 Allocation 
concealment  
Random allocation sequence, steps taken to conceal 
the sequence until interventions assigned  
 Y Y Y Y Y N Y 
 Implementation 
 
Random allocation sequence,  participant enrolment Y Y Y Y Y N Y 
Who generated random allocation sequence, 
enrolled clusters & assigned clusters to interventions 
Y Y Y Y Y Y Y 
Mechanism by individual participants included in 
clusters for purposes of trial  
Y Y Y Y Y Y Y 
where consent was sought  & whether consent 
sought before or after randomisation 
Y Y Y Y Y Y Y 
1
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Blinding who blinded after assignment to interventions  Y Y Y Y Y Y Y 
description of similarity of interventions N N N N N N N 
Statistical 
methods 
Statistical methods to compare groups outcomes Y Y Y Y Y Y Y 
additional analyses,  Y Y Y Y Y Y Y 
Results 
Participant flow  numbers randomly assigned, received intended 
treatment & analysed for primary outcome 
Y Y Y Y Y Y Y 
losses & exclusions after randomisation, with 
reasons 
Y Y Y Y Y Y Y 
Dates of recruitment & follow-up Y Y Y Y Y Y Y 
Why the trial ended or was stopped n/a n/a n/a n/a n/a n/a n/a 
baseline demographic, clinical characteristics  Y Y Y Y Y Y Y 
Numbers 
analysed 
participants included in analysis & whether analysis 
by original assigned groups 
Y Y Y Y Y Y Y 
Outcomes and 
estimation 
primary & secondary outcome, results & the 
estimated effect size & its precision  
Y Y Y Y Y Y Y 
binary outcomes, presentation of both absolute & 
relative effect sizes is recommended 
Y Y Y Y Y N Y 
Ancillary 
analyses 
Results of other analyses performed, subgroup, 
adjusted analyses, distinguishing pre-specified from 
exploratory 
Y Y Y Y Y Y Y 
Harms important harms or unintended effects in each group  N N N Y Y N N 
Discussion 
Limitations Trial limitations, sources of potential bias, 
imprecision, &, multiplicity of analyses 
Y Y Y Y Y Y Y 
Generalisability Generalisability of the trial findings Y Y Y Y Y N Y 
Interpretation Interpretation consistent with results, balancing 
benefits & harms, & considering relevant evidence 
Y Y Y Y Y N Y 
Other information 
Registration Registration number and name of trial registry N N N N N N N 
Protocol full trial protocol can be accessed, if available N N N N N N N 
Funding funding and other support, role of funders Y Y Y Y Y Y Y 
Y = Reported N = Not Reported N/A = Not Applicable 
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Table 12 Assessment of Risk of Bias in included studies 
Random sequence 
generation* 
Allocation 
concealment* 
Blinding of 
participants and 
personnel 
Blinding of outcome 
assessment 
Incomplete 
outcome data 
Selective 
reporting 
Other bias 
Manadhar: 2004 
LOW: Page  971: 
Matched 42 
clusters, 21 pairs 
topographic 
stratification, ethnic 
group distributions, 
& population 
densities. List of 
random numbers 
used to select 12 
pairs. 
LOW: Page 971: 
Randomly 
allocated one 
cluster per pair to 
intervention or 
control on basis of 
coin toss. 
HIGH: Page 972: 
Due to nature of 
intervention trial 
allocation not 
masked.  
 
HIGH: Page 972: 
Analysis of primary & 
secondary outcomes 
not done until before 
data monitoring 
committee meeting 
at 30 months, not 
stated if assessors 
blinded. 
LOW: Page 975, 
figure 3: Loss to 
follow up 5.4% and 
5.0% in intervention 
&control. 
breakdown  in 
figure 3 
LOW: Page 
975: All 
outcomes 
reported. 
Table 3,4 
LOW: Page 976: 
Small baseline 
difference in 
poverty and 
literacy 
favouring 
intervention. 
Authors do not 
consider these 
could account 
for differences in 
mortality.  
More: 2012 
LOW: Page 3: “In 
transparent 
process, social 
workers external to 
trial drew lots to 
select 48 clusters in 
blocks of eight per 
ward”. 
LOW: Page 3: 
same process 
used to allocate 
four clusters per 
block to 
intervention and 
control. “chose 
this method 
because of 
emphasis on 
participation and 
demystification of 
research.” 
HIGH: Page 3: 
nature of intervention 
precluded allocation 
concealment. 
HIGH: Page 4: 
Analysts blind to 
allocation. Page 7: 
local residents birth 
and death identifiers 
were aware of 
intervention in 
community, but 
focused on their task 
and did not dwell on 
comparative nature 
of trial. 
 UNCLEAR: Page 5 
figure 2: Achieved 
interviews for 84% 
and 83% births in 
intervention and 
control.  Some 
disparity across 
arms between 
interviews follow up 
of stillbirths and 
neonatal deaths. 
LOW: Page 
7,9: All 
outcomes 
reported  
LOW: Page 4: 
Baseline 
difference in 
age, Islam faith, 
poverty index, 
neonatal 
mortality. 
Unadjusted are 
primary analysis 
but adjusted 
analyses given.    
Azad: 2010 
1
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LOW: Page 1194: 
Clusters “randomly 
allocated to 
intervention or 
control stratified by 
district in presence 
of project staff and 
external individuals. 
Cluster names 
written on pieces of 
paper, folded and 
placed in a bottle.” 
LOW: Page 1194: 
For each district 
first three cluster 
names drawn 
from bottle 
allocated to 
women’s group 
intervention and 
the remaining to 
control. project 
manager drew 
papers from 
bottle. allocation 
sequence decided 
upon by project 
team before 
drawing papers. 
HIGH: Page 1195: 
“Neither study 
investigators nor 
participants masked 
to group allocation.” 
HIGH: Page 1195: 
No specific details 
given for those 
analysing data  
LOW: Page 1198: 
Interviews 
completed 84% and 
82% births in 
intervention and 
control. Main 
reason across 
groups for failure to 
interview was 
maternal migration  
LOW: Page 
1199: All 
outcomes 
reported  table 
2,3 
HIGH: Page 
1194: Control 
clusters 
included three 
areas with  
substantially 
worse health & 
socioeconomic 
indicators than 
rest of study 
area. 
researchers did 
not know this 
difference 
before 
recruitment and 
allocation of 
clusters 
therefore not 
excluded before 
allocation. 
Adjusted 
analyses 
undertaken but 
primary 
analyses all 
Tripathy: 2010 
1
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 LOW:Page 1183: 
external observer 
drew folded papers 
with numbers 
corresponding to 
clusters. done 
separately for each 
district. 
LOW: Page 1183, 
figure 2: first 
clusters drawn 
from basket 
allocated to 
intervention 
group, rest to 
control. 
undertaken in 
presence of 
external 
observers.  
HIGH: Page 1183: 
“Because of nature 
of intervention, 
neither intervention 
team nor participants 
were masked to 
assignment during 
trial.” 
HIGH: Page 1191: 
“no incentives or 
disincentives for 
under or over 
reporting deaths and 
births and several 
processes put in 
place to detect error” 
LOW: Page 1187, 
figure 6: Loss to 
follow up <1% and 
2% in intervention 
and control. 
LOW: Page 
1187: All 
outcomes 
reported table 
2,3  
LOW: Page 
1187: baseline 
differences 
show greater 
poverty and 
disadvantage in 
intervention 
clusters. 
Adjusted 
analyses given, 
do not influence 
findings. 
Colburn: 2013 
1
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LOW: Page 6: 
“Clusters allocated 
to each, both or no 
intervention with 
random number 
sequence. 
Randomisation 
stratified by 
interventions and 
district, numbers of 
intervention and 
control in each 
district balanced.” 
LOW: Page 6: 
ensure 
concealment of 
intervention 
allocation, 
identification 
numbers 
assigned for each 
cluster and 
random number 
generated for 
each. numbers 
sorted in 
ascending order, 
and new 'order' 
variable 
generated. 
sequence used to 
allocate each of 
intervention 
groups. sequence 
concealed until 
interventions 
assigned. One 
researcher 
generated 
allocation 
sequence and 
assigned clusters 
to groups in 
presence of two 
researchers.  
HIGH: Page 6: 
Neither participants 
nor those 
administering 
interventions blinded 
to group assignment. 
HIGH: Page 6: 
analysis plan was 
pre-specified before 
final analysis carried 
out. 
HIGH: Page 10: 
29% loss to follow 
up. Authors 
suggest birth rates 
in study matched 
expected from 
crude birth rate 
within 3%, and in-
migration probably 
broadly matched 
out-migration, many 
pregnancies 
recorded by key 
informants as ‘lost 
to follow-up’ may 
have been 
recorded as 
pregnancies by 
mistake, true loss-
to-follow-up 
probably much 
lower. Little 
difference in loss-
to-follow-up 
between arms. 
maternal deaths 
verified, 299/2087 
(14.3%) stillbirths 
and neonatal 
deaths unverified. 
LOW: Page 
10: All 
outcomes 
reported tables 
2-6 
LOW: Page 13: 
No data on 
individual level 
covariates. 
Small cluster 
variations found, 
adjustments 
made no 
difference to 
unadjusted 
models.   
Lewycka: 2013 
1
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LOW: Page 8: 
Random number 
sequence 
generated 
LOW: Page 8: 
Clusters allocated 
randomly. Two 
researchers 
allocated clusters 
using random 
number 
sequence. 
HIGH: Page 8: 
nature of 
interventions 
masking of allocation 
impossible at 
participant level. 
 
HIGH: Page 8: 
Masking at level of 
analysis and trial 
monitors.  Data 
collected 
independently, 
implementation no 
results fed back to 
inform intervention. 
LOW: Figure 4: 
Participants loss to 
follow up accounted 
for. 
LOW: Page 
17: All 
outcomes 
reported tables 
3-6 
UNCLEAR: 
Page 17: Some 
small baseline 
difference. 
Limitations 
section in 
discussion 
difficult to follow 
Fottrell: 2013 
LOW: Page 2: 
Same 
randomisation 
sequence in Azad 
2010 
LOW: Page 2: 
Same allocation 
concealment in 
Azad 2010   
HIGH: Page 3: 
Neither study 
investigators nor 
participants masked 
to group allocation.  
HIGH:  No details 
given for analysts. 
LOW: Page 5: 99% 
of interviews 
completed, 
interviews not 
completed due to 
maternal migration 
LOW: Table 2: 
All outcomes 
reported 
LOW: No other 
bias  
 
 
1
09
 
 
 
110 
 
CHAPTER 5: MATERNAL EMERGENCY TRANSPORT IN LOW AND 
MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW AND THEMATIC 
SYNTHESIS OF QUALITATIVE STUDIES 
ABSTRACT 
Background: Most maternal deaths are preventable with emergency obstetric care, 
therefore ensuring access to healthcare services is essential. A core component of 
access to care is emergency transport. Despite the acknowledged link between 
availability and accessibility of transport and health, there is little focused information 
on emergency transport of pregnant women.  
Methods: Systematic review and thematic synthesis of qualitative studies on transport 
for emergency obstetric care. MEDLINE, EMBASE, BNI, Cochrane library, CINAHL, 
African Index Medicus, ASSIA, QUALIDATA, the Reproductive Health Library, and the 
Science Citation Index were searched (inception-April 2012) without language 
restriction. Studies using qualitative methodology (focus groups and interviews) were 
included.  
Results: Searches identified 29 relevant articles. Eight major themes were identified: 
time for transport, transport options, geography, local support, autonomy, culture, 
finance, and ergonomics. Key issues were availability and speed of transport, terrain 
(mountainous, flooded or eroded), meteorological (rain or heat), support (family, 
community and professional), dependence on others for decision-making, cultural 
issues (preference for traditional health worker, embarrassment and beliefs), cost, lack 
of comfortable and safe positioning during transport.   
Conclusions: Individual themes should be appreciated within local context to provide 
illumination on local barriers and facilitators. Some potential solutions include 
motorcycle ambulance programme or collaboration with local minibus taxi services, 
community education and empowerment (raising awareness with women, partners, 
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birth attendants and leaders), subsidies, insurance schemes and vehicle and road 
maintenance.  
 
Impact of review: Published in International Journal of Gynecology and Obstetrics, 
informed ongoing transport project in Pakistan 
 
Citation of published work on which this chapter is based:  
Amie Wilson, Sarah Hillman, Mikey Rosato, John Skelton, Anthony Costello,  Julia 
Hussein, Christine MacArthur, Arri Coomarasamy:  A systematic review and thematic 
synthesis of qualitative studies on maternal emergency transport in low-middle income 
countries. International Journal of Gynecology and Obstetrics. 2013:122: pp192–
201 
 
5.1 BACKGROUND 
Transport and health are inextricably linked, with transport services relating to 
numerous aspects of healthcare, not just moving patients to a place of care. Transport 
systems are needed to ensure attendance of healthcare providers and adequate 
medical supplies including equipment, drugs and blood for transfusion services. 
Numerous reports have suggested mobility and transport as key requirements and 
determinants for health (138-142). Within the UK, the National Health Service 
acknowledges the positive impacts that an effective and affordable transport system 
can have on health outcomes (143), particularly in emergency cases. 
 
In many low income countries  it is estimated that less than one percent of the 
population has access to conventional emergency transport, such as an ambulance 
(144).  Motorised vehicle ownership is rare in low income countries, with the vehicle to 
person ratio as low as 30:100,000 people. Such shortage of vehicles means that very 
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few people have access to transport for work, social or health purposes, even though 
transport systems were recognised as a fundamental human need over three decades 
ago (145).  For many, access to transport services is not within easy reach; in Ethiopia, 
approximately half of all rural households had to travel distances over 15km to access 
public transport (141).  Even if vehicles were available in many low income countries, 
road systems are insufficient (146), and often unsafe (147).  
 
Most births in low and middle income countries occur outside of health facilities (138), 
and as most obstetric complications are unpredictable, access to emergency care in a 
timely manner is essential to reduce preventable deaths. Transport has a critical role in 
achieving MDGs 4 (reducing child mortality), 5a (reducing the maternal mortality) and 
5b (achieving universal access to reproductive health care)(148).  The majority of 
research on transport and health is concentrated on high income countries, and relates 
to safety (140, 149), or the associated health risks with specific modes of travel (e.g. 
flying  and deep vein thrombosis (139). The research conducted in low and middle 
income countries often relates to pollution or the spread of communicable diseases 
such as HIV (139). There is little focused and rigorously evaluated research on 
emergency transport of pregnant women (139, 141, 149-151).  Many reports that 
explore the role of transport on maternal health do not take into account the cultural, 
geographical and financial barriers to effective, efficient and acceptable transport. 
There is also limited synthesis and insight on emergency transport of pregnant women 
(139, 141, 149, 150). 
 
In this systematic review, we examine the qualitative literature on maternal emergency 
transport to explore people’s experiences of using transport, the options available to 
them and the barriers and facilitators encountered. We focussed on qualitative studies 
to elicit insights on how transport systems work and what might be done to improve the 
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acceptability and availability of different transport modalities, to improve policy and 
programme interventions relating to transport. 
 
5.2 METHODS  
Data sources and searches 
Databases were systematically searched for qualitative studies on emergency transport 
in low and middle income countries. MEDLINE, EMBASE, BNI, Cochrane library, 
CINAHL, African Index Medicus, ASSIA, QUALIDATA, the Reproductive Health 
Library, and the Science Citation Index (inception – April 2012) were searched without 
language restriction. Hand searching complemented electronic searches. The search 
terms were ‘ambulance’, ‘motorbike AND ambulance’, ‘bicycle AND ambulance’, 
emergency AND referral’, ‘emergency AND access’, ‘emergency AND transport’, and 
‘ambulance AND emergency’. These terms were selected iteratively through scoping 
searches (76). Qualitative filters were used to refine the search (‘focus group’, 
‘qualitative’, ‘observational methods’, ‘interview’, and ‘narrative’). Studies were included 
if they contained qualitative data alone or if they had both qualitative and quantitative 
data.  
 
Study selection and data extraction 
Studies presenting primary data and utilising qualitative data collection methods 
(interviews and focus groups) were included if they reported the processes and 
experiences of emergency transportation to a place of emergency care in low and 
middle income countries.  Studies that had no information on emergency transport, no 
qualitative data and no primary data were excluded. Studies from countries not 
classified by the World Bank as low or middle income were excluded (152).  Titles and 
abstracts were scrutinised by the author plus another reviewer (AW and SH) and full 
manuscripts of studies meeting the inclusion criteria were acquired; disagreements 
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were resolved by discussion with a third reviewer (AC). Some studies which did not 
address maternal transport exclusively, but had relevant qualitative information were 
included.  
 
Comprehensiveness of reporting:  
Independent assessment of the reporting criteria was performed by the author plus 
another reviewer (AW and SH), using the COREQ framework of the consolidated 
criteria for reporting qualitative research.  This framework aims to assess the 
trustworthiness and transparency of studies within their settings, by focusing on the 
research team and reflexivity, study design, and data analysis and reporting. (72) 
 
Synthesis of findings:   
Information was extracted on study characteristics, study quality and outcome data.  
Thematic synthesis (76) was used for analysis through examination and translation of 
common elements across the studies that explored transport in emergency obstetric 
care. Quotes from respondents and relevant texts in all studies were analysed by the 
author plus another reviewer (AW and SH). Both authors read and re-read texts. The 
data were then labelled to develop a code (75). Initial codes closely reflected the 
quotes from the manuscript. Codes were continuously refined and altered as more 
quotes were added. Codes then lead to the development of themes and a thematic 
framework was developed. The thematic framework was agreed between the author 
and another reviewer (AW and SH). Having applied the thematic framework to 
individual manuscripts, in order to build up a picture of the data as a whole and to 
consider the range of each theme, the data was charted. Charts were developed using 
themes against individual manuscripts. This method sought to develop an analytical 
framework, ensuring that the themes built up were cross-checked with other data within 
and then between studies, so that the validity of emerging explanations was tested and 
improved. This framework is shown in Figure 22. 
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5.3 RESULTS 
The literature search and study selection process is given in Figure 14.  Twenty nine 
qualitative studies providing information on transport for emergency healthcare in low 
and middle income countries were included in this review. Study characteristics are 
included in Table 12, including participants, sample size, study setting, methodology 
and analytical process used, and the main themes explored in the study. 
 
Study characteristics 
All studies were set in developing countries. Five studies focused on the perspectives 
of transport officials or stake holders (149, 153-156), five studies on transport providers 
or operators (141, 144, 157-159) and two studies also focused on transport users (159, 
160). Two studies focused on the perspectives of stake holders from the health sector 
(149, 154) and eleven studies focused on the perspectives of healthcare workers (161) 
(144, 155, 156, 159, 162-167).  Six studies focused on the perspective of women who 
had experienced pregnancy complications (136, 141, 144, 168-170), and eleven on the 
family members of the pregnant women (14, 137, 156, 160, 161, 167-169, 171-173).  
Some studies gave multiple perspectives. Seven studies specifically addressed issues 
relating to transportation of pregnant women (136, 141, 149, 160, 165, 169, 174), 
whereas nine studies looked at emergency transport within wider issues relating to 
healthcare access (154, 156-159, 162, 163, 166, 170). 
 
Fifteen studies collected data through the use of focus groups (136, 144, 149, 154-157, 
159, 160, 163, 164, 166, 169, 174, 175) and twelve studies collected data through 
interviews (14, 137, 153, 158, 162, 165, 167, 168, 170-173). 
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Figure 22 Data analysis framework used in the review 
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Figure 23 Study selection process and literature included within the review 
1
17
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Table 13 Study characteristics of studies included in the review
Study Perspective Focus of paper Data collection Method
*
 
Setting Participants Themes Response Analysis 
*
 
Benegusenga 
(149)
 
Stake holders of health & transport sectors. 
people at health centres 
Ingobyi transportation FGD. Int PA 
Rwanda 97 in Focus groups TOGEF NR NR 
Berhanu 
 (141)
 
Medical personnel, patients, transport 
operators/users. 
Safe transport for high risk patients  Qs. Int MM 
Ethiopia NR TOSGFE NR NR 
Brentlinger 
(161) 
Health workers, heads of households, village 
& council members, community leaders 
Utilisation of pregnancy related service  Survey. Int MM 
Mexico 1227 women TGCF 20 houses not int NR 
Cham 
(14) 
Family members, persons present at death Socio-cultural & health service factors 
associated with maternal death 
Int VA 
Gambia NR TOSGFEA 10 cases NR GT 
D’ambruoso 
(171)
 
Relatives of dead women  Causes of maternal death & Socio cultural 
factors. 
Int VA  
Burkina Faso, 
Indonesia 
174 Relatives  
TOACFE 
NR TA 
D’ambruoso 
(172)
 
Final caregivers Access to healthcare in obstetric 
emergencies 
Int VA 
Indonesia Families of 104 deceased women TGFE NR TA 
Hasan 
(157)
 
Community members, transport operators, 
doctors, nurses. 
Relationship between mobility & access to 
health in remote areas 
FGD. PA NR 
Bangladesh 300 households, 104 participants TOGFE NR NR 
Kawuwa  
(153)
 
Community, governmental or, female 
leaders, teachers, transport unions. 
Maternal mortality Factors. Barriers to 
treatment of obstetric issues.  
Int NR 
Nigeria 30 interviewees SFG NR NR 
Lori  
(168)
 
Women with severe morbidity/near-miss, 
family/carers of dead 
Circumstances surrounding maternal 
mortality & severe morbidity 
Int Descriptive  
Liberia 148 cases TOF NR DA 
Lungu  
(169)
 
Elders, chiefs, childbearing women/partners Bicycle ambulances for referral of pregnant 
women 
FGD. Int MM 
Malawi 10 villages.30 Focus groups. 92 Interviews ACF NR Iterative 
Magnanya  Stakeholders in the transport and health Linkages between mobility & health FGD Exploratory  
1
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(154) sector 
Kenya 389 respondents TOSGFE NR PHA 
Mashiri  
(162)
 
Homecare practitioner, leaders, community 
members, health officials 
Influence of mobility and access on rural 
healthcare 
Int. Qs. FGD MM 
South Africa 36 Interviews. 3 Focus groups TOSGCFE NR NR 
Mlay  
(136)
 
Women with obstetric emergencies or of 
reproductive age and men 
Emergency transport needs of rural 
pregnant women 
FGD. Int. Qs MM 
Tanzania 250 Interviews. 24 Focus groups TOSGACFE 7/10 attended TA 
Muleta  
(155)
 
Health professional, road authority officials Factors of healthcare facility access, 
development of obstetric fistula 
FGD. Int Case control 
Ethiopia 170 participants TOSGAFE NR LR 
Nyamandi 
(144)
 
Childbearing women, village heads or health 
workers, parents, leaders, uhuru riders 
Impact of the community ambulance among 
the community  
FGD. Int. CS MM 
Zimbabwe 120 Interviews. 10 Focus groups TOSGCFE NR NR 
Oyesola 
(164)
 
Community members, nurses, doctors, 
management personnel 
Attitudes, perceptions and practices to 
health care institutions.  
FGD. Int NR 
Nigeria NR OSGA NR NR 
Peterson 
(175) 
Neighbourhood caretakers. Referral of severely ill children to hospital FGD MM 
Uganda 18 Focus groups TOAF 77%  after 2/52 DA 
BEN 
(159) 
 
transport users, healthcare providers, 
transport providers, local authorities 
Relationship between access to health and 
access to transport 
FGD. Int MM 
Namibia 118 transport users, 43 health providers, 23 
transport providers  16 local authority 
members 
TOSACFE NR NR 
Maine 
(163)
 
Health providers. Barriers of health-care facilities when 
obstetric problems arise 
FGD FGD 
Nigeria, 
Ghana, Sierra 
Leone 
184 Focus groups TOSGACFE NR TA 
Price  
(170)
 
childbearing women  Women’s perceptions of barriers to EOC 
services, quality of care. 
Int Key 
Informant 
Nepal NR TOGSC NR AF 
Razzak  
(158)
 
Administrators of ambulance service and 
inpatients  
Prehospital system, mode of transport 
used, barriers to ambulances 
Int Int 
Pakistan 92 patients, 7 ambulance administrators TOGAF 1 refused EpiInfo 
1
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Samai  
(174)
 
community members Mode of referrals and transportation  FGD Preparatory 
Sierra Leone NR TGF NR NR 
Schmid 
(165)
 
Community members, leaders, healthcare 
providers/workers and traditional healers 
Emergency transportation plans for urgent 
obstetric care. 
Int MM 
Tanzania 110 Interviews GA NR NR 
Shehu 
(166)
 
community members, healthcare workers Transportation problems, causes of poor 
use of health services 
FGD.CS MM 
Nigeria NR TOSAFG NR NR 
Strestha  
(156)
 
Mothers, fathers, grandmothers, health 
workers, district officials, transport 
organisations, 
Transport barriers for health service access 
for females/poor people.   
FGD.Int.CS MM 
Nepal 93 mothers and 121 health service users TOSGCFA NR DA 
Terra 
deSouza 
(137) 
Mothers/female relatives of dead infants Factors contributing to neonatal deaths. Int VA 
Brazil 127 households OSF NR TA 
Turan  
(173)
 
Fistula patients and family members Community mobilization and safe 
motherhood education 
Int Ethnographic 
Eritrea 11 new patients, 5 family members, 15 follow 
up patients 
TOSAG 26/102 DA 
Urassa  
(167)
 
Relatives of dead women, healthcare staff Operational factors in maternal death  Int VA 
Tanzania 117 maternal deaths TOF NR NR 
Whitby 
(160)
 
Staff, widows, transport users, women, 
health assistants, women’s reps, fathers, 
couples 
Mobility in maternal health  FGD.Int.CS.PA MM 
Indonesia 18 Focus group (15 participants each), 112 
Interviews. 18 villages each (approx 20 
participants) 
TOGACFE NR NR 
Key E Ergonomics NR Not reported 
* as reported by the authors TA Thematic analysis T Time for transport 
Int Interviews GT Grounded Theory O Transport options 
MM mixed methods DA Descriptive analysis S Local Support 
1
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Qs Questionnaires LR Logistic Regression G Geography 
CS case study PHA Phenomenological analysis A Autonomy 
VA Verbal autopsy AF Analytical Framework C Culture 
FGD Focus group discussion PA Participatory approach F Finance 
1
21
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Comprehensiveness of reporting of included studies 
The comprehensiveness of reporting according to the COREQ checklist, varied across 
the studies (Table 14). Characteristics of the research team were reported in less than 
40% of the papers (11/29) and the interviewers’ relationship with the participants was 
reported in just 21% (6/29). The theoretical framework used was reported in 24% 
(7/29), although the sampling of participants was better described in 83% (24/29).  
Over half of the studies (62%, 18/29) provided an adequate description of the sample.  
The research setting was described in 55% (16/29) and the details of the interview 
guide were given in 45% (13/29). Derivation of the themes was reported in 66% 
(19/29). All studies (100%) showed consistency in data findings and reporting, and 
86% (25/29) demonstrated clarity in reporting and presenting the major themes 
evolving from the study. 
 
Synthesis 
Many forms of motorised and non-motorised transport were used to access emergency 
obstetric care in low and middle income countries. Non-motorised transport modes 
included carrying, animal transport, bicycle, and walking.  Motorised transport included 
cars, motorcycles, public and commercial transport, ambulances and jeeps. Various 
forms of motorised and non-motorised water transport were also used for emergency 
transport.  The framework used is shown below 
 
Eight major themes were identified Figure 24 . These were: time for transport, transport 
options, geography, local support, autonomy, culture, finance and ergonomics.  Key 
quotes illustrating these themes, drawn from the studies, are provided in Table 14. 
Table 14 contains quotes that are grouped according to the final themes that 
developed. 
 
 
 
 
123 
 
Figure 24 Themes and sub-themes indentified in maternal emergency transport 
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Time for transport 
This theme involves the time spent waiting for transport and the time spent travelling 
(speed of transport and distance covered). Eight studies reported travel and waiting 
time (14, 136, 144, 159, 160, 171, 172, 175). 
 
Travel time: Various travel times and speeds of emergency transport were reported in 
the literature, ranging from 10 minutes to one full day to reach a health facility. Twelve 
studies reported the journey as being between two to six hours (136, 155-157, 160, 
161, 166-168, 171, 173, 174) and six studies reported the time travelled as being in 
excess of six hours (136, 155, 156, 160, 166, 174).  
 “People must walk an hour and a half to get to the asphalt road”(160);   
Long transport time was associated with mortality by the authors in three studies (156, 
161, 167), and a timely transfer in one study demonstrated a favourable maternal 
outcome, whereas the majority emphasised the link between a lengthy journey and 
maternal death. One study reported an increase in mortality by 9% for every thirty 
minutes of vehicular travel. (176) 
 “My life was saved as the Uhuru* served me when I had complications at my last 
delivery. I was transported from the clinic to the hospital just in time and at a very low 
price”(144);  
“We took her to the health centre in the village... She was examined by a nurse who 
later transferred her to another health centre (44km away). There she spent the night, 
the following morning she was transferred to the hospital (36km away), on our way we 
had to cross the river at two different crossing points. Immediately after we reached the 
hospital she died”(14). 
*Motorcycle ambulance 
 
Waiting times: Participants in seven studies commented on the amount of time they 
had spent searching for, or waiting for transport to arrive; (14, 136, 144, 159, 160, 166, 
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175) a wait of up to two days was reported in two studies.(136, 166) Maternal and 
neonatal deaths were reported while waiting to travel by public transport. (177)   
 “I waited for transport [local public bus] for two days because the bus, the only one that 
comes to our village was out of order.”(136);   
“Patients get exhausted and even die whilst waiting for an ambulance”(159)  
 
Transport options 
Nine studies reported difficulties in finding transport, (136, 144, 155, 156, 160, 164, 
171-173) and participants from two studies described the complete lack of 
transportation (14, 171). 
“We looked for transport in the village throughout the night but could not get one”(14);  
“Men carried me on their shoulders to a bus stop at Erri Central (about 14 km from 
Kokmay) where I boarded a local bus to Babait Hospital. There was not any other 
option.”(136) 
Availability of transport options, or the lack of transport options, appeared to vary 
according to geographical location, especially within remote rural areas and economic 
situations, which can be dependent on distribution of public sector spending (178).  Full 
occupancy of vehicles preventing transport of the patient were reported in four studies 
(14, 136, 162, 163). 
“We took her to the main road to look for transport. We were there up to 12 midnight 
but couldn’t get transport. All vehicles that came were full”(14)  
 
Geography 
This theme describes the geographical (terrain) and meteorological aspects related to 
transport of emergency obstetric patients. Five studies reported that weather conditions 
or state of roads affected emergency transport (136, 160, 162, 172, 173). 
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Terrain:  Two studies reported poor road conditions, due to mountainous, flooded or 
eroded terrain (136, 160), although this was not in reference to a specific mode of 
transport. 
“The road is too rough going up the hills and down the valleys”(136) 
“A lot of roads have holes”(160). 
Terrain is suggested to directly affect the ability of women reaching emergency 
care.(153) However, some forms of transport such as the Uhuru (144) or eRanger 
(179) (motorcycle ambulance), were effective because they were particularly 
compatible with the local terrain. 
“Uhuru is the answer to rural transport irrespective of terrain”(144) 
 
Meteorological:  Heavy rains are cited in four studies as affecting emergency 
transport.(136, 160, 162, 172) These studies showed that inaccessible roads during the 
wet season can cause delays to journeys and unreliable operation of public transport 
services.  
“I was very uncomfortable travelling for 7 hours on a full bus, the roads were very 
slippery because of the heavy rains which made it worse”(136)  
Two studies suggested that the efficiency of different methods of transport varied with 
seasonal changes (156, 160). These studies showed that public transport was more 
reliable in the dry season although temperatures at this time of year impacted 
negatively on the journey experience. 
 
Local support 
The theme of local support includes the different sources of support and lack of support 
for pregnant women to access and use emergency transport. Participants from eight 
studies commented on the amount, or lack of support they received from the following 
sources; (136, 137, 144, 154, 160, 162, 171, 172) 
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Family: Three studies showed that family support, particularly a husband’s support, is 
necessary to access emergency transport.(155, 166, 175)  However, two studies 
showed that arrangements for childbirth, including emergency care and transport, are 
the sole responsibility of women. (136, 165) Only one study reported that women had 
received support from their husbands.(136)  The lack of support and women feeling 
alone when needing emergency transport was highlighted in three studies. (136, 171, 
172) 
“When you are in danger you are just left alone at home with your young children. What 
can you do, you cannot go to seek help and leave the children alone.”(136) 
 
Community: Four studies described community support or involvement in emergency 
transport; this varied from physical labour when carrying a patient on a stretcher, to 
providing means of transport, such as bicycles or cars, or financial contributions.(136, 
154, 160, 162) 
“In emergency situations, we cannot rely on hospitals and clinics....we have to depend 
on community members with a car or a taxi to help us”(162) 
 
Dependents:  In two studies women voiced the constraints they faced when seeking 
emergency transport while also looking after young children (136, 137). 
“Transportation was difficult, and I also have four other young children”(137) 
 
Refusal: Owners or drivers of vehicles refuse to provide emergency transport, it is 
suggested that this was because they were concerned about soilage in the case of 
haemorrhage (166) or the legal implications if a woman died whilst in transit (163).   
 
Autonomy 
This theme includes personal, financial, educational or family autonomy and can be 
facilitated or removed by family, community and other decision makers.  A distinction 
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can be made between support and autonomy: for instance, a woman’s partner can be 
supportive without affording her autonomy. The financial dependence of women on 
their husbands and families compromises their autonomy in accessing and using 
emergency care (136). Two studies expanded on this, finding that women were 
economically dependent on men, and had restricted or no independent finances to 
access and use emergency transport, unless designated by their husbands (160, 163). 
 “They [husbands] do not give a cent for transport”(136) 
Three studies suggested that women relied on others for decision making with regards 
to emergency transport (136, 155, 163).  Research found that women forgo emergency 
transport due to the domestic constraints or limitations placed on them by their 
husbands (162).  
 
Culture 
Various socio-cultural aspects associated with emergency transport were evident 
throughout the literature. Six studies discussed how existing cultural beliefs or social 
practices affected emergency transport of pregnant women. (14, 136, 160, 163, 169, 
171) One study discussed how emergency transport was not kept readily available as 
this was considered bad luck (170), whereas another study reported how pregnant 
women were deterred from using the bicycle ambulance, believing that publicising the 
onset of labour had the potential to summon evil spirits (169). 
“Here if people see you going to the hospital for a delivery, they can bewitch 
you.”(169). 
 
Embarrassment:  One study showed that users of emergency transport found the 
experience embarrassing and shameful particularly when they were bleeding heavily 
(136). This might be particularly distressing for women from regions where 
menstruation and bleeding are associated with pollution taboos. (170). 
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“I cannot explain how bad it was, bleeding whilst riding a bicycle up hills and down 
valleys” (136) 
Social exclusion and difference in caste within cultural groups was cited as a barrier to 
emergency transport services.  However one study found that all social classes within a 
specific region were able to use the ‘Uhuru’  without any discrimination (144). 
 
Finance 
The theme of finance involves the capacity or inability to pay for emergency transport, 
due to poverty or excessive transportation fees. Two studies highlighted that users felt 
they were financially exploited when in need of emergency transport (155, 156). The 
high cost of emergency transport was reported by respondents in five studies (136, 
158, 160, 162, 171). The costs escalated during the evening, the rainy season, where 
vehicle availability was limited, and where military road blocks were present (161). 
“The transport in our village is only lorry and very difficult for poor people to rent 
because it is very expensive” (160)  
“The ambulance was going to be very expensive which is why I was obliged to bring 
her by bicycle” (171) 
Motorcycle ambulance was found to be affordable in one study, in which 100% of 
respondents felt they could afford the ‘Uhuru’ (motorcycle ambulance) despite only 
20% being in formal employment  (144). 
“My life was saved as the Uhuru served me when I had complications at my last 
delivery. I was transported from the clinic to the hospital just in time and at a very low 
price”(144). 
 “All the villages are far from the main road and there is a problem to get transportation 
and this creates a good opportunity for heavy truck drivers to make a fortune from 
these poor women”(155);  
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Transport costs to health institutions are often higher than most people can afford 
(154).  For example, only 12% of participants in one study reported that there was an 
affordable vehicle available to hire (144). 
 
Ergonomics 
This theme encompasses the ergonomics of the transport, the journey experience and 
the comfort of the transport. Four studies commented on aspects relating to transport 
ergonomics (136, 155, 160, 171). 
 
Pain:  Two studies reported that users experienced pain when using emergency 
transport, particularly bicycles (136, 155, 163). In one of these studies 80% of 
respondents reported experiencing a painful journey, however the type of vehicle used 
was not reported (163). 
  “One can use a bicycle to take a pregnant woman to a hospital, but you can see the 
pain she is going through when you go through the rough roads”(136);  
 “A car [ambulance] would be great help because you will not experience the horrible 
bumps as you go to the district hospital”(136). 
 
Position:  The acknowledged optimal position for transfer of an obstetric patient is 
horizontal, with a left lateral tilt. Transport users are reported as feeling incapable of 
adopting the position required for emergency transport on a motorcycle (172). 
Benegusenga et al reported that 66% of respondents who had lost their child believed 
that their position during transit may have been responsible (149). 
 
5.4 DISCUSSION 
Findings 
Eight themes emerged from this synthesis of primary studies. The data showed the 
breadth and depth of the issue of emergency transport for pregnant women, and the 
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many interlinked physical, psychological, financial, social and cultural facets. It is 
apparent that the assumption that increasing transport will simultaneously increase 
accessibility of healthcare, and thus reduce maternal mortality, is not necessarily 
correct unless attention is paid to key proximal and distal factors (Figure 26). 
 
There is a scarcity of well designed and conducted research on emergency transport of 
pregnant women in low and middle income countries, and little conclusive evidence on 
the effectiveness of such transportation (180).  A literature review (181) examining 
auxiliary technologies related to transport and communication for obstetric 
emergencies highlighted the most significant issue was the short time interval available 
for action, limiting options for obstetric referrals. It also concluded through ‘cumulative 
experience’ that motorised transport is likely to be the most acceptable and effective 
transport option. Comprehensive reports (182) have focused on the ‘second delay’, the 
delay in reaching care, rather than focusing on transport alone. Such reports explore 
the conceptual understanding of the ‘second delay’, and review infrastructure, finances 
and communications in emergency obstetric care, as well as suggesting steps to tackle 
the ‘second delay’. Such reports often lack the perspectives of transport users 
themselves, or provided limited information on their views. 
 
This systematic review and meta-synthesis of qualitative research will enrich current 
knowledge on emergency transport of pregnant women. The intention of this review 
was to provide an overview of emergency transport and a fuller insight into the barriers 
and facilitators associated with emergency transport, drawing on the perspectives of 
transport users themselves.  The review was not intended to be generalisable to every 
low and middle income country, instead individual themes, facilitators and barriers 
could be appreciated within local contexts. 
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Figure 25 Determinants of emergency transport 
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Overcoming barriers and suggested facilitators 
Several means of emergency transportation in low to middle income countries were 
identified within the review although the results highlight that the suitability of 
emergency transport can vary between geographic locations and across seasons and 
cultures. Within this context the optimal means of emergency transport for obstetric 
patients would need to be capable of travelling at a reasonable speed, with immediate 
arrival to the woman in need and ensure a timely transport.  
 
Reducing time for transport: More than 60% of people in low income countries live 
more than 8km from their nearest health care facility (183), and maternal mortality is 
estimated to increase by a rate of 2% with every 10% increase in distance travelled to 
reach a place of care (183). There is therefore a need for an efficient and effective 
emergency transport service, to ensure women receive timely life-saving obstetric care. 
One study reduced the time for transport by placing motorcycle ambulances in the 
community (144), whereas another provided clear guidelines for emergency transport 
to prioritise the use of the vehicles, although details of these were not provided in the 
manuscript (184).  
 
Improving transport options: Transport options can be improved if a suitable, reliable, 
affordable service is available for pregnant women. For instance, an ongoing 
programme that has facilitated transport of labouring women in Pakistan involves a 
partnership with the local minibus taxi service; the taxi drivers provide an emergency 
service, including out-of-hours, for a fixed fee which is reimbursed from community and 
charitable sources (185). 
 
Overcoming geographical barriers: A number of studies have recommended ways of 
overcoming geographical barriers by road (149).  Exploration of local topographical 
challenges before investment in a specific emergency transport type (186), and 
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collaborating with local services suited to local terrain, such as minibus taxi services, 
can facilitate effective transport (185). 
 
Improving local support: Community education and awareness raising programmes 
have been shown to increase support and assistance for pregnant women requiring 
emergency transport (166).  For example drivers of commercial vehicles were reluctant 
to transport pregnant women, and often charged exorbitant fees. Following community 
mobilisation schemes and training, transport users gave a much more positive 
response, and transport providers were more amenable in providing transportation 
(166). Furthermore community education may address the cultural or social beliefs 
resulting in a lack of support, or the lack of realisation and awareness of the need for 
emergency transport (14). Women’s groups could potentially be used to overcome the 
physical barrier caused by dependants when space constraints are present, for 
example on public buses (120). 
 
Enhancing autonomy: Women’s groups, particularly participatory action groups, can 
play a key role in empowerment and education of women and wider community (120). 
The restricted independence some women face may pose an obstacle for emergency 
transport. This may apply to a lack of financial independence, or a dependence on 
other family member for decision making (166).  Community awareness raising and 
advocacy in support for safe motherhood may contribute to the success of emergency 
transportation projects (165, 179).  It is  suggested that transport is effective if the 
scheme is owned and accepted by the local community (187), although 
communication, advocacy and stable leadership are necessary to facilitate autonomy in 
emergency transport.(186)  
 
Addressing culture: Social exclusion and difference in caste within cultural groups was 
cited as a barrier to emergency transport services, however one study (144) found that 
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all social classes within a specific region were able to use the ‘Uhuru’  without any 
discrimination (144). Shehu recommended that  pollution taboos (166) could be 
challenged by educating transport operators. Community education and awareness 
raising also have the potential to influence cultural beliefs.  
 
Addressing finances: Money is not an absolute barrier, as relatives are sometimes able 
to collate necessary funds (163).   Four studies supported this finding, showing that 
people often sold livestock and other resources, or organised loans to raise funds for 
emergency transport (155, 159, 171, 175). Access to emergency transport was 
facilitated by subsidies from the local community (e.g. financial or resource) (136) or 
insurance schemes (e.g. poverty certificates) and charities and non-governmental 
organisations. Transport schemes organised and ran by the local community such as 
the Ingobyi scheme (locally made stretcher) can reduce financial barriers, and facilitate 
emergency transport. The scheme requires small, affordable financial contributions 
from members of the community which desire to be members of the scheme. 
Contributions ensure the maintenance of the vehicle and correct management of its 
use, so it is available and free to use in emergency situations (149). 
 
Addressing ergonomics: Achieving a safe and comfortable position is a key barrier in 
emergency transportation of obstetric patients. Nyamandi et al reported that 
respondents described the Uhuru (motorcycle ambulance) as a safe, effective 
emergency form of transport, particularly as the trailer could be adapted to suit the 
position of the passenger (144). 
 
5.5 CONCLUSION 
To achieve a suitable, efficient, effective, reliable, acceptable and affordable means of 
transport, a number of key recommendations can be made.  Clear guidance should be 
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given  to prioritise the use of the vehicle for emergency transport (184).If vehicles can 
be isolated for emergency use only this can be beneficial. There should be consistency 
in the availability of affordable transport options, suitable for use by pregnant women, 
allowing them to be transported in the optimal left lateral position. The vehicle of choice 
should be compatible with local economy. For example if the transport is being funded 
by the government or health ministry, the quality and type of vehicle may differ from the 
transport that is being funded by the community itself. 
 
Transport type should be compatible with local terrain. It is also beneficial if the 
transport is accepted and appreciated by local customs and cultures, this is to minimise 
potential obstructions to use by community members and peers.  Literature within this 
review has suggested that this is particularly important, not only with transport type but 
the cultural perspective of seeking and receiving maternity care. 
 
Drivers and communities should be educated in the importance of emergency obstetric 
transport to remove potential barriers. A project that has been shown to have greater 
effect once the community are involved is the Havelian project.  Through education of 
local stakeholders, and promotion by religious leaders, the project experienced greater 
success and was utilised by more women (185). Similar effects have been 
demonstrated in the many eRanger projects globally (179). 
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Table 14 Quotes used in data analysis from the studies included in the review grouped according to themes 
Time for transportation 
Travel time 
“It took a long time, because we walked slowly” (171)“People must walk an hour and a half to get to the asphalt road”(160) “I took my husband’s 
bike and rode very fast”(136) “My life was saved as the Uhuru served me when I had complications at my last delivery. I was transported from the 
clinic to the hospital just in time and at a very low price”(144) “I was very uncomfortable travelling for 7 hours on a full bus, the roads were very 
slippery because of the heavy rains which made it worse”(136) “We took her to the health centre in the village... She was examined by a nurse who 
later transferred her to another health centre  (44km away)There she spent the night, the following morning she was transferred to the hospital 
(36km away), on our way we had to cross the river at two different crossing points. Immediately after we reached the hospital she died”(14)“It was 
raining heavily, so when they called the midwife it took longer for her to arrive. Because the rain was heavy, she could not be saved by the time the 
midwife arrived”(172)“We arrived at the means of transport 1 hour after she died”(171) “The journey took two hours”(171) “Walking to  Babati is too 
far, maybe 7 hours.” (136) 
Waiting time 
“I had to wait for the public pus”(136)  “We took her to the health centre in the village... She was examined by a nurse who later transferred her to 
another health centre  (44km away) There she spent the night, the following morning she was transferred to the hospital (36km away), on our way 
we had to cross the river at two different crossing points. Immediately after we reached the hospital she died”(14)“Four vehicles are available to rent 
every afternoon, if there is an emergency before that, there is no vehicle available, nor is the mobile health unit available, the patient can only 
wait”(160)“If you do not have the money you have to look for it first. Sometime you may even have to spend a day or two looking for the money for 
the treatment. If you have coffee then you first sell it before you go”(175). “The following morning we went to the agricultural department to look for 
transport but their vehicle had already left for trek. It returned around1100am and thereafter it came to transport the patient to the hospital”(14)“I 
waited for transport [local public bus] for two days because the bus to Babati hospital.”(136)“Patients get exhausted and even die whilst waiting for 
an ambulance”(159)“I have confidence in the uhuru because of its availability, accessibility and affordability”(144) 
Transport options 
“My husband took me on a bike because there was no other means”(136)“Getting to hire a car is very rare”(136) “ The transport in our village is only 
lorry and very difficult for poor people to rent because it is very expensive” (160)“We planned to evacuate her but our ambulance had a breakdown 
a week ago”(14)“All the villages are far from the main road and there is a problem to get transportation”(155)“There was no vehicle...there wasn’t 
anyone who could help, it was late at night”(171)“Four vehicles are available to rent every afternoon, if there is an emergency before that, there is 
no vehicle available, nor is the mobile health unit available, the patient can only wait”(160) “My husband took me on a bike because there was no 
other alternative”(136) “Men carried me on their shoulders to a bus stop at Erri Central (about 14km from Kokmay) where I boarded a local bus to 
Babait Hospital. There was not any other option.”(136) “There were no cars, it was only people carrying you on their shoulders, two people or four 
people hold you in a blanket”(173) “We were there [main road]up to 12 midnight but couldn’t get transport”(14) “We looked for transport in the 
village throughout the night but could not get one”(14) “There was no vehicle.... maybe there was transport, but where?....the problem was there 
was no vehicle, we couldn’t move because of that”(171)“I have confidence in the uhuru because of its availability, accessibility and 
affordability”(144)“I was bringing her to the hospital but after three junctions I had to go back because I couldn’t stand her to be transported by 
motorcycle”(172) “The bus was very full” (136) “I was very uncomfortable travelling for 7 hours on a full bus, the roads were very slippery because 
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of the heavy rains which made it worse”(136)“It was sunny  and  hot making it worse for pregnant woman in a full packed bus”(136)“We took her to 
the main road to look for transport. We were there up to 12 midnight but couldn’t get transport. All vehicles that came were full”(14) 
Support 
Family 
“Husband placed me on a bike and pushed it”(136) “Husband took me on a bike”(136)  
Community 
“When a person is bitten by a snake and the local healers have failed him, he is put on a bed and between 4 to 6 young men transport him through 
the hills to Tonga health centre or the mission hospital”(154) “In emergency situations, we cannot rely on hospitals and clinics....we have to depend 
on community members with a car or a taxi to help us”(162)“What we normally see is, most of the time the sick person or woman in labour is carried 
on a stretcher by men on their shoulders”(136) “Such fare cannot be afforded individually. The entire village has got to contribute.”(136)“For sick 
people the payment can come after, most times it is free, sometimes i even help by giving them money”(160) “The community give as much money 
as they can for transport costs”(160)“We have to depend on community members with a car or taxi to help us”(162)“My husband borrowed a bicycle 
from our neighbour because there was no any better option”(136) “Thank god my fellow passenger offered me his seat so I could sit down”(136)“In 
such cases I would prefer to walk with someone”(162)“All social classes of the community were able to access the services of the Uhuru”(144) 
Dependants 
“When you are in danger you are just left alone at home with your young children. What can you do, you cannot go to seek help and leave the 
children alone.”(136)  “I cannot wait at the district hospital to give birth safely because I cannot leave my children alone”(136) “Transportation was 
difficult, and I also have four other young children”(137) 
Refusal 
“Drivers refuse to take sick people”(170) 
Geography 
Terrain 
“Uhuru is the answer to rural transport irrespective of terrain”(144)“This is a practical solution to rural transportation”(144)“The road is very 
bad”(136) “The road is too rough going up the hills and down the valleys”(136)“A lot of roads have holes”(160) “The road was slippery and the rain 
was pouring”(136)“The condition of the mobile health unit is not suitable for the geography of the region”(160) 
Meteorological 
“I was very uncomfortable travelling for 7 hours on a full bus, the roads were very slippery because of the heavy rains which made it worse”(136) “It 
was raining heavily, so when they called the midwife it took longer for her to arrive. Because the rain was heavy, she could not be saved by the time 
the midwife arrived”(172)“The road was slippery and the rain was pouring”(136) “In rainy season it is very difficult for vehicles to get 
through”(160)“But if it is too hot I sometimes feel my sickness coming”(162) “It was sunny  and  hot making it worse for pregnant woman in a full 
packed bus”(136) “Vehicles can only operate in the dry season, during the rainy season they cannot get through at all”(160) 
Autonomy 
1
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“I Personally decided to go to Babati district hospital because I was feeling dizzy and near the end of my pregnancy”(136) “I decided to go to the 
district hospital for treatment.”(136) “Men contribute to our sufferings. They go to pubs to drink local brew. Sometimes they do not leave you with 
even Tsh 100.”(136)  “They [husbands] do not give a cent for transport”(136) “I think our women do not seek medical care because they cannot 
express themselves to the healthcare providers.”(136) “women are not educated; they do not know their expected delivery dates.”(136) “As 
husbands we have  the responsibility of teaching our wives proper Swahili so they don’t feel shy and alone when admitted to a hospital and been 
attended by a worker from outside Manyata region...this could be one of the reasons women do not prefer giving birth with skilled health 
workers.”(136) 
Culture 
 “Here if people see you going to the hospital for a delivery, they can bewitch you.”(169) “[Never deliver] outside of the society 
bush”(163)“Traditionally at the time of pregnancy when you walk outside you should take a plant with you, this cures black magic, some people take 
a knife too”(160) “There was no disease, it was about magic. If  we get diseases due to magic, the doctor cannot see it, so getting treatment is 
different, she should go to the shaman”(171) “They go to a TBA seeking for help, most of the time we go to get the TBA to assist the delivery at the 
mothers home”(136) “Such a woman is sent to an experienced woman in the neighbourhood”(136) “Labour and child birth takes place at certain 
times... these correspond with Muslim praying times”(14)  
Embarrassment 
“I cannot explain how bad it was, bleeding whilst riding a bicycle up hills and down valleys” (136) “Health services are better but many women are 
scared to go to hospitals, particularly if it is their 6
th
 pregnancy and above because service providers rebuke them for not using family 
planning”(136) 
Financial 
“My life was saved as the Uhuru served me when I had complications at my last delivery. I was transported from the clinic to the hospital just in time 
and at a very low price”(144) “The transport in our village is only lorry and very difficult for poor people to rent because it is very expensive” (160)“If 
it’s after the clinics closing time of 1600, then transport becomes more expensive, and we also then have travel much further away”(162) “We were 
afraid of the money”(171)“Yes we don’t have any money”(171) “If you do not have the money you have to look for it first. Sometime you may even 
have to spend a day or two looking for the money for the treatment. If you have coffee then you first sell it before you go”(175) “Women stay at 
home for they are asked to pay a lot of money for transportation”(155)“The cost was expensive”(171) “The ambulance was going to be very 
expensive which is why I was obliged to bring her by bicycle”(171) “For emergencies we usually rent a vehicle for rp.50,000 it is expensive because 
the harvest time is only once a year”(160)“I was asked to buy fuel for the ambulance to take my wife. I bought 20 litres of diesel”(14)“This 
intervention cuts across all social classes, the poor and the rich are equally benefitting”(144)“I have confidence in the uhuru because of its 
availability, accessibility and affordability”(144) “All the villages are far from the main road and there is a problem to get transportation and this 
creates a good opportunity for heavy truck drivers to make a fortune from these poor women”(155) “The road made by the VDC is for jackals”(156)  
Ergonomics 
Pain 
1
39
 
 
 
140 
 
 
 
 
  
“You feel like the fetus is coming from the stomach”(136) “One can use a bicycle to take a pregnant woman to a hospital, but you can see the pain 
she is going through when you go through the rough roads”(136) “Particularly women in labour pain, they suffer a lot” (155) “It is very uncomfortable 
on a bicycle when in labour or in any other pain”(136) “I tried once, but after a very short distance I told them (the men carrying her), it is better I 
walk. I feel so uncomfortable.”(136) “The road condition and vehicle conditions right now are not comfortable but there is no other choice” (160)“I 
wish I was in an ambulance, the trip would have been comfortable”(136) “A car [ambulance] would be great help because you will not experience 
the horrible bumps as you go to the district hospital”(136) “Because in a car you are comfortable”(136) 
Position  
“She couldn’t even get on a motorcycle”(171) 
1
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Table 15 Quality assessment of included studies using the COREQ criteria 
Reporting Criteria N= (%)  References of studies reporting each criteria 
Characteristics of research team 
Interviewers or facilitator identified 11/29 (38%) (137, 144, 153-155, 158, 162, 165, 168, 171, 172, 175) 
Credentials 7/29 (24%) (137, 153, 162, 165, 168, 171, 172) 
Occupation 10/29 (34%) (136, 140, 144, 153, 165, 167, 168, 171-173) 
Sex 8/29 (27%) (137, 141, 144, 154, 156, 160, 162, 173) 
Experience and training 11/29 (38%) (137, 140, 144, 154, 156, 158, 162, 168, 171, 172, 175) 
Relationship with participants 
Relationship established 6/29 (21%) (144, 162, 163, 170-172) 
Participant knowledge of 
interviewer 
3 /29 (10%) (136, 144, 173)  
Interviewer characteristics 6/29 (21%) (160, 161, 163, 171-173) 
Theoretical framework 
Methodological orientation and 
theory 
7/29 (24%) (14, 149, 154, 157, 161, 168, 172) 
Participant selection 
Sampling 24/29 (83%) (141)(14, 136, 137, 144, 154-163, 165, 167-173, 175) 
 Method of approach 12/29 (41%) (136, 144, 158, 159, 161, 163, 165, 167, 168, 171, 172, 175) 
Sample size 21/29 (72%) (136, 137, 144, 149, 153-158, 160-162, 165, 167, 169, 171-173, 175) 
Non-participation 6/29 (21%) (136, 137, 158, 161, 173, 175) 
Setting 
Setting of data collection 16/29 (55%) (14, 136, 137, 141, 144, 149, 153, 154, 158, 159, 164, 171-173, 175) (167)  
Presence of non-participants 4/29 (14%) (144, 157, 171, 172) 
Description of sample 18/29 (62%) (136, 137, 144, 153, 155-163, 167, 168, 171, 173, 175)  
Data collection 
Interview guide 13/29 (45%) (141)(136, 137, 144, 153, 155, 157-159, 161, 162, 170, 171) 
Repeat interviews 0/29   
Audio/visual recording 10/29 (34%) (14, 136, 144, 153, 160, 163, 171-173, 175) 
Field notes 4/29 (14%) (136, 153, 170, 171) 
Duration 7/29 (24%) (136, 144, 153, 160, 163, 168, 171) 
Data saturation 1/29 (3%) (172) 
Transcripts returned 0/29   
Data analysis 
1
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Number of data coders 1/29 (3%)  (149) 
Description of the coding tree 1/29 (3%) (136)  
Derivation of themes 19/29 (66%) (14, 136, 137, 149, 156, 158-160, 162, 163, 167-173, 175) 
Software 15/29 (52%) (136, 137, 144, 149, 155, 156, 159-161, 167, 169, 171-173, 175, 188) 
Participant checking 4/29 (14%) (149, 156, 161, 170) 
Reporting 
Quotations presented 18 /29 (62%) (14, 136, 137, 144, 149, 154-157, 159, 160, 162, 168, 169, 171-173, 175) 
Data and findings consistent 29/29(100%) (14, 136, 137, 141, 144, 149, 153-175) 
Clarity of major themes 24/29 (83%) (14, 136, 137, 141, 144, 149, 153-156, 158-163, 167-169, 171-173, 175) 
Clarity of minor themes 12/29 (41%) (137, 141, 144, 149, 154, 160, 162, 163, 167, 171-173)  
1
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Figure 26 Determinants of emergency transport
Figure 3. Factors of maternal emergency transport.
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CHAPTER 6:  CAN MOTIVATIONAL INTERVIEWS IMPROVE 
CONTRACEPTIVE COMPLIANCE AND REDUCE UNMET CONTRACEPTIVE 
NEED: A SYSTEMATIC REVIEW AND META-ANALYSIS 
ABSTRACT 
Background: Reproductive health services provide an important protective function 
within communities. Enabling family planning can empower women, and effective 
contraceptive use can directly reduce the incidence of maternal deaths by averting 
around 230 million potential births every year.  Effective family planning also has the 
potential to reduce poverty and malnutrition, particularly in regions where food security 
and unemployment is a concern. The use of behavioural and theory based 
interventions to improve contraceptive compliance and uptake have recently been 
addressed, however good quality evidence on the effectiveness of motivational 
interviewing to improve contraceptive practice in developing countries is lacking.  
Methods: MEDLINE, EMBASE, AMED, BNI, Cochrane library, CINHAL, LILACS, 
African Index Medicus, Web of Science, the Reproductive Health Library, and the 
Science Citation Index (inception-August 2012) were searched without language 
restriction.  RCTs were selected. In the absence of sufficient data from developing 
countries, data from developed countries was used and the generalisability discussed. 
Data was extracted from each study on study characteristics, quality and outcome 
data. The outcome measures were use of effective contraception and subsequent 
births.  
Results: Eight RCTs were included within the review, with a total of 3424 participants. 
Seven were from developed countries, one was set in a developing country. Effective 
contraceptive use between zero up to four months significantly increased with 
motivational interviews when compared to the control (RR 1.32 95%CI 1.11, 1.56: 
p=0.002).  There was no effect on contraceptive use with motivational interviews 
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between four up to eight months and eight up to twelve months. There was also a no 
significant effect on subsequent pregnancies or births. 
Conclusion: Motivational interviews increase effective contraceptive use in a 
population at high risk of unintended pregnancy between zero up to four months.  This 
research complies with current global health research on improving family planning, 
however there is substantial implication for generalisability of this finding as most of the 
studies were conducted in developed countries. 
 
Impact of review: This review was used to support the application ‘Motivational 
Interviewing as part of Public Health Midwives consultation to improve contraceptive 
uptake in northern Sri Lanka:  a cluster randomised trial ’seeking funding from the 
‘Implementation Research Platform (IRP) call for proposals in Northern Sri Lanka’.   
 
6.1 BACKGROUND 
Reproductive health services provide an important protective function within 
communities (189). Not only does family-planning empower women, effective 
contraceptive use directly reduces the incidence of maternal deaths by averting around 
230 million potential births each year (190).  Effective family-planning has the potential 
to reduce poverty and malnutrition, particularly in regions where food security is a 
concern (191).  It is estimated that 222 million women in developing countries want to 
delay pregnancy or cease childbearing, but are not actively using contraception (192). 
Barriers to contraceptive use could be due to supply and demand (192), education 
around contraceptive use, cultural and social constraints or opposition (192), or the 
side effects or cost of contraception (193).  Consistent and effective contraceptive use 
is also recognised as problematic, compliance with oral contraception has been 
demonstrated to be low in some regions (194). Research has demonstrated that 48.5% 
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of women using oral contraceptives used this method incorrectly, thus resulting in an 
unintended pregnancy rate of 5.7% (194).  
 
Despite this, modern contraceptive use has improved in many countries, with a global 
increase from 54% in 1990 to 57% in 2012, however modern contraceptive use in sub-
Saharan Africa remains low (192), and improvement has been minimal since 1990, 
from 23% to 24% in 2012 (192). The unmet need for contraception also remains high 
(box 1), it is estimated that 53% of women of reproductive age in Africa have an unmet 
need for modern contraception. Comparatively the level of unmet need in Asia is lower 
at 21%. Thus progress towards achieving MDG 5b (improving universal access to 
reproductive health care) is less in sub-Saharan Africa. 
 
The use of behavioural and theory based interventions to improve contraceptive uptake 
and contraceptive compliance have recently been addressed (195) (196, 197).  Prior to 
this motivational interviews were commonly associated with changing addictive 
behaviours (198-200), thus are used with alcoholics, drug users or obese patients 
(201-203). Recently however, they have been used with adolescents (204) and 
pregnant women (205-207) to invoke changes in ‘risky’ behaviour (such as unprotected 
sexual intercourse).  Yet good quality evidence on the effectiveness of motivational 
interviewing to improve contraceptive practice in women of reproductive age in 
developing countries is lacking, therefore a systematic review was performed to 
examine the effect on motivational interviews on contraceptive uptake, to address 
areas where unmet contraceptive need is greatest. 
 
Motivational interviewing 
Motivational interviewing is a counselling approach that aims to facilitate and engage 
the participant’s intrinsic motivation to change their behaviour. When compared with 
non-directive counselling, motivational interviewing is suggested to be more goal-
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oriented and more participant-centred, thus aiming to induce behaviour change by 
encouraging participants to explore and address any ambivalence. Motivational 
interviewing encourages the participant to think about the changes that could be made, 
rather than the counsellor offering suggestions. The key concepts of motivational 
interviews are the participant recognising and accepting the need to make changes in 
their lives, this approach encourages the participant to consider their readiness to 
change their behaviour (208, 209). The main goals of motivational interviews are to 
engage participants, encourage talk of change, and induce motivation to make positive 
changes. The principles of motivational interviewing are based on autonomy, 
collaboration, exploration, and evocation. Motivational interviews are often conducted 
in a one to one setting, with a participant and counsellor contained in a space where 
the participant is able to talk freely and discuss sensitive or confidential information. 
The interview should last between 90 and 150 minutes (210)  
 
Box 1:    Unmet need of family planning: WHO 
The number of women of reproductive age who are married or in a union, who are 
fecund and sexually active but are not using any method of contraception, and report 
not wanting any more children or wanting to delay the birth of their next child.
 
6.2 METHODS 
Data sources and searches 
Databases were searched for RCTs on motivational interviewing to improve 
contraceptive use. MEDLINE, EMBASE, AMED, BNI, Cochrane library, CINHAL, 
BIOMED Central, PsycINFO, LILACS, African Index Medicus, Web of Science, the 
Reproductive Health Library, and the Science Citation Index were searched (from 
database inception to August 2012). Hand searching complemented electronic 
searches, and reference lists were checked. The search terms were terms were 
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‘motivational interview*, contraception, family planning, maternal, pregnancy’.  No 
language restrictions were applied to the search. 
 
Study selection and data extraction 
RCTs were selected, if the study examined the effect of motivational interviewing on 
contraceptive use.  Initially the electronic searches were scrutinised and full 
manuscripts of appropriate studies were acquired. Final decisions on inclusion or 
exclusion of manuscripts was made after inspection of these manuscripts by the author 
and another reviewer (AW and KN). Information was extracted from each article on 
study characteristics, quality and outcome data by the author and another reviewer 
(AW, KN).  The outcome measures were use of effective contraception and 
subsequent births, these outcomes were measured at various time points throughout 
the studies. In the absence of sufficient data from developing countries, data from 
developed countries was used and the generalisability of the findings discussed.  
 
Methodological quality assessment 
The studies were assessed for methodological quality using quality assessment tools 
appropriate for the study design. Therefore the CONSORT (211) statement was used 
to evaluate the RCTs against a 25 item checklist for trials design, intervention, 
randomisation, blinding and analysis. Risk of bias in the studies was assessed using 
the Cochrane risk of bias tool (130). 
 
Data synthesis 
The random effects model was used to pool the risk ratios from individual studies at 
time points of zero up to four months, four up to eight months, and eight up to twelve 
months. This model was used to account for variability within the studies, including the 
intervention, the intervention dose and the method in which the outcomes were 
measured. Figure 27 is a graphical representation of the time points at which the 
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outcomes of effective contraceptive use were reported in the studies. Due to the 
variability in the timing of the follow up assessments, as reported in Figure 27, and the 
lack of rationale provided by the authors for selection of such time points, time points 
were pooled into the following categories; zero up to four months, four up to eight 
months, and eight up to twelve months. If a study reported two time points within the 
pooled time category, the first reported time point reported by the study author was 
used within the analysis. Heterogeneity of treatment effects was evaluated using forest 
plots, χ2 and I2tests; the terms low, moderate, and high heterogeneity were assigned to 
I2 values of over 25%, 50%, and 75%, respectively. Analyses were done using Revman 
5.0 statistical software. 
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Figure 27 Graphical representation of the time points at which the outcomes of effective contraceptive use were reported in the studies
1
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6.3 RESULTS 
The processes of literature search and selection are given in Figure 18. Eight RCTs 
with a total of 3424 participants were included in the review.  
 
Study characteristics  
The characteristics of the studies included are given in Table 15. Outcome data 
reported in the studies is shown in Table 16.  All included studies, were set in upper or 
upper-middle income countries and all participants were women of reproductive age, 
although there was some variation in the population between the studies. One trial by 
Rendall-Mkosi et al however was set in South Africa (212). The WHO categorise South 
Africa as a developing country, and although this is an upper-middle income country as 
per world bank classification, the included participants were from rural districts and of 
low socio-economic status, thus the findings of this study may be generalisable to other 
developing countries. 
 
Two studies by Barnet et al and Kirby et al included only women under the age of 
eighteen, and were described by the authors as adolescents (204, 213). Two other 
studies by Ingersoll et al and Ceperich et al included only participants aged between 18 
and 24 years of age (214, 215). Half of the studies included women participating in high 
level alcohol consumption (‘Risky drinking’) (212, 214, 216, 217) as well as ineffective 
contraceptive use. 
 
There was also clinical heterogeneity between the interventions of the included studies, 
although all were based on motivational interviews. Four studies offered single 
sessions, lasting between 60-75 minutes (213-216), including the study by Kirby et al of 
which offered a further nine follow up phone calls over a period of 12 months (213). 
One study by Petersen et al offered two sessions including a booster session at two 
months later (197), but no details on the length of the sessions were reported. Two 
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studies by Floyd et al and Rendall-Mkosi et al delivered the intervention through five 
sessions, interviews in both studies being up to 60 minutes in length. The study by 
Floyd et al conducted the sessions over 14 weeks (217), whereas the sessions were 
conducted over a period of two months in the other study by Rendall-Mkosi (212). The 
intervention in the remaining study by Barnet et al consisted of nine sessions (204) that 
were conducted over a period of two years, sessions were 20 minutes in duration. 
Baseline rate of effective contraceptive use also varied across the studies, with some 
studies reporting a complete absence of effective contraceptive at baseline (212, 216, 
217), and others, such as Petersen et al, reporting a 59% baseline rate of effective 
contraceptive (197).
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Figure 28 Results of search strategy and identification of publications included in the review
Total citations identified from electronic searches n= 2415
Total citations from hand searching n = 5
Citations excluded after screening title and/or abstracts: n = 2390
Primary articles fulfilling inclusion criteria for systematic review: n = 8
Articles excluded after review of full text with reasons
Incorrect intervention n =4
Incorrect study design n =12
Incorrect population n =5
Total excluded n = 21
Full manuscripts retrieved for detailed evaluation: n = 29
1
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Table 16 Study characteristics of studies included in the review 
 
Population, Setting Intervention Control Outcome 
RCTs: Women of reproductive age in upper-middle income countries 
Ingersoll 2005: USA - DEVELOPED COUNTRY 
University students aged 18-24 
risk of alcohol exposed 
pregnancy from a mid-Atlantic 
urban university. Sexual 
intercourse with a man in past 
90 days using ineffective 
contraception, risky drinking 
levels. 
DEVELOPED COUNTRY 
(n=114) BALANCE package (Birth Control and Alcohol Awareness: 
Negotiating Choices Effectively) Sessions included 90 day recording 
timeline follow back data on drinking and contraception, exercises on 
decisional balance, temptation and confidence charts. No details provided 
on training of counsellors. No baseline rate of effective contraceptive use 
but 47% did not use any contraception (inc withdrawal). 
Duration: One session lasting 60-75 mins 
(n=114) 
Informational 
pamphlet about 
women’s health. 
No baseline rate 
of effective 
contraception 
44% did not use 
contraception  
(inc withdrawal) 
Risk drinking (five or more 
standard drinks per occasion 
at least once in past 90 days 
or eight or more per week), 
ineffective contraception use 
(sexual intercourse in last 90 
days with ineffective 
contraceptive use), risk for 
alcohol exposed pregnancy. 
Petersen 2007: USA - DEVELOPED COUNTRY 
Aged 16-44 in 3 primary 
healthcare facilities in North 
Carolina, Mar 2003 and Sept 
2004, at risk of unintended 
pregnancy, not pregnant or 
planning pregnancy within a 
year, not currently using IUD or 
partners not sterilised. Approx 
60% participants aged 26-44 
(n=365) Pregnancy and STD prevention counselling; emphasizes the 
development of the clients self efficacy. Explore discrepancy between 
pregnancy intention and contraceptive use, between STD risk and 
condom use; sharing information with participants; promoting behaviours 
to reduce risk. Intervention delivered by experienced health educators 
trained for project.  Booster session two months later by phone or face to 
face, (85% had both sessions). Counselling standardised by providing 
counsellors with 30-40 hours training on contraceptives, pregnancy and 
STD prevention counselling, motivational interviewing, clinic operation, 
study design and implementation, basics of smoking cessation, exercise 
and nutrition counselling. Quality control measures were used through the 
study period.  Baseline rate 59% effective contraceptive use 
Duration: Two sessions (at least one face to face) over three months, 
no detail on length of session 
(n=372) Session 
of general 
health 
counselling. 
Baseline rate 
58% effective 
contraceptive 
use 
 
Change in level of 
contraceptive use, e.g. from 
a non-user to low or high-
level user. Low level, missed 
contraceptive pills, used 
condoms inconsistently, 
diaphragm, contraceptive 
patch. High level, oral 
contraceptive taken every 
day, consistently used the 
patch, vaginal ring or 
condoms. 
Floyd 2007: USA - DEVELOPED COUNTRY 
Aged 18-44, at risk of alcohol 
exposed pregnancy from 6 
diverse settings in Florida, 
Texas, Virginia between Jul 
(n=416) Motivational intervention counselling and contraceptive 
consultation. Sessions involved rapport building, review of current and 
advice on contraceptive practice and alcohol consumption, use of 
contraception journal, intercourse and alcohol consumption, self 
(n=414) 
Received 
information only. 
Baseline rate 
Risky drinking (five or more 
standard drinks in one day or 
eight or more drinks in a 
week), ineffective 
1
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2002-Jan 2004. No condition 
causing infertility, not pregnant 
or planning pregnancy in next 9 
months, sexual vaginal 
intercourse in last 3 months with 
fertile man without effective 
contraception, engaged in risky 
drinking. 
evaluation of behaviour, feedback on journal recordings, review goals and 
commitment to change. Contraceptive counselling visit involved 
determining appropriate and suitable methods of counselling.  Counselling 
delivered by 21 trained counsellors (master’s level education and above), 
supervised by project choices efficacy study team and six contraceptive 
care providers. 98% received at least one session, 63% received all 4 
sessions; mean number of visits was 3.2 sessions. Baseline rate 0% 
effective contraceptive use  
Duration: Five sessions over 14 weeks, lasting between 45-60 
minutes 
0% effective 
contraceptive 
use 
 
contraception (occurrence of 
vaginal sex when 
contraception not used or 
used ineffectively), risk for 
alcohol exposed pregnancy 
Barnet 2009: USA - DEVELOPED COUNTRY 
Pregnant teenagers, aged 12-18 
>24 weeks gestation. Excluded 
if the pregnancy not live birth 
and withdrawn if infant died in 
neonatal period. Intervention 
implemented in post partum 
period. 
(n=167) Initiated 6 weeks postpartum, continuing quarterly to 24 months 
postpartum. Nine sessions were possible, yet >7 sessions classed as 
adherence.  Computer-assisted motivational intervention: CAMI uses 
software developed for study and programmed with algorithms based on 
trans-theoretical model. CAMI counsellors conducted a 20-minute stage 
matched motivational interviewing session to enhance teen’s motivation to 
use contraception and remain non-pregnant. Half of participants received 
enhanced home based visit. Intervention ceased if participant became 
pregnant. Counsellors trained by completing a 2.5 day course on trans-
theoretical model, motivational interviewing and CAMI protocol. 
Counsellor proficiency ascertained by videotaping the sessions. 24% 
attended > 7 intervention sessions. Details for baseline effective 
contraceptive use not reported, 23% always used condom 
Duration: Nine sessions conducted for a period of up to two years. 
Sessions were 20 minutes in duration 
(n=68) Usual 
care, no 
description 
provided. 
Details for 
baseline 
effective 
contraceptive 
use not 
reported, 19% 
always used  
condom 
 
Repeat births at 24 months 
and repeat pregnancy 
outcomes. 
 
Kirby 2010: USA - DEVELOPED COUNTRY 
Reproductive health clinic in San 
Francisco aged 14-18 2005-
2007, not pregnant or trying to 
become pregnant, had sexual 
intercourse in last three months, 
not consistently using a 
hormonal method of 
contraception (IUD or 
contraceptive implant).  
(n=402) Motivational interviewing principles and techniques included in 
phone calls. Staff trained in family planning methods, adolescent risk 
behaviour and counselling techniques, also received training on content of 
calls and appropriate conduct. Interviewers trained on motivational 
interviewing by trained psychologists, and received motivational 
interviewing guide and training materials designed for intervention. four 
calls observed before allowed to conduct intervention alone. Counsellors 
completed 2.7 calls per participant rather than 9 specified in protocol, only 
11% received 6 or more phone calls. Details for baseline effective 
(n=403) Regular 
clinic services 
no regular follow 
up calls. Details 
for baseline 
effective 
contraceptive 
use not reported 
separately for 
Measures of contraceptive 
use (condom and hormonal); 
frequency, compliance, non-
use of contraception. 
Emergency contraceptive 
use, STDs, pregnancy, 
abortion, birth. Correct use of 
contraceptive method 
1
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contraceptive use not reported separately for intervention and control, 
11% used hormonal contraception at baseline. 
Duration: One face to face visit followed by nine phone calls over 12 
months. Length of phone calls was not reported. 
intervention and 
control, 11% 
used hormonal 
contraception at 
baseline. 
Ceperich 2011: USA - DEVELOPED COUNTRY 
University students aged 18-24 
at risk of alcohol exposed 
pregnancy from a mid-Atlantic 
urban university. Not planning 
pregnancy in next year. sexual 
intercourse with man in last 90 
days used contraception 
ineffectively and partook in risky 
drinking.  
(n=101) BALANCE package (Birth Control and Alcohol Awareness: 
Negotiating Choices Effectively) included personalized feedback. 
Sessions included 90 day recording timeline follow back data on drinking, 
contraception, exercises on decisional balance, temptation and 
confidence charts. Counsellors had master’s degrees in psychology or 
social work, received training in motivational interviewing and balance 
counselling manual. Interviews videotaped for quality control. Motivational 
interview techniques and principles were practised at least twice a month. 
No baseline rate of effective contraceptive use provided but 53% did not 
use any contraceptive means (inc withdrawal). 
Duration: One session lasting 60-75 minutes 
(n=106) 
Informational 
pamphlet about 
women’s health. 
No baseline rate 
of effective 
contraceptive 
use provided but 
48% did not use 
contraceptive 
means (inc 
withdrawal). 
Risk drinking (consuming five 
or more standard drinks per 
occasion at least once in 
past 90 days or eight or more 
per week), ineffective 
contraception use (sexual 
intercourse in the last 90 
days with ineffective 
contraceptive use), risk for 
alcohol exposed pregnancy, 
rate of alcohol exposed 
pregnancy at 4 months 
Ingersoll 2012: USA - DEVELOPED COUNTRY 
Aged 18-44 from 2 cities and 
surrounding areas Virginia, risk 
of alcohol exposed pregnancy 
(at least one episode of 
unprotected vaginal sex with a 
male partner and drinking 
alcohol at risky levels during the 
past 90 days. Without confirmed 
infertility, English speaking, 
intending to reside in local 
community for next 6 months. 
Excluded women current or 
intending to get pregnant, opioid 
dependence without 
antagonistic treatment, actively 
suicidal and cognitive problems. 
(n=73) Build rapport; provide personalized feedback on drinking, 
contraception and alcohol exposed pregnancy risk. Information given on 
alcohol exposed pregnancy and fetal alcohol syndrome. Counsellors 
encouraged a contraception visit to explore options and referred 
participants to community women’s health resources and offered 
informational brochures. Counsellors had post graduate degrees and 
trained in motivational interviews. Weekly supervision of counsellors. 
Baseline rate 0% effective contraceptive use 
Duration: One session lasting 60 minutes 
(n=144) either 
informational 
brochure or 
informational 
video. Baseline 
rate 0% 
effective 
contraceptive 
use 
Drinks per drinking day, 
ineffective contraception rate, 
alcohol exposed pregnancy 
risk at 3/6 months. 
Rendall-Mkosi 2012: South Africa- DEVELOPING COUNTRY 
1
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6 primary care clinics in Western 
Cape, South Africa aged 18-44, 
not pregnant, engaged in risky 
drinking, ineffective or no 
contraceptive use, not 
undergone sterilisation or 
hysterectomy, had vaginal sex in 
last 3 months, resided in 25 km 
of main town. 
(n=82) Rapport building, session programme, assessing the participants 
readiness to change and confidence in enacting behaviour change, 
development of change plan, implementation of the plan, assessing 
challenges and problem solving. Contraception was integrated throughout. 
Sessions conducted by locally recruited and trained lay counsellor. 
Sessions held 2 months in a convenient place and time for participants. 
Quality control of intervention ensured through regular meetings between 
trainers and counsellors. 51% participants completed 5 sessions, 12% 
(10) did not attend any sessions. Baseline rate 0% effective contraceptive 
use 
Duration: Five sessions over two months lasting 60 minutes 
(n=83) 
Information 
pamphlet on 
fetal alcohol 
syndrome 
prevention and 
women’s health 
handbook. 
Baseline rate 
0% effective 
contraceptive 
use. 
Risk of alcohol exposed 
pregnancy at 12 months, 
risky drinking and ineffective 
contraception at 3 and 12 
months, risk of alcohol 
exposed pregnancy at 3 
months (engaged in risky 
drinking and not using 
effective contraception at 
follow-up). 
  
1
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Table 17 Effective or high level contraceptive use up to four months, between four and eight months and between eight and twelve months (table contains data for only 
those patients followed up) (*assumptions from data reported in the studies (%)) 
Study Using effective or high level 
contraception up to four 
months (%) 
Using effective or high level 
contraception between four 
to eight months (%) 
Using effective or high level 
contraception between eight to 
twelve months (%) 
Subsequent births or 
pregnancies at 12-24months n 
(%) 
Intervention Control Intervention Control Intervention Control Intervention Control 
Ingersoll 58/94 
 (61.7) 
50/105 
(47.6) 
NR NR NR NR NR NR 
Petersen
*
 
 
233/323 
(72) 
218/346 
(66) 
212/331 
(63) 
215/331 
(62) 
217/349 
(64) 
200/334 
(60) 
35/349 
(10) 
34/334 
(10) 
Floyd 152/332 (45.8) 95/333  
(28.4) 
143/299 
(47.7) 
100/305  
(32.8) 
164/291 
(56.3) 
117/302 
(38.7) 
NR NR 
Barnet NR NR NR NR NR NR 26/167 
(15) 
17/68 
(25) 
Kirby
*
 NR NR 257/313 
(82) 
263/313 
(84) 
184/231  
(80) 
187/231 
 (81) 
NR NR 
Ceperich 68/101 
(67.3) 
59/106 
(55.7) 
NR NR NR NR NR NR 
Ingersoll 26/57  
(45.8) 
46/117 
 (40) 
24/45 
 (55.3) 
49/105 
 (46.6) 
NR NR NR NR 
Rendall-Mkosi 20/56  
(35.7) 
7/61  
(11.5) 
NR NR 26/61  
(42.6) 
16/64 
 (25) 
NR NR 
1
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Study quality 
The eight studies achieved scores between 16 and 30 on the CONSORT (218)  
statement checklist, with most studies reporting adequately on background, objectives, 
limitations, generalisability and interpretation (Table 17).  When assessed for risk of 
bias most studies scored low risk of bias in random selection, incomplete outcome data 
and selective reporting, with an unclear risk of bias in blinding of participants, outcome 
assessors and allocation concealment. All studies apart from one, scored high risk of 
bias in other sources of bias due to the method in which data was collected (Table 18). 
 
Effective contraceptive use between zero to four months 
Six studies (197, 212, 214-217) reported on effective contraceptive use between zero 
to four months. Meta-analysis showed a significant increase in effective contraceptive 
use with motivational interviews when compared to the control (RR 1.32 95%CI 
1.11,1.56: p=0.002:Figure 29). There was moderate heterogeneity in the analysis (I2= 
67%: p=0.010).  
 
Effective contraceptive use between four and eight months 
Four studies (197, 213, 216, 217) reported on effective contraceptive use between four 
and eight months. Meta-analysis showed no significant difference in effective 
contraceptive use with motivational interviews when compared to the control (RR 1.10, 
95%CI 0.93, 1.32: p=0.27: Figure 30).There was high heterogeneity in the analysis (I2= 
83%, p=0.0004).  
 
Effective contraceptive use between eight and twelve months 
Four studies (197, 212, 213, 217) reported on effective contraceptive use between 
eight and twelve months. Meta-analysis showed no significant difference in effective 
contraceptive use with motivational interviews when compared to the control (RR 1.18, 
95%CI 0.96, 1.46: p=0.12: Figure 31). Heterogeneity was high (I2= 86%: p=<0.0001).  
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Motivational interviews to reduce subsequent pregnancies or births at 12-24 months 
Two studies (197, 204) reported on the reduction of subsequent pregnancies at 24 
months.  No significant effect was shown on the incidence of subsequent pregnancies 
with motivational interviews (RR 0.80 95%CI 0.51, 1.26. p= 0.34: I2=39%, p=0.20: 
Figure 32). 
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Figure 29 Effective contraceptive use between zero to four months with participants that have participated in motivations interviews and participants that have received 
standard care 
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Figure 30 Effective contraceptive use between four and eight months with participants that have participated in motivations interviews and participants that have 
received standard care 
 
 
1
62
 
 
 
163 
 
 
Figure 31 Effective contraceptive use between eight and twelve months with participants that have participated in motivations interviews and participants that have 
received standard care 
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 Figure 32 Subsequent pregnancies or births at 12-24 months Motivational interviews with participants that have participated in motivations interviews and participants 
that have received standard care 
1
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6.4 DISCUSSION 
Main Findings 
Motivational interviews have a significant effect on the improvement of effective 
contraceptive use between zero to four months in a population at high risk of 
unintended pregnancy, but no effect at other time points. No significant difference was 
seen in subsequent pregnancies or births at 12-24 months (RR 0.80 95%CI 0.51, 
1.26).  There was moderate to high statistical heterogeneity in all three analyses, as 
well as clinical heterogeneity between the interventions within the trials. It is possible 
that the heterogeneity in the analysis in Figure 29 and Figure 31 may be due to the 
difference in the population in one study by Rendall-Mkosi et al (212), as the largest 
effect was seen in favour of the intervention. The study by Rendall-Mkosi et al included 
women of a similar age range (18-44) at risk of alcohol exposed pregnancy, however 
unlike the other studies, it was reported that the women within this study were 
predominantly poor, often part-paid with alcohol for working within the agricultural 
sector, experienced poor living conditions and had a low level of education. One further 
study by Floyd et al (217) showed a larger effect when compared to other studies. It is 
possible that the heterogeneity in Figure 30, and the larger effect in both the studies by 
Rendall-Mkosi et al and Floyd et al (212, 217) may be due to the educational difference 
in the population. Only a third of the population in the study by Floyd et al had college 
education and most participants were recruited from women jails or alcohol treatment 
centres.  All of the other studies included in the review recruited university students 
only. Compliance in the studies by Rendall-Mkosi et al and Floyd et al was low (51% 
(212) and 63% (217) yet they had the greatest effect. Rather than the interviews having 
a motivational effect, in populations with low education levels there will be a greater 
scope for providing new information which may be all that was needed in some cases 
to change behaviour. 
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Moreover, one could suggest that the significant improvement in the first reported time 
point (between zero up to four months), compared to subsequent time points (four up 
to eight months and eight up to twelve months) could be due to the participants 
forgetting the message of the intervention. The study by Petersen et al that provided 
booster sessions at 2 months post intervention (197) showed improved contraceptive 
usage when compared to other reported time points in the study.  
 
Strengths and Limitations 
Although not a methodological limitation, the main limitation of this review for this thesis 
is that all of the RCTs included in the review were conducted in upper-middle income 
countries, which has obvious implications for generalisability of the review findings to 
low-middle countries, where resources may be limited. The cost and intensity of the 
intervention (as demonstrated in the table of characteristics) may not be suitable or 
sustainable for developing countries, therefore the generalisability of the results to low 
income setting must be debated. The study by Rendall Mkosi et al however, was set in 
a developing country (South Africa), and included participants of low socioeconomic 
status from a rural setting. Given that this trial alone showed the largest effect size 
compared to all other trials, it could be suggested that motivational interviews are likely 
to be effective within a developing country setting, however this could be due to the 
information transmitted and the educational component of the intervention, rather than 
a motivated conscious change in the participant’s behaviour. Nevertheless, 
sustainability of this intervention, due to the high cost and intensity, may impede the 
implementation of this intervention outside of the research context. Furthermore the 
culture and lifestyle of the population studied may differ from that of women in some 
developing countries. For example sexual promiscuity, sexual relationships before 
marriage, and alcohol consumption may not be as widely practiced within some 
developing countries, as it is in the countries studied. It is therefore possible that this 
type of intervention may only have the demonstrated effect on some population. 
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Methodological limitations of the review include the heterogeneity in the intervention, 
the delivery of the intervention, and the intervention concentration. Additional limitations 
in the analysis could be the pooling of the time points reported, and including 
estimations of outcome for two studies (197, 213) within the analysis. Due to the 
variability in the actual reported time points across the eight studies, there was 
insufficient data in each category to provide meaningful analysis. Therefore the time 
points reported in the studies were plotted on a graph (Figure 27) to observe if a cluster 
effect was present around time specific time points. As this was not observed the time 
points were pooled in categories (zero up to four, four up to eight, eight up to twelve).    
 
There is possible risk of reporting bias in the primary data, as the majority of the 
studies relied on self reporting of contraceptive use, and episodes of risky behaviour in 
relation to unsafe sexual activity.  There may also be bias in the outcome data reported 
by the participants, as outcomes may have underreported, this was therefore assessed 
to have a high risk of bias within ‘other bias.’ There were also some discrepancies in 
the data that we attempted to resolve by contacting authors, however due to the 
methods of statistical analysis used in the primary analysis, exact numbers for the 
control and intervention arm could not be provided, only estimates were given (213), 
thus a further limitation within our analyses.   
 
Existing evidence 
Motivational interviews have been examined previously in a Cochrane Review that 
tested theory based interventions that aimed to promote or inform contraceptive use 
(196), however it included studies with a wide variety of types of interventions, 
including home-based mentoring, pamphlets, computer-delivered interventions, general 
health counselling, group youth and parent programs, educational tools as well as 
motivational interviews.  Four trials (197, 213, 214, 217) primarily examined the effect 
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of motivational interviewing on alcohol exposed pregnancy (214, 217), the prevention 
of pregnancy and sexually transmitted infections (197), and improvement in 
contraceptive use (213). No key patterns were identified with theory type, intervention, 
or target population, therefore it is suggested that more thorough use of single theories 
would help inform the field about what is effective.   
 
Motivational interviewing training for general practitioners (219) has also been explored 
in a systematic review, different aspects of motivational interviewing training for GPs 
were evaluated.  The review included studies of interventions that addressed alcohol 
counselling for pregnant women, as well as counselling for abuse, smoking, medication 
adherence, diabetes, lifestyle, exercise and diet. The review concluded that 
motivational interviewing can improve client communication and counselling concerning 
lifestyle related issues, however the methodological and clinical heterogeneity of the 
studies within the review means that the results should be interpreted with caution. 
 
Policy and practice implications 
The importance of addressing maternal and child in developing countries has been 
identified (190, 220), and attempts have been made to prioritise maternal health needs 
through promoting and supporting essential services, and developing guidelines (221) 
(222). However, there is a scarcity of data on the effectiveness of these programs. It is 
apparent from this review that good quality evidence on the effectiveness of 
contraceptive counselling based on motivational interview techniques is lacking (195).  
Previous research has demonstrated varying levels of success on contraceptive uptake 
and unintended pregnancy, however the clinical heterogeneity across the studies, both 
within the interventions and the populations, causes difficulty with drawing firm 
inferences between the intervention and the effect. Although there is high cost and 
intensity associated with this interview, the delivery method (i.e. one to one contact with 
a health worker) evades any possible cultural, social or religious ‘taboos’ associated 
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with contraception,  as healthcare providers are in a unique position to discuss and 
explore contraceptive practices (194, 195, 223), and issues that may be culturally 
sensitive and not openly discussed, thus permitting generalisability to other regions. 
Moreover, the only study set in a developing country showed the greatest effect on 
effective contraceptive use with motivational interviews, albeit classed as a middle to 
high income country. 
 
Unanswered questions and future research 
Overall there appears to be a lack of evidence on the effect of motivational interviewing 
to improve contraceptive use and compliance on women of reproductive age in 
developing countries, with only a single study being set in a developing country. Thus 
an RCT would provide good quality evidence on the effect of motivational interviewing 
on contraceptive practice in post conflict areas where contraceptive need is unmet.  
This review was used to support the application ‘Motivational Interviewing as part of 
Public Health Midwives consultation to improve contraceptive uptake in northern Sri 
Lanka:  a cluster randomised trial ’seeking funding from the  ‘Implementation Research 
Platform (IRP) call for proposals in Northern Sri Lanka’.   
 
6.5 CONCLUSION 
It is apparent from our review that motivational interviews significantly increase 
effective contraceptive use in a population at high risk of unintended pregnancy from 
developed countries, between zero up to four months after the intervention has been 
delivered.  Furthermore, the only study that was set in a developing country showed 
the largest effect on effective contraceptive use with motivational interviews, even with 
poor compliance in the intervention group. As the WHO is working to promote 
contraception by producing evidence-based guidelines on service delivery of 
contraceptive methods, and adapt, implement and improve delivery methods to meet 
 
 
170 
 
the needs of individuals, this research complies with current global health research on 
improving family planning. 
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Table 18 Quality assessment: CONSORT statement reporting checklist 
Item 
  
Checklist item  
 
Ingersoll Floyd Ceperich Kirby Petersen Barnet Ingersoll Rendall-
Mkosi 
Title and abstract 
 Identification as RCT in title N Y N N Y Y N Y 
Structured summary of trial 
design, methods, results, 
conclusions  
N Y N Y Y Y Y Y 
Introduction 
Background and 
objectives 
Scientific background, 
explanation of rationale 
Y Y Y Y Y Y Y Y 
Specific objectives or hypotheses Y Y Y Y Y Y Y Y 
Methods 
Trial design Description of trial design 
including allocation ratio 
N Y N N N N Y N 
Important changes to methods 
after commencement  
N N N N N N N Y 
Participants Eligibility criteria for participants Y Y Y Y Y Y Y Y 
Settings and locations where 
data were collected 
N Y N N Y N N N 
Interventions interventions with sufficient 
details to allow replication, how/ 
when administered 
Y Y Y Y Y Y Y Y 
Outcomes Completely defined pre-specified 
primary and secondary outcome 
measures, including how and 
when assessed 
Y Y Y Y Y Y Y Y 
Any changes to trial outcomes 
after trial commenced 
N N N N N N N N 
1
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Sample size How sample size determined N Y N Y Y N N Y 
applicable, explanation of interim 
analyses and stopping guidelines 
N/A N/A N/A N/A N/A N/A N/A N/A 
Randomisation: 
Sequence  
generation 
Method to generate random 
allocation sequence 
Y Y Y Y Y Y Y Y 
randomisation; details of 
restriction  
N Y N Y Y Y Y Y 
Allocation  
concealment  
mechanism 
Mechanism to implement random 
allocation sequence describing 
steps taken to conceal the 
sequence until interventions 
assigned 
N Y N N Y N Y Y 
Implementation Who generated random 
allocation sequence, enrolled 
participants, and assigned 
participants to interventions 
Y N Y N N N Y Y 
Blinding who was blinded after 
assignment to interventions  
N Y N Y N N Y Y 
If relevant, description of 
similarity of interventions 
N/A N/A N/A N/A N/A N/A N/A N/A 
Statistical 
methods 
Statistical methods used to 
compare groups for primary and 
secondary outcomes 
Y Y Y Y Y Y Y Y 
Methods for additional analyses, 
subgroup analyses, adjusted 
analyses 
Y Y Y Y Y Y Y Y 
Results 
Participant flow  numbers of participants randomly 
assigned, received intended 
treatment, and analysed for 
primary outcome 
Y Y Y Y Y Y Y Y 
losses and exclusions after 
randomisation, together with 
Y Y Y N N Y Y Y 
1
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reasons 
Recruitment Dates defining the recruitment 
and follow-up 
N Y N Y Y Y Y Y 
Why trial ended or stopped N N N N N N N N 
Baseline data baseline demographic and 
clinical characteristics  
Y Y Y Y Y Y Y Y 
Numbers 
analysed 
number of participants included 
in analysis and whether analysis 
by original assigned groups 
Y Y Y N Y Y Y Y 
Outcomes and 
estimation 
primary and secondary outcome, 
results and estimated effect size 
and precision  
Y Y Y N N Y Y Y 
For binary outcomes, 
presentation of both absolute and 
relative effect sizes  
N Y Y N Y N Y Y 
Ancillary 
analyses 
Results of any other analyses 
performed, subgroup analyses, 
adjusted analyses, distinguishing 
pre-specified from exploratory 
N Y Y N N Y Y Y 
Harms important harms or unintended 
effects  
Y N Y N N N N N 
Discussion 
Limitations Trial limitations, addressing 
sources of potential bias, 
imprecision, and, multiplicity of 
analyses 
Y Y Y Y Y Y Y Y 
Generalisability Generalisability of the trial 
findings 
Y Y Y N Y Y Y N 
Interpretation Interpretation consistent with 
results, balancing benefits, 
harms, considering other relevant 
evidence 
Y Y Y N Y N Y Y 
Other information 
Registration Registration number, trial registry N Y N N N N Y N 
1
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√ = Reported     X = Not Reported 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protocol full trial protocol can be accessed N Y N N N N N N 
Funding Sources of funding and support  Y Y Y Y Y Y Y Y 
1
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Table 19 Risk of Bias in Included Studies: RCTs 
Random sequence 
generation 
Allocation 
concealment 
Blinding of 
participants and 
personnel 
Blinding of outcome 
assessment 
Incomplete outcome 
data 
Selective 
reporting 
Other bias 
Ingersoll 2005 
LOW: Page 175: 
counsellor opened a 
randomisation 
envelope 
UNCLEAR: No 
details provided 
on allocation 
concealment 
other than 
randomisation 
envelopes used 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
UNCLEAR: No 
details provided on 
blinding of outcome 
assessment 
LOW: Page 177: 
Data provided for 
follow up rates, those 
lost to follow up. 
Rates similar within 
the intervention and 
control  
LOW: Page 
178: All 
outcomes 
reported on  
HIGH: Page 179: 
outcome data is 
self-reported 
there is potential 
for under 
reporting of risky 
behaviour 
Floyd 2007 
LOW LOW HIGH LOW  LOW LOW HIGH 
Page 3: Random 
allocation was 
controlled by a data 
coordinating centre. A 
randomisation 
program developed to 
generate unique 
identifiers to randomly 
assign each ID to 
either intervention or 
control. 
Page 3: Each 
unique study ID 
was then printed 
on opaque 
envelope, a card 
inside envelope 
indicated group 
status to which 
study participant 
receiving ID 
number was 
assigned. 
Envelopes 
sealed, boxed in 
numeric order, 
drawn in 
numeric order. 
Page 3: It was not 
possible to blind 
study participants 
or those 
administering 
intervention to 
group assignment  
Page 3: study sites 
blind to ID 
number’s group 
status until 
envelopes opened. 
Staff blinded to 
group assignment 
conducted follow up 
interviews 
Page 4: Large 
amount loss to follow 
up but ITT analysis 
completed and 
similar numbers loss 
to follow up in each 
arm 
Page 7: All 
outcomes 
reported on 
Page 5: 
Difference in 
number of sexual 
partners between 
control and 
intervention arm 
(although not 
statistically 
significant) 
Page 8: As 
outcome data is 
self-reported 
there is potential 
for under 
reporting of risky 
behaviour 
Petersen 2007 
1
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LOW: Page 22: 
Random numbers 
table to generate 
group assignment in 
permuted block sizes 
of 100. 
LOW: Page 22: 
Placed sealed 
envelopes with 
the assignments 
at each site. 
Enveloped 
opened after 
participants 
were screened. 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
UNCLEAR: No 
details provided on 
blinding of outcome 
assessment 
UNCLEAR: Page 24: 
Limited information 
given on participants 
lost to follow up 
LOW: Page 
25: All 
outcomes 
reported 
HIGH: Page 25: 
numerical 
numerators and 
denominators not 
provided for 
outcome 
measures, 
percentages 
given  
Page 26: outcome 
data is self-
reported there is 
potential for under 
reporting of risky 
behaviour 
Barnet 2009 
 LOW: Page 437: 
Computer generated 
randomisation 
LOW: Page 437: 
Randomisation 
applied to 
consecutively 
consenting 
teens using 
permuted blocks 
of 6 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
UNCLEAR: No 
details provided on 
blinding of outcome 
assessment 
LOW: Page 439: 
Data provided for 
follow up rates, those 
lost to follow up. 
Rates similar within 
intervention and 
control arms 
LOW: Page 
442:All 
outcomes 
reported 
LOW: Page 437: 
Intentionally more 
participants in 
intervention than 
control and not 
balanced on key 
variables but a 
multivariate 
analysis was 
performed to 
control for this. 
Kirby 2010 
1
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LOW: Page 252: 
Random number 
generator. 
UNCLEAR: No 
details provided 
on allocation 
concealment 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
LOW: Page 253: 
Interviewers were 
blinded to study 
group assignments 
until final follow up 
as had to ask 
intervention group 
additional questions 
LOW: Page 254: 
Data provided for 
follow up rates, those 
lost to follow up. 
Rates similar within 
the intervention and 
control. Numerators 
not given only 
percentages. 
LOW: Page 
254 : All 
outcomes 
reported 
HIGH: Page 257: 
outcome data is 
self-reported 
there is potential 
for under 
reporting of risky 
behaviour 
Page 257: self-
selection bias is 
possible as only 
included women 
willing to receive 
phone calls, 
however < 10% 
declined as were 
unwilling to take 
calls, therefore 
unlikely bias 
affected results. 
Ceperich  2011 
LOW: Page 385: 
Randomisation 
envelope 
UNCLEAR: No 
details provided 
on allocation 
concealment 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
UNCLEAR: No 
details provided on 
blinding of outcome 
assessment 
LOW: Page 385: 
Data provided for 
follow up rates, lost 
to follow up. Rates 
similar within 
intervention and 
control  
LOW: Page 
387 table 2, 
3 figures 2, 
3. All 
outcomes 
reported 
HIGH: outcome 
data is self-
reported there is 
potential for under 
reporting of risky 
behaviour 
Ingersoll  2012 
1
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UNCLEAR: Page 2: 
Random assignment 
but not other details 
provided 
UNCLEAR: No 
details provided 
on allocation 
concealment 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
LOW: Page 3: 
Research assistant 
conducting 
assessments 
masked to 
assignment 
UNCLEAR: Page 5: 
Data provided for 
follow up rates, those 
lost to follow up. 
Rates differ within 
intervention and 
control arms, no 
reasons provided for 
loss to follow up or 
differences 
LOW: Page 7 
: All 
outcomes 
reported 
HIGH: outcome 
data is self-
reported there is 
potential for under 
reporting of risky 
behaviour 
Rendall-Mkosi 2012 
LOW: Page 5: 
Computerised 
individual 
randomisation 
LOW: Page 5: 
Sealed 
envelope 
UNCLEAR: No 
details provided 
on blinding of 
participants and 
personnel 
HIGH: Page 5: 
Blinding 
fieldworkers to 
group allocation of 
participants was 
difficult in small 
rural community 
setting, fieldworkers 
did not perform 
counselling only 
gave 
questionnaires. 
LOW: Figure 1: Data 
provided for follow up 
rates, and those lost 
to follow up. Rates 
similar within 
intervention and 
control arms 
LOW: Page 9 
table 2 : All 
outcomes 
reported 
HIGH: Page 11: 
outcome data is 
self-reported 
there is potential 
for under 
reporting of risky 
behaviour 
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CHAPTER 7:  A COMPARISON OF CLINICAL OFFICERS 
WITH MEDICAL DOCTORS ONOUTCOMES OF CAESAREAN 
SECTION IN THE DEVELOPING WORLD: META-ANALYSIS OF 
CONTROLLED STUDIES 
ABSTRACT 
Background:  Many low to middle income countries have a shortage of trained 
medical doctors. Clinical officers were temporarily posted to alleviate the shortage of 
medical doctors in some low to middle income countries, however since then they have 
become a more permanent strategy. There is uncertainty about the effectiveness and 
safety of clinical officers performing caesarean sections. This systematic review 
examines the effectiveness and safety of clinical officers (healthcare providers trained 
to perform tasks usually undertaken by doctors) carrying out caesarean section in 
developing countries compared with doctors. 
Methods:  Systematic review with meta-analysis was performed. Medline, Embase, 
Cochrane Central Register of Controlled Trials, CINAHL, BioMed Central, the 
Reproductive Health Library, and the Science Citation Index (inception-2010) were 
searched without language restriction. Controlled studies were selected and 
information was extracted from each selected article on study characteristics, quality, 
and outcome data. Risk of bias was assessed using the Newcastle Ottawa Scale. 
Results:  Six non-randomised controlled studies (16 018 women) evaluated the 
effectiveness of clinical officers carrying out caesarean section. Meta-analysis found no 
significant differences between the clinical officers and doctors for maternal death 
(odds ratio 1.46, 95% confidence interval 0.78 to 2.75; p=0.24) or for perinatal 
death (OR 1.31, 95%CI 0.87 to 1.95; p=0.19). The results were heterogeneous, with 
some studies reporting a higher incidence of both outcomes with clinical officers. 
Clinical officers were associated with a higher incidence of wound infection (OR 1.58, 
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95%CI 1.01 to 2.47; p=0.05) and wound dehiscence (OR 1.89, 95%CI 1.21 to 2.95; 
p=0.005). Two studies accounted for confounding factors. 
Conclusion:  Clinical officers and doctors did not differ significantly in key outcomes 
for caesarean section, but the conclusions are tentative owing to the nonrandomised 
nature of the studies. The increase in wound infection and dehiscence may highlight a 
particular training need for clinical officers. 
Impact of review: Published in BMJ, informed WHO recommendations on task-
sharing: OPTIMIZEMNH 
Citation of paper published from this work on which this chapter is based 
Amie Wilson, David Lissauer, Shakila Thangaratinam, Khalid S Khan, Christine 
MacArthur, Arri Coomarasamy. A comparison of clinical officers with medical doctors 
on outcomes of caesarean section in the developing world: meta-analysis of controlled 
studies. BMJ 2011;342:d2600 
 
7.1 BACKGROUND 
There is a global deficit of qualified medical personnel, especially specialist medical 
practitioners, for example obstetricians and gynaecologists. Many low to middle income 
countries have a shortage of trained medical doctors. Rural areas are predominantly 
affected, as doctors largely congregate in urbanised regions as they are easier to travel 
to, or the facilities posses a great supply or quality of resources (224). A variety of 
reasons have been linked to the depletion in medical and clinical workforce, including 
the migration of trained staff due to brain drain. Brain drain is when skilled 
professionals, namely healthcare professionals leave their country of training or origin 
to work in a more resource rich setting. This is often due to aspirations for career 
progression where there is a lack of opportunity, the frustration with lack of resources, 
both human and clinical impeding medical care, and the desire for improve personal 
income. Figure 33 demonstrates the factors that have been associated with brain drain 
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in the literature (224-227). Fear of exposure to blood-borne infections, or sickness or 
death due to Human Immunodeficiency Virus are also contributing factors. 
 
Clinical officers were initially temporarily posted to alleviate the shortage of medical 
doctors in some low to middle income countries (135, 226, 228). However, they have 
now become a more permanent strategy, operating in many countries. Clinical officers 
are described today as the ‘backbone’ of healthcare in several settings across the 
globe (228). Clinical officers are not medical doctors, they have a separate training 
programme, but their roles include many medical and surgical tasks that are usually 
performed by doctors, such as anaesthesia, diagnosis and treatment of medical 
conditions, and prescribing. The perceived benefits of using clinical officers compared 
to doctors are the reduced training and employment costs, as well as enhanced 
retention within the local health systems (226, 227, 229).  
 
The scope of practice of a clinical officer within obstetrics is often determined by the 
country in which they practice (225).  In nineteen out of forty seven Sub-Saharan 
African countries, clinical officers are authorised to provide obstetric care, yet in only 
five countries are they permitted to perform caesarean sections and other emergency 
obstetric surgery (228).   Given that caesarean section is the most common major 
surgical procedure in Sub-Sahara Africa (230), and must be delivered in a timely 
fashion to save a mothers and babies life (231), clinical officers could potentially play 
an important role in increasing accessibility and availability of emergency obstetric 
care, particularly caesarean section, and thus ultimately reduce maternal mortality. 
However, currently there is uncertainty about the role of clinical officers (224), their 
training, effectiveness and their safety.  
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Yet given the central role that clinical officers could potentially have in increasing the 
obstetric care provision, we have systematically reviewed and meta-analysed the 
effectiveness and safety of clinical officers in caesarean section surgery.
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Figure 33 Factors Associated with Brain drain in the literature (224-227)
1
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7.2 METHODS 
Data sources and searches 
Databases were searched for relevant literature on clinical officers within obstetrics in 
developing countries, with particular attention to maternal and perinatal mortality rates, 
and adverse maternal outcomes. The databases that were searched were MEDLINE, 
EMBASE, Cochrane, CINHAL, BIOMED Central, the Reproductive Health Library, and 
the Science Citation Index (from database inception to August 2010). Hand searching 
complemented the electronic searches performed, and reference lists were checked. 
Search terms were ‘clinical officer’, ‘medical officer’, ‘assistant medical officer’, ‘medex’, 
and ‘non physician clinicians’. Pregnancy specific terms were not included within the 
search terms to increase the sensitivity of the search, to ensure all studies with relevant 
data were identified. No language restrictions were applied to the search.  
 
Study selection and data extraction 
As there was an absence of randomised evidence comparing caesarean section 
outcomes of clinical officers and medical doctors, controlled studies comparing clinical 
officers and medically trained doctors for caesarean section in the developing world 
setting were selected, if they reported on any clinically relevant maternal or perinatal 
outcomes.  Firstly the electronic searches were scrutinised and full manuscripts of 
relevant studies were obtained. A final decision on inclusion or exclusion of 
manuscripts was made after examination of these manuscripts by the author and 
another reviewer (AW and DL), a third reviewer was involved if there were 
discrepancies in the decision for inclusion. Information was extracted from each 
selected article on study characteristics, study quality and outcome data.  Descriptive 
studies were also examined to explore the role of the clinical officer further. 
 
Methodological quality assessment 
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The selected studies were assessed for adequacy of reporting using the Strobe 
checklist (69). The STROBE statement is a checklist of 22 items considered essential 
for sound reporting of observational studies. The items included relate to the article’s 
title and abstract, the introduction, the methods, the results of the study and the   
discussion section. Other information such as funding is also featured. The checklist 
differs slightly for reporting case-control studies, cohort studies and cross sectional 
studies.  Studies were also assessed for risk of bias using the Newcastle Ottawa Scale 
(71). The controlled studies were evaluated for representativeness of the cohorts, 
selection of the cohorts, ascertainment of the intervention and the outcome, 
comparability of the cohorts, as well as the length and adequacy of follow-up. The risk 
of bias was regarded as low if a study obtained four stars for selection, two stars for 
comparability and three stars for ascertainment of exposure (71). Medium risk of bias 
was suggested to exist in studies with two or three stars for selection, one for 
comparability and two for exposure. Any study scoring one or zero stars for selection, 
comparability or exposure was deemed to have a high risk of bias.  
 
Data synthesis 
Odds ratios from individual studies were pooled using the random effects model to 
account for the variability in the setting, cadre training and cases included in the 
studies. Heterogeneity of treatment effects was evaluated using forest plots, chi square 
and I2 tests; the terms low, moderate, and high heterogeneity were assigned to I2 
values of over 25%, 50%, and 75% respectively. Where possible, data for adjusted 
estimates were presented on the forest plot to account for confounding factors. 
Analyses were performed using Revman 5.0 statistical software. 
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7.3 RESULTS 
Six non-randomised controlled cohort studies, with a total of 16,018 women, were 
found to be suitable for inclusion in our review (Figure 26). Characteristics of the 
included studies are shown in (Table 19). There was medium risk of bias in selection, 
and medium to high risk of bias in comparability and outcome assessment for most 
studies when assessed on the Newcastle-Ottawa Scale (Table 20).  
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Figure 34 Results of search strategy and identification of publications included  
Total citations identified from electronic searches n= 7678
Total citations identified from hand searching n= 12
Citations excluded after screening title and/or abstracts: n = 7634
Primary articles fulfilling inclusion criteria for systematic review n= 6
Articles excluded after review of full text with reasons
Incorrect study design n =22 
Incorrect outcome n=  6
Unable to obtain n = 0
Incorrect population n = 31
Total excluded n = 59 
Full manuscripts retrieved for detailed evaluation: n = 65 
Figure 2. Study selection process in the systematic review of Cell Salvage in ectopic surgery
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Maternal Mortality 
All six studies compared clinical officers with medical doctors for the outcome of 
maternal mortality. The meta-analysis showed there was no significant difference 
between the two groups (OR 1.46, 95% CI 0.78 to 2.75, p=0.24: Figure 27). However, 
the analysis found significant heterogeneity (p = 0.03) which was quantified to be 
moderate (I2 = 60%). One (231) of the two studies (226, 231) that showed an increase 
in maternal mortality with clinical officers performing caesarean section in the crude 
analysis, found that the increase was no longer statistically significant when the 
analysis was adjusted for rural setting, previous caesarean section, haemorrhage, 
other peri-operative medical complications and the level of training of surgeon 
(adjusted OR 1.4 95%CI 0.7 to 2.9). The second study (226) that showed an increase 
in maternal mortality with the clinical officers also adjusted the analysis, but for reported 
diagnosis and referral status;  however the adjusted estimates were not provided. The 
overall maternal mortality rate in the six studies was high at 1.2%.  
 
Perinatal mortality 
Five studies (15,665 women) compared caesarean sections performed by clinical 
officers and medical doctors for the outcome of perinatal mortality. The meta-analysis 
showed no significant difference between the groups (OR 1.31, 95% CI 0.87 to 1.95 
p=0.19: Figure 27). The analysis found significant heterogeneity (p < 0.01), quantified 
to be high with an I2 of 88%. One (231) of the two studies (226, 231) that showed an 
increase in perinatal mortality with clinical officers in the crude analysis, found that this 
was no longer statistically significant when adjusted for confounding factors (adjusted 
OR 1.1 95% CI 0.8 to 1.3). The overall perinatal mortality in the pooled five studies rate 
was high at 10.7%. 
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Figure 35 Caesarean section outcomes: comparison of clinical officers with medical doctors  
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Wound infection 
Two studies (226, 232)(4,436 women) compared the rates of wound infection in 
caesarean sections when performed by clinical officers and medical doctors. The meta-
analysis found a significant increase in wound infection when caesarean section was 
performed by clinical officers when compared with medical doctors (OR 1.58, 95% CI 
1.01 to 2.47, p=0.05: Figure 27). There was no significant heterogeneity (p = 0.40, I2 = 
0%).  
 
Wound dehiscence  
Three studies (224, 226, 232)(6,507 women) compared the rates of wound dehiscence. 
The meta-analysis showed a significance increase in wound dehiscence with clinical 
officers performing caesarean section when compared to medical doctors (OR 1.89, 
95% CI 1.21 to 2.95, p=0.005: Figure 27). There was no evidence of significant 
heterogeneity in the analysis (p=0.38, I2 = 0%). 
 
Training of clinical officers  
All six papers gave training details of clinical officers; training length and specification 
varied between countries. In Zaire (233) and Burkina Faso (226) nurses attended a 2 
year training course to become clinical officers, with an additional 1-2 years of surgical 
training in Zaire, but no details were reported on experience or length of service. The 
clinical officer cadre varied in the studies with one study (in Zaire)(233) reporting the 
cadre to be nurses that were trained to perform obstetric surgery, such as caesarean 
sections, laparotomies and supracervical hysterectomies (233). The nurses in this 
study were trained for a minimum of three years at secondary school, followed by a 
further two years of nurse training, then an additional 1-2 years of surgical training 
(233), but again no details on experience were reported. In the study set in 
Mozambique (224), clinical officers were assistant medical officers with three years 
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surgical training in general surgery, obstetrics, gynaecology, orthopaedics, trauma, 
intensive care,  and neurosurgery  (224). No details were reported on experience or 
length of service. Clinical officers in both studies in Malawi undertook a 3 year health 
foundation course, with a year as an intern at a hospital or in surgical training (231, 
232). One study reported that clinical officers were licensed to practice independently, 
and performed major emergency and elective surgery. The majority of the clinical 
officers in this study had over four years surgical experience (232). In the study set in 
Burkina Faso (226) clinical officers underwent a six month curriculum in emergency 
surgery to perform operative obstetric care, and registered nurses completed an extra 
two years additional surgical training. No details on the level of experience were 
reported. The clinical officers in the study set in Tanzania (234) were assistant medical 
officers that were authorised to provide clinical services, such as prescriptions and 
minor surgery. They were also permitted to perform obstetric care and caesarean 
sections. They were all secondary school graduates with 3 years medical training, plus 
a further 2 years clinical training, including 3 months in surgery and 3 months in 
obstetrics. 
 
Description of cases 
In the study conducted in Zaire (233) only 12% of patients were operated on by 
doctors, the remainder operated on by clinical officers.  Separate case details were not 
provided for each cadre. The majority of caesarean section were performed for 
cephalopelvic disproportion and obstructed labour. This study included participants in 
two hospitals, however one of the hospitals in this study was without a medical doctor 
for one year. The nurses in this study performed all of the caesarean sections, however 
in one of the other units in this study, the resident medical doctor routinely operated on 
the most complicated and critical cases. The medical doctor in this unit would only 
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perform the caesarean section when no nurses were available. In the study set in 
Mozambique (224) clinical officers conducted around half of all caesarean sections, 
most of which were performed for fetal distress (32.2%). The most common reason for 
caesarean section in the medical doctor group was also fetal distress (29%). Most 
emergency operations were performed by clinical officers, and all elective caesarean 
sections were performed by doctors. In the study in Malawi by Fenton et al (231), a 
third of caesarean sections were performed by doctors, the remainder performed by 
clinical officers.  No separate details for the surgeons were reported for the indication 
for caesarean section; again the majority were performed for obstructed labour (63%). 
In the other study in Malawi by Chilopora et al (232) the majority of caesarean sections 
were conducted by clinical officers (88%), as before, separate details for both groups 
were not reported in relation to the indication of the operation. The most common 
indication was cephalopelvic disproportion or obstructed labour (57.7%). In the study 
conducted in Burkina Faso (226), the majority of caesarean sections were performed 
by medical doctors (68%). A higher percentage of these operations were conducted in 
an urban hospital, only 9% were conducted in a rural hospital. This however was 
opposite in the clinical officer group, 73% of caesarean sections in this group were 
performed in a rural hospital. The main indication in both clinical officer and medical 
doctor groups was obstructed labour (53% and 39% respectively). The women who 
were referred for complications were not significantly more of less likely to be operated 
on by medical doctors in relation to clinical officers. In the study by McCord et al that 
was set in Tanzania (234) 87% of caesarean sections were performed by clinical 
officers. The most common indication in both cadre groups was the ‘absolute maternal 
indication’ which included women who experienced ante-partum haemorrhage, 
postpartum haemorrhage, malpresentation, eclampsia, ectopic pregnancy, ruptured 
uterus, sepsis and repair of vesico-vaginal fistula (33.1% and 33.6% respectively).   
 
 
194 
 
Table 20 Characteristics of included studies 
 Clinical Officer Medical Doctor 
White 1987: Zaire 
Cadre details, 
training 
Nurses trained to perform C/S, laparotomies, supracervical hysterectomies: 
Minimum of 3 yrs at secondary school, 2 yrs nurse training. 1-2yrs additional 
surgical training 
Medically qualified doctor. Not given 
Population, 
Characteristics 
Pregnant women needing c/s at 2 rural hospitals or health centres in 
northwest Zaire. Characteristics not given  
As before 
Amount, Indication 
for C/S (%) 
310 (88%) No separate details given on surgeon and indication for c/s, only 
given for Karawa hospital (321 c/s): Cephalopelvic disproportion and 
obstructed labour 159 (50%). uterine inertia 70 (22%).previous c/s 54 
(17%)fetal distress 22(7%) placenta praevia 16( 4%)  
43(12%) 
As  before 
Surgeon  allocation, 
type of operation 
One unit was without a MD for 1 yr, nurses performed all c/s. In one unit MD 
did not routinely perform most complicated operations.  In other unit MD 
operated on most critical cases. MD performed c/s when no nurse available, 
or training medical students. Operation type not given 
As before 
Potential 
confounders 
Delay in seeking care, delay in reaching care (transportation), other medical 
complications 
No adjustments made. 
As   before 
Outcome MMR As  before 
Pereira 1996: Mozambique 
Cadre details and 
training 
Assistant medical officers (clinical officers with surgical training).3 yrs some 
surgical experience in general surgery, obstetrics, gynaecology, 
orthopaedics, trauma, intensive care, neurosurgery. 
Trained obstetricians and gynaecologists.   
Not given 
Population, 
Characteristics 
Pregnant women needing c/s at central hospital. c/s rate 16.5% was only 
hospital performing c/s. Age 25.3yrs, parity 2.2. Shanty town 353 (37%). 
antenatal care 948 (99%). twin pregnancy 25 (3%) 
As before Age 25.5yrs, parity 2.2, shanty town 404(36%), 
antenatal care 1101 (99%), twin pregnancy 21(2%) 
Amount, Indication 
for C/S (%) 
958(46%) Fetal distress. 308 (32.2%) Cephalopelvic disproportion.177 
(18.5%) previous c/s 89 (9.3%). placental abruption or praevia 79 
(8.2%).impending uterine rupture 72 (7.5%). eclampsia 31 (3.2%). pre-
eclampsia 26 (2.7%). no information 176 (18.4%) 
1113 (54%) Fetal distress 326 (29%) cephalopelvic 
disproportion 212 (19%) previous c/s 133 (11.9%) 
placental abruption or praevia 74 (6.6%) impending 
uterine rupture 68  (6.1%) eclampsia 40 (3.6%) pre-
eclampsia 33 (3%).no information 227 (20.5%) 
1
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Surgeon  allocation, 
type of operation 
No random allocation for ethical reasons. Some selection occurred when 
patients allotted to CO or MD.  c/s only 682 (71%). c/s+ Subtotal 
hysterectomy 8 (1%). c/s + total hysterectomy 
3 (0.5%). c/s + uterine repair 4 (0.5%). c/s + tubal ligation 257 (26.5%).no info 
4 (0.5%) 
It is noted that emergencies prevented MD attending 
complicated c/s. Furthermore medical doctors carried out 
all elective c/s n=145 (7.0%) c/s only 832 (74.5%). 
c/s + Subtotal hysterectomy 10 (1%). c/s + total 
hysterectomy 4 (0.5%) c/s + uterine repair 5 (0.5%). c/s + 
tubal ligation 256 (23%) no info 6 (0.5%) 
Potential 
confounders 
Age, parity, shanty own residence, antenatal care, twin pregnancy. No 
adjustments made 
As before 
Outcome MMR, duration of post operative stay,  wound rupture or separation, condition 
of the newborn 
As before 
Fenton 2003: Malawi 
Cadre details and 
training 
clinical officer surgeons:  3 year foundation health course, plus 1 year in 
surgical training 
Medically qualified doctor: Not given 
Population, 
Characteristics 
Women requiring c/s, after 28 weeks, including surgery for ruptured uterus. 
23 district and 2 central hospitals. No separate details given on surgeons for 
characteristics: District hospital 5236 (65%). urban hospital 2834 (35%) 
As before 
Amount, Indication 
for C/S (%) 
5256 (65%) No separate details given on surgeon and indication for c/s. 
Obstructed labour 5110 (63%). fetal distress 885 (11%).ante-partum 
haemorrhage 384 (5%). pre-eclampsia 268 (3%). haemorrhagic shock 610 
(8%). ruptured uterus 333 (4%). other 480 (6%) 
2814(35%) As before 
 
Surgeon allocation, 
type of operation 
Not given 
 
Not given 
Potential 
confounders 
Previous c/s, pre operative complications, fever, status and training of 
anaesthetist and surgeon, anaesthesia, blood loss, blood transfusion. 
Adjusted for confounders 
As before 
Outcome MMR, PMR As before 
Chilopora 2007:Malawi 
Cadre details and 
training 
CO: Licensed to practice independently, perform major emergency and 
elective surgery. Length of surgical experience: 44% >4yrs 24.3% 2-3 yrs 
21.4% <1 yr  9.3% 0 0.6% no data 
3 Years plus 1 year internship at  a hospital 
MD: Trained medical doctors. Length of surgical 
experience: 59% >4yrs: 19.9% 2-3yrs 17.2%<1yr: 3.9% 
no data:  Not given 
Population, 
Characteristics 
All women undergoing c/s during study period were included in 38 district 
hospitals, 
most were emergency c/s. Groups operated on by CO and MD had no major 
differences 
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Amount, Indication 
for C/S (%) 
1875(88%) No separate details given on surgeon and indication for c/s: 
Cephalopelvic disproportion or obstructed labour 1230 (57.7%). previous c/s 
452 (21.2%). fetal distress 264(12.3%). impending uterine rupture 87 (4%) 
antepartum haemorrhage77 (3.6%). cord prolapse 62 (2.9%). failure to 
progress 60 (2.8%).breech in primigravida 3(2.5%)  
eclampsia 49 (2.3%) 
256(12%) 
Surgeon  allocation, 
type of operation 
Not given c/s only 1569 (84%). c/s + subtotal hysterectomy 11 (0.5%). c/s + 
total hysterectomy 7(0.5%) c/s + uterine repair 59 (2.5%). c/s + tubal ligation 
224 (12%) not indicated 5 (0.5%) 
c/s only  185 (72%). c/s + subtotal hysterectomy  
8 (3%). c/s + total hysterectomy 3 (2%) c/s + uterine repair 
7(3%) c/s + tubal ligation 53 (20%).not indicated 0 (0%) 
Potential 
confounders 
Duration of surgeon’s practice, region of hospital, type of operation (if 
hysterectomy needed also). No adjustments made 
As before 
Outcome MMR, infection, wound dehiscence, fever, PMR As before 
Hounton 2009: Burkina Faso 
Cadre details and 
training 
CO: CO working in both rural and urban hospital. 6 month special curriculum 
CO to perform emergency surgery OR 2 year additional surgical training for 
registered nurses 
Trained MD only based at urban hospitals Obstetricians 
Population, 
Characteristics 
2305 pregnant women needing c/s section in 22 public sector urban and rural 
hospitals  
Age 25yrs urban hospital 198 (27%) rural hospital 535 (73%) 
As above Age 25yrs urban hospital   877 (56%) rural 
hospital 143 (9%) 
Amount, Indication 
for C/S (%) 
733(32%) Obstructed labour 388 (53%) ruptured uterus 81 (11%) eclampsia 
15 (2%) haemorrhage 44 (6%) Other 205(28%) 
1572(68%) Obstructed labour  398 (39%) ruptured uterus  
112 (11%) eclampsia 71 (7%) haemorrhage 51 (5%) other 
388 (38%) 
Surgeon allocation, 
type of operation 
No details given on selection of operator, retrospective study. However 
medical doctors were associated with more referred cases, although not 
statistically significant. 
As before 
Potential 
confounders 
Place of hospital, maternal age, reported clinical conditions; obstructive 
labour, ruptured uterus, eclampsia, haemorrhage, referral from other unit, 
type of anaesthesia. Adjustments made, but adjusted statistics not given. 
As before 
Outcome MMR, PMR, haemorrhage, wound infection, wound dehiscence. As before 
McCord 2009: Tanzania 
Cadre details and 
training 
CO: Officially authorised assistant medical officers to provide clinical 
services; prescriptions, minor surgery. Permitted to perform obstetric care 
and c/s. Secondary school graduates with 3 years medical training, plus a 
further 2 years clinical training, including 3 months in surgery and 3 months in 
obstetrics. 
Trained MD:Medical school graduates with >1 year 
internship 
1
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Population, 
Characteristics 
1088 pregnant women in 14 mission and government hospitals. Not given As above. Not given 
Amount, Indication 
for C/S (%) 
945(87%) Absolute maternal indication (ante-partum haemorrhage, 
Postpartum haemorrhage, malpresentation, eclampsia, ectopic pregnancy, 
ruptured uterus, sepsis and repair of vesico-vaginal fistula) 312 (33.1%) 
major acute problem (no details given) 63 (6.6%) major chronic problem 
(severe anaemia, symptomatic AIDS, symptomatic malaria) 172 (18.2%). No 
information 398 (42.1%) 
143(13%) Absolute maternal indication (ante-partum 
haemorrhage, postpartum haemorrhage, malpresentation, 
eclampsia, ectopic pregnancy, ruptured uterus, sepsis, 
repair of  vesico-vaginal fistula) 48(33.6%).major acute 
problem (no details given) 14 (9.8%). major chronic 
problem (severe anaemia, symptomatic AIDS, 
symptomatic malaria) 22 (15.3%). no information 59 
(41.3%) 
Surgeon allocation, 
type of operation 
No reason given for choice of operator. However clinical officers were more 
likely to perform c/s with absolute maternal indicators or clear fetal indicator. 
CO had more difficulties obtaining blood for transfusion. Not given 
No reason given for choice of operator. However MD were 
less likely to perform c/s for absolute maternal indicators 
or clear fetal indicator.  MD had less difficulties obtaining 
blood for transfusion. Not given 
Potential 
confounders 
Condition on admission, type of operation, indication for operation, blood 
transfusions. No adjustments made. 
As above 
Outcome MMR, PMR As before 
1
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Table 21 Risk of Bias Assessment in cohort studies:  Newcastle Ottawa Scale (Y= reported: N: not reported) 
 Selection Comparability Outcome 
Article Representati
veness 
of exposed 
cohort 
Selection of 
non-exposed 
cohort 
Ascertainm
ent of 
exposure 
Demonstration 
that outcome 
not present at 
start 
Comparability of 
cohorts on the 
basis of the 
design or 
analysis (2 
points available) 
Assessment 
of outcome  
Follow up 
long 
enough for 
outcomes 
to occur 
Adequacy of 
follow up of 
cohorts 
White
 
1987 
Y N Y Y N Y N N 
Pereira
 
 1996 
Y Y Y Y N Y N N 
Fenton
 
 2003 
Y N Y Y YY Y N N 
Chilopora
 
 2007 
Y N Y Y N Y N Y 
Houton
 
 2009 
Y N Y Y Y Y N N 
Mccord
 
 2009 
Y N Y Y N Y N N 
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7.4 DISCUSSION 
Main findings 
The meta-analysis demonstrated no significant difference in maternal or perinatal 
mortality in caesarean sections performed by clinical officers, compared with medical 
doctors. However, when the outcomes of wound dehiscence and wound infection were 
compared, both were found to be significantly more frequent in caesarean sections 
performed by clinical officers compared with medical doctors.  
 
Strengths and limitations 
All of the six studies examined were comparative cohort studies. However, as they 
were not randomised trials, there is the potential for bias in these studies. There was 
medium risk of bias in selection, and medium to high risk of bias in comparability and 
outcome assessment for most studies when assessed on the Newcastle-Ottawa scale.  
For example, in Pereira et al (224) elective caesarean sections were exclusively carried 
out by medical doctors, whist emergencies were carried out by both medical doctors 
and clinical officers. As elective caesarean section is associated with better outcomes 
when compared with emergency caesarean section (235), this arrangement would 
have conferred an advantage to medical doctors. Furthermore, clinical officers tend to 
be located in rural areas (226) where access to life saving facilities such as blood 
transfusion and high dependency care may not be available. Fenton et al (231) 
addressed such issues by adjusting for rural setting, previous caesarean section, 
haemorrhage, other peri-operative medical complications and the level of training of the 
surgeon. Their initial analysis showed an excess in maternal and perinatal mortality 
associated with clinical officers. However, when adjusted for the above factors there 
was no longer a significant difference in these outcomes. This suggests that in this 
study there may have been more high risk cases in the clinical officer group.  It is also 
plausible that the bias could also be in the other direction. For instance the perceived 
 
 
200 
 
severity of the situation may have resulted in a medical doctor performing the 
caesarean section rather than a clinical officer. This may cause bias in favour of clinical 
officers.  Although most studies reported no differences in patient characteristics or 
indication for caesarean section, and some studies adjusted for various factors (226, 
231), there can still be residual confounding. 
 
There was significant heterogeneity for maternal and perinatal outcomes, which may 
reflect the diversity of the setting and the population, indications for surgery, surgical 
approach and training and role of the clinical officers in these studies. Given such 
clinical heterogeneity, it is unsurprising that statistical heterogeneity was identified in 
the analyses. Formal exploration of the reasons for statistical heterogeneity by study 
features was limited due to the small number of studies identified in our review. 
However, when there was adjustment for confounding factors, the observed 
heterogeneity was noted to be reduced.  
 
Practice and policy implications  
While we acknowledge caution when interpreting the meta-analysis findings due to the 
non-randomised nature of the included studies, this remains the best current evidence 
on these outcomes. 
 
There was an increase in wound infection and dehiscence with clinical officers. This 
was consistent in the two studies that examined these outcomes. We speculate that 
these outcomes may be associated with surgical technique and a need for enhanced 
training. Pereira et al (224) highlighted that 97% of caesarean sections were through a 
vertical abdominal incision, which is known to be associated with increased wound 
dehiscence and other adverse outcomes when compared with horizontal incisions 
(235). Thus, there may be substantial scope for improvement in surgical technique. 
There is evidence that specialist training of clinical officers can improve outcomes. 
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Fenton (231) measured the incidence of maternal death from anaesthesia, when 
administered by clinical officers who had received formal training and those that did 
not. The maternal mortality rate was much higher in those that had not received 
training (2.4%), when compared to those that had (0.9%). It is also possible that the 
increase in wound infection and wound dehiscence may be due to the difference in the 
case mix between the clinical officer and the medical doctor group. For example, the 
clinical officer cadre conducted more emergency caesarean sections, often associated 
with increased morbidity compared to elective procedures, but also clinical officers 
operated in more rural settings, which are often associated with less resources and 
poorer outcomes.  
 
This review assesses the important and specific role of clinical officers in performing 
caesarean section, which is an immediate determinant of outcome. However, this must 
be placed within the wider context of the many distant and intermediate determinants of 
maternal health and mortality (11) (Figure 36). Part of the value of the clinical officer 
cadre is that their role can be adapted to suit local needs and conditions. Yet as there 
are no internationally agreed curricula or scope of practice guidelines (225), the 
importance of evaluating clinical officers in their specific setting needs to be 
recognised. 
 
Unanswered questions and future research 
Little work has been conducted to assess the role of clinical officers in addressing 
these wider determinants they can have an important impact on these factors.  
Therefore the impact of the clinical officers on increasing access to services (228, 236),  
the clinical officer’s role within family planning (225)  and within broader preventative 
health programmes (228, 237)  to reduce maternal mortality could be assessed 
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7.5 CONCLUSION 
This meta-analysis suggests that the provision of caesarean section surgery by clinical 
officers does not result in a significant increase in maternal or perinatal mortality. 
Enhanced access to emergency obstetric surgery through greater deployment of 
clinical officers, in countries with poor coverage by medical doctors, can form part of 
the solution to meet MDGs 4 (reducing child mortality) and 5 (improving maternal 
health). 
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Figure 36 Determinants of maternal mortality (distant, intermediate, immediate)
Distant determinants 
 
Intermediate determinants 
 
Immediate determinants 
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CLINICAL INTERVENTIONS   
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CHAPTER  8: PROPHYLACTIC ANTIBIOTICS FOR UTERINE 
EVACUATION: A SYSTEMATIC REVIEW AND META-ANALYSIS 
 
ABSTRACT 
Background: Infection is a serious potential consequence of surgical treatment of 
miscarriage and can be associated with mortality and serious morbidity. In areas where 
abortion services are inadequate or are limited by law, many cases are suggested to be due 
to physical interference to induce miscarriage. Critical to any method of surgical uterine 
evacuation, in the case of abortion or miscarriage, are mortality and morbidity, but also the 
effects on future childbearing. Therefore a systematic review with meta-analysis was 
performed to assess the effectiveness of prophylaxis antibiotics compared to placebo, for 
surgical uterine evacuation in cases of miscarriage or abortion. 
Methods: Embase, Medline, CENTRAL and PsycINFO bibliographic, African Index Medicus 
(AIM), Index Medicus for the Eastern Mediterranean Region (IMEMR), Index Medicus for the 
South-East Asian Region (IMSEAR), Latin American and Caribbean Health Sciences 
Information (LILACS), Pan America Health Organisation (PAHO) and Western Pacific Region 
Index Medicus (WPRIM) (from inception to July 2011) were searched without language 
restrictions.  Hand searching complemented electronic searches, and reference lists were 
checked.  Studies of randomised controlled design were selected, with the outcome of 
infectious morbidity. Relative risks (RR) from the individual studies were pooled for RCTs, 
using a random effects model.  
Results: Twenty one RCTs (n=11,384 women) were identified as suitable for inclusion. 
Meta-analysis of 18 RCTs showed a reduction in infectious morbidity with prophylactic 
antibiotics in surgical abortion (RR: 0.59 95%CI 0.47 to 0.73, p<0.001). Three trials were 
included for miscarriage, meta-analysis was not considered suitable. 
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Conclusion:  Meta-analysis of 18 RCTs showed an average reduction in infectious morbidity 
in cases of surgical abortion with prophylactic antibiotics by 41%. Data on miscarriage was 
insufficient to draw inferences. 
Impact of review: Informed the antibiotics In Miscarriage Surgery trial (AIMS Trial) funded 
by the MRC, Wellcome and DFID 
 
8.1 BACKGROUND 
Miscarriage and abortion affects many women across the globe, with approximately 33 
million pregnancies ending in miscarriage (238), and 43.8 million pregnancies ending in 
abortion every year (239).  In areas where abortion services are inadequate or are limited by 
law, many cases are suggested to be due to physical interference to induce miscarriage 
(unsafe abortion)(240).  In areas where induced abortion is limited by law women may be 
reluctant to disclose the true nature of the miscarriage for fear of social stigma, legal 
connotations or treatment denial (241).  Cases of unsafe abortion thus may be reported as 
miscarriage. 
 
An estimated 60 – 70% of women with miscarriage have surgery to remove retained 
pregnancy tissues from the uterus (242).  For many hospitals in low income countries 
miscarriage surgery is the most common operation performed. Miscarriage surgery accounts 
for the majority of gynaecology admissions (242) in some hospitals, with some regions 
performing an average of 160 suction evacuations each month (243).  
 
Infection is a serious potential consequence of surgical abortion and surgical treatment of 
miscarriage and can be associated with mortality and serious morbidity. In developed 
countries, where surgical procedures are carried out in sterile conditions, with sterile 
equipment and where practices are guided by policies, infectious morbidity is often less 
prevalent. Whereas in developing countries, equipment used for invasive procedures (e.g. 
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surgical abortion or miscarriage surgery) may be poorly sterilised, patients may be 
immunocompromised due to malnutrition, HIV, malaria or anaemia, and infection control 
procedures in the clinical setting may not be in place or adhered to, thus putting the patient at 
greater risk of infection. Death from unsafe abortion is one the main causes of maternal 
mortality within low income countries, attributable to approximately 13% of deaths (241). In 
2008 it is estimated that 21.2 million unsafe abortions took place within developing regions, 
compared to 400,000 across the rest of the globe (241).  
 
Critical to any method of surgical uterine evacuation, in the case of abortion or miscarriage, 
are also the effects on future childbearing (244). Pelvic infection can lead to scarring, 
increased rates of ectopic pregnancy, and permanently fertility impairment (245). In high 
income countries, from which most data originates, infection occurs in approximately 6% of 
women following surgical treatment of miscarriage (246, 247). In a low income setting the 
infection rate after miscarriage surgery has been reported to be as high as 30% (240).  
Despite these figures prophylactic antibiotics are not recommended for surgical treatment of 
miscarriage, unlike surgical abortion: instead if sepsis develops aggressive treatment is 
advocated to reduce morbidity and mortality (248, 249).  The bacteria suggested to be 
responsible for infectious morbidity in the included studies are gram positive cocci, 
anaerobes, gram coagulase-negative staphylococci, corynebacterium, lactobacillus (250, 
251), Gardnerella vaginalis (252), and Chlamydia trachomatis (253).  These bacteria and 
other associated bacteria along with antibiotics that can be used to treat the infections 
caused are demonstrated in Figure 38. However choice of antibiotic for a patient with a pelvic 
infection should be guided by an awareness of the susceptibility patterns of organisms in the 
setting as well as the organisms frequently involved, as this can vary from setting to setting 
(254). It is reported in the literature that in animal models there is a higher frequency of 
female pelvic infection from anaerobic bacteria and gram positive bacteria compared to other 
bacteria (254). 
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The latest Cochrane review (255) recognised the lack of available evidence to inform 
practice guidelines, with a conclusion that there is “ a real and urgent need to find out 
whether antibiotics should be routinely used in cases of incomplete abortion” (miscarriage), 
particularly in low income regions where there is a high prevalence of undisclosed unsafe 
abortions.  There appears to be a lack of clinical guidance both internationally and national 
on current prophylactic antibiotic policy for miscarriage surgery, but existing guidance on 
prophylactic antibiotic use in abortion. Figure 37 demonstrates examples of organisations 
that provide recommendations on prophylactic antibiotic use in miscarriage surgery and 
surgical abortion. The majority of organisations recommend prophylactic antibiotic use in 
surgical abortion (249, 256-258), however for miscarriage surgery the majority of 
organisations recommend administration of antibiotics only if infection occurs (248, 259, 
260).   
 
A systematic review and meta-analysis was performed to assess the effect of prophylactic 
antibiotics on infectious morbidity in surgical uterine evacuation in abortion and miscarriage 
surgery. 
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Organisation/ Country 
Prophylactic antibiotics for induced abortion 
surgery 
Prophylactic antibiotics for  
miscarriage surgery 
World Health 
Organisation 
 Recommend use (249)  
Not recommended unless signs of infection 
(248) 
Royal College of 
Obstetricians and 
Gynaecologists 
 
Recommend use (258)  Insufficient evidence to recommend routine antibiotic prophylaxis (260) 
Scottish Intercollegiate 
Guidelines Network 
 
Recommend use (257) 
 
Insufficient evidence to recommend routine 
antibiotic prophylaxis (257) 
American College of 
Obstetricians and 
Gynaecologist 
 
Recommend use (261)  
Not recommended unless signs of infection 
(261) 
Ugandan  Ministry of 
Health   
No recommendations on prophylactic 
antibiotics for induced abortion surgery  
(259)  
No guidelines or consistent practice on 
prophylactic antibiotics, antibiotics are 
recommended if signs of infection present (259) 
National Abortion 
Federation  
 
Recommend use (256)  Not recommended (256) 
 
 
Figure 37 Prophylactic antibiotic recommendations 
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Bacteria reported in trial Most Effective Antibiotic 
Gram-
positive 
bacteria 
 
Lactobacillus Ampicillin, Amoxicillin/clavulanic acid   
Gram positive cocci 
 
Chloramphenicol , Amikacin , Enrofloxacin , 
Rifampin, Cephalothin   
Anaerobes 
Gram coagulase-negative staphylococci, 
Corynebacterium,  
Gardnerella vaginalis  
Chlamydia trachomatis  
Amoxicillin/clavulanic acid, Ampicillin, Ceftiofur, 
Ceftizoxime, Cephalothin, Chloramphenicol, 
Erythromycin,  Penicillin G, Trimethoprim-
Sulfonamide 
 
 
Figure 38 Causative bacteria and effective antibiotics (http://www.dragpharma.cl/pdfs/antibiotic-talbles.pdf) 
 
2
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8.2 METHODS 
Data sources and searches 
Embase, Medline, CENTRAL and PsycINFO bibliographic, African Index Medicus (AIM), 
Index Medicus for the Eastern Mediterranean Region (IMEMR), Index Medicus for the South-
East Asian Region (IMSEAR), Latin American and Caribbean Health Sciences Information 
(LILACS), Pan America Health Organisation (PAHO) and Western Pacific Region Index 
Medicus (WPRIM) were searched (from inception to July 2011). Hand searching 
complemented electronic searches, and reference lists were checked. The terms ‘abortion’, 
‘miscarriage’, ‘antibiotics’ and ‘infection’ were used to identify relevant publications. 
Keywords, word variations and terms associated with these terms were used as part of the 
search strategy. No language restrictions were applied to the search. 
 
Study selection and data extraction 
RCTs were selected.  Initially the electronic searches were scrutinised and full manuscripts 
of relevant studies were acquired. Final decisions on inclusion or exclusion of manuscripts 
were made after inspection of these manuscripts by the author and another reviewer (AW 
and RC) and when necessary a second reviewer was involved in decisions (AC). Information 
was extracted from each article on study characteristics, quality assessment and outcome 
data by the author and two other reviewers (AW and RC or AC).  The outcomes that were 
focussed on were infectious morbidity.  
 
Methodological quality assessment 
The RCTs were assessed for methodological quality using the CONSORT statement (68),  
assessing for randomisation and sequence generation, baseline comparability, blinding, 
follow-up, and appropriate statistical analysis (ITT). Risk of bias was also assessed using the 
Cochrane risk of bias tool (102). 
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Statistical Analysis 
The random effects model was used to pool the risk ratios from individual RCTs. The fixed 
effects model was not deemed suitable for use as more than a single source of variability 
existed within the included studies, therefore the random effects model was used to account 
for the variability within the intervention (i.e. the dose, type and frequency of antibiotics, as 
well as the patient characteristics).  Induced abortion and miscarriage trials were pooled 
separately. Data from these trials were then pooled separately for participants deemed at low 
risk and high risk of infectious morbidity. Women deemed at low risk of developing pelvic 
infection included women without a history of pelvic inflammatory disease, or negative for 
sexually transmitted infections such as Chlamydia, gonorrhea and syphilis. Whereas women 
deemed at high risk of developing pelvic infection included women with a history of pelvic 
inflammatory disease, the presence of Chlamydia, or abnormal vaginal flora. This sub-group 
analysis was performed in an attempt to make the results transferable to women undergoing 
similar surgical procedures in areas that may incur greater risk of infectious morbidity (e.g. in 
cases of unsafe abortion or invasive surgery in developing countries with patients that may 
be immunosupressed). Heterogeneity of treatment effects was evaluated using forest plots, 
X2, and I2 tests; the terms low, moderate and high heterogeneity were assigned to I2 values 
of over 25%, 50%, and 75% respectively. Analyses were performed using the Revman 5.0 
statistical software. 
 
8.3 RESULTS 
Results of search 
The study selection process in provided in Figure 29. Characteristics of the included studies 
are shown in Table 21 for Evacuation of the uterus in abortion and Evacuation of the uterus 
in miscarriage.  
 
Evacuation of the uterus in abortion: Eighteen RCTs were included in this review, with a total 
of 9328 women (Figure 39). The studies compared the outcome of infectious morbidity in 
 
 
213 
 
women who received either prophylactic antibiotics, or control treatment (placebo or no 
drug), undergoing surgical evacuation for abortion. 
 
Evacuation of the uterus in miscarriage: Three RCTs were included in this review, with a total 
of 785 women (Figure 39). The studies compared the outcome of infectious morbidity in 
women who received either prophylactic antibiotics, or control treatment (placebo or no 
drug), undergoing surgical evacuation of the uterus for miscarriage treatment. 
 
Due to the lack of good quality data on surgical treatment of miscarriage and abortion in 
developing countries (1/21)(240) the available data on surgical treatment of miscarriage and 
abortion in developed countries has been focused on, however the outcome has been 
assessed in terms of high and low risk categories in an attempt to make these results more 
transferable to women undergoing similar surgical procedures in areas that may incur greater 
risk of infectious morbidity (e.g. in cases of unsafe abortion or invasive surgery in developing 
countries). 
 
 
 
 
214 
 
 
Figure 39  Study selection of included studies in the review 
Total citations identified from electronic searches n=7064: Total citations identified from 
hand searching n=5
Total citations identified from previous Cochrane review n=19
Citations excluded after screening title and/or abstracts: n =6967
Primary articles fulfilling inclusion criteria for systematic review n=21:
n =3 (Miscarriage: incomplete abortion)
n=18 (Termination of pregnancy: induced abortion) 
Articles excluded after review of full text with reasons
Inappropriate population n =4
Not locatable n=2
No relevant data n =11
Incorrect study design n =28
Duplicate n =41
Incorrect comparator n=14
Total excluded n = 100
Full manuscripts retrieved for detailed evaluation: n =121  
Figure 1. Study selection process in the systematic review of prophylactic management of abortion/ miscarriage
2
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Study quality 
The 21 RCTs varied in quality, a breakdown is provided below: 
Evacuation of the uterus in abortion: 16 reported satisfactory baseline comparability, 15 were 
double blinded, and 11 reported appropriate randomisation. However, only 7 trials reported a 
sample size calculation and a follow up rate of more than 80%, with only one trial reporting 
that an intention to treat analysis (ITT) had been conducted (Table 22). Most studies had low 
risk of bias for blinding of participants and study personnel, incomplete outcome data, 
selective reporting and other sources of bias. More than half of the studies had unclear risk 
of bias for random sequence generation, but allocation concealment and blinding of outcome 
assessors was unclear in most of the studies.  
 
Evacuation of the uterus in miscarriage: Two reported satisfactory baseline comparability, 1 
was double blinded, and 3 reported appropriate randomisation. However, only 2 trials 
reported a sample size calculation and a follow up rate of more than 80%, with only 1 trial 
reporting that an intention to treat analysis (ITT) has been conducted (Table 22). Most 
studies had low risk of bias for incomplete outcome data, selective reporting and other 
sources of bias. All of the studies had low risk of bias for random sequence generation, but 
allocation concealment and blinding of outcome assessors was unclear in most of the 
studies.  
 
Outcomes 
Evacuation of the uterus in abortion: Meta-analysis of 18 RCTs (9,328 women) showed a 
significant reduction in infectious morbidity by an average 41% with prophylactic 
administration of antibiotics in abortion (RR: 0.59 95%CI 0.47 to 0.73, p<0.0001; Figure 30). 
There was limited but not statictically significant heterogenity in the results (I2=23%, P=0.18).  
 
Evacuation of the uterus in miscarriage:  Three RCTs (785 women) were identified.  Given 
the poor quality of the studies, the clinical heterogeneity in the antibiotic regimen, and the 
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83% non-compliance in the only study conducted in a low income country (240), a meta-
analysis was judged to be inappropriate. All three trials showed no difference in infectious 
morbidity with prophylactic antibiotics or placebo treatment (Figure 31).  
Women at high risk of developing pelvic infection from surgical abortion: Meta-analysis of 13 
RCTs showed an average 51 % reduction in infectious morbidity when prophylactic 
antibiotics are administered to women undergoing surgical abortion deemed at high risk of 
infectious morbidity.  This includes women with a history of pelvic inflamatory disease, the 
presence of chlamydia, or abnormal vaginal flora (RR 0.49 95% CI 0.34 to 0.71; p=0.0002; 
Figure 33).  There was limited but not significant hetrogenity in the results (I2 = 24%; p = 
0.20).  
 
Women at low risk of developing pelvic infection from surgical abortion: Meta-analysis of 9 
RCTs found a significant reduction in infectious morbidity by an average of 58%  with 
propylactic administration of antibiotics to women deemed at low-risk of developing pelvic 
infection (RR 0.42 95% CI 0.26 to 0.68; p=0.0004; Figure 32). This includes women without a 
history of pelvic inflamatory disease, or negative for sexually transmitted infections such as 
chlamydia, gonnorhea and syphillis. There was significant heterogenity within the analysis (I2 
= 52%; p = 0.03).  
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Figure 40 Infective morbidity in antibiotic group and placebo group in surgical abortion 
Figure 4. Surgical uterine evacuation in abortion with prophylactic antibiotic administration or placebo 
Study
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Figure 41 Infective Morbidity in antibiotic group and placebo group in Miscarriage 
Figure 5. Surgical uterine evacuation in miscarriage, with administration of prophylactic antibiotics or placebo
Study
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Figure 42 Infective Morbidity in antibiotic group and placebo group in Surgical Abortion of Low Risk Patients 
2
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Figure 43 Infective Morbidity in antibiotic group and placebo group in Surgical Abortion of High Risk Patients
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Table 22 Characteristics of included studies within the review 
Author 
Country 
Sample size 
Population 
Intervention Control Infectious complications 
Incidence/total events 
(HR-high risk : LR –low risk) 
Risk category 
High Income Countries 
Cormier 
1988  
France  
39 Women undergoing 
surgical abortion 
Cefotetan No prophylaxis Intervention: 1/20 
Control: 0/19 
No description 
Crowley 
2001  
UK 
273 Women with bacterial 
vaginosis undergoing 
induced abortion  
(surgical abortion) 
2g 
metronidazole 
suppository 
(per-operatively) 
Identical placebo  
(per-operatively) 
Intervention  total 11/100:  
HR 11/100                                                                  
Control: total 18/90:  
HR 18/90 
High Risk: all women with  
bacterial vaganosis 
Darj 1987  
Sweden 
769 Women undergoing 
induced abortion (surgical 
abortion) 
Four tablets of 
doxycycline 
100mg  
Four tablets of 
placebo  
Intervention: total 8/386.  
LR 5/302. HR 3/80.  
Control: Total 24/383. LR 15/303. 
HR 9/84 
Low Risk: women with no 
history of PID. High Risk: 
women with previous PID 
Heisterberg 
1985a 
Denmark  
119 Women undergoing 
elective first trimester 
abortion (surgical 
abortion) 
Metronidazole  Placebo  Intervention: Total 2/51:  
LR 0/38: HR 2/13:  
Control: Total 10/49:  
LR 6/37.HR 4/12 
Low Risk: women with no 
history of PID. High Risk: 
women with previous PID 
Heisterberg 
1985b 
Denmark  
474 Women undergoing 
first trimester abortion ( 
surgical abortion) 
Penicillin/ 
Pivampicillin  
Placebo  Intervention: total 16/250:  
LR 14/217. HR 2/33 
Control:  total 25/224. 
LR 21/192. HR 4/32 
Low Risk: women with no 
bacteraemia. High Risk: 
women with positive 
bacteraemia. Unable to 
separate data of women +/- 
history of PID 
Heisterberg 
1985c 
Denmark 
532 Women undergoing 
first-trimester 
abortion (surgical 
abortion) 
Lymecycline  Placebo  Intervention:  total 25/269:  
HR 7/29 
Control: Total 25/263. 
HR 3/19 
High Risk: Chlamydia 
positive. Unable to separate 
data of low risk women, no 
breakdown provided for 
women without mycoplasma 
hominis 
2
21
 
 
 
222 
 
Heisterberg 
1987 
Denmark 
135 Women with a history 
of PID undergoing 
induced first-trimester 
abortion   (surgical 
abortion) 
Metronidazole  Placebo  Intervention: Total 7/64. 
HR 7/64.  
Control: total 7/54 
HR 7/54 
High Risk: all women with a 
history of PID 
Heisterberg 
1988 
Denmark 
55 Women undergoing 
first-trimester abortion ( 
surgical abortion) 
Lymecycline  Placebo  Intervention: total 2/24.  
HR 2/24 
Control: Total 7/31 
HR 7/31 
High Risk: all women with a 
history of PID 
Henriques 
1994 
Denmark 
 
996 Women admitted for 
legal termination of 
pregnancy at <12wks 
gestation     (surgical 
abortion) 
Ceftriaxone 
(both groups)  
Standard 
treatment 
High risk: 
preoperative 
injection of 
ampicillin and 
metronidazole, 
followed by oral 
doses of 
metronidazole 
and pivampicillin 
3x daily for 4 
days. Low risk: no 
prophylactic 
antibiotics were 
given to women in 
this group 
Intervention:  total 12/512. LR 
1/109 
Control: total 10/274. LR 9/107 
Low Risk: no history of PID, 
negative for Chlamydia. Data 
for high risk excluded due to 
different intervention and 
control treatments, both arms 
in the high risk category 
received antibiotics 
Krohn 1986 
Sweden 
305 Women undergoing 
first-trimester abortion 
with vacuum aspiration  
Sulbactam/ 
Ampicillin  
Placebo Intervention: 4/145 
Control: 11/140 
 
Unable to separate into 
categories, Chlamydia swabs 
only taken on over 100 
participants 
Larsson 
1992 
Sweden 
231 Women undergoing 
first-trimester legal 
abortion and fulfilling 
criteria for bacterial 
vaginosis (surgical 
abortion) 
Metronidazole Placebo Intervention: Total 3/84.  
HR 3/84 
Control:  Total 11/90. HR 11/90 
High Risk: women with 
bacterial vaginosis but 
negative for Chlamydia 
2
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Larsson 
2000 
Sweden 
1655 Women attending 
for surgical abortion prior 
to 11+4 
gestation (surgical 
abortion) 
2% clindamycin 
cream  
Placebo cream  Intervention: total 29/650.  
HR 3/181 
Control: Total 30/626.  
HR 12/181 
High Risk: women with 
abnormal vaginal flora 
Unable to extract data for 
women with normal vaginal 
flora, no breakdown provided 
for intervention and control 
arms 
Levallois 
1988 
Canada 
1100 Women seeking 
induced abortions  
(surgical abortion) 
Doxycycline 
100mg  
Placebo  Intervention: total 2/502.  
LR 2/502. HR 1/33 
Control: total 15/497. 
LR 15/497. HR 11/42 
Low Risk: women negative for 
Chlamydia 
High Risk: women positive for 
Chlamydia 
Nielsen 
1993 
Denmark  
1073  Women with 
induced first-trimester 
abortions (surgical 
abortion) 
Ofloxanin  Placebo  Intervention:  total 55/525.  
LR 35/376. HR 20/149 
Control:  total 73/548.  
LR 46/389. HR 27/159 
Low Risk: women with no 
history of PID 
High Risk: women with  
previous PID 
Prieto 
1995 USA 
345 Women with 
incomplete 
abortion (miscarriage) 
Doxycycline 
100mg IV and 
suction 
curettage 
(experimental 
gp)  
Normal saline and 
suction curettage 
(control gp)  
Intervention: 8/120                                    
Control: 7/120 
Unable to separate into risk 
categories, no breakdown of 
data provided for the 
intervention and control arms 
for risk categories 
Ramin 
1995 USA 
300 Women with 
incomplete abortion 
(miscarriage)  
Doxycycline  Placebo Intervention:  total 1/137: 
HR 0/7 
Control: Total 4/152: HR 0/11  
High Risk: women positive for 
Chlamydia, gonorrhoea and 
syphilis. Unable to extract 
data for low risk participants 
as some swab results were 
inconclusive, or swabs were 
not performed 
Sonne-
Holm1981 
Denmark 
564 Women undergoing 
induced first-trimester 
abortions (surgical 
abortion) 
2 million IU of 
penicillin G 
intramuscularly 
(1 ½ hrs before 
op, then 3 hrs 
after op) 
followed 
by 350mg 
Placebo Intervention:  total 14/254: 
LR 13/207. HR 1/47 
Control: total 26/239:  
LR 13/180. HR 13/58 
Low Risk: women with no 
history of PID 
High Risk:  women with a 
history of PID 
2
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pivampicillin 
three times daily 
for four days 
Sorenson  
1992 
Denmark 
432 Women undergoing 
induced abortion before 
12 weeks gestation  
(surgical abortion) 
Erythromycin  Placebo  Intervention:  total 20/189:  
HR 1/13 
Control:  Total 30/189:HR 6/14 
High Risk: women positive for 
Chlamydia +/- gonorrhoea . 
Unable to extract data for 
women Chlamydia and 
gonorrhoea negative as 
breakdown not provided for 
trial arms 
Spence 
1982 USA 
Women undergoing 
second trimester intra-
amniotic injection 
abortions (surgical 
abortion) 
2g Sodium 
cephalothin (IV) 
Placebo (IV) Intervention: Total 2/97:  
LR 2/97 
Control:  Total 9/101: LR 9/101 
Low: women without any 
mention of any risk factors; 
presumed low risk 
 
Low income countries 
Seeras 1989 
Zimbabwe 
140 women with 
incomplete abortion 
(miscarriage) 
tetracycline Control Intervention: total 25/60:  
LR 25/60. Control: total 23/75: LR 
23/75 
Low risk: women without any 
mention of any risk factors: 
presumed low risk 
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Table 23 Quality assessment of included studies: CONSORT checklist (Y = Reported N = Not Reported N/A= Not applicable) 
Item 
  
Checklist item  
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1
9
9
4
 
Title and abstract 
 Identification as a RCT 
in title 
N Y N N Y Y N Y Y 
Structured summary of 
trial design, methods, 
results, conclusions  
N Y N Y Y Y Y Y Y 
Introduction 
Background 
and objectives 
Scientific background 
and explanation of 
rationale 
Y Y Y Y Y Y Y Y Y 
Specific objectives or 
hypotheses 
Y Y Y Y Y Y Y Y Y 
Methods 
Trial design Description of trial 
design including 
allocation ratio 
N N N Y Y Y Y N N 
Important changes to 
methods after trial 
commencement with 
reasons 
N N N N N N N N N 
Participants Eligibility criteria for 
participants 
Y Y Y Y Y Y Y Y Y 
Settings and locations 
where data collected 
Y Y Y Y Y Y Y Y Y 
2
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Interventions interventions for group 
with sufficient details to 
allow replication, 
including how/when 
actually administered 
Y Y Y Y Y Y Y Y Y 
Outcomes Completely defined pre-
specified primary and 
secondary outcome 
measures, including 
how/when they were 
assessed 
Y Y Y Y Y Y Y Y Y 
Any changes to trial 
outcomes after trial 
commenced, with 
reasons 
N N N N N N N N N 
Sample size How sample size 
determined 
N Y N Y N N N Y Y 
When applicable, 
explanation of any 
interim analyses and 
stopping guidelines 
N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Randomisation: 
Sequence  
generation 
Method used to 
generate random 
allocation sequence 
Y Y Y Y Y Y Y Y Y 
Type of randomisation; 
details of any restriction  
Y Y Y Y N N Y Y Y 
Allocation  
concealment  
mechanism 
Mechanism used to 
implement random 
allocation sequence 
describing steps taken 
to conceal sequence 
until interventions 
assigned 
Y Y Y Y Y N Y Y Y 
 Who generated random Y N Y N N N Y Y Y 
2
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Implementatio
n 
allocation sequence, 
enrolled participants, 
assigned participants to 
interventions 
Blinding If done, who blinded 
after assignment to 
interventions and how 
Y Y Y Y N Y Y Y N 
If relevant, description of 
similarity of interventions 
N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Statistical 
methods 
Statistical methods used 
to compare groups for 
primary/secondary 
outcomes 
Y Y Y Y Y Y Y Y Y 
Methods for additional 
analyses, such as 
subgroup analyses and 
adjusted analyses 
Y Y Y Y Y Y Y Y Y 
Results 
Participant 
flow  
For each group, 
numbers of participants 
randomly assigned, 
received intended 
treatment, analysed for 
primary outcome 
Y Y Y Y Y Y Y Y Y 
For each group, losses 
and exclusions after 
randomisation, with 
reasons 
Y Y Y N N Y Y Y Y 
Recruitment Dates defining periods 
of recruitment and 
follow-up 
Y Y N Y Y Y Y Y Y 
Why trial ended or was 
stopped 
N N N N N N N N N 
Baseline data table showing baseline 
demographic and 
Y Y Y Y N Y Y Y Y 
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clinical characteristics 
for each group 
Numbers 
analysed 
For each group, number 
of participants included 
in each analysis and 
whether analysis by 
original assigned groups 
N Y N N N N N N N 
Outcomes and 
estimation 
For each primary and 
secondary outcome, 
results for each group, 
and estimated effect 
size and precision  
Y Y Y N N Y Y Y Y 
For binary outcomes, 
presentation of both 
absolute and relative 
effect sizes is 
recommended 
N Y Y N N N Y Y N 
Ancillary 
analyses 
Results of other 
analyses performed, 
including subgroup 
analyses, adjusted 
analyses, distinguishing 
pre-specified from 
exploratory 
N Y Y N N Y Y N N 
Harms All important harms or 
unintended effects in 
each group  
Y N Y N N N N N N 
Discussion 
Limitations Trial limitations, 
addressing sources of 
potential bias, 
imprecision, if relevant, 
multiplicity of analyses 
Y Y Y Y Y Y Y Y Y 
Generalisabilit
y 
Generalisability of trial 
findings 
Y Y Y N Y Y Y N Y 
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Interpretation Interpretation consistent 
with results, balancing 
benefits and harms, 
considering other 
evidence 
Y Y Y N Y N Y Y Y 
Other information 
Registration Registration number and 
name of trial registry 
N Y N N N N Y N N 
Protocol Where full trial protocol 
can be accessed, if 
available 
N N N N N N N N N 
Funding Sources of funding and 
other support role of 
funders 
Y Y Y Y Y Y Y Y N 
2
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Title and abstract 
 Identification as a 
randomised trial in 
the title 
N Y N Y Y Y N Y N N N N N 
Structured 
summary of trial 
design, methods, 
results, conclusions  
N Y N Y Y Y Y Y N N Y Y Y 
Introduction 
Background 
and objectives 
Scientific 
background and 
explanation of 
rationale 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
Specific objectives 
or hypotheses 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
Methods 
Trial design Description of trial 
design including 
allocation ratio 
N Y N N N N Y N N N N Y Y 
Important changes 
to methods after 
trial 
commencement 
with reasons 
N N N N N N N N N N N N N 
Participants Eligibility criteria for 
participants 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
Settings and 
locations where 
N Y N N Y N N N Y Y Y Y Y 
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data collected 
Interventions interventions for 
each group with 
sufficient details to 
allow replication, 
including how and 
when administered 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
Outcomes Completely defined 
pre-specified 
primary and 
secondary outcome 
measures, 
including how/when 
were assessed 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
changes to trial 
outcomes after trial 
commenced, with 
reasons 
N N N N N N N N N N N N N 
Sample size How sample size 
determined 
N N N Y N Y N Y Y Y Y N N 
When applicable, 
explanation of any 
interim analyses 
and stopping 
guidelines 
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Randomisation: 
Sequence  
generation 
Method used to 
generate random 
allocation sequence 
N N Y N Y N Y Y Y N Y N Y 
Type of 
randomisation; 
details of restriction  
N N Y N Y N Y Y Y N Y N Y 
Allocation  
concealment  
mechanism 
Mechanism used to 
implement random 
allocation sequence 
N N Y N Y N Y Y Y N Y N Y 
2
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describing any 
steps taken to 
conceal sequence 
until interventions 
assigned 
 
Implementatio
n 
Who generated the 
random allocation 
sequence, enrolled 
participants, and 
assigned 
participants to 
interventions 
N N Y N N N Y Y Y Y Y N Y 
Blinding If done, who 
blinded after 
assignment to 
interventions/how 
Y Y Y Y Y Y N N N Y Y Y Y 
If relevant, 
description of 
similarity of 
interventions 
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Statistical 
methods 
Statistical methods 
used to compare 
groups for primary 
and secondary 
outcomes 
Y N Y Y Y Y Y Y Y Y Y Y Y 
Methods for 
additional analyses, 
such as subgroup 
analyses and 
adjusted analyses 
N N N Y N N Y Y Y N N N Y 
Results 
Participant 
flow  
For each group, 
numbers of 
participants who 
randomly assigned, 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
2
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received intended 
treatment, and 
analysed for the 
primary outcome 
For each group, 
losses and 
exclusions after 
randomisation, with 
reasons 
N N N Y N N Y Y N N Y N Y 
Recruitment Dates defining 
periods of 
recruitment and 
follow-up 
N Y N Y Y Y Y Y N Y Y Y Y 
Why trial ended or 
stopped 
N N N N N N N N N N N N N 
Baseline data table showing 
baseline 
demographic and 
clinical 
characteristics for 
each group 
N Y N Y Y Y N Y Y Y Y Y Y 
Numbers 
analysed 
each group, 
number of 
participants 
included in analysis 
and whether 
analysis by original 
assigned groups 
Y Y Y N Y Y Y Y N N N N N 
Outcomes and 
estimation 
each primary and 
secondary 
outcome, results for 
each group, the 
estimated effect 
size and precision  
Y Y Y N Y Y Y Y Y Y Y Y Y 
binary outcomes, 
presentation of both 
N Y Y N N N Y Y Y Y Y Y Y 
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absolute and 
relative effect sizes 
is recommended 
Ancillary 
analyses 
Results of any 
other analyses 
performed, 
including subgroup 
analyses and 
adjusted analyses, 
distinguishing pre-
specified from 
exploratory 
N Y Y N N Y Y Y N N N N N 
Harms All important harms 
or unintended 
effects in each 
group  
Y N Y N N N N N N N N N N 
Discussion 
Limitations Trial limitations, 
addressing sources 
of potential bias, 
imprecision, if 
relevant, multiplicity 
of analyses 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
Generalisabilit
y 
Generalisability of 
trial findings 
Y Y Y N Y Y Y N Y Y Y Y Y 
Interpretation Interpretation 
consistent with 
results, balancing 
benefits and harms, 
and considering 
other relevant 
evidence 
Y Y Y N Y N Y Y Y Y Y Y Y 
Other information 
Registration Registration 
number and name 
N Y N N N N Y N N N N N N 
2
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of trial registry 
Protocol Where full trial 
protocol can be 
accessed, if 
available 
N N N N N N N N N N N N N 
Funding Sources of funding 
and other support 
role of funders 
Y Y Y Y Y Y Y Y Y N N N N 
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Table 24 Risk of Bias in RCTs  
 
Random sequence 
generation 
Allocation concealment Blinding of 
participants and 
personnel 
Blinding of 
outcome 
assessment 
Incomplete 
outcome data 
Selective 
reporting 
Other bias 
Cormier 1988 
UNCLEAR: Page 829: 
Random allocation, no 
further details provided 
on random sequence 
generation 
LOW: Page 829: 
Allocation information 
carried in sealed 
envelope  
HIGH: Page 829: No 
control was given to 
participants  
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 831: 
Complete data set 
given for excluded 
from analysis 
LOW: Page 
831: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Crowley 2001 
LOW: Page 397: 
Random number 
table 
LOW: Page 397: 
sequentially numbered 
drug containers of 
identical appearance 
LOW: Page 397: 
Blinding of 
participants and key 
study personnel 
ensured, and unlikely 
that the blinding 
could 
have been broken as 
all unaware of 
allocation 
LOW: Page 397: 
Blinding of 
participants and 
key study 
personnel 
ensured, and 
unlikely that the 
blinding could 
have been broken 
as those 
collecting follow 
up data unaware 
of allocation 
UNCLEAR: Page 
398: Loss to follow 
up rates given, 
balanced across 
arms, no further 
data or reasons 
provided for loss to 
follow up 
LOW: Page 
399: All 
outcomes 
reported: 
table 2 and 3 
HIGH: Page 
398: 
Recruitment 
slower than 
expected and 
study 
terminated 
before target 
sample size 
reached due to 
lack of 
resources. 
Darj 1987 
UNCLEAR: Page 
755: Random 
allocation, no further 
details provided on 
random sequence 
generation 
UNCLEAR: Page 755: 
Randomly allocated in 
blocks of ten to two 
groups, no further details 
given 
LOW: Page 755: 
Intervention given in  
double blind fashion 
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
HIGH: Page 756: 
Complete data set 
missing for women 
excluded from 
analysis, reason 
given for 3 women. 
LOW: Page 
756: All 
outcomes 
reported 
table 2 -5 
LOW: Appears 
to be free from 
other sources 
of bias 
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Heisterberg 1985a 
 LOW: Page 371: 
Random number 
sequence 
LOW: Page 371: 
Allocated to either 
metronidozole or placebo 
groups, each group 
contained ten patients 
using random numbers, 5 
in each received placebo 
and 5 metronidozole’ 
LOW: Page 371: The 
randomisation was 
not known to 
therapist and 
patients until the trial 
was concluded 
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 372: 
Complete data set 
given for excluded 
from analysis 
LOW: Page 
372: All 
outcomes 
reported 
HIGH: Page 
372:Treatment 
regime subject 
to change 
according to 
judgement of 
gynaecologist 
in charge 
Heisterberg 1985b 
UNCLEAR: Page 73: 
Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 73: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
UNCLEAR: No 
information provided 
on blinding 
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 74: 
Data was provided 
for all patients not 
included in the 
analysis 
LOW: Page 
75: All 
outcomes 
reported 
HIGH: Page 
75: Blood 
drawn for 
cultures a few 
minutes after 
bacteria were 
released into 
blood stream 
during abortion 
procedure. 
Heisterberg 1985c 
UNCLEAR: Page 72: 
Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 72: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
LOW: Page 72: 
double  blinded  
UNCLEAR: Page 
72: double  
blinded  but no 
specific 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 73: 
Data was provided 
for all patients not 
included in analysis 
LOW: Page 
73: All 
outcomes 
reported 
HIGH: Page 
74:Unbalance
d non- 
compliance  
with treatment 
(4 placebo, 11 
active) due to 
gastro-
intestinal 
effects, 
remained in 
analysis 
Heisterberg 1987 
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LOW: Page 15: 
Random number 
sequence 
UNCLEAR: Page 15: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
LOW: Page 15: 
double  blinded  
UNCLEAR: Page 
15: Classed as 
double  blinded  
but no specific 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 16: 
Data was provided 
for all patients not 
included in the 
analysis 
LOW: Page 
16: All 
outcomes 
reported 
HIGH: Page 
17: Sample 
size too small 
to demonstrate 
significant 
difference. 
microorganism
s not sensitive 
to treatment-
metronidozole 
Heisterberg 1988 
UNCLEAR: Page 
241: Randomised 
allocation stated, no 
further details on 
random sequence 
generation 
UNCLEAR: Page 241: 
Allocation performed in 
blocks of 10, each block 
containing 5 regimes of 
lymecycline and 5 of 
placebo 
LOW: Page 243: 
Randomisation was 
not known to patient 
or staff. 
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
UNCLEAR: Page 
243: Incomplete 
data set for those 
lost to follow up or 
excluded 
LOW: Page 
224: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Henriques 1994 
LOW: Page 611: 
Computer based 
randomisation 
LOW: Page 611: 
Allocation information 
carried in sealed envelope 
not opened until woman 
given study number 
UNCLEAR: No 
information provided 
on blinding 
UNCLEAR: No 
information 
provided on 
blinding 
UNCLEAR: Page 
612: Incomplete 
data set for lost to 
follow up or 
excluded 
LOW: Page 
612: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Krohn 1981 
UNCLEAR: Page 
101: Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 101: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
LOW: Page 101: 
double  blinded  
UNCLEAR: No 
information 
provided on 
blinding 
LOW: Page 26: 
Data provided for 
all patients not 
included in analysis 
LOW: Page 
102: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Krohn 1986 
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UNCLEAR: Page 
576: Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 576: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
UNCLEAR: Page 
576: Classed as 
single  blinded no 
information provided 
on blinding 
UNCLEAR: Page 
576: Classed as 
single  blinded no 
information 
provided on 
blinding 
LOW: Page 577: 
Data provided for 
all patients not 
included in analysis 
LOW: Page 
576: All 
outcomes 
reported 
LOW: Page 
577: Although 
only 100 
participants 
has swabs for 
C.trachomatis, 
this was not an 
outcome set 
out to be 
measured 
Larsson 1992 
UNCLEAR: Page 
101: Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 101: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
LOW: Page 101: 
Double blinded, 
placebo and active 
treatment were 
identical.  
LOW: Page 101: 
Double blinded, 
all data fed into 
computer before 
code indicating 
placebo or active 
treatment broken 
LOW: Page 102: 
Data provided for 
all patients not 
included in 
analysis. Yet 
unable to examine 
8 smears due to 
contamination or 
specimen 
insufficiency.  
LOW: Page 
101: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Larsson 2000 
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LOW: Page 392: 
Block randomisation 
UNCLEAR: Page 392: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
LOW: Page 391: 
Double blinded, 109 
smear randomly 
reinvestigated 
without knowledge of 
result from air dried 
smears.  
LOW: Page 392: 
All records 
scrutinised by 2 
authors to decide 
if patient fulfilled 
diagnosis criteria, 
was done before 
code of placebo 
or active 
treatment broken 
and before smear 
result included in 
analysis. 
LOW: Page 393: 
Data provided for 
all patients not 
included in analysis 
and lost to follow 
up. 5 had to be 
excluded due to 
contamination or 
specimen 
insufficiency. 
LOW: Page 
394: All 
outcomes 
reported 
HIGH: Page 
395: Selection 
bias may have 
occurred if 
physicians 
seeing women 
with obvious 
BV chose not 
to enrol them 
into study, to 
avoid possible 
placebo 
treatment, as 
was an 
unexpectedly 
low incidence 
of BV 
Levallois 1988 
LOW: Page 101: 
Randomisation was 
prepared by a micro-
professor, 
equalization each 20 
patients. 
LOW: Page 101: each of 
the three capsules was 
placed in a sealed bag 
and given on randomly 
determined schedule to 
each consecutive woman. 
Randomisation codes 
were kept secret until 
analysis began.  
LOW: Page 101: 
Double blinded, 
placebos and active 
alike in appearance 
and randomisation 
codes kept secret  
LOW: Page 101: 
Double blinded, 
performed by  
trained nurse 
using pre-coded 
forms 
LOW: Page 103: 
Data was provided 
for patients not 
included in 
analysis, 0.3% lost 
to follow up 
LOW: Page 
103: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Nielsen 1993 
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UNCLEAR: Page 
557: Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 557: 
Randomised allocation 
stated, no further details 
provided on allocation 
concealment 
LOW: Page 556: 
double  blinded  
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 557: 
Data was provided 
for all patients not 
included in analysis 
LOW: Page 
557: All 
outcomes 
reported 
HIGH: Page 
558: Most 
anaerobic 
bacteria are 
resistant to 
ofloxacin, 
treatment in 
study was not 
effective 
against BV 
caused by 
anaerobic 
bacteria, may 
explain failure 
of our regime. 
Prieto 1995 
LOW: Page 692: 
Computer software 
randomisation 
LOW: Page 692: Random 
block sequence allocation 
in numbered, opaque, 
sealed packets prepared 
independently  
HIGH: Page 692: 
Unblinded yet 
placebo given 
HIGH: Page 692: 
Unblinded but 
physicians 
performing follow 
up not aware of 
allocation 
HIGH: Page 693: 
High rates of loss to 
follow up, identical  
in both arms, no 
data for participants 
LOW: Page 
694: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Ramin 1995 
LOW: Page 214: 
Randomised by 
sealed envelope 
UNCLEAR: no details 
given on allocation 
concealment 
LOW: Page 214: 
double  blinded  
UNCLEAR: Page 
214: Classed as 
double  blinded  
but no further 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 215: 
Data was provided 
for all patients not 
included in analysis 
LOW: Page 
215: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Seeras 1989 
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LOW: Page 607: 
Randomised by 
sealed envelope 
UNCLEAR: no details on 
allocation concealment 
UNCLEAR: No 
information provided 
on blinding 
UNCLEAR: No 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
LOW: Page 609: 
Data provided for 
all patients not 
included in analysis 
LOW: Page 
608: All 
outcomes 
reported 
HIGH: Page 
608: poor 
compliance of 
treatment 
(82.6% cases) 
Sonne Holm 1981 
UNCLEAR: Page 
693: Randomised 
allocation stated, no 
further details 
provided on random 
sequence generation 
UNCLEAR: Page 693: 
Randomised allocation 
stated, no further details 
on allocation concealment 
LOW: Page 693: 
double  blinded  
UNCLEAR: Page 
693: Classed as 
double  blinded  
no further 
information 
provided  on 
blinding of data 
outcome 
assessors or 
analysts 
HIGH: Page 694: 
7.8% loss to follow 
up, no details 
provided for 60% 
patients lost to 
follow up 
LOW: Page 
695: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Sorensen 1992 
LOW: Page 435: 
Randomisation in 
consecutively 
numbered blocks of 
tablet boxes 
UNCLEAR: Page 435: 
Randomisation in 
consecutively numbered 
blocks of tablet boxes, no 
further details on 
allocation concealment 
LOW: Page 434: 
double  blinded  
LOW: Page 435: 
clinical and 
laboratory 
personnel blinded 
to treatment 
allocation. Results 
of C.trachomatis 
tests blinded. 
LOW: Page 435: All 
patients followed up 
by some form (mail, 
telephone, visit) 
LOW: Page 
437: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
Spence 1982 
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UNCLEAR: Page 
503: Randomly 
assigned, no further 
details 
UNCLEAR: Page 503: 
Randomly assigned to 
one of two groups, no 
further details 
LOW: Page 503: 
group assignment 
was double blind; 
pharmacy kept code 
and prepared all 
solutions. code not 
broken until 200 
patients studied 
LOW: Page 503: 
group assignment 
was double blind; 
the pharmacy 
kept code and 
prepared all 
solutions. code 
not broken until 
200 patients 
studied 
LOW: Page 505: All 
patients followed up 
LOW: Page 
505: All 
outcomes 
reported 
LOW: Appears 
to be free from 
other sources 
of bias 
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8.4 DISCUSSION  
Findings 
This meta-analysis has shown a significant reduction in infectious morbidity with the 
administration of prophylactic antibiotics in women undergoing surgical abortion, 
accounting for an average of 41% reduction in the given population.  When the 
population was divided into sub groups of risk categories, a reduction of 58 % was 
noted in women deemed at low risk of pelvic infection, and a reduction of 51% in 
women deemed at high risk of developing pelvic infection. Various antibiotic regimes 
were included in the treatments groups of the trials. It is important to note that the most 
effective treatment may vary according to the setting and local sensitivities. 
Furthermore the availability of different types of antibiotics may vary in settings with 
limited resources; therefore it is important to consider other effective and available 
antibiotics.  
 
Limitations 
There is sufficient high quality evidence on prophylactic antibiotic administration in 
surgical abortion. However the overall evidence on miscarriage consists of a limited 
number of poor quality studies that are vastly heterogeneous in the antibiotic regimen, 
as well as outcome, and have low compliance rates with the antibitoics. Therefore no 
inferences could be drawn on the impact of prophylactic antibiotics on infectious 
morbidity in surgical treatment of miscarriage. 
 
Existing Research 
Surgical abortion: A meta-analysis was conducted by Sawaya et al in 1996 (262),  the 
twelve included trials mainly being conducted in the 1980’s, eleven of which feature 
within our review. Our analysis excluded one trial (Westrom et al (263) included in 
Sawaya’s (262) review  due to lack of randomisation.  Four more RCTs have been 
published since this review was conducted over a decade ago (246, 247, 264, 265).   
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Our review also included six additional RCTs (240, 250, 266-269) some of which were 
excluded by Sawaya (262) (266) (267) due to lack of blinding. Sawaya et al (262) found 
a reduction of 42% in infectious morbidity (RR 0.58 95% CI 0.47 to 0.71) with women 
receiving prophylactic antibiotic therapy during surgical abortion.   A further review was 
conducted by Penney in 1997 discussing the risk factors for post-abortion infective 
morbidity, however the data on prophylactic antibiotic administration is taken from the 
Sawaya (262) review and the manuscript contained no new data on infectious 
morbidity with prophylactic antibiotic administration with abortion. 
 
Miscarriage surgery:  Prophylactic antibiotics following surgical miscarriage treatment 
to reduce sepsis has been identified as an area where there is a crucial need for further 
research (255). The results of this question have the potential to have considerable 
implications for maternal health, particularly in low income settings where associated 
mortality and morbidity from sepsis following surgical treatment for ‘miscarriage’ or 
unsafe abortion is substantial. To date there has been little research in this area. A 
Cochrane review investigated the evidence for antibiotic prophylaxis compared to no 
prophylaxis following miscarriage (255). This review included only one of the three 
studies in our review, the two further studies included in our review, but excluded from 
the Cochrane review were Prieto et al (246), and Ramin et al (247). Prieto et al (246) 
was excluded due to loss to follow-up exceeding their inclusion criteria, and the reason 
for the exclusion of Ramin et al (247) was not stated.  This review, with a single study 
(n = 140 women) concluded that there was ‘insufficient evidence to evaluate a policy of 
routine antibiotic prophylaxis to women with incomplete abortion’ (miscarriage), and a 
‘real and urgent need to find out whether antibiotics should be routinely used in cases 
of incomplete miscarriage’. 
 
Policy and practice implications 
 
 
246 
 
Prophylactic administration of antibiotics is recommended for women undergoing 
surgical evacuation for abortion, where there is an associated risk of developing 
infections and pelvic inflammatory disease (258, 267), including women who currently 
have genital tract infections such as N.gonorrhoea, C. Trachomatis, or bacterial 
vaginosis (258). However the value of prophylactic administration for surgical uterine 
evacuation without such risk factors is less clear (267); This could apply to cases of 
unsafe abortion presenting as ‘miscarriages,’ and antibiotics not administered as per 
clinical and current WHO guidelines (Figure 34).  As there is little reliable evidence 
available on the administration of prophylactic antibiotics in miscarriage, one could 
suggest that the findings from the meta-analysis of uterine evacuation in women 
deemed at low risk of developing pelvic infection could be used to guide practice. The 
procedure of surgical uterine evacuation in miscarriage and abortions are alike, 
however the risk of developing pelvic infection may vary depending on setting. Where 
abortion is permitted by law the procedure is often conducted in a safe and sterile 
manner, yet in countries where abortion is restricted by law, unsafe abortion may 
present as a ‘miscarriage’, and may be initiated in an unsanitary manner with the 
insertion of unsterile objects into the uterus.  Furthermore, infection rates of Chlamydia 
and gonorrhoea in women presenting with ‘miscarriage’ are often high and 
compromised immunity from HIV/AIDS or malnutrition and anaemia may mean that this 
group of women are at a greater risk of pelvic infection. 
 
Unanswered questions and future research 
As there is little reliable evidence available on the role of prophylactic antibiotics in 
miscarriage a high quality RCT is needed to guide practice on this area, particularly in 
regions where the risk of developing pelvic infection is high. 
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8.5 CONCLUSION 
There now appears to be sufficient, up to date evidence for the administration of 
prophylactic antibiotics in abortion, yet there is little reliable evidence available on the 
administration of prophylactic antibiotics in surgical uterine evacuation for miscarriage. 
A RCT is needed to guide practice on this area, particularly in low resource settings 
where the risk of developing pelvic infection may vary from a high resource setting. 
Prophylactic antibiotics may reduce the burden of death and disease from sepsis 
following surgical treatment in low income countries. This will directly address MDG5 
(reducing maternal mortality), where progress has been uneven and slow, particularly 
in settings where the aetiology of the miscarriage is unknown. 
 
This review was used in support of an application that was successfully funded by 
MRD, DfID and Wellcome (£1.6 million) ‘Effectiveness of antibiotic prophylaxis during 
surgical evacuation of the uterus for miscarriage management in low income countries 
(AIMS): a multinational, randomised, double-blind placebo-controlled trial’ 
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CHAPTER 9: CELL SALVAGE IN CAESAREAN SECTION: A 
SYSTEMATIC REVIEW AND META-ANALYSIS 
ABSTRACT 
Background: Obstetric haemorrhage is one of the leading causes of maternal death 
globally. Significant morbidity is also associated with obstetric haemorrhage, 
particularly in low income countries where there is a shortage of available blood to 
transfuse for cultural, financial and practical reasons. Thus the need for alternatives to 
homologous blood transfusion in low income countries is great. 
Methods: A systematic review of available evidence was conducted (RCTs, cohort 
studies, and case series). The databases MEDLINE, EMBASE, AMED, the Cochrane 
library, CINHAL, African Index Medicus, Web of Science, the Reproductive Health 
Library, and the Science Citation Index were searched without language restrictions 
(from database inception to February 2012). Information was extracted on study 
characteristics, quality of the included studies and outcome data. Outcomes were pre 
and post operative haemoglobin, estimated blood loss, amount of autologous blood re-
infused, and use of additional homologous blood for transfusion.  
Results:  Eleven studies were included (1983 women): One RCT, two cohort studies 
and eight case series. Post-operative haemoglobin dropped by 0.90g/l from the pre-
operative haemoglobin in the group that received cell salvage in the RCT, and by 
3.70g/l in the group that did not receive cell salvage.  In the case series this reduction 
was 1.78g/l in those that underwent cell salvage. The groups that received cell salvage 
in the RCT and cohort studies appeared to be transfused more homologous blood than 
the groups that did not receive cell salvage. However there was no trend in estimated 
blood loss with additional homologous blood transfused in the case series. There was 
also no significant difference in serious adverse effects, or length of hospital stay 
reported with cell salvage within the studies. 
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Conclusion: It is possible that cell salvage may be beneficial in restoring normal 
haemoglobin levels for women that have undergone caesarean section, however 
further primary research of sound quality is needed to draw firm inferences on the use 
in caesarean section.  
 
9.1 BACKGROUND 
Obstetric haemorrhage is one of the leading causes of maternal death globally, with 
87% of deaths from haemorrhage occurring in developing regions (270). Significant 
morbidity is also associated with obstetric haemorrhage. Blood transfusion has been 
shown to reduce maternal mortality rates and research suggests that a substantial 
proportion of maternal deaths could be prevented with access to blood transfusion 
(271). Thus blood transfusion is recognised as one of the essential components of 
comprehensive emergency obstetric care. However in many low income countries this 
core component is often not achieved for a variety of reasons.   
 
Research has demonstrated a correlation with maternal mortality and morbidity and the 
availability of blood transfusion. A complete lack of available blood to transfuse, or a 
lack of timely blood transfusion are commonly cited problems (271). This could be due 
to a number of reasons, for example inadequate storage facilities, inadequate 
transport, cultural barriers or high costs associated with blood donation.    
 
There are however other problems associated with blood transfusion in developing 
countries. There is the risk of potential bacterial contamination during reinfusion, as the 
equipment may be re-used for transfusions and poorly sterilised, thus allowing bacteria 
to enter the central circulation directly and put the patient at risk of septicaemia. There 
may also be pathogens contained in the blood, HIV, Hepatitis B and C are often more 
prevalent in developing countries. It is suggested that Africa has some of the highest 
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prevalence rates of these infections in the world (272). The possibility of acquiring HIV 
from an HIV contaminated unit of blood is almost 100%. It is suggested that between 5 
and 15% of HIV infections have been transmitted by transfusion of infected blood or 
blood products (273, 274). Although blood donation screening is suggested to have 
improved globally, comprehensive transfusion policies suited to local context are 
lacking, and many transfusion-related tests are still not conducted (272). HIV and 
Hepatitis are not the only blood borne viruses that contaminate donor blood; malaria 
and syphilis can be transmitted to the blood recipient. There are also serious 
transfusion related reactions associated with homologous transfusion (e.g. haemolytic 
reaction); these are often caused by the transfusion of incorrect blood, due to clinical 
errors in the transfusion process, such as incorrect identification of patients, blood units 
or labelling errors.  
 
It is possible that cell salvage may be ineffective in some situations. For example if 
blood collection is delayed due to the time taken to set up the equipment needed, a 
large amount of blood that could have been salvaged may have already been lost. 
Blood cannot be salvaged retrospectively. Furthermore the time taken to prepare the 
blood for re-infusion may mean the patient becomes more hypovolemic and 
haemodiluted before re-infusion is able to occur, thus resuscitation of the patient is 
more difficult. Cell salvage alone may also not be sufficient to restore the blood lost; 
patients may still require transfusion of plasma and platelets.  
 
Cell salvage can reduce the risks associated with homologous blood transfusion which 
may be particularly useful in areas where the prevalence of blood borne viruses such 
as HIV are high, or where there are difficulties with cross-matching. Cell salvage may 
also be a more culturally or religiously acceptable option in groups that decline 
homologous blood products such as Jehovah’s witnesses (275).  However both types 
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of transfusion are not without risk and the risk of blood transfusion against not 
transfusing blood should always be considered. 
 
Today, intraoperative blood cell salvage is commonly used in cardiac, orthopaedic and 
vascular surgery. NICE guidance (276) describes intraoperative blood cell salvage as 
an efficacious technique for blood replacement. In obstetrics however, it has not been 
routinely adopted because of the theoretical safety concerns associated with 
pregnancy such as haemolytic disease in future of pregnancies due to 
alloimmunisation, and amniotic fluid embolism (276).  Although the uses of salvaged 
blood has been endorsed by CEMACH (277), NICE (276) guidance suggests that this 
procedure must be carried out by multidisciplinary teams that have knowledge and 
experience of  the process of intraoperative blood cell salvage.   
 
Autologous blood collection can occur pre-operatively; this is when blood collection is 
performed through venepuncture before an operative procedure. Blood cell salvage 
however is performed intraoperatively, this is where the blood that is shed during an 
operation is collected and filtered to produce autologous red blood cells for transfusion 
back to the patient. Re-infusion of collected blood can occur intraoperatively or 
postoperatively. During caesarean section, blood that is lost can be aspirated from the 
surgical field and collected in a reservoir where a filter removes debris. The filtered 
blood is washed and re-suspended for transfusion, during or after the operation. The 
concept of autologous blood transfusion in obstetrics is documented from 1818 (278), 
with a much simpler procedure to the one described above. The serous fluid found in 
the body cavities as a result of trauma, or in ruptured ectopic pregnancies, was re-
instated back into the patients veins (279), this will be further discussed in chapter ten. 
The more advanced procedure that concerns this review was utilised on a large scale 
in 1962 for operations such as cholecystectomy (280). 
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A systematic review was performed using the data from all available studies, and the 
applicability of the findings to low resource setting are discussed. 
 
9.2 METHODS 
Data sources and searches 
Databases were searched for literature on cell salvage in caesarean section. Although 
the focus was on developing countries, if no data were available from developing 
countries, the available data was examined. The applicability of the data to developing 
countries was then considered and discussed. The population was women who 
underwent preoperative or intra-operative cell salvage with re-infusion. The databases 
MEDLINE, EMBASE, LILACS, the Cochrane library, CINHAL, African Index Medicus, 
the Reproductive Health Library, and the Science Citation Index were searched (from 
database inception to February 2012). Hand searching complemented electronic 
searches, and reference lists were checked. The primary search terms were ‘cell 
salvage’, ‘blood salvage’, erythrocyte salvage’, ‘cell saver’, autologous transfusion’, 
‘autotransfusion’ AND ‘caesarean section’ OR ‘obstetrics’.  No language restrictions 
were applied to the search. 
 
Study selection and data extraction 
The best possible evidence available was included in the review following the hierarchy 
of evidence, starting from well conducted RCTs and proceeding to expert opinions if 
necessary. In the absence of sufficient data from RCTs alone for this review, lower 
levels of evidence available were included, both RCTs, non-randomised cohort studies 
and case series were selected, as these were the evidence available.  Initially the 
electronic searches were scrutinised and full manuscripts of appropriate studies were 
acquired. Final decisions on inclusion or exclusion of manuscripts was made after 
inspection by the author and another reviewer (AW and HH). Information was extracted 
from each article on the study characteristics and the outcome data.  
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The quality of the included studies were assessed by the author and another reviewer 
(AW, HH).  The outcome measures were pre operative haemoglobin, post operative 
haemoglobin, the transfusion of additional homologous blood, the amount of 
autologous blood re-infused, serious adverse events and length of hospital stay. Where 
possible data for outcomes of caesarean section only were included in the analysis, 
other modes of delivery (vaginal and instrumental) and gynaecological or obstetric 
surgery (laparotomy) were excluded. For cases receiving the intervention we included 
the outcome data of those that received only autologous blood, individual data was 
excluded from the study analysis if additional homologous blood was given and thought 
to influence the outcome measure (i.e. post-operative haemoglobin). Studies that did 
not provide separate outcome data for autologous and homologous transfusions were 
excluded, as were studies that collected blood during caesarean section for purposes 
other than re-infusion.  
 
Methodological quality assessment 
The studies were assessed for methodological quality and adequacy of reporting using 
the tools appropriate for the study design. RCTs were assessed using the CONSORT 
statement (68). Cohort studies were assessed using the STROBE statement (a 
checklist for all observational studies) (69), and the MINORS (70) checklist was used to 
assess the case series. The CONSORT statement assesses trials for adequacy of 
reporting on randomisation and sequence generation, baseline comparability, blinding 
and appropriate statistical analysis. The STROBE statement assesses adequacy for 
reporting on setting, participants, variables, bias, quantitative variables, statistical 
methods and generalisability in observational studies. The MINORS checklist assesses 
for reliability, consistency and validity. The items are scored between 0 and 2 for the 
adequacy of the reporting, with the ideal score being 16 for non-comparative studies 
and 24 for comparative studies. Where possible studies were assessed for risk of bias 
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using the appropriate tools (e.g. Cochrane collaborations risk of bias tool (102) and the 
Newcastle-Ottawa Scale (71). 
 
Data synthesis 
The fixed effects model was used to plot and compare the means and standard 
deviations for pre and post operative haemoglobin (of studies that reported this) in the 
RCT. As there was only one study in this analysis the fixed effects model was 
appropriate, as the intervention was the only source of variation. The random effects 
model was used in the case series analysis to account for the variation across the 
studies. Revman 5 software was used for the analysis to calculate the mean difference 
and inverse variance for pre and post haemoglobin. Heterogeneity of treatment effect 
was assessed using forest plots and χ2 tests, and determined the magnitude by 
calculating the I2 statistic. Other outcomes are reported narratively. 
 
9.3 RESULTS 
The processes of literature search and selection are given in Figure 44. Eleven studies 
were included in the review from the 1439 articles identified from the searches. All of 
the studies meeting the inclusion criteria of the review were included due to the 
shortage of available data. The studies included were one RCT (68 participants), two 
cohort studies (373 participants) and eight case series, totalling 1542 women (Table 
24). All of the included studies were conducted in developed countries due to the lack 
of available data available from developing countries, however the applicability of the 
findings to developing countries will be discussed.  
 
Study characteristics  
The RCT (281) was set in Italy and included 68 women having caesarean section. Both 
groups had similar patient characteristics. Women in the intervention group received 
intra-operative cell salvage and re-infusion. The criterion used in the study for re-
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infusion of salvaged blood was not reported.   Women in the control group did not 
receive cell salvage and re-infusion. The two cohort studies were set in USA and UK 
and included 226 (282) women and 147 (283) women having caesarean section. 
Women that received cell salvage had intra-operate cell salvage and re-infusion in both 
studies. The other group of women in both cohort studies did not receive cell salvage 
and re-infusion. Both studies included women at high risk of postpartum haemorrhage 
or refusal of blood transfusion. Neither of the cohort studies reported criteria for re-
infusion of salvaged blood.  The case series were set in Tokyo (284), UK (285-287), 
Australia (288), USA (289), Ireland (290) and Singapore (291). The women in the case 
series by Ralph et al (286), McDonnell et al (288), Sullivan et al (287) and King et al 
(285) also underwent intra-operative blood collection and re-infusion. Whereas the 
women in the case series by Watanabe et al (284), McVay et al (289), O’Dwyer et al 
(290) and Yeo et al (291) underwent ante-natal blood collection and intra-operative re-
infusion. 
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Figure 44 Study selection process in the systematic review of Cell Salvage in Caesarean Section 
Total citations identified from electronic searches n=1406 
Total citations identified from reference lists or hand searching n=33
Total n=1439
Citations excluded after screening title and/or abstracts: n =1354
Primary articles fulfilling inclusion criteria for systematic review n=11
Articles excluded after review of full text with reasons
Inappropriate population n = 2
Incorrect intervention n = 6
Incorrect study design n = 37
Incorrect outcome n= 29
Total excluded n =74
Full manuscripts retrieved for detailed evaluation: n =85 
Figure 1. Study selection process in the systematic review of Cell Salvage in Caesarean Section
2
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When assessed for adequacy of reporting the RCT received a score of 12 out of a 
possible 22, with details lacking on sequence, allocation, implementation, blinding and 
recruitment (68). The cohort studies achieved a score of 12 and 14 out of a possible 22 
for adequacy of reporting, details were lacking in both studies on data sources, bias, 
other analysis and funding (69). Case series adequately reported between 50% and 
70% (range 8/24-17/24) of items required in the Minors (70) checklist (Table 26). The 
RCT (281) was assessed as having unclear risk of bias for random sequence 
generation, allocation concealment and blinding, however there was low risk of bias in 
outcome data, selective outcomes and other bias. The cohort studies (282, 283) were 
deemed as having low to medium risk of bias for selection, high risk of bias for 
comparability, and medium to low risk of bias for outcome assessment (Table 27). 
Case series were not assessed for risk of bias. 
 
Does re-infusion of salvaged blood improve haemoglobin?  
The RCT and seven of the case series reported on pre or post operative haemoglobin, 
totalling 901 participants (281, 285-291). The RCT (281) demonstrated higher  
haemoglobin levels for the first four days following the caesarean section, when 
compared to the control group, even though pre-operative haemoglobin was lower in 
the intervention arm. The RCT was found to have mean difference of -0.09 (95%CI -
1.59 to -0.21: p=<0.001:Figure 45) between the post operative haemoglobin and pre 
operative haemoglobin following re-infusion of salvaged blood, whereas the control had 
a mean difference of -3.70g/l (95%CI -4.39 to -3.01: p=<0.001) between the post 
operative haemoglobin and pre operative haemoglobin. Meta-analysis of the seven 
case series (285-291) demonstrated a weighted mean difference between the post 
operative and pre operative haemoglobin of -1.78 (95%CI -2.39 to -1.16: p=<0.0001; 
Figure 46) following re-infusion of salvaged blood. There was however significant 
heterogeneity in this analysis (I2=62%, p=0.03). 
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Figure 45 Weighted Mean Difference in Pre and Post operative Haemoglobin in RCT 
2
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Figure 46 Weighted Mean Difference of pre and post operative haemoglobin in case series 
2
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Does a greater blood loss increase the likelihood of additional homologous 
transfusion?    
The RCT (281) demonstrated a reduced need for additional homologous transfusion in 
the group that received re-infusion of salvaged blood, when compared to the control 
group, however no details were provided on estimated blood loss. One cohort study 
(282) reported a median blood loss of 690ml (range 300-9000ml) and a mean 1,120ml 
in the group that received cell salvage. In the group that did not receive cell salvage the 
median blood loss was 800ml (200-4500ml) and the mean blood loss was 1,098mls. 
The standard deviation was not reported for either group. No further information was 
reported by Malik et al on estimated blood loss other than this summary statistic for 
each group in the study. The group that received cell salvage were transfused with 
more homologous blood (31units) than the group that did not (29 units). This may be 
due to selection bias, as patients anticipated as having a greater blood loss were 
included in the cell salvage group. However, given the conflicting data on estimated 
blood loss that is reported in the summary statistics (e.g. greater mean but lower 
median in the cell salvage group), albeit incomplete (lacking the standard deviation) it 
is difficult to draw conclusions on this.  Five case series (282, 284, 287-289, 291) (765 
participants) reported estimated blood loss and a further five case series (282, 284-
286, 289) reported the additional use of homologous blood products.  
 
There was no trend in estimated blood loss with requirements for additional 
homologous blood in the case series (Figure 37). Case series reporting an average 
estimated blood loss between 500–1000 mls, classified as minor postpartum 
haemorrhage, had additional homologous transfusion rates of 5.5% (286) and 56% 
(289). Case series reporting average blood loss between 1000–2000 ml (moderate 
postpartum haemorrhage) had additional homologous transfusion rates of 26% (285), 
28% (287), and 66% (288). One case series reporting severe post partum 
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haemorrhage (more than 2000 ml) (284)  reported 8.9% of patients requiring additional 
homologous blood.  
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Figure 47 Estimated blood loss use of additional homologous blood 
Degree of Post Partum Haemorrhage
Minor Moderate Severe
2
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Is autologous transfusion associated with serious adverse effects? 
Two cohort studies and three case series (282-285, 288) reported on this outcome, and 
no serious adverse effects in the patients that were transfused with autologous blood 
were reported. This included amniotic fluid embolism (282, 283) acute respiratory 
distress syndrome (283), rhesus isoimmunisation (282) and thromboembolism (282). 
The cohort study by Rebarber et al that reported on this outcome, no significant 
difference was found in infectious complications (283) and disseminated intravascular 
coagulation (283) between the group that received cell salvage and the group that did 
not. 
 
Is cell salvage associated with a shorter hospital stay? 
Limited data was reported on post operative hospital stay, however a shorter duration 
of hospital stay was shown with cell salvage when compared to no transfusion in one 
study by McVay et al (289), but another study found no significant difference between 
the groups that did and did not have cell salvage (290). 
 
 
264 
 
Study 
Setting 
Population Cases  of cell salvage  
Method used 
Cases with C/S and reinfusion  
Criteria for re-infusion  
RCT Intervention Control Intervention Control Intervention Control 
Rainaldi 
1998  
Italy 
34 women with 
C/S.Mean age: 
33.6yrs. Mean 
weight:73.3kg. 
Mean height: 
161cm 
34 women with 
C/S. Mean age: 
31.9yrs. Mean 
weight: 71.6kg. 
Mean height: 
160cm 
34: Intra-operative 
cell salvage and  
re-infusion 
34: No cell salvage 34 C/S: NR 34: No reinfusion of 
salvaged blood 
Cohort studies Cell salvage No cell salvage Cell salvage No cell salvage 
Rebarber 
1998  
USA 
226 patients with C/S or similar surgical 
procedures 3 hospitals Jan 1988 – Jul 
1997 
139: Intra-operative 
cell salvage and re-
infusion  
87: No cell salvage 139 C/S: NR 87: No reinfusion of 
salvaged blood 
Malik 
2010  
UK 
147 patients with placenta praevia or 
Jehovah’s witness having C/S Jul 2005 
– Aug 2008. Mean age 32yrs. Mean 
parity 1.46. Mean previous C/S 2.2 
77: Intra-operative 
collection and re-
infusion 
70: No cell salvage 77 C/S : NR 70: No reinfusion of 
salvaged blood 
Case Series 
Watanabe 
2011 
Tokyo 
314 patients at high risk of excessive 
blood loss, or difficult to match for 
transfusion. Mean gestation: 37.8wks 
57.6% had C/S, mean age 34.8yrs. 
Excluded donating: maternal medical 
complication or fetal growth restriction or 
abnormalities 
56: Antenatal autologous blood 
transfusion from  pre-op patient donation 
5 weeks before C/S 
56 C/S : Unstable vital signs or low urine 
output 
Ralph 
2011  
UK 
70 women having C/S. Mean age: 33 
yrs 
68% Elective C/S. 27% Emergency C/S  
excluded: category 1, women not read 
study information 
70: Intra-operative autologous collection 
at C/S, re-infusion 2-6hrs post collection 
70 C/S: EBL>1lt and a full bowl of blood was 
processed. Did not depend on post op Hb 
McDonnell 
2010  
Australia 
51 Patients at high risk of haemorrhage 
or at risk of refusing donor transfusions 
Mar 2007 – Jul 2009 
21: intra-operative cell salvage and re-
infusion 
20 C/S (5 autologous reinfusion only):  
Discussion with obstetrician and anaesthetist, 
all re-infused if sufficient blood for processing 
McVay 
1989  
USA 
273 3rd trimester pregnancy blood 
donors between Jan 1987 – June 1988. 
Delivery data available 209 deliveries. 
24: Antenatal pre-operative blood 
donation (single or multiple donations) up 
to 3 days before delivery. 7 transfusions in 
18 C/S (17 autologous re-infusion only): Re-
infused to all patients, even if homologous 
transfusion not deemed necessary. 
Table 25 Table of study characteristics of included studies in the review 
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Cell salvage and re-infusion in 18 C/S, 6 
vaginal births. 40% primiparous, 42% 
over 35 yrs 
operating theatre 
O’Dwyer 
1993  
Ireland 
266 Patients having elective c/s, total 
abdominal hysterectomy and vaginal 
repair. Mean age 32yrs 
Pre-operative blood donation and re-
infusion 
56 C/S : year 1 patients received routine 
transfusions without clinical need, year 2 
transfusion if actively bleeding/ anaemic   
Sullivan 
2011 UK 
107 patients undergoing cell salvage 
during C/S Jan 25 2007, Jul 6, 2009. 
36: intraoperative cell salvage and re-
transfusion 
36 C/S:>800mls collected 
King 
2009 UK 
46 patients at high risk of haemorrhage 
having cell salvage May-Oct 2007 
19: Intra-operative collection and re-
infusion  
19 C/S: Active bleeding, Hb <8g/l, 
symptomatic anaemia 
Yeo 
1999 
Singapore 
20 patients with C/S. Antenatal 
collection > 36/40 gestation 
8: Antenatal autologous blood collection 
and intraoperative reinfusion 
8 C/S : No real indication or excessive blood 
loss, tendency to transfuse autologous blood 
2
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Study EBL*  
 
Autologous blood 
re-infused*  
Hb *¥ Additional 
homologous 
blood (%) 
Maternal complications Outcome  of intervention 
compared to control (for 
comparative studies) 
RCT Int Con Int Con Int Con Int Con Int Con  
Rainaldi 
1998 
NR NR 363 (153) 0 Pre: 
10.7 
Post 
day 1: 
9.8 
Pre: 
11.7 
Post 
day 1: 
8 
1/34 
(2.9) 
8/34 
(23.5) 
14 previous 
C/S, 3 
placenta 
praevia,5 
fibroids,2 
placental 
detachment 
9 previous 
C/S, 1 
placenta 
praevia,0 
fibroids,1 
placental 
detachment 
Hb concentrations during 1st 4 
days post op higher, pre op Hb 
lower, need for homologous blood 
lower, hospital stay shorter in 
intervention group than control (5.3 
vs. 7.3 days p=0.003) 
Cohort studies Cell salv No cell 
salv 
Cell salv No cell 
salv 
Cell 
salv 
No cell 
salv 
Cell 
salv 
No cell 
salv 
Cell salv No cell salv  
Rebarber 
1998 
NR NR H:250(12
5-4750) 
G:543(22
5-1160) 
Y: 450 
(200-
11250) 
0 NR NR NR NR median 6 
(range3-15) 
hysterectomy  
median 5 
(range3-59) 
hysterecto
my 
No cases acute RDS, amniotic 
fluid embolism identified. No 
significant difference between DIC, 
infectious morbidity, or post-
partum hospitalisation between cell 
salvage group and no cell salvage 
group. 
Malik 
2010 
690 
(300-
9000) 
800 
(200-
4500) 
13 units 
re-infused 
0 NR NR 31 
units  
29 
units  
10 fibroids,5 
previous 
massive 
haemorrhage
, 6 multiple 
C/S, 1 
ruptured 
uterus 
NR Larger EBL, less homologous 
blood transfused, no adverse 
outcomes reported in cell salvage 
group compared to no cell salvage 
group. 
Case series 
Watanbe  
2011 
2243(1090) NR Delivery: 10.8 
(1.1) 
5/56 (1.6%)   28 placenta praevia, 9 leiomyoma, 12 low lying placenta, 1 
previous C/S, 3 previous haemorrhage 
Ralph  
2011 
900 (400-7000) 324(118-1690) Pre: 11.3 (1)  
Post: 9.0 (1.3) 
13/70 (56%) 2 ruptured uterus, 1 fibroid, 1 placenta praevia/ Accrete 
McDonnell 
2010 
1960 (364) 359(242-546) Pre: 13.6 (10.9) 
Post: 10.1 (6.8) 
14/21 (66%) 5 placenta praevia +/- placenta accrete, most had hysterectomy  
Table 26 Data of outcomes reported in included studies (estimated blood loss, amount of autologous blood reinfused, haemoglobin, 
additional homologous transfusion, maternal complications) 
2
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 *Mean and SD or Median and range (ml) ¥ Post op excludes additional homologous transfusion data. H=Hinsdale, G=Good Samaritan, Y=Yale new haven  
McVay 
1989 
900(150-2000) 1.2 units (0.56 unit) Pre: 11.5 (0.91)  
Post: 10.0 (1.2) 
1/18 (5%) 4 placenta praevia, 7 previous C/S, 1 low lying placenta 
O’Dwyer 
1993 
NR 68 units (64.7 unit) Pre: 12.3 (0.9) 
Post:11.3 (0.96) 
NR NR 
Sullivan  
2011 
1274 268 Pre: 9.5  
Post: 8.9 
10 (28%)  All at high risk of haemorrhage (placenta praevia, multiple repeat 
C/S, ante-partum haemorrhage. 
King 
2009 
120  (500-2000) 300 (200-800) Pre: 11.55±2.3 
Post: 9.4 ± 0.8 
5 (26%) 4 placenta praevia, 3 fibroids, 2 multiple C/S, 2 previous 
haemorrhage 
Yeo  
1999 
390 (250-600) NR Pre:12.09 (10.5-
13.5) 
NR NR 
2
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Table 27 Quality assessment: Reporting checklist of RCT (Y=Reported; N=Not Reported) 
Topic Consort checklist  
Rainaldi 1998 
Title and abstract 
 Identification as RCT in title N 
Structured summary of trial design, methods, results, 
conclusions 
N 
Introduction 
Background 
objectives 
Scientific background, explanation of rationale Y 
Specific objectives or hypotheses Y 
Methods 
Trial design Description of trial design including allocation ratio Y 
Important changes to methods after trial commencement, 
reasons 
N 
Participants Eligibility criteria for participants N 
Settings and locations where data collected N 
Interventions interventions for group with sufficient details to allow 
replication, including how and when actually administered 
Y 
Outcomes Completely defined pre-specified primary and secondary 
outcome measures, including how and when assessed 
Y 
Any changes to trial outcomes after trial commenced, reasons N 
Sample size How sample size was determined Y 
When applicable, explanation of any interim analyses and 
stopping guidelines 
N/A 
Randomisation 
Sequence 
Generation 
Method used to generate random allocation sequence N 
Type of randomisation; details of restriction N 
Allocation 
concealment  
mechanism 
Mechanism  to implement random allocation sequence, 
describing any steps taken to conceal the sequence until 
interventions assigned 
N 
Implementation Who generated random allocation sequence, enrolled 
participants, assigned participants to interventions 
N 
Blinding If done, who blinded after assignment to interventions and how N 
If relevant, description of similarity of interventions N/A 
Statistical 
methods 
Statistical methods used to compare groups for primary and 
secondary outcomes 
Y 
Methods for additional analyses, such as subgroup analyses 
and adjusted analyses 
N 
Results 
Participant flow  numbers of participants were randomly assigned, received 
intended treatment, and analysed for primary outcome 
Y 
losses and exclusions after randomisation, with reasons N 
Recruitment Dates defining periods of recruitment and follow-up N 
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Why trial ended or stopped N 
Baseline data A table showing baseline demographic and clinical 
characteristics for each group 
Y 
Numbers 
analysed 
For each group, number of participants included in each 
analysis and whether analysis by original assigned groups 
N 
Outcomes and 
estimation 
primary and secondary outcome, results for group, and 
estimated effect size and precision  
Y 
binary outcomes, presentation of both absolute and relative 
effect sizes is recommended 
Y 
Ancillary 
analyses 
Results of other analyses performed, subgroup analyses and 
adjusted analyses, distinguishing pre-specified from 
exploratory 
N 
Harms All important harms or unintended effects in group  N 
Discussion 
Limitations Trial limitations, addressing sources of potential bias, 
imprecision, multiplicity of analyses 
Y 
Generalisability Generalisability of trial findings Y 
Interpretation 
 
Interpretation consistent with results, balancing benefits and 
harms, considering other relevant evidence 
N 
Other information 
Registration 
 
Registration number and name of trial registry 
 
N 
Protocol 
 
Where full trial protocol can be accessed, if available 
 
N 
Funding 
 
Sources of funding, other support role of funders 
 
N 
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Table 28 Quality assessment: Reporting checklist for cohort studies 
 
STROBE Checklist Rebarber 1998 Malik 2010 
Title and abstract 
Design Y N 
Summary Y Y 
Introduction 
Background Y Y 
Objectives N Y 
Methods 
Study design Y N 
Setting Y N 
Participants Y N 
Variables Y Y 
Data sources N N 
Bias N N 
Study size Y Y 
Quantitative variables Y N 
Statistical methods Y N 
Results 
Participants Y Y 
Descriptive data N Y 
Outcome data N Y 
Main results N Y 
Other analysis N N 
Discussion 
Key results Y N 
Limitation N Y 
Interpretation Y Y 
Generalisability Y Y 
Other information 
Funding N N 
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Table 29 Quality assessment: Reporting checklist for case series 
 
 
 
 
 
 
  
Minors checklist 
 McVay 
1989 
O’Dwyer 
1993 
Yeo  
1999 
King  
2009 
McDonnell  
2010 
Ralph  
2011 
Sullivan 
2011 
Watanabe 
2011 
Aim 1 2 2 2 1 2 2 2 
Inclusion of patients 2 2 2 1 1 2 2 2 
Prospective data 
collection 
1 2 2 1 1 2 1 2 
Appropriate end 
points 
2 2 2 2 1 2 2 2 
Unbiased end point 
assessment 
0 0 
 
0 0 1 1 0 0 
Appropriate follow up 1 0 
 
0 0 0 2 2 2 
Loss of follow up 
<5% 
1 2 2 2 2 2 2 2 
Prospective study 
size calculation 
0 0 0 0 0 0 0 0 
Adequate control 
group 
1 
 
- 1 2 1 - - 1 
Contemporary groups 1 - 1 2 0 - - 1 
Baseline equivalence 0 - 0 1 0 - - 1 
Statistical  
Analysis 
2 - 1 2 0 - - 2 
2
71
 
 
 
272 
 
Table 30 Risk of Bias in RCT (Y= Reported; N= Not Reported) 
Random sequence 
generation 
Allocation 
concealment 
Blinding of 
participants and 
personnel 
Blinding of 
outcome 
assessment 
Incomplete outcome 
data 
Selective 
reporting 
Other bias 
Rainaldi 1998 
UNCLEAR: Page 
195: Randomly 
allocated no further 
details 
UNCLEAR: 
Page 195: No 
details 
provided 
UNCLEAR: 
No details 
reported 
UNCLEAR: No 
details reported 
LOW:Page 197: Data 
provided for all 
patients 
LOW: Page 197: 
All outcomes 
reported 
LOW: Appears to be no 
other sources of bias  
Selection Comparability Outcome 
Representativeness Selection on 
comparison 
Ascertainment 
of exposure 
Demonstration of 
outcomes 
Comparability(2 points 
available) 
Outcome 
assessment 
Follow up 
length 
Adequate 
follow up 
Rebarber 1998 
Y Y Y Y N Y Y N 
Malik 2010 
N Y Y Y N Y Y Y 
 
 
  
2
74 
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9.4 DISCUSSION 
Main findings 
The systematic review reports the outcomes of pre and post operative haemoglobin, 
estimated blood loss during the caesarean section, the use of additional of homologous 
blood transfusion and adverse events in cases of cell salvage in caesarean section.  In the 
RCT post-operative haemoglobin dropped by 0.90g/l from the pre-operative haemoglobin in 
the group that received cell salvage, whereas the control group post-operative haemoglobin 
dropped by 3.70g/l from the pre-operative haemoglobin. The post-operative decrease in 
haemoglobin was 1.78g/l in the case series. The groups that received cell salvage in the 
cohort studies were transfused more homologous blood than those that did not receive cell 
salvage, but this may be due to selection bias. However, there was no trend in estimated 
blood loss with additional homologous blood transfusion in women that received cell salvage 
in the case series. There was no significant difference in serious adverse effects reported 
using cell salvage, or length of hospital stay, although there was limited data available on this 
outcome.  
 
The selection bias that may exist in relation to this finding, may be due to the inclusion of 
more patients at greater risk of post partum haemorrhage due to various clinical 
characteristics and risk factors, such as multi-parity, multiple pregnancy, uterine fibroids and 
previous caesarean section, in the cell salvage group. Therefore the increased likelihood of 
additional homologous transfusion may not be related to the process of re-infusion of 
autologous blood, but to the patient and their clinical picture, which may differ from that of the 
patient in the group that did not receive cell salvage (because these patients were less likely 
to experience post partum haemorrhage). It is however difficult to draw firm inferences on 
this as only one cohort study reported estimated blood loss. A higher mean blood loss was 
reported in the group that received cell salvage (no standard deviation was reported) yet a 
lower median blood loss. 
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Study Limitations 
There was a complete lack of data originating from developing countries; therefore all of the 
included studies in the review were from developed countries. Due to the complexities and 
costs associated with the training and resources required for this procedure, the applicability 
of this type of cell salvage in a low resource setting would need to be debated. 
 
The type of study design from which the majority of the data originates (case series) is a 
serious limitation within this review. The methodological quality of most of the studies 
included in the review was also poor, with the majority lacking control in the study design; In 
the RCT there was lack of blinding and adequate concealment of treatment allocation. The 
cohort studies were retrospective and lacked information on the setting, data sources and 
attempts to address bias. Furthermore the sample size of the studies included were 
predominantly small, therefore there may be insufficient power to detect rare outcomes such 
as amniotic fluid embolism and maternal death.  
 
A further limitation of the review was that although the majority of studies within the analysis 
focus on women undergoing caesarean section, and outcomes have been analysed for 
caesarean section where possible (288, 289), for one large study (314 patients) it was not 
possible to exclude the outcomes of women having vaginal or instrumental births from those 
having caesarean section, thus it is acknowledged that this is likely to incur bias within the 
results (284). 
 
In addition to this a large proportion of the caesarean sections performed within the studies 
were elective procedures, therefore one could speculate that haemoglobin would have been 
checked prior to surgery to identify and correct anaemia before the caesarean section was 
performed. Furthermore four of the included studies (284, 289-291) performed preoperative 
blood collection for intra-operative donation, in which women with an Hb below 10.g/l (284) 
and 11.0g/l (289, 291) were excluded. As no low Haemoglobin values were included within 
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these groups, selection bias could confer an advantage to this group giving higher 
haemoglobin levels. Attempts have been made to address this by comparing weighted mean 
differences rather than comparing the pre and post haemoglobin values.  
 
Estimated blood loss also differed between the group that received cell salvage and the 
group that did not (only reported in one cohort study), this could be influenced by the 
inclusion criteria of some studies, as some only recruited patients at risk of increased blood 
loss (e.g. placenta praevia) in the group that received cell salvage. Yet as conflicting data 
was provided on this outcome in this study it is difficult to draw inferences. Most studies 
however included patients at a similar risk of haemorrhage (282, 284, 285, 287, 288)  
although reasons for re-infusion varied across studies. For example some studies only re-
infused salvaged blood when clinically indicated through unstable vital signs (284) or 
anaemia (285), whereas others re-infused when estimated blood loss was greater than 
800ml (287) or one litre (286). Yet some studies re-infused without clinical need if there was 
sufficient blood salvaged for processing and re-infusion (288, 289) (291) 
 
Existing Research 
The reduced need for homologous red cell transfusion has been demonstrated in a 
Cochrane review (292) in elective adult cardiac and orthopaedic surgery with the use of intra-
operative cell salvage. This type of surgery is quite different and due to the additional 
concerns of amniotic fluid embolism and maternal fetal alloimmunisation in caesarean 
section, these results cannot be generalised to obstetric patients. To date there is no 
Cochrane review on the use of cell salvage in caesarean section. There has been one 
literature review published recently (293) that examined the safety, efficacy, indications and 
contraindications of cell salvage in obstetrics, however this did not take a systematic 
approach, the methodology was unclear, and studies were omitted from the review. Two 
previous literature reviews were published in 2008 (294) and 2009 (295), but since these 
publications seven more studies have been published on cell salvage in caesarean section.  
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From the literature, it is apparent that the safety concerns with cell salvage are often 
perceived as a barrier to use in obstetrics. Issues with training and the complexity of 
equipment have been raised (296),   however the theoretical risk of transfusing salvaged 
blood that may contain small amounts of amniotic fluid has recently been debated (297).   
 
Practice and policy implications 
Cell salvage could possibly be suggested as a safe and effective intervention to increase 
haemoglobin levels for women undergoing caesarean section. Although this review includes 
data from poor quality studies that are vulnerable to bias, it suggests that minimal adverse 
affects are associated with cell salvage in caesarean section. In the absence of good quality 
data from developing countries, is not possible to suggest policy implication for this 
procedure. Furthermore, there are serious cost implications with the type of cell salvage 
explored in this review. A unit of homologous is suggested to cost approximately £120 
(although this cost does fluctuate globally with the cost of processing (298), whereas the 
equipment required for cell salvage, is much more costly. For example the cell salver 
machine is over £4000, the cost of the collection and infusion kits are £77, plus the running 
and maintenance costs of the machine  (298).  Therefore it is unlikely that this intervention is 
sustainable within a developing country, where limited funds and resources are put into 
healthcare. 
 
Moreover the practical implications associated with cell salvage should also be taken into 
consideration. There may be a delay in the patient receiving adequate treatment (i.e. blood 
transfusion of salvaged blood) due to the time taken to set up the apparatus. This may also 
result in blood being lost and not being able to be salvaged, as it is not possible to 
retrospectively salvaged shed blood. In turn this may result in the patient’s condition 
deteriorating. In addition, the time taken to process the blood for reinfusion may result in 
further deterioration of the patient’s condition.  
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There is also an additional risk associated with the transfusion of salvaged blood is the 
theoretical risk of coagulopathy reported in the literature, this could occur with the reinfusion 
of activated clotting factors, as the blood may no longer be coagulable following the process 
of fibrinolysis, due to a deficiency in fibrinogen and factors V, VII and X (299). The risk of the 
transfusion being ineffective should therefore be taken into consideration when discussing 
this service with patients. 
 
Unanswered questions and future research  
Primary research of sound quality is needed to draw firm inferences on the safety and 
effectiveness of cell salvage in caesarean section. A health economics assessment is also 
needed to assess the feasibility of this intervention in developing countries. 
 
9.5 CONCLUSION  
Accounting for the substantially greater blood loss between the groups that received cell 
salvage and the groups that did not, and the similarities in the pre and post operative 
haemoglobin, it is speculated that cell salvage may be beneficial in achieving normal 
haemoglobin levels for women that have undergone caesarean section.  The applicability of 
these findings however, to a low resource setting needs to be questioned due to the training 
and resource costs associated. Cell salvage using the method in which was included in the 
studies in this review, may not be a financially sustainable option, it may also not be an 
economically viable alternative to homologous transfusion, as this is often associated with 
lower costs. No firm inferences can be drawn from the conclusions of this review on cell 
salvage in caesarean section in women in developing countries, due to the setting of the 
studies and the quality of the data. It is acknowledged that the study design of most of the 
included studies (case series) is vulnerable to bias and confounding.  However despite this, 
this remains the best evidence available on cell salvage in caesarean section to date. Further 
primary research of sound quality, with health economics is needed to draw firm inferences 
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on the use of cell salvage in caesarean section, and the feasibility of it in developing 
countries. 
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CHAPTER 10: CELL SALVAGE IN ECTOPIC PREGNANCY: A SYSTEMATIC 
REVIEW 
ABSTRACT 
Background: Haemorrhage from ruptured ectopic is a major cause of maternal death in 
many low income countries. Significant morbidity is also associated with massive 
haemorrhage, particularly in countries where resources are limited or there is a shortage of 
available blood to transfuse for financial, cultural or practical reasons. Simple cell salvage 
has been used in many low resource settings as an alternative to homologous blood 
transfusion. 
Methods: A systematic review of available evidence was conducted (RCT, Cohort studies 
and case series). The databases MEDLINE, EMBASE, AMED, BNI, the Cochrane library, 
CINHAL, LILACS, African Index Medicus, Web of Science, the Reproductive Health Library, 
and the Science Citation Index (inception-May 2012) were searched without language 
restriction. Data were extracted from each study on study characteristics, study quality and 
outcome data. Outcomes were pre and post operative haemoglobin, additional use of 
homologous blood transfusion, serious adverse effects and length of hospital stay. 
Results: Seventeen papers were included (2220 women), one RCT, two cohort studies and 
14 case series. The RCT demonstrated a greater increase in post operative haematocrit in 
the group that received cell salvage, compared to the control group. The use of additional 
homologous blood transfusion in addition to transfusion of salvaged blood was reported in 
half of the group that received cell salvage in the cohort study. Comparatively 4.9% of 
women that received cell salvage in the case series received additional homologous blood. 
No significant difference was found in infectious morbidity in the RCT or the cohort study. 
The majority of the deaths reported in the case series were reported as not associated with 
the transfusion of salvaged blood.  
Conclusion: It is possible that simple cell salvage in ectopic pregnancy could be safe and 
effective alternative to donor transfusion if culturally unacceptable or unavailable. However 
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further primary research of sound quality is needed to draw firm inferences on the use of 
simple cell salvage in ectopic pregnancy.  
 
10.1 BACKGROUND 
Haemorrhage from ruptured ectopic pregnancy is a major cause of maternal death, 
particularly in low income countries where resources are limited or there is a shortage of 
available blood to transfuse (as discussed previously in chapter eight). Significant morbidity 
is also associated with haemorrhage from ruptured ectopic pregnancy.  
 
Blood transfusion is one of the essential components of comprehensive emergency obstetric 
care (270, 300), however many low income countries lack this core component.  The 
availability of blood can directly affect maternal mortality rates, for example in Sub-Saharan 
Arica where blood donation rates are very low, maternal mortality rates are high (301). As 
stated before there is a need for alternatives to homologous donor blood transfusion in low 
income countries, not only for caesarean section but for other obstetric and gynaecological 
procedures.  
 
The notion of autologous blood transfusion in gynaecology and obstetrics was first 
acknowledged in 1818 (278), this process involved collecting the blood found in the body’s 
cavities as a result of ruptured ectopic pregnancy and re-infusing it back into the patients 
veins (279), this process is described below. Today cell salvage is a more advanced 
procedure in high income countries (previously described in chapter eight), having been used 
widely for operations such as cholecystectomy since 1962 (280). It is also commonly used in 
cardiac, orthopaedic and vascular surgery, with NICE guidance (276) describing intra-
operative blood cell salvage as an efficacious technique for blood replacement.  Yet in low 
income countries cell salvage remains a more basic technique, and this is the technique that 
will concern this review. Not only can cell salvage be used in areas that lack homologous 
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blood transfusion services, it can reduce the risks associated with homologous blood 
transfusion, for example blood borne infections and transfusion related reactions. This may 
be particularly significant in areas where the prevalence of HIV and other blood borne 
infections are high. Cell salvage may also be a more suitable option culturally, for groups 
such as Jehovah’s Witness that may decline homologous blood products (275).   
 
Although intra-operative autologous blood transfusion has a long history in the treatment of 
haemorrhage from ruptured ectopic pregnancies, and is frequently used in areas where there 
are limited resources (270), little is known about clinical outcomes of exclusive 
autotransfusion in ectopic pregnancy (302). A systematic review and meta-analysis was 
performed using the data from all available studies, and the applicability of the findings to low 
resource settings are then discussed. 
 
The process of cell salvage 
In the case of cell salvage for ruptured ectopic pregnancy, the Tanguieta funnel is the most 
common method used (270). A perforated funnel is placed in the peritoneal cavity to collect 
the pooled blood, then a small incision in the peritoneum is performed to avoid blood 
spillage. The blood is then collected by aspiration or scooped using a sterile galipot or ladle. 
Clots and debris are filtered out by passing the blood through a gauze filter into a receiving 
bowl. The blood is then aspirated into a sterile syringe, transferred into an intravenous 
transfusion set that has been prepared with an anti-coagulant solution. It will then be re-
infused back into the patient (303).   
 
Risks associated with transfusion 
The risks of blood transfusion relative to those of not transfusing blood should always be 
considered.  The serious risks that can occur with homologous transfusion are less likely in 
autologous transfusion, as they are often due to the transfusion of incorrect blood, caused by 
clinical errors in the transfusion process, such as incorrect identification of patients, blood 
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units or labelling errors. Yet there are still risks associated with homologous transfusion, 
particularly in low resource settings where the method of autologous transfusion, as 
described above is used. The equipment may be re-used for transfusions and poorly 
sterilised, allowing bacteria to directly enter the central circulation, thus putting the patient at 
risk of septicaemia. An additional theoretical risk noted by Carty et al (304), as associated 
with the transfusion of salvaged blood is the possibility of coagulopathy: this could occur with 
the reinfusion of activated clotting factors, as the blood may no longer be coagulable 
following the process of fibrinolysis, due to a deficiency in fibrinogen and factors V, VII and X 
(299).   
 
10.2 METHODS 
Data sources and searches 
Databases were searched for literature on cell salvage in ectopic pregnancy. The focus was 
on developing countries, however if no data were available from developing countries, the 
available data was examined, and the applicability to developing countries discussed. The 
population was women with ectopic pregnancy who underwent cell salvage with re-infusion. 
MEDLINE, EMBASE, Cochrane library, CINHAL, LILACS, African Index Medicus, the 
Reproductive Health Library, and the Science Citation Index were searched (from database 
inception to February 2012). Hand searching complemented electronic searches, and 
reference lists were checked. The primary search terms were ‘cell salvage’, ‘blood salvage’, 
‘cell salver’, ‘erythrocyte salvage’, autologous transfusion’, ‘autotransfusion’, ‘tubal 
pregnancy’ and ‘ectopic pregnancy’.  No language restrictions were applied to the search. 
 
Study selection and data extraction 
The best possible evidence available was included in the review following the hierarchy of 
evidence, starting from well conducted RCTs and proceeding to expert opinions if required. 
As there was a lack of adequate data from RCTs alone, lower levels of available evidence 
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were included; RCTs, non-randomised cohort studies and case series were selected, as 
these were the evidence available. Initially the electronic searches were scrutinised and full 
manuscripts of appropriate studies were acquired. Final decisions on inclusion or exclusion 
of manuscripts was made after inspection of these manuscripts by the author and another 
reviewer (AW and HH).  Information was extracted from each article on study characteristics, 
quality and outcome data by the author and another reviewer (AW, HH).  The outcome 
measures were pre operative and post operative haemoglobin levels, estimated blood loss or 
haemoperitineum, use of additional homologous blood, duration of post operative hospital 
stay, and serious adverse events. Individual data was excluded from the study analysis if an 
additional intervention was given and it was thought to influence the outcome measure, for 
example if additional homologous blood was given post-operative haemoglobin may be 
influenced. Therefore the outcome data of participants who received only autologous blood in 
the cell salvaged group were included in the analysis. Studies that did not provide separate 
outcome data for autologous and homologous transfusions were excluded, as were studies 
that collected blood for purposes other than re-infusion.  
 
Methodological quality assessment 
The studies were assessed for methodological quality using reporting assessment tools 
appropriate for the study design. The CONSORT (211) statement was used to assess RCTs, 
the STROBE (69) statement was used to assess the cohort studies, and the MINORS (70) 
checklist was used for case series studies. These have been discussed previously in chapter 
eight. Where possible studies were assessed for risk of bias using the appropriate tools (e.g. 
Cochrane collaborations risk of bias and the Newcastle Ottawa Scale (71).   
 
Data synthesis 
Outcomes are reported narratively, and data from RCTs, cohort studies and case series are 
reported separately. There was insufficient data to conduct a meaningful meta-analysis, 
therefore it was not deemed appropriate with the outcome data available. 
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10.3 RESULTS 
The processes of literature search and selection are given in Figure 38. Seventeen studies 
were suitable for inclusion within the review with a total of 2220 participants that were 
undergoing surgery for ruptured ectopic pregnancy. This included one RCT (139 women), 
two cohort studies (176 women) and 14 case series (1905 women). Characteristics of the 
included studies are shown in Table 28, and the outcome data reported for women 
undergoing cell salvage for ectopic pregnancy is shown in Table 29. Unlike chapter eight, 
where all of the included studies originated from developed countries, most studies in this 
review originate from developing countries.  All of the studies meeting the inclusion criteria of 
the review were included due to the shortage of available data.  
 
Study characteristics 
The one RCT by Selo-Ojeme (299) was set in Nigeria and included 139 women with 
Haemoperitoneum greater than 500mls, or where there was evidence of haemorrhagic 
shock. Women with sickle cell were excluded, as were those with a leaking chronic ectopic 
pregnancy. The intervention group (received autologous transfusion) and the control group 
(received homologous transfusion) had 56 patients in each group. The intervention group 
received all of the collected intraperitoneal blood through re-infusion. The method that was 
used to salvage the blood in the intervention group involved making an opening in the top of 
a fluid bag large enough to allow the pouring of the salvaged blood from the midline 
subumbilical incision that was made. Artery forceps were used to hold up the edges of the 
incised parietal peritoneum, to prevent subcutaneous blood from mixing with intraperitoneal 
blood. A galipot was then used to scoop out the intraperitoneal blood into a sterile bowl, 
which was then covered with doubled latex gauze to act as a filter. The full bowl was then 
turned into the infusion container that had already been cleaned with spirit. No anticoagulant 
was used. The control group women received the total number of units that had been 
obtained for them (usually through patient relatives). Baseline characteristics were similar for 
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the intervention and the control group, with the majority of women being nulliparous (89% 
and 87% respectively), gestational age below ten weeks (87% and 89%) with a history of 
miscarriage or abortion (75% and 71%), and a history of sub-fertility (20% and 23%). 
This trial reported pre-operative and post operative haemocrit, wound infection, fever, 
mortality, haemoperitoneum, hospital stay greater than seven days, surgery duration and 
transfusion greater than one litre. 
 
The two cohort studies by Duncan et al and Selo-Ojeme et al included 53 patients (305) and 
123 patients respectively (306), however in the study by Duncan et al (307), only a small 
proportion of the patients received autologous transfusion for ruptured ectopic pregnancy (8 
patients), there were also no patients that received homologous transfusion alone to 
compare outcomes with. The other study by Selo-Ojeme et al (299) reported on 33 patients 
that received autologous transfusion and 85 patients that received homologous transfusion 
for ruptured ectopic pregnancy. The methods of cell salvage used were similar to the method 
described above (299). Limited baseline characteristics were reported for patients in both 
studies, with Duncan et al reporting participants age (range 19-41 median 37) (307) and 
Selo-Ojeme et al reporting gestational age below 12 weeks gestation (94% and 90.5% in the 
autologous and homologous groups respectively). The studies reported on the outcomes of 
mortality, post operative complications, haemoperitoneum, duration of hospital stay, 
transfusion of additional homologous blood and the volume of blood transfused. 
 
Study quality 
When assessed for quality the RCT received a score of 16 out of a possible 22 on the 
CONSORT (211)  statement checklist (Table 34)  with details lacking on blinding, 
implementation, study objectives, statistical methods, recruitment and ancillary analysis. The 
cohort studies received a score of 11 out of 22 on the STROBE statement, lacking details on 
study design, study size, statistical methods, descriptive data, other analyses and limitations 
(Table 35). The case series received a median score of 6 on the MINORS checklist out of a 
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possible 16 (range 1-9). Most case series reported a clearly specified aim, described the 
inclusion of consecutive patients, gave unbiased endpoint assessment, appropriate follow up 
and had a loss of follow up of less than 5%. Most case series did not have a prospective 
study size calculation, or prospective data collection (Table 36). Risk of bias in the RCT was 
low for sequence generation, allocation concealment, incomplete outcome data, selective 
reporting and other bias (Table 37). However there was unclear risk of bias in blinding of 
participants and outcome assessors. Risk of bias in the cohort studies was assessed as low 
for selection in one study, and high in another, this was also true for comparability, and 
outcome assessment (Table 37). Risk of bias was not assessed for case series.  
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Figure 48 Study selection process in the systematic review of Cell Salvage in ectopic surgery
2
87
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Does re-infusion of salvaged blood improve haemoglobin?  
The RCT demonstrated a greater increase in haemocrit, from pre operative 
measurement to post operative measurement in the group that received the 
intervention (0.095), compared to the control (0.057). The authors did not report if this 
difference was significant, and the paper contained insufficient data to calculate this, 
this was also the reason for not calculating mean difference in this analysis. Six case 
series (308-313) also reported on this outcome, post-operative haemoglobin is given 
from autologous transfusion patients only. Some studies showed an increase in 
haemoglobin from pre-operation to post-operation, between 1.3 to 4.8g/l (309-311, 
313), whereas others showed a decrease, between 1.3-1.8g/l (308, 312). 
 
Does autologous transfusion increase the likelihood of additional homologous 
transfusion?    
The additional use of homologous blood transfusion in conjunction to autologous 
transfusion was reported in seven studies (307-309, 311-315). One cohort study 
reported that 50% (4/8) of participants receiving cell salvage, also received additional 
homologous blood transfusion. No data on this outcome was provided for the women 
that did not receive cell salvage. Three out of 6 case series also reported the use of 
additional homologous blood transfusion, with a total of 44 participants out of 295 
(14.9%) receiving additional homologous blood. No data were provided for the groups 
that did not receive cell salvage. 
 
Is autologous transfusion associated with serious adverse effects? 
Infectious morbidity: Post operative infection and fever was reported in 4 studies (299, 
306, 311, 316). The RCT demonstrated no significant difference in infectious morbidity 
between the intervention and control groups overall (RR 0.92 95%CI 0.60, 1.41: 
p=0.70). No cases of sepsis were reported in either group, and 20 cases of fever and 3 
cases of wound infection were reported in the autologous group, and 21 cases of fever 
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and 4 cases of wound infection were reported in the homologous group: no further 
details were provided on either of these outcomes. The cohort study by Selo-Ojeme et 
al also demonstrated no significant difference for the outcome of infectious morbidity 
(RR 0.90 95%CI 0.42, 1.93: p= 0.79). In this study 6 cases of fever and 1 case of 
wound infection were reported in the autologous group, and 18 cases of fever and 2 
cases of wound infection were reported in the homologous group, again no further 
details were provided on either of these outcomes.  Ten of the participants out of a total 
476 (2.1%) who had received cell salvage in the reporting case series developed post 
operative infection, this included one case of hyperpyrexia and rigors after 100ml of 
autologous blood was infused in the study by Pathak et al (316), no further details were 
provided on the other 9 cases reported in the study by Priuli et al (311).  
 
Serious adverse effects: Sixteen studies (299, 306-314, 316-321) reported on serious 
adverse effects associated with autologous transfusion. None were reported in the 
RCT or in the cohort studies, in either of the groups that received cell salvage or the 
groups that did not. The case series however reported 11 maternal deaths (310, 316, 
317, 319, 321), although 9 of the deaths were specifically stated by the authors as not 
being associated with the transfusion they had received. One death was due to mitral 
stenosis (310), 3 were due to severe irreversible hypovolemic shock (317, 319, 321), 
and  6 deaths were described as unrelated to the autologous transfusion but further 
details were lacking (316). A single death reported by Jongen et al from pulmonary 
oedema was suggested to be associated with autologous transfusion (317), and 
another case series by Laskey et al reported a case of severe pulmonary oedema from 
which the patient recovered (321). 
 
Is cell salvage associated with a shorter hospital stay? 
Seven studies reported on post operative hospital stay (299, 306, 309-311, 315, 319). 
The RCT (223) demonstrated no significant difference between the intervention and the 
 
 
290 
 
control group, in the proportion of participants that had a post operative hospital stay 
greater than 7 days (RR 1.33 95%CI 0.49, 3.59: p=0.57). Eight patients (14.3%) 
receiving cell salvage, and 6 patients (10.7%) receiving donor transfusion experienced 
a hospital stay greater than 7 days (299). One cohort study by Selo-Ojeme et al also 
demonstrated no significant difference with post operative hospital stay greater than 8 
days (RR 0.64 95%CI 0.07, 5.55: p=0.69)(299, 306). One patient (3%) receiving cell 
salvage, and 4 patients (5%) receiving donor transfusion experienced a hospital stay 
greater than 8 days (306), whereas 32 (97%) patients receiving cell salvage, and 81 
(95%) patients receiving homologous transfusion experienced a hospital stay of less 
than 8 days (306) in this study. Five case series reported this outcome, the mean 
duration of hospital stays reported in the studies were 5.6 days, 6.9 days, 8.6 days 
(three centres in one study), 7 days, 7.4 days, 8.5 days and 9.8 days.  
 
10.4 DISCUSSION 
Main findings 
There is a shortage of high quality studies in cell salvage for ectopic pregnancy, with 
only one RCT, but some data was available from developing countries. From this 
limited data it could be suggested that simple cell salvage in ectopic pregnancy could 
be a safe and effective alternative to homologous transfusion. It is however 
acknowledged that no firm inferences can be drawn from the conclusions of this review 
as the data lack sufficient quality and are vulnerable to bias. Attempts have been 
made, where possible to minimise this within our analyses.  Post-operative 
haemoglobin was calculated from autologous transfusion patients only; patients who 
received additional homologous transfusion were excluded from the analysis of this 
outcome to reduce bias in outcome measurement. It is possible that the larger increase 
in haemoglobin and the greater volume of blood received by patients receiving cell 
salvage may be due to performance bias as it is suggested that women were 3 times 
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more likely to have higher post operative haemocrit than women who received 
homologous blood transfusion, as all efforts are made to re-infuse the maximum blood 
possible (223). Comparatively donor blood (homologous) is often given in much smaller 
amounts, particularly in low resources settings, where minimal amounts are given, 
often only enough to sustain the patient’s life (299, 306). 
 
Although the RCT included patients with similar characteristics in both intervention and 
control groups, and had the same criteria for receiving blood transfusion in both groups 
(299), the authors stated that women receiving autologous blood transfusion “were 6 
times more likely to be re- transfused with more than one litre of blood”, thus had a 
greater volume of blood in the autologous group. The increased levels of haemoglobin 
and haemocrit in the autologous group therefore, may be related to the volume of 
autologous blood re-infused, rather than it being due to a more effective method per se. 
The lower volume of blood in the homologous group is likely to be due to a lack of 
availability, as described earlier.   
 
The proportion of minor and major adverse effects reported within the review was 12% 
(67/553), however many were suggested to be related to the moribund or clinical state 
in which the patient presented, rather than the transfusion process (310, 316-319, 321). 
81% of the deaths reported in the studies were reported as not being associated with 
autologous transfusion, although causes of death were not always reported. Serious 
complications are known to be a possible occurrence due to extracellular haemorrhage 
when stale and haemolysed blood is autotransfused (322), yet in acute ruptured 
ectopic pregnancy the intraperitoneal blood remains capable of normal oxygen 
transport (303), therefore associated procedural complications should be minimal. The 
deaths reported within the review were mainly due to irreversible hypovolemic shock 
(317, 319, 321) or pulmonary embolism (317).  A quarter of the cases of pulmonary 
oedema resulted in death (n=1/4), and these cases were thought to be due to rapid 
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transfusion (314). It might be that this could indicate a particular training need with this 
procedure given that levels of expertise were good reported. Post operative infection 
was reported in 13 patients, a further 28 patients (299, 306, 316, 321) were also 
reported as having minor infections associated with the operative procedure. 
Prophylactic antibiotics were given to patients in two studies (308, 311), and there was 
a reduced incidence of infective morbidity in these studies (4% n=9/223) when 
compared to studies that did not administer prophylactic antibiotics (10% n=34/330) 
(299, 306, 307, 309, 310, 312-314, 316-321). 
 
Study Limitations 
The methodological quality of the studies included in the review was poor.  The RCT 
lacked blinding and adequate concealment of treatment allocation. The cohort studies 
did not attempt to address sources of bias or give details on the study limitation, and 
case series studies failed to adequately report the inclusion of consecutive patients, the 
appropriateness of end points and endpoint assessment, as well as the 
appropriateness of follow up. It is acknowledged that the study design of most the 
included studies (case series) are vulnerable to bias and confounding, and that the 
sample size of the studies included were also predominantly small, therefore more 
likely to have insufficient power to detect rarer outcomes. 
 
Although the review included data from both developed and developing countries, 
unlike the method used in caesarean section it is not associated with a high cost or 
training needs. Furthermore its use in developing countries has been demonstrated in 
the studies included in the review. Moreover, as the type of cell salvage is alike in all of 
the included studies the potential for performance bias is reduced.    
 
Existing Research 
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As discussed previously the reduced need for homologous blood transfusion has been 
demonstrated in a Cochrane review (323) in elective adult cardiac and orthopaedic 
surgery with the use of intra-operative cell salvage, but there is no Cochrane review on 
cell salvage in ectopic pregnancy. There has been one literature review published 
recently (270) that examined the safety, efficacy, indications and contraindications of 
cell salvage in both obstetrics and gynaecology, including ruptured ectopic pregnancy. 
This review did not take a systematic approach, the methodology is unclear, and 
studies included were omitted from this review. Furthermore since publication of this 
review three more studies have been published on cell salvage in ectopic pregnancy, 
including one RCT, hence the need for an up to date systematic review. 
 
Practice and policy implications 
Cell salvage could be suggested as a safe and effective intervention to increase 
haemoglobin levels for women with ruptured ectopic pregnancy in the absence of 
reliable and safe homologous blood transfusion system. In the absence of data from 
high quality studies, this review suggests that there seems to be minimal adverse 
effects associated with cell salvage in ectopic pregnancy. The complications that are 
reported as associated with the process of cell salvage could be addressed by 
improving the technique of re-infusion. Pulmonary oedema is often caused by rapid re-
infusion, thus training and policy guidance on the conduct of cell salvage, in particular 
the speed of re-infusion, may reduce this complication. This is also likely to improve 
outcomes associated with infection and bacterial contamination. 
    
It is acknowledged that no firm inferences can be drawn from the conclusions of this 
review for the reasons stated above, yet this remains the best evidence available on 
cell salvage in ectopic pregnancy.  Further primary research of sound quality is needed 
to draw firm inferences on the safety and effectiveness of cell salvage in ectopic 
pregnancy. 
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10.5 CONCLUSION  
It is possible that cell salvage could be suggested as a safe and effective treatment for 
haemorrhage from ruptured ectopic pregnancy in the absence of alternative life saving 
treatment such as a safe, reliable homologous blood transfusion service. Due to the 
low cost and limited training needs and resources associated with the procedure, cell 
salvage would seem to be suitable for use low resource settings based on the current 
available literature. No firm inferences can be drawn from the conclusions of this review 
due to the quality of the data. It is acknowledged that the study design of most of the 
included studies (case series) is vulnerable to bias and confounding.  However despite 
this, this remains the best evidence available on cell salvage in ectopic pregnancy to 
date. Further primary research of sound quality is needed to draw firm inferences on 
the use of cell salvage in ectopic pregnancy in developing countries. 
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Table 31 Characteristics of Included Studies
Population Re-infusion 
criteria  
Intervention Comparison Setting Outcome 
Randomised Controlled Trial 
Selo-Ojeme 2007 
139 women with ruptured ectopic 
pregnancy, Jun 00–May 05. excluded 
if unable to understand trial, sickle 
cell disease or leaking chronic 
ectopic pregnancy.27 excluded not 
met study criteria 
Haemoperiton
eum >500mls 
evidence of 
haemorrhagic 
shock 
56 patients salvage 
auto-transfusion 
 
56 patients 
donor blood 
transfusion 
University 
hospital, 
Nigeria 
preop haemocrit, haemoperitoneum, 
postop haematocrit,  surgery duration, 
death, fever, wound infection, >1lt 
transfused, hospital stay >7days, >0.06 
haematocrit difference between pre-
operative/post operative value  
Cohort Study 
Duncan 1974 
53 patients total: 26 having surgery 
for major injuries, 8 ruptured ectopic 
pregnancy,  19 miscellaneous 
conditions, with potential of blood 
loss > 1000mls May 71-Feb 73 
(45 excluded as cell salvage given 
for major injury or other procedure) 
Significant 
EBL, potential 
for further 
EBL. 
8 patients receiving 
autologous transfusion 
for ruptured ectopic  
no 
comparison 
(with donor 
transfusion 
alone) 
University 
hospital 
Texas 
volume of blood  transfused, additional 
homologous blood, death 
Selo-Ojeme 1997 
123 cases of ruptured ectopic 
Obafemi Awolowo University hospital 
Jan 92–Dec 95 
(5 excluded received both autologous 
and homologous transfusion) 
NR 33 patients received 
autologous blood 
transfusion 
85 patients 
received 
homologous 
blood 
transfusion 
University 
hospital 
Nigeria 
Haemoperitoneum, amount of blood 
transfused, post operative complications, 
duration of hospital stay 
Case Series 
Stabler 1934 
45 cases of tubal gestation, 34 cases of acute rupture 13 patients received autologous 
transfusion 
UK Duration of hospital stay, pre and post op 
Hb, death, haemodynamic condition 
Logan 1948 
40  collapsed patients with ectopic pregnancy  40 patients with ectopic pregnancy 
receiving autologous transfusion 
South 
Africa 
Death, amount of blood collected, 
complications, Hb post op, RBC pre op. 
Bourrell 1960 
2
95
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31 women with ruptured ectopic pregnancy and 
laparotomy 
7 women having intraoperative blood 
salvage and autotransfusion. 2 
required additional postoperative 
autologous blood transfusion. 
Morocco EBL, additional homologous blood, post 
operative hospital stay, volume of blood 
salvaged/re-infused  
 
Klebanoff 1970 
10 patients receiving cell salvage 4 patients with ectopic pregnancy 
having cell salvage 
Texas Volume re-infused, pre/post op Hb, 
duration of hospital stay, death 
Pathak: 1970 
1055 cases ruptured ectopic 1954-1967  530 patients received autologous 
transfusion (168 received only 
autologous blood) 
West Indies Amount of blood transfused, Hb level (no 
breakdown between groups), death, major 
transfusion reactions,  
Maleki 1975 
22 patients with ruptured ectopic pregnancy receiving 
autotransfusion 
results of 4 patients with ruptured 
ectopic reported outcomes 
Iran EBL, amount of blood transfused, Pre op 
Hb, Post op Hb, additional homologous 
blood 
Merrill 1980 
160 patients with ectopic pregnancy 38 patients with ectopic pregnancy 
received autotransfusion 
Texas Death, major complication, amount of 
blood re-infused, additional homologous 
blood 
Laskey 1991 
69 patients with ectopic pregnancy 1988-1989 58 patients with ruptured ectopic 
pregnancy received autotransfusion 
Liberia Death, major and minor complication 
Yamada 1996 
13 patients with ectopic pregnancy 13 patients with ectopic pregnancy 
having laparoscopy 
Japan EBL, amount of blood re-infused, 
additional homologous blood,  
Jongen 1997 
90 women with ectopic pregnancy seen between 1990 
and 1995 
48 women who received autologous 
blood during laparotomy for ectopic 
pregnancy 
Tanzania Additional use of homologous blood, 
death, haemoperitoneum 
Yamada 2003 
18 patients with suspected large haemoperitoneum 
from ectopic pregnancy or ovarian bleeding 
11 patients with ectopic pregnancy 
received autologous blood transfusion 
Japan Adverse reactions to transfusion, EBL, 
amount of blood processed, pre op Hb, 
post op Hb 
Takeda 2006 
2
96
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112 women with ectopic pregnancy between 2000-
2005 treated by laparoscopic surgery 
17 women (15 had ruptured ectopic) 
who had intraoperative cell salvage 
and autotransfusion (using the C.A.T.S 
system and leukocyte reduction filter) 
Japan EBL, amount of re-infused blood, degree 
of haemoperitoneum, post operative 
hospital stay, Hb pre and post op, 
haemodynamic condition 
Priuli 2009 
212 patients from 2 hospitals in Benin with ruptured 
ectopic pregnancy 
212 patients received autologous blood 
transfusion 
 
Benin Haemodynamic condition, volume of 
haemoperitoneum, salvaged blood 
transfused, homologous transfusion, 
haemoglobin levels pre and post op, post 
operative course 
2
97
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 Study 
Year 
 
Pre operative 
haemoglobin  
g/l (SD) 
Volume of blood 
salvaged and re-infused 
(ml) mean and SD or 
median and range 
Estimated blood loss 
median (range) 
Post operative 
haemoglobin 
g/l (SD) 
Randomised controlled trial 
 Intervention Comparison Intervention Comparison Intervention Comparison Intervention Comparison 
Selo-Ojeme 2007 Haemocrit 
0.192 
Haemocrit 
0.204 
>1000ml 34 
(60%) 
>1000ml 11 
(19.6%) 
1750 (430-
3700) 
1580 (380-
3450) 
Haemocrit 
0.287 
Haemocrit 
0.261 
Cohort studies 
Duncan 1974 NR N/A 1306 (584) N/A NR N/A NR N/A 
Selo-Ojeme 1997 NR NR 1420 880 1840 1500 NR NR 
Case series (cell salvage only) 
Stabler 1934 4.8 (0.3) NR NR 6.1 (0.5) 
Logan 1948 NR NR NR NR 
Bourrel1960 NR 1614ml 2000 (1200-2700) NR 
Klebanoff 1970 NR 1825 (471) NR NR 
Pathak 1970 NR 915 (250-3000) NR NR 
Maleki 1975 7 (1.82) 1212 (103) NR 11.8 (0.28) 
Merrill 1980 NR 1300 (450-8500) NR NR 
Laskey 1991 NR NR NR NR 
Yamada 1996 12.2 (1.57) 288 (92) 327 (178) 10.6 (1.28) 
Jongen 1997 NR NR NR NR 
Yamada 2003 11.2 (1.94) 670 (600-2600) 661 (405) 9.4 (1.64) 
Takeda 2006 6.1 (0.9) 1200 (560-2570) 680 (209) 8.4 (1.1) 
Priuli 2009 7.0 (1.8) 1476 (676) 947 (540) 
1238 (386) 
933 (420) 590 (344) 
850 (255) 
8.3 (1.8) 
Table 32 part a: Data of outcomes reported in the included studies (haemoglobin, estimated blood loss,volume of blood salvaged)  
2
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Study 
Year 
 
homologous blood 
product use 
Post operative hospital 
stay as stated % or mean 
number of days (SD) 
Infectious morbidity  
 
Serious adverse effects 
 
Randomised controlled trial 
 Intervention Comparison Intervention Comparison Intervention Comparison Intervention Comparison 
Selo-Ojeme 2007 NR NR >7 days: 8 
(14.3%) 
>7 days: 6 
(10.7%) 
20 fever 
(35.7%) 3 
wound 
infection 
(5.3%) 
21 fever 
(37.5%) 4 
wound 
infection 
(7.1%) 
None None 
Cohort studies 
Duncan 1974 4 (50%) N/A NR N/A NR N/A None N/A 
Selo-Ojeme 1997 NR NR <8 days: 32 
(97%) 
>8 days 1 
(3%) 
<8 days 81 
(95%) >8 
days:4(5%) 
6 fever 
(18%) 
1wound 
infection 
(5%) 
18 fever 
(21%)  
2 wound 
infection 
(7%) 
None None 
Case series (cell salvage only) 
Stabler 1934 NR 8.5 (1.56) NR 1 death (not transfusion 
related) 
Logan 1948 NR NR NR 2 cases ileus, 1 case 
jaundice 
Bourrel 1960 NR 9.8 (8-14) NR NR 
Klebanoff 1970 NR 7 (0) NR 1 death (shock) 
Pathak 1970 NR NR 1 fever 1 hypotension, 6 deaths 
(not transfusion related) 
Maleki 1975 1 (25%) NR NR None 
Merrill 1980 21 (55%) NR NR 2 pulmonary oedema, 2 
post operative wound 
infections (not transfusion 
linked) 2clinical 
coagulopathy 
Laskey 1991 NR NR NR 1 death, 1 wound infection 
(not transfusion linked), 1 
pulmonary oedema (due to 
Table 33 part b: Data of outcomes reported in the included studies (use of homologous blood, post operative stay, infectious morbidity and serious adverse events)  
2
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rapid re-infusion) 
Yamada  1996 None NR NR None 
Jongen 1997 NR NR NR 2 deaths (shock and 
pulmonary embolism) 
Yamada 2003 None NR NR None 
Takeda 2006 None 7.4 (6.2) NR None 
Priuli 2009 22 (10%) 8.6(3) 6.9(7.3) 5.6(0.5) 
 
9 (4.2%) None 
3
00
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Table 34 Quality Assessment: reporting checklist of RCT  
(Y = Reported: N = Not Reported) 
Topic Consort checklist  
Selo-ojeme 2007 
Title and abstract 
 Identification as RCT  in title N 
Structured summary of trial design, methods, results, conclusions N 
Introduction 
Background 
objectives 
Scientific background, explanation of rationale Y 
Specific objectives or hypotheses Y 
Methods 
Trial design Description of trial design, allocation ratio Y 
Important changes to methods after trial commencement , with reasons N 
Participants Eligibility criteria for participants Y 
Settings and locations where data were collected Y 
Interventions The interventions for each group with sufficient details to allow replication, how, 
when actually administered 
Y 
Outcomes Completely defined pre-specified primary and secondary outcome measures, how 
and when assessed 
Y 
Any changes to trial outcomes after commenced, reasons N 
Sample size How sample size determined Y 
When applicable, explanation of any interim analyses, stopping guidelines N/A 
Randomisation 
Sequence 
generation 
Method used to generate random allocation sequence Y 
Type of randomisation; details of restriction Y 
Allocation 
concealment  
mechanism 
Mechanism  to implement random allocation sequence, describing steps taken to 
conceal sequence until interventions assigned 
N 
Implementation Who generated the random allocation sequence, who enrolled participants, and who 
assigned participants to interventions 
Y 
Blinding who blinded after assignment to interventions and how N 
If relevant, description of the similarity of interventions N/A 
Statistical 
methods 
Statistical methods used to compare groups for primary and secondary outcomes Y 
Methods for additional analyses, such as subgroup analyses and adjusted analyses N 
Results 
Participant flow  For each group, numbers of participants who randomly assigned, received intended 
treatment, were analysed for primary outcome 
Y 
For each group, losses and exclusions after randomisation, with reasons Y 
Recruitment Dates defining periods of recruitment and follow-up N 
Why the trial ended or was stopped N 
Baseline data A table showing baseline demographic and clinical characteristics for each group Y 
Numbers 
analysed 
number of participants included in each analysis and whether the analysis by 
original assigned groups 
Y 
Outcomes and 
estimation 
primary and secondary outcome, results for each group, estimated effect size and 
precision  
Y 
binary outcomes, presentation of both absolute and relative effect sizes is 
recommended 
Y 
Ancillary analyses Results of any other analyses performed, including subgroup analyses and adjusted 
analyses, distinguishing pre-specified from exploratory 
N 
Harms All important harms or unintended effects in each group  N 
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Discussion 
Limitations Trial limitations, addressing sources of potential bias, imprecision, multiplicity of 
analyses 
Y 
Generalisability Generalisability (external validity, applicability) of the trial findings Y 
Interpretation 
 
Interpretation consistent with results, balancing benefits and harms, considering 
other relevant evidence 
Y 
Other information 
Registration 
 
Registration number and name of trial registry 
 
N 
Protocol 
 
full trial protocol can be accessed, if available 
 
N 
Funding 
 
Sources of funding and other support (such as supply of drugs), role of funders 
 
N 
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Table 35 Quality Assessment: reporting checklist of cohort studies (Y = Reported: N = Not 
Reported) 
 
 
  STROBE Checklist Duncan 1974 Selo-Ojeme 1997 
Title and abstract 
Design N N 
Summary Y Y 
Introduction 
Background Y Y 
Objectives N N 
   
Methods 
Study design N Y 
Setting Y Y 
Participants Y N 
Variables N N 
Data sources N Y 
Bias N N 
Study size N N 
Quantitative variables Y N 
Statistical methods N N 
Results 
Participants Y Y 
Descriptive data N N 
Outcome data Y Y 
Main results Y Y 
Other analysis N N 
Discussion 
Key results Y Y 
Limitation N N 
Interpretation Y Y 
Generalisability Y N 
Other information 
Funding N N 
2
3
3
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Table 36 Quality Assessment: reporting checklist of case series (Y = Reported: N = Not Reported) 
Minors checklist 
Aim Stabler 
1934 
Logan  
1948 
Bourrell 
1960 
Klebanof 
1970 
Pathak 
1970 
Maleki 
1975 
Merrill 
1980 
Laskey 
1991 
Yamada 
1996 
Jongen 
1997 
Yamada 
2003 
Takeda 
2006 
Priuli 
2009 
Aim 1 1 1 2 2 2 1 1 2 2 2 2 1 
Inclusion of 
patients 
0 0 0 0 1 1 1 1 1 1 1 1 1 
Prospective data 
collection 
0 0 0 0 0 2 1 0 1 0 1 0 2 
Appropriate end 
points 
0 0 0 0 1 2 1 0 1 1 1 0 1 
Unbiased end 
point  
0 0 0 0 0 1 1 0 1 1 1 1 1 
Appropriate 
follow up 
0 0 0 1 1 1 1 1 1 1 1 1 1 
Loss of follow up 
<5% 
0 1 0 2 1 0 2 0 2 1 2 2 2 
Prospective 
study size 
calculation 
0 0 0 0 0 0 0 0 0 0 0 0 0 
Adequate control 
group 
- 
 
- - - - - - - - - - - - 
Contemporary 
groups 
- - - - - - - - - - - - - 
Baseline 
equivalence 
- - - - - - - - - - - - - 
Statistical  
analysis 
- - - - - - - - - - - - - 
3
04
 
 
 
305 
 
Table 37 Risk of Bias (Y = Reported: N = Not Reported) 
 
Random sequence 
generation 
Allocation 
concealment 
Blinding of 
participants and 
personnel 
Blinding of 
outcome 
assessment 
Incomplete 
outcome data 
Selective 
reporting 
Other bias 
Selo-Ojeme: 2007 
LOW: Page 109: 
Computer 
generated random 
sequence 
LOW: Page 
109:Sealed 
serially 
numbered 
envelopes 
UNCLEAR: 
No details 
provided 
UNCLEAR: No 
details provided 
LOW: Page 109: All 
patients outcomes 
reported, no loss to 
follow up 
LOW: Page 109 
table 2: All 
outcomes 
reported on 
LOW: No other bias 
Selection Comparability Outcome 
Representativeness Selection of 
comparison 
Ascertainment 
of exposure 
Demonstration of 
outcomes 
Comparability (2 
points available) 
Outcome 
assessment 
Follow up 
length 
Adequacy of 
follow up 
Duncan 1973 
Y N N Y N N Y N 
Selo-Ojeme 1997 
Y Y Y Y Y Y Y Y 
  
3
05
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CHAPTER 11: SYMPHYSIOTOMY FOR OBSTRUCTED 
LABOUR IN DEVELOPING COUNTRIES: A SYSTEMATIC 
REVIEW AND META-ANALYSIS  
 
ABSTRACT 
 
Background: Obstructed labour is a major cause of maternal mortality. Caesarean 
section is advocated to reduce mortality and morbidity associated with obstructed 
labour, but caesarean section in developing countries can be associated with many 
risks and it is not always readily available. In sub-Saharan Africa only 0.5% of all 
women requiring a caesarean section receive the operation that they need. 
Symphysiotomy can be an alternative treatment for obstructed labour; it requires fewer 
resources and does not require specialist surgical skills. Although some research has 
suggested it compares favourably to caesarean section in developing countries, there 
is much scepticism around this procedure.  The outcomes of symphysiotomy for 
obstructed labour compared to caesarean section in low to middle income countries 
have therefore been systematically reviewed and meta-analysed 
Methods: Systematic review with meta-analysis. MEDLINE, EMBASE, Cochrane 
library, CINAHL, African Index Medicus, the Reproductive Health Library, and the 
Science Citation Index (inception- January 2013) were searched without language 
restriction. Cohort studies comparing symphysiotomy and caesarean section (as the 
controls) were selected, with the outcomes of maternal mortality and morbidity and 
perinatal and neonatal mortality. Relative risks (RR) from the individual studies were 
pooled using random effects model. 
Results: No RCTs and Six cohort studies (1015 women) comparing symphysiotomy 
and caesarean section for obstructed labour in developing countries were included.  
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There was no significant difference in maternal mortality with symphysiotomy when 
compared to caesarean section (RR 0.48 95%CI 0.13, 1.76; p=0.76), and no significant 
difference in perinatal mortality when compared to caesarean section (RR 1.13 95%CI 
0.52,2.43 p=0.76) , even though the number of events were very low. Incontinence and 
fistulae were both more likely with symphysiotomy than caesarean section (RR 11.76 
95%CI 3.43, 40.27; p=<0.001 and RR 7.15 95%CI 1.25, 41.17; p=0.003), however 
haemorrhage and infection were less likely with symphysiotomy when compared to 
caesarean section (RR 0.36 95%CI 0.20,0.60; p=0.001 and RR 0.25 95%CI 0.07, 0.92; 
p=0.04). Scar pain was the only long term outcome where there was a difference 
between the two groups (p=<0.001), and was more prevalent with caesarean section.  
Conclusion: It could be suggested that symphysiotomy could be a safe alternative to 
caesarean section in areas where resources are limited or greater risks are involved. 
Haemorrhage and infection are two leading causes of maternal mortality, both of which 
are reduced with symphysiotomy, however limited data with very few events reported 
on this analysis.  
 
11.1 BACKGROUND 
Several interventions have been implemented with the aim of reducing maternal 
mortality, however limited healthcare resources and availability of skilled personnel 
severely hinder improvements in this.  The WHO states that women should have 
access to comprehensive obstetric care facilities where treatments such as blood 
transfusion and caesarean section can be performed. The recommended caesarean 
section rate suggested by WHO is between 5%-15%, yet this data originates from 1985 
(324), and is not targeted at developing countries specifically. Therefore the ideal major 
obstetric intervention rate (e.g. caesarean section) necessary to avoid maternal 
mortality and severe morbidity today in developing countries is unknown (325).   
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Caesarean section is suggested to be the most common major operation performed to 
save a mother’s life, yet in Sub-Saharan Africa very few women receive the caesarean 
section they need (326): this is suggested to be low as 0.5% in some countries, of the 
total women requiring caesarean section (327). Comparatively, it is suggested by some 
that the caesarean section rate is too high in some hospitals, and in need of reduction, 
especially as the safety of the procedure in developing countries is not comparable to 
that of developed countries. Caesarean section can be associated with severe 
morbidity and mortality, despite being performed under the safest conditions (328). In 
addition to this the consequences of a scarred uterus from caesarean section on 
subsequent pregnancies can be catastrophic, particularly if appropriate obstetric care is 
not sought or available 
 
Symphysiotomy can be performed as an alternative to reduce the morbidity and 
mortality associated with obstructed labour, but unlike caesarean section it does not 
require special surgical skills and can be carried out by a midwife trained in this 
technique (329). Symphysiotomy is the artificial separation of the symphysis pubis with 
a surgical instrument, usually a scalpel to enlarge the pelvic diameter, to facilitate the 
birthing process in cases of obstructed labour (Figure 39). This is normally performed 
under local anaesthetic by a midwife, doctor or clinical officer, and requires minimal 
equipment (scalpel, urinary catheter, gloves and local anaesthetic). Symphysiotomy 
can widen the symphysis by up to 2.5cm (330). Aftercare usually consists of elastic 
strapping across the front of the pelvis for stability and pain reduction, and knees are 
usually strapped with bandages in a figure of eight. Bed rest is advised for three to five 
days, with increasing mobility advocated after five days, bladder catheterisation is also 
advised for five days (330, 331) 
 
In high income countries caesarean section is used to reduce morbidity and mortality 
from obstructed labour (332), yet in low income countries where obstructed labour is 
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more prevalent due to early age pregnancy, malnutrition, skeletal stunting and pelvic 
immaturity, caesarean section may not be available, or it may carry added risks. 
Caesarean section may also not be a culturally viable option in some regions, as 
vaginal delivery is deemed the sanctification of womanhood, even if it is made possible 
by symphysiotomy (333).  
 
Symphysiotomy is not without risk, yet the benefits and risks of each operative 
procedure should be outweighed for the patient and the particular setting. Previous 
research has suggested that symphysiotomy compares favourably with caesarean 
section in terms of risk for the mother’s life (334), yet there remains much scepticism 
around this practice (335). Further research has been conducted since the latest 
review (336) (330), there is now more comparative data from cohort studies available, 
hence the need for an updated systematic review to assess the evidence on this 
practice.  
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Figure 49 Symphysiotomy: The artificial separation of the symphysis pubis with a scalpel to enlarge the 
pelvic diameter to facilitate the process of birth. 
 
11.2 METHODS 
Data sources and searches 
Databases were searched for studies comparing symphysiotomy and caesarean 
section (as controls) for obstructed labour in developing countries. Following the 
hierarchy of evidence, the best available evidence was included in the review. 
PUBMED, EMBASE, Cochrane library, CINAHL, African Index Medicus, the 
Reproductive Health Library, and the Science Citation Index were searched (from 
database inception to January 2013). Hand searching complemented electronic 
searches, and reference lists were checked. The search terms were ‘symphysiotomy’.  
No language restrictions were applied to the search. 
 
Dividing the cartlidge 
with a scalpel 
Catheter inserted 
into the bladder  
Finger inserted into 
the vagina to move 
the urethra from 
the path of the 
scalpel 
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Study selection and data extraction 
In the absence of RCTs, cohort studies comparing symphysiotomy and caesarean 
section (as the controls) for obstructed labour in developing countries were selected 
following the hierarchy of evidence.  Lower levels of evidence were not included in this 
review, the author and another reviewer aimed to reduce methodological heterogeneity 
by including the available cohort studies. Initially the electronic searches were 
scrutinised and full manuscripts of relevant studies were acquired. Final decisions on 
inclusion or exclusion of manuscripts were made after inspection of these manuscripts 
by the author and another reviewer (AW and ET). Information was extracted from each 
article on study characteristics, study quality and outcome data by the author and 
another reviewer (AW, ET).  The outcomes of interest were maternal and perinatal 
mortality, fistulae, infection, haemorrhage, pyrexia and incontinence in symphysiotomy 
and caesarean section.  
 
Methodological quality assessment 
The cohort studies were assessed for adequacy of reporting using the STROBE 
checklist (69). Risk of bias in the studies was assessed using the Newcastle Ottawa 
Scale (71). The studies were evaluated for representativeness of the cohorts of 
symphysiotomy and caesarean section, selection of the cohorts, ascertainment of the 
intervention and the outcome, comparability of the cohorts, as well as the length and 
adequacy of follow-up. The risk of bias was deemed low if a study obtained four stars 
for selection, two stars for comparability and three stars for ascertainment of exposure 
(71). Medium risk of bias was suggested to exist in studies with two or three stars for 
selection, one for comparability and two for exposure. Any study scoring one or zero 
stars for selection, comparability or exposure was classed as having high risk of bias.  
 
Statistical Analysis 
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Data for effect estimates (Risk Ratios) and corresponding 95% confidence interval 
were extracted. Effect estimates and their 95% CI were then meta-analysed using the 
generic inverse-variance method using a random effect model to account for the 
variability in the setting and clinical indication of the caesarean section or 
symphysiotomy of the women included. Heterogeneity of treatment effects was 
evaluated using forest plots, chi square tests and its magnitude determined by 
computing I2 statistic. Analyses were performed using REVMAN 5.0 statistical software.  
 
11.3 RESULTS 
Six cohort studies set in developing countries were included in the review, 2 
prospective comparative cohort studies with consecutive participant inclusion (330, 
331), and 4 retrospective cohort studies (336-339). The process of literature search 
and selection is given in Figure 40. A total of 1015 women were included in our review, 
365 cases (woman who had symphysiotomies) and 650 controls (women who had 
caesarean section). All studies compared the outcomes of symphysiotomy and 
caesarean section. Study characteristics are shown in Table 32, and the data of the 
outcomes reported in the studies is provided in Table 33.  
 
Study characteristics 
All six cohort studies included in the review compared symphysiotomy and caesarean 
section for obstructed labour, and were set in developing countries; Nigeria, Papua 
New Guinea (2 studies), Tanzania, India and Zimbabwe. The earliest study included by 
Hartfield et al was conducted between 1961 and 1969 and set in Nigeria (331), 
however the most recent study by Basak et al was conducted between 2005 and 2006 
and set in India (330). Both of these studies by Hartfield et al and Basak et al were 
conducted prospectively and included all women that presented at the labour ward 
during the study period, during any time of the day. Three studies did not provide any 
details on the manner in which participants were selected (337-339). All studies 
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reported similar selection criteria for patients, for example women presenting on labour 
ward with features of obstructed labour due to cephalopelvic disproportion. Similar 
patient characteristics were reported in the group that received symphysiotomy and 
caesarean section in the study by Hartfield et al (331). In the study by Mola et al no 
significant difference in parity or length of first or second stage of labour between the 
two groups was reported (339), however in the other study by Mola et al significantly 
more primigravid participants were reported in the symphysiotomy group (338). The 
study by van Roosmalen et al reported a lower maternal height in the symphysiotomy 
group when compared to the caesarean section group (337). Only one study (by Mola 
et al) reported the inclusion of women with breech presenting fetuses (338), whereas 
the studies by Basak et al, van Roosmalen et al and Mola et al included vertex 
presentation only (330, 337, 339). The presentation of the fetus was not reported in the 
studies by Hartfield et al and Ersdal et al (331, 336). In the studies by Basak et al and 
Ersdal et al, women with musco-skeletal disorders were excluded (330, 336). Basak et 
al and Mola et al also excluded women with severe obesity or a macrosomic fetus 
(>4kg)(330) (338). Mola et al and van Roosmalen et al excluded pregnant women with 
a dead fetus (337, 338). All studies reported on maternal mortality and neonatal or 
perinatal mortality, fistula, incontinence, haemorrhage and infection were other 
commonly reported outcomes. 
 
Study quality 
The studies achieved scores of between 8 to 16 out of 22 on the strobe checklist, 
details were lacking on study design, study size, bias, data sources, variables, 
statistical methods, participants, descriptive data, study limitations and funding (Table 
35).  The studies were deemed to have low risk of bias for selection, medium to low 
risk of bias for comparability, and medium to low risk of bias for outcome on the 
Newcastle Ottawa Scale (Table 36). 
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Figure 50 Study selection process in studies included in the review  
Total citations identified from electronic searches n=608
Total citations identified from reference lists or hand searching n=7
Citations excluded after screening title and/or abstracts: n =554
Primary articles fulfilling inclusion criteria for systematic review n=6
Articles excluded after review of full text with reasons
Incorrect study design n = 24
Inappropriate outcome n = 2
Unable to obtain n=4
Incorrect intervention n = 2
Duplication n=1
Total excluded n =55
Full manuscripts retrieved for detailed evaluation: n =61 
Figure 1. Study selection process in the systematic review of symoh
3
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Maternal Mortality 
Five cohort studies (two prospective and three retrospective) (952 women) reported on 
maternal mortality (330, 331, 337-339). Meta-analysis demonstrated no significant 
difference in maternal death with symphysiotomy when compared to caesarean section 
(RR 0.48 95%CI 0.13, 1.76 p=0.27: Figure 41), however this was only based on 14 
events. There was no evidence of heterogeneity in the analysis (I2= 0% p=0.81). 
 
Perinatal Mortality 
Four cohort studies (one prospective and three retrospective) (877 women) reported on 
perinatal mortality (331, 337-339). Meta-analysis demonstrated no significant difference 
in perinatal mortality with symphysiotomy when compared to caesarean section (RR 
1.13 95%CI 0.52, 2.43 p=0.76: Figure 42), and was based on over 100 events. There 
was moderate heterogeneity in the analysis (I2=65% p=0.04). 
 
Fistulae 
Two cohort studies (553 women) reported on this outcome (331, 338), meta-analysis 
demonstrated an increase in fistulae with symphysiotomy when compared to 
caesarean section (RR 7.15 95%CI 1.25, 41.17 p=0.03: Figure 43, however this was 
based on 8 events. There was no evidence of heterogeneity in the analysis (I2=0% 
p=0.38), although data reporting on this outcome was limited. 
 
Haemorrhage 
Two cohort studies (418 women) reported on haemorrhage (330, 331). Meta-analysis 
demonstrated less cases of haemorrhage with symphysiotomy when compared to 
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caesarean section (RR 0.36 95%CI 0.20, 0.66;p=0.001: Figure 44). There was no 
evidence of heterogeneity in this analysis (I2=0% p=0.57), although data reporting on 
this outcome was limited.  
 
Infection 
Three cohort studies (588 women) reported on infection (330, 338, 339). Meta-analysis 
demonstrated less infection with symphysiotomy when compared to caesarean section 
(RR 0.25 95%CI 0.07, 0.92 p=0.04: Figure 45). There was high heterogeneity in the 
analysis (I2=74% p=0.02) and data reporting on this outcome was limited. Limited 
information was provided on the infective complications experienced, the study by Mola 
et al reported this outcome as wound or genital tract infections without any further 
description (338), this was also the case for the caesarean section group in the study 
by Basak et al (330), yet more information was provided on the infectious complications 
experienced in the symphysiotomy group, where a case of vulval cellulitis is reported. 
The other study by Mola et al reported wound infections needing drainage or resuturing 
(339), again no further details were given. 
 
Pyrexia 
Two cohort studies (418 women) reported on this outcome (330, 331), meta-analysis 
demonstrated no significant difference with symphysiotomy when compared to 
caesarean section (RR 0.75 95%CI 0.43, 1.31 p=0.32: Figure 46. There was moderate 
heterogeneity in the analysis, although this was not significant (I2=55% p=0.15), again 
data reporting on this outcome was limited.  
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Incontinence 
Three cohort studies (723 women) reported on incontinence (331, 338, 339). Meta-
analysis demonstrated more cases of incontinence with symphysiotomy when 
compared to caesarean section (RR 11.76 95%CI 3.43, 40.27 p=<0.0001: Figure 47), 
although this was only based on 19 events. There was no evidence of heterogeneity in 
the analysis (I2=0% p=0.96). No data was provided for baseline prevalence of urinary 
incontinence in any of the studies, and varying descriptions but no definitions were 
given in the included studies for this outcome. These included stress incontinence and 
stress incontinence needing operation treatment. 
 
Long-term follow up 
Two cohort studies compared the long-term outcomes of symphysiotomy and 
caesarean section (Table 34) (331, 336). One study by Hartfield et al reported 
outcomes between 20 months and 10 years (331), and the other (by Ersdal et al) 
reported outcomes up to 15 years. The mean reported outcome follow up time was 4 
years for symphysiotomy and 2.9 years for caesarean section  (336). Long term 
outcomes for pain when walking (12 events (8/34 vs 4/29), dancing (3 events (1/34 vs. 
2/29), jumping (5 events (3/34 vs. 2/29) and carrying (5 events (3/34 vs. 2/29) showed 
no significant difference between the groups in the study by Ersdal et al (336). Scar 
pain however was more likely (p<0.001) in the caesarean section group (51.7%) when 
compared to the symphysiotomy group (2.9%). There were also no differences 
between the groups for dyspareunia (15 events (10/34 vs 5/29), infertility (2 events 
(0/34 vs 2/29) or incontinence (6 events) 3/95 vs 3/77). The study by Hartfield et al also 
reported no significant difference between symphysiotomy and caesarean section for 
sub-fertility (8 events (4/61 vs 4/48), scanty, irregular or painful menstrual cycle (10 
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events (3/61 vs 7/48), incontinence, backache, leg pain, abdominal pain or muscle pain 
(331). Limited data reported on long term outcomes with a sample size of 172 women. 
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Figure 51 Maternal Mortality in symphysiotomy and caesarean section 
3
19
 
 
 
320 
 
 
Figure 52 Perinatal Mortality in symphysiotomy and caesarean section 
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Figure 53 Fistulae in symphysiotomy and caesarean section 
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Figure 54 Haemorrhage in symphysiotomy and caesarean section 
3
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Figure 55 Infection in symphysiotomy and caesarean section 
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 Figure 56 Pyrexia in symphysiotomy and caesarean section 
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Figure 57 Incontinence in symphysiotomy and caesarean section 
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11.4 DISCUSSION  
Findings 
There was no significant difference for maternal mortality with symphysiotomy when 
compared to caesarean section, this however was only based on 14 events, with 2 in 
the symphysiotomy group and 12 in the caesarean section group. There is also no 
significant difference in perinatal mortality when symphysiotomy is compared with 
caesarean section (37 vs. 66 events). There are less cases of fistulae and incontinence 
with caesarean section compared to symphysiotomy (7 vs. 1 and 17 vs. 2), and 
haemorrhage (12 vs. 46), infection (14 vs. 102) and pyrexia (85 vs. 111) were less 
frequent with symphysiotomy when compared to caesarean section, although again 
most of these inferences are based on a small number of events in most of the 
analyses.  
 
Limitations 
The main limitation of this review was the potential selection bias due to the lack of 
control (i.e. blinding) in the study design. For example women undergoing 
symphysiotomy may be of lower educational status and from a lower socioeconomic 
class, thus may prefer this operative procedure due to the lower associated cost and 
cultural implications with caesarean section. If this group of women were living in 
poverty their health may also be compromised by malnutrition, anaemia and other 
conditions (such as malaria, HIV, TB). Moreover symphysiotomy is often reserved for 
‘extreme cases’ of obstructed labour, for example when a patient is too ill for the 
clinician to safely perform a caesarean section, this often occurs in cases where 
women have experienced significant delays in seeking and receiving treatment. It is 
possible that these factors could bias outcomes in favour of caesarean section rather 
than symphysiotomy.  
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None of the included studies adjusted for confounding factors, such as those given 
above, or the duration of labour, delay in receiving treatment, or the cadre and 
experience of operator. The small sample size of the included studies was an 
additional limitation, thus most inferences were based on limited numbers of events. 
Although there was no significant difference in maternal mortality with symphysiotomy 
when compared to caesarean section, most maternal deaths in the symphysiotomy 
group (331, 337) were due to pre-eclampsia, rather than complications associated with 
the operative procedure.  Whereas deaths from caesarean were due to complications 
associated with the procedure, such as haemorrhage and infection. The retrospective 
design of the majority of the cohort studies is also another limitation, as only two were 
prospective studies. 
 
 
There was no significant difference in perinatal mortality, although there were slightly 
fewer perinatal deaths with caesarean section, however this could be biased in favour 
of caesarean section, as symphysiotomy is normally reserved for extreme cases, often 
complicated by severe fetal distress. It can also be argued that the skill and experience 
of clinicians to accurately diagnose the degree of cephalopelvic disproportion, and the 
correct timing of the treatment (symphysiotomy or caesarean section), could be 
reflected in the perinatal outcome.  As symphysiotomy is a less common procedure, 
the lack of experience may reflect the slightly higher incidence of perinatal deaths 
(331). Thus as the experience of the operator increased the results of the operation 
may have been improved (338). Furthermore, one of the indications for symphysiotomy 
in some studies were failed trial of vacuum or forceps, this may further add to the 
higher rates of perinatal mortality (337). 
 
A further limitation could be the disparity in the measurement of the subjective 
outcomes reported on such as pain. This limitation may also apply to incontinence and 
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pyrexia as studies reporting this outcome do not give the definition that was used for 
this outcome therefore it may vary from study to study. There is therefore a possibility 
that measurement bias maybe present in this analysis. Selection bias may also be 
present within the studies as none were blinded, although the baseline characteristics 
reported  shown little difference between the two groups, it is likely that experience and 
opinion of operating clinician may affect participant selection (336), as may parity and 
maternal age (336, 338) or financial capability to pay for the procedure (330)  
 
Moreover, some outcomes such as incontinence may occur over time with or without 
symphysiotomy or caesarean section. None of the studies within the review provide 
information on the prevalence on incontinence within the population studied, nor do 
they state if this outcome was present prior to the symphysiotomy or caesarean 
section. As research has suggested that the incidence of incontinence in young women 
is 12.8%, and increases to 46% for women aged 50-60 years(340), the association with 
symphysiotomy or caesarean section and incontinence is therefore questionable. 
 
Existing research 
A Cochrane review has been published (341), yet in the absence of randomised data, 
no trials were included within this review thus the authors’ concluded that research was 
needed to provide robust evidence of the effectiveness and safety of symphysiotomy 
compared caesarean section in clinical situations in which the relative risks and 
benefits are uncertain. However a systematic review (334) including retrospective case 
series that were published between 1990-1999, concluded that with training, 
symphysiotomy poses no greater risks and compares favourably with caesarean 
section, in terms of risk for the mother’s life. Symphysiotomy is also less complex and 
less expensive than caesarean section. A retrospective review of operative deliveries 
over ten year period (1986-1995) in Nigeria (342) that included 1719 caesarean 
sections and 1091 symphysiotomies suggested that the practice of symphysiotomy 
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reduced the caesarean section rate, and may prevent many cases of maternal mortality 
and morbidity from operative deliveries in subsequent pregnancies. The maternal and 
perinatal outcomes of symphysiotomy however were not reported, they also did not 
compare them to caesarean section, therefore this study was not included within the 
review.   
 
Policy and practice implication  
Obstructed labour remains a leading cause of maternal mortality, and although 
caesarean section is advocated to reduce morbidity and mortality from obstructed 
labour (332), there are many associated risks with caesarean section in developing 
countries, not only for the current pregnancy but for the woman’s future reproductive 
health. Caesarean section scares the uterus and puts it at risk of rupture in future 
pregnancies. In areas where resources are limited and lengthy transfers between 
health centres are common, greater risks are associated with caesarean section, thus 
reinforcing preference for symphysiotomy. 
 
In countries where mortality from caesarean section is low, such as developed 
countries with current standards of obstetric care, symphysiotomy is obsolete as it is 
deemed an ‘old operation’ that was practiced before caesarean section became 
‘respectable’ (343). Even at the peak of the procedures popularity, it is suggested that 
symphysiotomy was not widely used in Britain and North America (344). There are 
known associated short and long term complications with both symphysiotomy and 
caesarean section such as urinary incontinence and pyrexia  (345), and our analysis 
albeit from limited data suggests that incontinence might be greater with caesarean 
section. However the complications that are responsible for a large proportion of 
maternal deaths (haemorrhage and infection) are suggested to be lower with 
symphysiotomy when compared to caesarean section in our meta-analysis. 
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Although neither procedure is without risk it is suggested that there is an important 
barrier for symphysiotomy in the mind of the obstetrician (346), and is generally 
influenced by their perceptions and experience with the procedure. It is however 
essential to weigh up the risks and benefits of each procedure, in line with the setting, 
the population and the resources available, and the patients reproductive history and 
future. The method of delivery chosen should incur the least likelihood of present or 
future maternal or fetal compromise.  
 
Unanswered questions and future research 
Further primary research of sound quality is needed to draw firm inferences on the 
safety of symphysiotomy for obstructed labour. The outcomes should be compared to 
the outcomes of caesarean section in developing countries. The appropriateness and 
ethical grounds of using an RCT to answer this question is debatable. This is because 
caesarean section is one of the most common surgical procedures performed 
worldwide and has good data on the benefits and risks associated with the procedure 
(347). Caesarean section is generally associated with a low complication rate (348); yet 
like many surgical procedures, this rate can fluctuate with the skill of the operator, the 
reason for the procedure, the clinical environment and any existing co-morbidities or 
complications (347), thus the complication rate may differ significantly between 
developed and developing countries. A comparable body of evidence however, is not 
available for the risks and benefits associated with symphysiotomy (341), and it is a 
much less common procedure. Unlike caesarean section given that there is limited 
data available on the safety and complications associated with this procedure, it would 
not be possible to fully inform participants of the risks associated with both 
interventions (i.e. caesarean section and symphysiotomy), in the setting of a RCT. 
Furthermore, in a facility setting where both options were feasible in terms of 
equipment and staff training it is likely to be difficult to persuade the operator that both 
are equally safe. In the community setting, from a practical and organisational point of 
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view an RCT would be difficult. Therefore an RCT would not be ethical or practical 
instead a well conducted, well reported large cohort study could be a more ethically 
sound approach. 
 
11.5 CONCLUSION 
Obstructed labour remains a leading cause of maternal mortality. In areas where 
caesarean section is unavailable or in areas where resources are limited, greater risks 
can be associated with caesarean section, or when transferring a woman from one 
facility to another for a caesarean section. Although the inferences made are on the 
limited data available from both prospective and retrospective cohort studies, at risk of 
selection and measurement bias, our analysis suggests that symphysiotomy could be a 
favourable and appropriate alternative. Haemorrhage and infection are common 
causes of maternal mortality, and from our analysis of limited data (58 and 116 events 
respectively) these appear to be lower in the symphysiotomy group compared to 
caesarean section. Long term complaints of patients who underwent symphysiotomy 
reported similar complaints to those that underwent caesarean section, although scar 
pain was significantly less frequently reported with symphysiotomy.  In summary, 
symphysiotomy may be useful in certain situation where caesarean section is too risky 
or unavailable. However no real conclusions can be made from the data available in 
this review.  
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Table 38 Characteristics of studies included in the review, comparing the outcomes of symphysiotomy and caesarean section 
 
Study Study population and selection Symphysiotomy Caesarean Section Outcome 
Hartfield 
1973  
Nigeria, 1961-1969. Aged 16 to 45.  
Moderate - severe CPD, half patients 
laboured >24 hours.  
Consecutive patients having 
symphysiotomy and C/S matched,  
No other details provided on selection 
(n=105) Symphysiotomy immediately prior 
to delivery combined with episiotomy.  
80% performed by lead obstetrician. 
Performed under local anaesthetic.  
After care: Bed rest for 8 -10 days, 
encouraged to lie on side, reduced 3-5 
days later in study. 
(n=105) C/S.  
80% performed by 
lead obstetrician  
8 C/S under local 
anaesthetic 
MMR and PMR, major 
maternal complications. 
Symptoms at 6 weeks 
follow up, complications at 
long-term follow up (20 
months – 10 years). Mean 
number of days in hospital, 
temperature >38.0
o
C, blood 
transfusion rate. 
Mola 
1981  
Papua New Guinea 1974 -1980,  
CPD 
Majority of women primigravid and had 
supervised labours.  
Retrospective study consecutive inclusion 
of women  
No further details are provided. 
(n=85) Symphysiotomy using the Seedat 
and Crichton method immediately prior to 
delivery combined with episiotomy.  
After care: catheter drainage of bladder for 
24 hours, up to 10 days if blood stained 
and antibiotics. Analgesia and bed rest in 
lateral position, knees loosely bound for 12 
hours. Movement encouraged after 12 
hours and to ambulate after 48 hours. 
Discharged when ambulant, avoid undue 
exercise for 6 weeks. 
(n=258) C/S late in 
labour  
MMR, PMR, fistula, UTI, 
incontinence, haematoma, 
osteitis pubis, paralytic 
ileus, wound or genital tract 
infection, C/S, 3rd degree 
tear, problems at 6 weeks. 
van 
Roosmalen 
1987  
Tanzania 1976-1983  
CPD  
Most women low parity, maternal height 
lower in the symphysiotomy group.  
No details reported on selection. 
(n=54) Symphysiotomy using the Seedat 
and Crichton method.  
Live fetus, vertex presentation. 
(n=100) C/S MMR and serious 
morbidity. PMR 
Mola 
1995  
Papua New Guinea 1988-1994  
Failed attempted at assisted delivery of 
cephalic presentations.  
Majority of patient’s primigravid. 
Retrospective, all cases of failed assisted 
delivery included.  
No further details provided. 
(n=62) Symphysiotomy using the Seedat 
and Crichton technique.  
No details reported on after care. 
(n=108) C/S MMR, PMR and morbidity, 
agars <7 at 5 mins, >24 
hours admission to special 
care baby unit, post 
operative stay >10 days, 
need for further surgery. 
3
32 
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Basak 
2011  
India May 2005-Sept 2006 
Presenting on labour ward, features of 
obstructed labour (1, obstructed labour 
due to mild to moderate CPD  with fetus 
alive, vertex presentation, advanced 
cervical dilatation, well engaged fetal 
head. 2, obstructed labour after failed 
instrumental delivery. 3, trapped after 
coming head in breech delivery, shoulder 
dystocia).  
Excluded: musco-skeletal disorders, 
severe obesity, major CPD, previous C/S, 
estimated fetal weight >4kg, or dead 
fetus.  
Prospective study of all women that 
presented on labour ward during any time 
of the day.  
Retrospective follow up study. Attempts 
made to time match since index delivery 
as much as possible. No further details 
provided. 
(n=25) Symphysiotomy 6 required use of 
forceps and 6 required ventouse.   
After care: Bed rest preferably on side with 
iliac strapping in the form of a figure of 8 on 
the knees for 3 days. Indwelling catheter 
for minimum of 5 days. Mobilisation to 
begin on 5
th
 day or when catheter is 
removed. Discharged at 7 days, advised to 
avoid weight bearing activities for 3 months 
(n=50) C/S MMR and morbidity (PPH, 
sepsis, genitourinary 
trauma, pelvic pain, gait 
problems). NMR and 
morbidity due to birth 
asphyxia, intracranial 
haemorrhage, 
cephalohematoma and 
hypoxic ischemic 
encephalopathy. 
Ersdal 
2008  
Zimbabwe 1990-1994.  
Previous normal vaginal deliveries, parity 
1-8, previous exclusive vaginal delivery, 
aged 15-45,no orthopaedic disorders 
(n=34) Symphysiotomies earlier than these 
dates also included, procedures performed 
by experience doctors.  
(n=29) C/S. Often 
had failed vacuum 
delivery. 
NMR, maternal morbidity 
(serious soft tissue injuries 
in birth canal, 
haemorrhage, sepsis). Pain 
on walking/ dancing/ 
jumping/carrying. Pain in 
scar, dyspareunia, 
infertility, incontinence. 
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Table 39 Data of outcomes reported (maternal mortality, pain, fistulae, laceration, haemorrhage, infection, pyrexia, incontinence, neonatal mortality, perinatal mortality, 
length of hospital stay, poor wound healing), comparing symphysiotomy and caesarean section (*pelvic pain) 
Study 
Year 
Hartfield 
1973 
Mola 
1981 
Van Roomalen 
1987 
Mola 
1995 
Basak 
2011 
sym cs sym cs sym cs sym cs sym cs 
Maternal Mortality N(%) 1/105 
(1) 
2/105 
(2.1) 
0/86 
(0) 
3/258 
(1) 
0/54 
(0) 
5/100 
(5) 
0/65 
(0) 
0/108 
(0) 
1/25(4) 2/50(4) 
Pain N(%) NR NR NR NR NR NR NR NR 8/25* 
(32) 
0/50* 
(0) 
Fistulae N(%) 4/105 
(4.2) 
1/105 
(1) 
3/86 
(3.5) 
0/258 (0) NR NR NR NR NR NR 
Laceration N(%) 4/105 
(4.2) 
0/105 
(0) 
NR NR NR NR NR NR NR NR 
Haemorrhage N(%) 8/105 
(8.4) 
19/105 
(19.9) 
 
NR NR NR NR NR NR 4/25 
(16) 
27/50 
(54) 
Infection N(%) NR NR 10/86  
(11.8) 
47/258 
(18.2) 
NR NR 3/65 
(4.6) 
29/108 
(26.8) 
1/25  
(4) 
26/50 
(52) 
Pyrexia N(%) 80/105 
(84) 
91/105 
(95.5) 
NR NR NR NR NR NR 5/25 (20) 20/50 
(40) 
Incontinence N(%) 7/105 
(7.3) 
0/105 
(0) 
8/86  
(9.4) 
2/258  
(0.8) 
NR NR 2/65 
(3) 
0/108 
(0) 
NR NR 
Neonatal Mortality N(%) NR NR NR NR NR NR NR NR 7/25 
(28) 
12/50 (24) 
Perinatal Mortality N(%) 17/105 
(17.8) 
7/105 
(7.3) 
7/86  
(8) 
41/258 
(16) 
11/54 
(5.9) 
13/100 
(13) 
2/65 
(3) 
5/108 
(4.6) 
NR NR 
Days in hospital 
Mean no days 
11.2 11.4 13.3 
(9.8) 
12.9 (8.2) NR NR NR NR NR NR 
Delayed/poor wound 
healing N(%) 
17/105 
(17.8) 
39/105 
(40.9) 
NR NR NR NR NR NR NR NR 
3
34
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Table 40 Long term follow up outcome data comparing the outcomes of symphysiotomy and caesarean 
section 
 
  
Outcome Ersdal 
2008 
 
 Hartfield 
1973 
sym cs significance 
(p value) 
 sym cs significance 
(p value) 
Pain on walking n (%) 8/34 
(23.5) 
4/29 
(13.8) 
0.33 Dysmenorrhoea 
n(%) 
3/61 
(4.9) 
3/48 
(6.3) 
0.76 
Scanty periods 
n(%) 
0/61 
(0) 
1/48 
(2.1) 
0.41 
Pain on dancing n (%) 1/34 
(2.9) 
2/29  
(6.9) 
0.52 Irregular 
menstrual cycle 
n(%) 
0/61 
(0) 
3/48 
(6.3) 
0.15 
Pain on Jumping n (%) 3/34 
(8.8) 
2/29 
(6.9) 
0.78 Sub-fertility 
n(%) 
4/61 
(6.6) 
4/48 
(8.3) 
0.72 
Pain on carrying n (%) 3/24 
(8.8) 
2/29 
(6.9) 
0.84 Stress 
incontinence 
n(%) 
2/61 
(3.3) 
1/48 
(2.1) 
0.71 
Painful scar n (%) 1/34 
(2.9) 
15/29 
(51.7) 
<0.01 Utero-vaginal 
prolapse 
1/61 
(1.6) 
0/48 
(0) 
0.86 
Frequent 
backache n(%) 
0/61 
(0) 
2/48 
(4.2) 
0.23 
Dyspareunia n (%) 10/34 
(29.4) 
5/29 
(17.2) 
0.41 Occasional 
backache n(%) 
6/61 
(9.8) 
7/48 
(14.6) 
0.45 
Frequent leg 
pain n(%) 
2/61 
(3.3) 
0/48 
(0) 
0.37 
Infertility n (%) 0/34 
(0) 
2/29 
(6.9) 
0.12 Occasional leg 
pain n(%) 
7/61 
(11.5) 
5/48 
(10.4) 
0.86 
Unexplained 
abdominal pain 
n(%) 
0/61 
(0) 
1/48 
(2.1) 
0.41 
Incontinence n (%) 1/34 
(2.9) 
2/29 
(6.9) 
0.47 Headache n(%) 0/61 
(0) 
1/48 
(2.1) 
0.41 
General muscle 
pain n(%) 
0/61 
(0) 
1/48 
(2.1) 
0.41 
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Table 41 Strobe reporting checklist for cohort studies (Y=reported, N=not reported) 
 
  
Cohort Studies 
 
STROBE Hartfield 
1972 
Mola 
1981 
Van 
Roosmalen 
1987 
Mola 
1995 
Basak 
2011 
Ersdal 
2008 
Title and 
Abstract 
design N N N N Y N 
summary Y Y N Y Y Y 
Introduction background Y Y N Y Y Y 
objectives Y Y N Y N Y 
Methods study design Y N N N Y Y 
setting Y Y Y Y Y Y 
participants Y N N Y Y Y 
variables N N N Y Y Y 
data sources N N N Y N Y 
Bias N N N Y N Y 
study size N N N N N N 
quant. variables Y N N Y N N 
stat. methods N N N Y N N 
Results participants N Y Y N N Y 
descriptive data N Y N N N Y 
outcome data Y Y Y N Y Y 
main results N Y N N Y Y 
other analysis N Y N Y N N 
Discussion key results N Y Y N Y Y 
limitation N N N N N N 
interpretation N Y N Y N Y 
generaliability Y Y Y Y Y Y 
Other funding N N N N N Y 
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Table 42 Risk of Bias for cohort studies (Y=reported, N=not reported) 
 
  
Cohort Studies Hartfield 
1972 
Mola 
1981 
Van 
Roosmalen 
1987 
Mola 
1995 
Basak 
2011 
Ersdal 
2008 
Selection Representativeness Y Y Y Y Y Y 
Selection on 
comparison 
Y Y Y Y Y Y 
Ascertainment of 
exposure 
Y Y Y Y Y Y 
Demonstration of 
outcomes 
Y Y Y Y Y N 
Comparability Comparability (2 
points available) 
Y YY Y Y Y Y 
Outcome 
 
Outcome 
assessment 
N Y N Y Y N 
Follow up length Y Y Y Y Y Y 
Adequacy of follow 
up 
N Y N Y Y Y 
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CHAPTER 12:  ANTI-SHOCK GARMENT FOR OBSTETRIC 
HAEMORRHAGE IN DEVELOPING COUNTRIES: A 
SYSTEMATIC REVIEW AND META-ANALYSIS  
ABSTRACT 
 
Background: Post-partum haemorrhage is one of the leading causes of maternal 
mortality. The Anti-shock garment is suggested to be one of the most effective 
therapeutic procedures to control haemorrhagic shock. It can be used for treatment 
within a healthcare facility, but also when patients are being transferred to a health 
facility for treatment. In developing countries many women experience delays in 
receiving appropriate treatment for haemorrhage. The Anti-shock garment is suggested 
to improve outcomes when used in conjunction with standard obstetric haemorrhage 
care. The outcomes of women where the anti-shock garment was used in addition to 
standard obstetric haemorrhage treatment was systematically reviewed and meta-
analysed, and compared to the outcomes of standard obstetric haemorrhage treatment 
alone. 
Methods: Systematic review with meta-analysis. PUBMED, EMBASE, Cochrane 
library, CINAHL, AMED, African Index Medicus, the Reproductive Health Library, and 
the Science Citation Index were searched (inception- March 2013) without language 
restriction. All available studies were included (quasi-experimental studies, case series 
case and reports) in the absence of randomised data and sufficient data from cohort 
studies. The outcomes of maternal mortality and morbidity, estimated blood loss and 
requirements for blood transfusion. Relative risks (RR) from the individual studies were 
pooled using random effects model. 
Results: Two quasi-experimental studies (before and after), two case series and five 
case reports (1836 women) were included.  Maternal mortality and morbidity were less 
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frequent when the anti-shock garment was used in addition to standard obstetric 
haemorrhage treatment (mortality: RR 0.54 95%CI 0.34, 0.86; p=0.009. morbidity: RR 
0.25 95%CI 0.11, 0.56; p=0.007), although this was based on limited data (69 and 32 
events respectively). One case of mortality and five cases of morbidity were reported in 
the case series studies. 
Conclusion: It is possible to speculate that the anti-shock garment may contribute to 
improving outcomes of women with obstetric haemorrhage, when it is used in addition 
to standard treatment. The evidence however is based on poor quality data that is 
vulnerable to bias and confounding, and also a limited number of events. 
 
12.1 BACKGROUND 
The Anti Shock Garment  
The Anti-shock garment has three sections, one for each leg, and another for the 
abdomen (Figure 58). The suit compresses the blood vessels in the legs, pelvis and 
abdomen, shunting the blood to the vital organs in the chest and head (349). It reduces 
the radius and transmuralpressure of abdominal, uterine, and lower-body blood 
vessels, therefore decreasing blood flow (350). The Anti shock garment is applied by 
the following steps. First the garment should be opened and placed under the woman 
with the top of the garment at her lowest rib. If she is unconscious, she can be rolled 
her onto her side and the garment be placed underneath her. The Garment should then 
be stretched and fastened tightly around the patient, starting with the ankle segments 
labelled 1 in Figure 58). The leg segments (labelled 2 and 3 in Figure 58) should be 
stretched and fastened around the knees (section 2) and the tights (section 3). Section 
4, the pelvic section should be secured tightly at the level of the symphysis pubis. 
Segment 5 should be placed over the umbilicus, and closed by securing segment 5 
with segment 6 (351). The application of the garment should result promptly in a 
decreased pulse and increased systolic blood pressure. It is not however suitable for 
 
 
340 
 
use with a viable fetus in utero (352), so would be suitable for post-partum use, in 
cases of ectopic pregnancy, or in cases of intrauterine death. Postpartum haemorrhage 
is the single largest cause of maternal death worldwide.  Many clinical and 
pharmacological interventions are in place to prevent and treat post-partum 
haemorrhage (270, 353-356), but these are often only suitable for administration by 
trained staff at the facility level. 
  
Figure 58 Anti-Shock Garment (sections numbered in order of application of the garment, as described 
above) source: www.voice-online.co.uk/sites/default/files/imagecache/455/garment.jpg 
Births  in developing countries take place within the community, without the assistance 
of a skilled birth attendant (83), many women do not receive essential interventions that 
can reduce the risk of morbidity and mortality from post-partum haemorrhage (353-
355), such as active management of the third stage of labour. Moreover, as many 
births are attended by unskilled and untrained attendants early warning signs of post-
partum haemorrhage may not be detected and timely care not sought.  
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The decision to access care and to actively seek life-saving treatment may be delayed 
further by the financial, cultural or geographic barriers faced by many women (15, 136, 
162). This is particularly important as women suffering post-partum haemorrhage need 
to receive appropriate treatment promptly to reduce the risk of mortality and severe 
morbidity. It is suggested that unless appropriate medical care is received promptly, 
demise can occur within two hours (12). The use of the Anti-shock garment or G-suit 
was first documented in obstetrics in 1958 (357), however it was then more readily 
used with trauma patients. In the 1960’s field surgeons in Vietnam reported great 
success with the use of this garment on injured soldiers (358), and today it is still used 
in the pre-hospital management of trauma patients (359) (360). The use of the anti-
shock garment in post-partum haemorrhage has become more common in the last few 
decades (352, 360-366), whereas in the 1980’s it was suggested to be one of the most 
effective therapeutic procedures in the United States, in obstetrics and gynaecology to 
control haemorrhagic shock from post-partum haemorrhage (349).  
 
Although it is used for the treatment of haemorrhagic shock within a healthcare facility 
(352), or when sufficient quantities of blood are not available to transfuse, it can also be 
used to improve outcomes of women with obstetric haemorrhage being transferred to a 
health facility. This may be particularly valuable in rural areas of developing countries 
where lengthy delays are common with receiving adequate treatment. For example a 
vehicle first has be found to transfer the patient from the community, then the journey 
may be long and time consuming due to the distance travelled, or the type of vehicle or 
terrain. Then once a facility has been reached there may be further delays with surgery 
or access to blood transfusion (15, 136, 156, 172). 
 
As the Anti-shock garment has been suggested to improve outcomes when used in 
addition to standard obstetric haemorrhage care (351, 366, 367), the literature 
available was systematically reviewed and meta-analysed  on the outcomes of women 
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in which the anti-shock garment was used in addition to standard clinical obstetric 
haemorrhage treatment.  
 
12.2 METHODS 
Data sources and searches 
Databases were searched for literature on the outcomes of the anti-shock garment on 
women experiencing obstetric haemorrhage in developing countries. PUBMED, 
EMBASE, Cochrane library, CINAHL, AMED, African Index Medicus, the Reproductive 
Health Library, and the Science Citation Index were searched (from database inception 
to March 2013). Hand searching complemented electronic searches, and reference 
lists were checked. The search terms were ‘anti-shock garment, anti shock trousers, G-
suit, gravity suit, pneumatic suit, PASG and NASG. No language restrictions were 
applied to the search. 
 
Study selection and data extraction 
The best available evidence was included within the review, by following the hierarchy 
of evidence. In the absence of RCT, and sufficient data from studies of comparative 
design alone (quasi-experimental studies and case-control studies), case series and 
reports were also selected, no other studies were available.  Initially the electronic 
searches were scrutinised and full manuscripts of relevant studies were acquired. Final 
decisions on inclusion or exclusion of manuscripts were made after inspection of these 
manuscripts by the author and another reviewer (AW and ET). Information was 
extracted from each article on study characteristics, outcome data and study quality by 
the author and another reviewer (AW, ET).  The outcomes of maternal mortality, 
morbidity, pre-operative and post-operative haemoglobin, and the need for blood 
transfusion were focussed on.   
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Methodological quality assessment 
The quasi-experimental studies were assessed for adequacy of reporting using the 
TREND checklist (368). Risk of bias in the studies was assessed using the Newcastle 
Ottawa Scale (71), although this tool is designed mainly for cohort and case series 
studies it is recognised as a tool for assessing risk of bias in non-randomised studies 
by Cochrane (369). There are no recommended tools to assess risk of bias in quasi-
experimental (before/after studies) specifically. Therefore the studies were evaluated 
for representativeness of the groups, selection of the groups, ascertainment of the 
intervention and the outcome, comparability of the groups, as well as the length and 
adequacy of follow-up. The risk of bias was deemed low if a study obtained four stars 
for selection, two stars for comparability and three stars for ascertainment of exposure 
(71). Medium risk of bias was suggested to exist in studies with two or three stars for 
selection, one for comparability and two for exposure. Any study scoring one or zero 
stars for selection, comparability or exposure was classed as having high risk of bias.  
Case series studies were assessed using the MINORS checklist for adequacy of 
reporting (70), this contains eight items. Studies are assessed for reliability, 
consistency and validity. The items are scored between 0 and 2 for the adequacy of the 
reporting, with the ideal score being 16. 
 
Statistical Analysis 
Data for effect estimates (Risk Ratios) and corresponding 95% confidence interval 
were extracted for the comparative studies. Effect estimates and their 95% CI were 
then meta-analyzed using the generic inverse-variance method using the random 
effects model to account for the variability in the population and the setting. 
Heterogeneity of treatment effects was evaluated using forest plots, chi square tests 
and its magnitude determined by computing I2 statistic. Analyses were performed using 
REVMAN 5.0 statistical software. Data for the case series studies is reported 
narratively. 
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12.3 RESULTS 
The process of literature search and selection is given in Figure 59. The best available 
evidence is included in the review following the hierarchy of evidence. Two quasi-
experimental studies (before and after) (1806 women) (362, 370), two case series (20 
women) (352, 371), and five case reports (10 women) (357, 372-375) were included in 
the review, no RCTs were available. The characteristics of the studies included are 
shown in Table 37, and the data for the outcomes reported is provided in Table 38.  
 
Characteristics of the studies 
The two quasi-experimental studies (362, 370) included a total of 1806 women 
experiencing obstetric haemorrhage. Both studies were set in developing countries 
(Nigeria and Egypt). They were before and after studies and examined the effect of the 
non-pneumatic anti-shock garment in addition to standard obstetric haemorrhage 
management, following a period when treatment was standard obstetric haemorrhage 
management without the use of the anti-shock garment. Both of these studies had 
similar inclusion criteria for participants, women with obstetric haemorrhage, with signs 
of shock and blood loss over 750mls, with one sign of haemodynamic instability, for 
example a pulse above 100bpm or a systolic blood pressure below 100mmHg. The 
primary outcome measures for these studies were measured blood loss, severe end-
organ failure morbidity (renal failure, pulmonary failure, cardiac failure, or central 
nervous system dysfunctions) and mortality. The two case series (352, 371) included a 
total of 20 women experiencing obstetric haemorrhage whom developed severe 
hypovolemic shock, classified by an estimated blood loss greater than 750ml, with a 
systolic blood pressure below 100mmHg, or a pulse above 100bpm. Both studies were 
set in Pakistan and also used the non-pneumatic anti-shock garment in addition to 
standard obstetric haemorrhage management which included administration of 
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intravenous crystalloid fluids, monitoring of vital signs and blood transfusion to restore 
haemoglobin to above 7 g/l. The primary outcome measures of the case series were 
mortality, morbidity (including any complications recorded in the medical notes), mean 
arterial blood pressure, estimated blood loss, haemoglobin concentration pre and post 
anti-shock garment, units of blood received in transfusion. The five case reports, 
reported on ten cases using the ‘Gravity suit’ or ‘MAST suit’ for women experience 
obstetric haemorrhage due to placenta praevia, percreta or acreta, placental abruption, 
retained placenta or abdominal pregnancy. The location setting of most of the case 
reports in not stated in the manuscripts. The outcomes reported were morbidity, 
mortality, blood transfusion and hospital stay. 
 
Study quality 
The before and after quasi-experimental studies did not report if consecutive inclusion 
of participants took place. Instead it was stated that the attending physician/clinician 
decided if the anti-shock garment would be used or not. In accordance with the TREND 
checklist the studies adequately reported on most items, however details was lacking 
on the unit of delivery of the intervention, and the deliverer of the intervention, methods 
used to assign units to the intervention, blinding, methods used for inputting missing 
data, flow chart of study participants, description of pre-specified causal pathway, and 
important adverse events. The studies both achieved scores of 45 out of a possible 59 
marks (Table 39). The quasi-experimental studies were deemed to have low risk of 
bias in selection, ascertainment of exposure, and medium risk of bias in comparability 
on the Newcastle Ottawa Scale (Table 40). The case series reported adequately on 
most items achieving scores of 11 and 12 out of a potential 16 marks, sufficient details 
were lacking on prospective study sample size calculation, an unbiased endpoint 
assessment and the inclusion of consecutive patients (Table 41). 
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Figure 59 Selection process on studies included in the review  
3
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Maternal Mortality 
Meta-analysis of the two quasi-experimental studies demonstrated fewer cases of 
maternal mortality with the anti-shock garment (RR 0.54 95%CI 0.34, 0.86; p=0.009: 
Figure 50, this analysis however was based on only 69 events. There was no evidence 
of heterogeneity in this analysis (I2=0%). The case series studies and case reports 
reported a single case of maternal mortality amongst 30 cases (3.3%). 
 
Maternal Morbidity 
Meta-analysis of the quasi-experimental studies demonstrated fewer cases of maternal 
morbidity with the anti-shock garment (RR 0.25 95%CI 0.11, 0.56; p=0.0007: Figure 
51), this analysis was based on only 32 events. There was no evidence of 
heterogeneity in this analysis (I2=0%). Morbidity included organ system dysfunctions 
relating to severe obstetric haemorrhage such as acute respiratory distress syndrome, 
cerebral impairment (including seizures, unconsciousness, or cognitive or motor loss), 
renal failure and heart failure. Only the before and after study that was set in Egypt 
(370) provided further clarification on the morbidities experienced by the participants, 
two women in the pre intervention group were reported to have renal failure and one 
was reported to have renal impairment. In the intervention group two women were 
reported to have cerebral impairment. The case series studies and case reports 
reported five cases of morbidity among the 30 cases (16.6%), which included sepsis, 
respiratory distress syndrome, pulmonary atelectasis, jaundice and disseminated 
intravascular coagulation (DIC). 
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Figure 60 Maternal Mortality in participants being treated with the anti-shock garment or without the anti-shock garment 
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Figure 61 Maternal Morbidity in participants being treated with the anti-shock garment or without the anti-shock garment 
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Blood transfusion 
Blood transfusion was required by 86.5% (662/765) of patients in the pre-intervention 
group, and 90.3% (940/1041) of patients in the intervention group, of both of the quasi-
experimental studies. When meta-analysed there was no significant difference between 
the two groups (RR1.11 95%CI 0.87, 1.41; p=0.41: I2=90% p=0.001: Figure 52). This 
analysis was based on 1602 events.  Case series and case reports documented blood 
transfusion in 96% (27/28) of the patients. The median amount of blood units 
transfused was 38 (range 13-63) in the case reports, with a mean of 4.67 (SD 1.37) 
and 2.54 (SD 1.27) units in the case series studies (Figure 53). 
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Figure 62 Blood Transfusion received by participants being treated with the anti-shock garment or without the anti-shock garment
3
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Figure 63 Units of blood transfused in participants being treated with the anti-shock garment  
3
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Table 43 Characteristics of studies included in the review 
STUDY Study population and setting Garment Pre-intervention Intervention Outcomes 
Quasi-experimental study (before and after) 
Miller 
2006 
Egypt: Four tertiary care centre. 
Obstetric haemorrhage, signs of shock 
and PPH >750mls, one sign of 
haemodynamic instability (pulse 
>100bpm, systolic BP <100mmHg) 
Non-pneumatic 
anti-shock 
May-August 2004 
n=158 standard 
evidence based 
protocol for 
haemorrhage/shock. 
Sept – Dec 2004 
n=206 Standard care 
plus Non-pneumatic 
anti-shock garment 
EBL (calibrated blood 
collection drape) 
 
Miller 
2010 
Nigeria: Four referral facilities  
Mar 2004 – Dec 2007(n=452) 
Egypt: Two referral facilities  
Jun 2006–May 2008(n=990) 
PPH >750mls and one sign of 
haemodynamic instability (pulse 
>100bpm, systolic BP <100mmHg) 
Non-pneumatic 
anti-shock 
(n=607) standard 
evidence based 
protocol for 
haemorrhage/shock. 
(n=835) Standard 
care plus Non-
pneumatic anti-shock 
garment 
Death, blood loss, severe 
end-organ failure morbidity 
(renal failure, pulmonary 
failure, cardiac failure, CNS 
dysfunctions), mortality, 
emergency hysterectomy, 
Case series studies 
Hensleigh 
2002 
Pakistan: June – July 2001  
Obstetric haemorrhage, severe shock.  
Non-inflatable 
anti-shock  
n=6 managed with anti-shock garment plus 
standard treatment (1 woman had mitral 
value stenosis and developed dyspnoea, 
therefore this data was not analysed). 
Standard treatment includes intravenous 
crystalloid fluids, vital sign monitoring, blood 
transfusion to restore Hb>7 g/l 
Mean arterial blood 
pressure, morbidity (any 
recorded complications), 
EBL, controlled 
haemorrhage, Hb 
Brees 
2004 
Pakistan: Aug– Nov 2003  
Obstetric haemorrhage, hypovolemic 
shock: EBL >750ml, systolic BP 
<100mmHg, pulse 100bpm,  
Non-inflatable 
anti-shock 
n=14 managed with anti-shock garment plus 
standard treatment. Standard treatment 
includes intravenous crystalloid fluids, vital 
sign monitoring, blood transfusion to restore 
Hb>7 g/l 
Morbidity, mortality, EBL, 
Hb pre and post anti-shock 
garment, blood transfusion. 
Case Reports 
Gardner 
1958 
One cases of placenta percreta treated 
with the anti-gravity suit 
Gravity suit 1 woman with placenta percreta and 
placental abruption 
Morbidity, mortality, blood 
transfusion 
3
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Pelligra 
1979 
Three cases of obstetric haemorrhage 
that were treated with the G-suit 
Gravity suit 
and MAST suit  
3 women; one with placental abruption and 
abdominal pregnancy; one with placenta 
praevia; one with placenta acreta 
Blood transfusion, 
Mortality, morbidity 
Sandberg 
1983 
Three cases of abdominal pregnancy 
that were treated with the anti-gravity 
suite 
Antigravity suit 3 women; all abdominal pregnancy, one with 
placenta acreta, one with retained placenta 
Mortality, morbidity, blood 
transfusion, hospital stay 
Andrae 
1999 
Two cases of obstetric haemorrhage that 
are treated with MAST (military anti-
shock trousers) 
MAST trousers 2 women; one with placenta accrete; one 
with post partum haemorrhage.  
Mortality, morbidity,  
Ramachan
dran 
2004 
One case of abdominal pregnancy 
followed by massive haemorrhage 
treated with MAST suit 
MAST suit 1 woman with abdominal pregnancy Morbidity, mortality, blood 
transfusion 
  
2
6
9
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Table 44 Data of outcomes reported in the included studies (blood loss, blood transfusion, morbidity and mortality) in participants that received the anti-shock garment in 
addition to standard obstetric haemorrhage management, and participants that received only standard obstetric haemorrhage management (NR=not reported) 
Quasi-experimental 
(before and after) 
Blood Loss in drape 
(median, range mls) 
Blood Transfusion Morbidity  Mortality 
Pre Intervention Pre (%) Intervention (%) Pre (%) Intervention (%) Pre (%) Intervention 
(%) 
Miller 2006 500 (0-
2400) 
250 (0-900) 96/158 (61.1) 155/206 (75.2) 3/158 (1.9) 2/206 (0.98) 2/158(1.3) 0/206(0) 
Miller 2010 400 (IQR 
250-500) 
200 (IQR 
150-250) 
566/607(93.3) 785/835 (94.0) 21/607 (3.5) 6/835 (0.7) 38/607 (6.3) 29/835 (3.5) 
Case Series Blood Loss (median, range 
mls) 
Blood 
Transfusion 
(%) 
Units transfused 
mean (SD) 
Hb before 
Mean (SD) g/l 
Hb after Mean 
(SD) g/l 
Mortality (%) Morbidity (%) 
Hensleigh 2002 2375 (1200-4000) 6/6 (100) 4.67(1.37) 5.17 (1.96) 8.07 (0.77) 0/6 (0) 0/6 (0) 
Brees 2004 3000 (2000-4500) 13/14 (93) 2.54 (1.27) 8.5 (2.89) 7.21(1.86) 1/14 (7) 1/14 (7) 
Case Report Blood Loss  
(median, range mls) 
Blood 
Transfusion 
(%) 
Units transfused 
mean (SD) 
Hb before 
Mean (SD) g/l 
Hb after Mean 
(SD) g/l 
Mortality Morbidity (%) 
Gardner 1958 NR 1/1 (100) 58 NR NR 0/1 1/1 (100) 
Pelligra 1979 NR 3/3 (100) Median 38  
(13-63) 
NR NR 0/3 2/3 (66) 
Sandberg 1983 NR 3/3 (100) 4,000 – 19,000 mls 
(median 9,000) 
NR NR 0/3 2/3 (66) 
Bengt 1999 NR NR NR NR NR 0/2 0/2 
Ramachandran 
2003 
NR 1/1 (100) 36 11.2 11.8 0/1 0/1 
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12.4 DISCUSSION  
Findings 
Maternal morbidity and mortality from obstetric haemorrhage is reduced when the anti-
shock garment is used in addition to standard treatment, when compared to standard 
treatment alone, although these analyses were based on studies that are vulnerable to 
bias and a small number of events. There was no significant difference in the incidence 
of blood transfusion between the two groups; however the case series and case report 
studies reported 96% of patients requiring blood transfusion.  
 
Limitations 
The main limitation of the review is the poor quality of the available studies and the 
limited number of events included and analysed. With such small numbers it is difficult 
to make inferences on the effect of the anti-shock garment on the outcomes of women 
experiencing obstetric haemorrhage. Although two quasi-experimental studies are 
included, both lacked control in participant selection, as the attending physician 
decided whether the anti-shock garment was used. With this it is possible that the bias 
could be in favour of the pre-intervention group in the quasi-experimental studies, as 
the anti-shock garment may have been used on only those women deemed in grave 
condition in the intervention phase, therefore such patients may have worse outcomes. 
This can be demonstrated by the lower blood pressure recordings in the group that 
were treated with the anti-shock garment, indicating a worse study entry condition for 
patients in the intervention arm (362, 370). There are further limitations in the before 
and after study design. It is possible that the effect of time and experience in managing 
cases of haemorrhage and hypovolemic shock may have improved outcomes as the 
study progressed, thus bias may be in favour of improved outcomes in the group that 
were treated with the anti-shock garment. 
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Due to the nature of the studies included within this systematic review the demographic 
details of the patients was heterogeneous, reproductive history (gravida and parity), 
aetiology of haemorrhage, and condition of study entry varied greatly. This was notable 
even between the quasi-experimental studies; yet there appeared to be no evidence of 
heterogeneity in the analysis. The intervention also varied across the included quasi-
experimental studies and case series, this however is likely to be due to improvements 
in the design of the garment over time, since its initial use. 
 
Another limitation of the review is that both quasi-experimental studies were conducted 
by the same study group, although this may reduce heterogeneity in the intervention 
being evaluated, and the method in which the outcomes are measured, they may have 
a particular interest in the intervention, that in the absence of a robustly designed study 
(such as an RCT) may introduce into the results. 
 
Existing Research 
Since the publication of two literature reviews in 2007 (367) and 2008 (351) have been 
conducted by the same author, this systematic review appears to be the first.  Since 
publication of the literature reviews two comparative studies using the Anti-shock 
garment in the treatment of obstetric haemorrhage have been published (350) (363), 
therefore an updated review of a systematic design was needed. There is currently no 
randomised data on the use of anti-shock garment in obstetric haemorrhage. 
 
Policy and practice implications 
The anti-shock garment is a low-cost, re-usable intervention that does not require 
clinical skill for application, thus it could be applied by lay health workers in community 
settings, where the majority of births occur.  As obstetric haemorrhage is a leading 
cause of maternal mortality and morbidity in developing countries the potential effect 
could contribute to improvements in maternal outcomes in developing countries. The 
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findings of this review suggest that it is possible that the use of the Anti-shock garment 
might improve outcomes for women by reducing maternal mortality and morbidity from 
obstetric haemorrhage. It is not possible to discuss potential policy implications without 
further high quality research. 
 
Unanswered questions and future research 
Good quality primary research is required to draw firm conclusions on the effect of the 
anti-shock garment in addition to standard obstetric haemorrhage management in 
women from developing countries. The outcomes this research could guide policy, 
practice and further research. 
 
12.5 CONCLUSION 
The evidence in this review is based on a small number of events from studies that are 
vulnerable to bias and confounding, this is the best evidence available to date. There is 
a suggestion that the anti-shock garment may improve outcomes of women with 
obstetric haemorrhage, when it is used in addition to standard treatment, but high 
quality evidence is needed. 
 
  
 
 
362 
 
Table 45 TREND: reporting criteria in quasi-experimental studies (Y=reported N= not reported) 
Topic TREND checklist Miller 2010 Miller 2006 
Title and abstract 
Title and abstract Information how units allocated Y Y 
Structured summary abstract Y Y 
information  sample population Y Y 
Introduction 
Background  Scientific background, explanation of rationale Y Y 
 Theories used in designing intervention Y Y 
Methods 
Participants Eligibility criteria for participants at different levels Y Y 
method of recruitment including sampling method Y Y 
Recruitment setting Y Y 
Setting and location data collected Y Y 
Interventions details of intervention for each study condition and how 
administered 
Y Y 
content Y Y 
delivery method Y Y 
unit of delivery N N 
deliverer N N 
setting Y Y 
exposure quantity and duration Y Y 
time span N N 
activities Y Y 
Objectives Specific objectives and hypotheses Y Y 
Outcomes Completely defined pre-specified primary and secondary 
outcome measures 
Y Y 
Methods used to collect data Y Y 
Information on validated instruments used Y Y 
Sample size How sample size determined N Y 
Assignment 
method 
Unit of assignment to study conditions Y Y 
Method used to assign units to study conditions N N 
Inclusion of aspects employed to help minimise potential 
bias 
Y N 
Blinding participants and outcome assessors masked and how N N 
Unit of analysis Description of the smallest unit that is being analysed to 
assess intervention 
Y Y 
If the unit of analysis differs between assignment, 
analytical method used to account for this 
Y Y 
Statistical  
methods 
Statistical methods used to compare study groups  Y Y 
Methods for additional analyses, subgroup or adjusted 
analyses 
Y Y 
Methods for imputing missing data N N 
Statistical software Y Y 
Results 
Participant flow  Flow of participants through each stage N N 
enrolment Y Y 
assignment Y Y 
allocation N Y 
follow up Y N 
analysis Y Y 
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Description of protocol deviation N N 
Recruitment Dates defining periods of recruitment and follow-up Y Y 
Baseline data baseline demographic and clinical characteristics for each 
group 
Y Y 
baseline characteristics for each study condition Y Y 
baseline comparisons Y Y 
comparison between study population at baseline and 
target 
N N 
Baseline equivalence Data on  study group equivalence at baseline Y Y 
Numbers analysed Indication of whether analysis strategy was ITT N Y 
Number of participants included in each analysis  Y Y 
Outcomes and 
estimation 
primary and secondary outcome, results for each group, 
estimated effect size and precision 
Y Y 
inclusion null/negative findings Y Y 
Inclusion of results from pre-specified causal pathways N N 
Ancillary analyses summary of other analyses performed Y N 
Adverse events All important adverse events or unintended effects in 
each 
N N 
Discussion 
Interpretation 
 
Interpretation consistent with results balance benefits 
harms, considering other evidence 
Y Y 
Generalisability Generalisability of trial findings Y Y 
Overall evidence 
 
General interpretation of results in context of current 
evidence 
Y Y 
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Table 46 Risk of Bias in quasi-experimental studies (Y=reported, N=not reported) 
 
Quasi-Experimental Studies Miller 
2006 
Miller 
2010 
Selection Representativeness Y Y 
Selection on comparison Y Y 
Ascertainment of exposure Y Y 
Demonstration of outcomes Y Y 
Comparability Comparability (2 points available) Y YY 
Outcome 
 
Outcome assessment Y Y 
Follow up length Y Y 
Adequacy of follow up Y Y 
 
Table 47 Minors checklist of reporting in case series 
 
Case Series Hensleigh 2002 Brees 2004 
Clearly stated aim 2 2 
Inclusion of consecutive patients 1 1 
Prospective data collection 2 2 
Appropriate end points 2 1 
Unbiased endpoint assessment 1 1 
Appropriate Follow up 2 2 
Loss of follow up <5% 2 2 
Prospective study size calculation 0 0 
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CHAPTER 13:  INTERPRETATION 
The questions stated in the introduction (Table 3) have been addressed through 
systematically reviewing the evidence on each intervention aimed to reduce maternal 
mortality in developing countries. This has been achieved through the following objectives: 
a) Reviewed, synthesised and assessed the literature on community based 
interventions 
b) Reviewed, synthesised and assessed the literature on task-sharing interventions 
c) Reviewed, synthesised and assessed the literature on clinical interventions 
d) Made recommendations for practice 
e) Made recommendations for research 
The findings of these reviews are shown in Table 48. This table also depicts the MDGs that 
may be influenced by the intervention. Perinatal and neonatal mortality rates were also 
examined within this thesis where possible, although maternal mortality was the primary 
focus. Neonatal and perinatal mortality rates are useful when examining interventions to 
reduce maternal mortality, as greater improvements are often seen in these outcomes first, 
due to the sample size and power needed to show an effect in maternal mortality.   
Overall evidence on interventions to reduce maternal mortality 
Strategies Incorporating the Training and Support of TBAs: Perinatal and neonatal deaths 
were significantly reduced with interventions incorporating the training and support of TBAs. 
There was no significant reduction shown in maternal mortality, greater power being needed 
to show this, but both randomised and non-randomised studies demonstrated a trend 
towards reduction. It was suggested that greater reductions in maternal mortality are likely to 
be shown if the intervention was applied to a wider population.  Essential components of the 
package consisted of appropriate training, access to resources such as clean birth kits, as 
well as links to effective referral pathways, and continued skill development.  
 
Participatory Learning and Action Cycle with Women’s Groups: Maternal and neonatal 
mortality were significantly reduced with women’s participatory learning and action groups.  
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Groups conducted within a rural setting, containing at least 30% of pregnant women, 
showed the most marked reductions in mortality rates. Women involved within participatory 
action groups often demonstrated enhanced awareness of maternal health problems, and 
can also show the desire and motivation to address them. Participatory learning and action 
cycles can develop knowledge, skills and critical consciousness, as well as enhance 
community involvement. Women’s groups also have the potential to indirectly improve health 
outcomes through empowerment and advocacy, which may have repercussions on female 
education, employment and poverty.   
 
Emergency transportation for pregnant women: Key issues with emergency transport of 
pregnant women were availability and transport speed, terrain, meteorology, support, 
dependence for decision-making, cultural issues, cost, and lack of safe, comfortable 
positioning during transit. Key recommendations for a suitable, efficient, effective, reliable, 
acceptable and affordable means of transport, were clear guidance to prioritise the use of 
vehicles; consistent availability of affordable options that were suitable for pregnant women 
and allowed them to be transported in the optimal left lateral position; a transport type 
compatible with local terrain, as well as local customs and cultures. Community 
engagement, education and awareness raising can potentially promote gender equality, and 
empower women. Collaborations with industry and partnerships with organisations also have 
the potential to influence the development of global partnerships. 
 
Motivational interviews to reduce unmet contraceptive need: Motivational interviews 
improved effective contraceptive use between zero to four months after the intervention, yet 
there appeared to be no significant effect at other time points. A trend towards reduction in 
subsequent pregnancies or births at 12-24 months appeared to be demonstrated, although 
no significant effect was shown. This effect was seen on populations mainly from developed 
settings, at high risk of  unintended pregnancy, so the transferability of the review findings to 
a developing world setting were questionable due to cultural differences and cost 
implications given that the intervention is intensive. The cost of the intervention, and the size 
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and the outcome of the overall effect should be assessed. The overall lack of data on the 
effect of motivational interviewing to improve contraceptive use and unmet contraceptive 
need in developing countries indicated that a RCT would be necessary to provide good 
quality evidence.  This intervention complies with the WHO in working to promote 
contraception by producing evidence-based guidelines on service delivery of contraceptive 
methods, as well as adapt, implement and improve delivery methods to meet the needs of 
individuals. 
 
Clinical officers performing caesarean section: The provision of caesarean section surgery 
by clinical officers did not result in a significant increase in maternal or perinatal deaths when 
compared to doctors. The incidence of wound dehiscence and wound infection however, 
was more frequent. Greater deployment of clinical officers, in countries with poor coverage 
of medical doctors can enhance access to emergency obstetric surgery. The role of the 
clinical officer can be adapted to suit local needs and conditions, therefore clinical officers 
could be utilised to address other determinants of health within various settings. Although 
the studies were all non-randomised, they were large and showed consistency in the 
findings. 
 
Prophylactic antibiotics in surgical abortion and miscarriage surgery: Prophylactic antibiotic 
administration in surgical abortion significantly reduces infectious morbidity. There is 
sufficient evidence available from RCTs to guide practice and policy. Although all of the data 
came from developed countries, the results were deemed transferable to developing 
countries where the effect could be greater as the risk of developing pelvic infection may be 
greater. There were however limited data on the prophylactic antibiotic administration in 
surgical treatment of miscarriage, thus no inferences were drawn. A RCT is needed to guide 
practice and policy in low resource settings, where the risk of developing pelvic infection may 
vary from a high resource setting. Prophylactic antibiotics may reduce morbidity and 
mortality associated with sepsis following surgical treatment of miscarriage in low income 
countries, particularly in settings where the aetiology of the miscarriage is unknown. 
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Cell salvage as an alternative to homologous blood transfusion in caesarean section 
surgery: It was speculated that cell salvage could be beneficial in achieving normal 
haemoglobin levels for women that have undergone caesarean section, and could possibly 
be used as an alternative to homologous blood transfusion. However as the studies used to 
draw these inferences were derived from a developed world setting, and the study design of 
most of the included studies (case series) were vulnerable to bias and confounding, no firm 
inferences were able to be drawn from the conclusions of the review. Further primary 
research of high quality is needed to draw firm inferences on the use of cell salvage in 
caesarean section. 
 
Cell salvage as an alternative to homologous blood transfusion for ruptured ectopic 
pregnancy surgery: It is speculated that cell salvage could be used in the treatment for 
haemorrhage from ruptured ectopic pregnancy in the absence of alternative life saving 
treatment such as a safe, reliable homologous blood transfusion service. It could also be 
used if homologous transfusion is not culturally acceptable. Due to the low cost and limited 
training needs that were associated with the procedure, cell salvage was deemed suitable 
for use low resource settings however as the data from which these conclusions were drawn 
lacked sufficient quality and were vulnerable to bias and confounding, no firm inferences 
were drawn. Primary research of high quality is needed to draw firm inferences on the safety 
and effectiveness of cell salvage in ectopic pregnancy. 
 
Symphysiotomy for obstructed labour: Symphysiotomy was demonstrated as a possible 
alternative to caesarean section. This procedure can be performed in instances where 
resources are limited, when caesarean section is associated with greater risks, or when 
caesarean section is unavailable or greatly delayed (putting the woman at greater risk of 
uterine rupture). Haemorrhage and infection are significant contributors to maternal mortality 
globally, and these complications appeared to be less frequent with symphysiotomy when 
compared to caesarean section. No additional long term complaints were reported with 
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symphysiotomy when compared to caesarean section. However this review was based on a 
limited number of events from cohort studies that were vulnerable to bias and confounding. 
Well designed studies are needed before any conclusions could be drawn. 
 
Anti-shock garment for women with postpartum haemorrhage: Use of anti-shock garment in 
addition to standard haemorrhage management appeared to reduce maternal mortality and 
morbidity from obstetric haemorrhage, when it was used in addition to standard treatment. 
The anti-shock garment is a low-cost, re-usable intervention that does not require clinical 
skill for application, thus it could be applied by lay health workers in community settings, 
where the majority of births occur.  These inferences however were again based on a limited 
number of events from only two quasi-experimental studies, two case series and numerous 
case reports so were vulnerable to bias and confounding. 
 
Determinants of maternal health 
The interventions that have been reviewed in this thesis can be placed in the context of the 
determinants of maternal mortality framework (16). Each intervention has the pregnant 
woman at the centre, and aims to improve outcomes by reducing the factors that contribute 
to maternal death (e.g. untrained birth attendance, unavailability of caesarean section or 
blood transfusion). The interventions that affect the immediate determinants of maternal 
health are those that are associated with improving outcomes when pregnancy 
complications occur (Figure 64), this includes cell salvage in both ectopic pregnancy and 
caesarean section, and the anti-shock garment.  
The interventions that address the intermediate determinants focus on the health status of 
the woman, and her access to and use of health services, as well as her healthcare seeking 
behaviour. It includes interventions that affect the care the woman receives, such as clinical 
officers providing caesarean section to improve availability and accessibility of emergency 
obstetric surgery, and training and supporting TBAs to improve accessibility of care for 
women not cared for by skilled birth attendants, and to fill the care ‘coverage gaps’. It also 
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involves antibiotic administration to prevent infective morbidity in abortion, and emergency 
transportation of pregnant women for timely emergency obstetric care to improve maternal 
outcomes (Figure 64). 
 
The interventions that address the distant determinants of maternal health are often a more 
complex package of interventions that affect the family and wider community as well as the 
individual woman; this includes participatory learning and actions cycles with women’s 
groups, and motivational interviews to improve contraceptive use (Figure 64). Training and 
supporting TBAs can also affect the distant determinants of maternal health as in many 
regions their remit of care extends beyond intra-partum care, and includes family planning, 
malarial prophylaxis and preventing HIV transmission (376, 377). 
 
Life course approach 
The life course approach can be used in conjunction with the determinants of maternal 
health framework when considering both the implementation of interventions, and the 
possible effects that the interventions may have, other than those intended. Figure 65 
demonstrates the span of time in which the reviewed interventions target, from the pre-
conception period to the post-partum period; this demonstrates the predictable reproductive 
journey that many women make. Many of the interventions reviewed have the potential to 
influence a much wider time span than at point of delivery, the life course approach 
recognises this (378). For example participatory learning and action cycles with women’s 
groups may not only improve outcomes for those involved at the specific time of 
involvement, it may also influence future decision making and practices for future 
generations. This approach can guide the timings of the interventions, suggesting 
opportunities to address key health issues and key life stages. It is also intended to put 
women in control of their care, and to make it more responsive to their needs. 
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Figure 64 Interventions targeting determinants 
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Figure 65 timeline of interventions 
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Taking a life course approach to women’s health care, encourages consideration of the 
biological, behavioural, environmental and social exposures throughout each woman’s life 
through four main principles (378) (Figure 65).  The first is information; ensuring women 
have access to consistent, reliable and accurate information about health and their individual 
health, in a manner in which they can process. This could be delivered through interventions 
such as women’s groups or motivational interviews, but is likely to affect the acceptability 
and success of all interventions. The second is experience; understanding the relationship 
between past reproductive experiences, health-seeking behaviours and previous healthcare 
interactions (i.e. with staff or services), and how these may influence current and future 
health practices. This principle could have particular bearing on the use of TBAs, or 
emergency transportation, but again is likely to affect the acceptability and use of all 
interventions.  The third is integration; encouraging greater integration of different health 
care services across different sectors. It is important to consider the horizontal as  
Well as the vertical integration of services. This concept applies to all interventions, as the  
horizontal and vertical implementation is necessary for success. Interventions implemented  
in isolation are less likely to have a positive impact. This is reiterated in the evaluation of 
emergency transport projects, as without community involvement, and local services being  
integrated, barriers to this service being utilised remain (14, 144, 166) (chapter five). This  
however can be a more complex process, particularly with intervention packages such as 
training and supporting TBAs. The fourth is data; ensuring the provision of joined-up, person- 
based, longitudinal data to inform women and healthcare systems about their needs and the  
services available. This applies to all interventions and is necessary for their implementation,  
acceptability and utilisation. 
 
 
374 
 
 
Figure 66 Life course approach 
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Impact 
The aim of this thesis was to systematically review the evidence on interventions to reduce 
maternal mortality, however this thesis in isolation will not invoke improvements in maternal 
health. It is therefore essential to consider the impact of this research, and any policy and 
practice implementation that has followed.  
 
One of the systematic reviews conducted in this thesis (chapter  8: prophylactic antibiotics 
for uterine evacuation: a systematic review and meta-analysis) was used to guide application 
for funding from the Medical Research Council, for an international, multi-centre RCT on 
sepsis in miscarriage. Funding of £1.6 million was successfully received. The AIMS Trial 
(Antibiotics In Miscarriage Surgery) commenced in March 2013, and is endorsed by  
◊   International Federation of Gynaecology and Obstetrics (FIGO)  
◊   WHO (WHO) - through Dr Metin Gulmezoglu) 
◊   Royal College of Obstetricians and Gynaecologists  
◊   Early Pregnancy – Clinical Studies Group (EP-CSG)  
◊   The Association of Obstetricians and Gynaecologists of Malawi  
◊   Miscarriage Association 
◊   Association of Early Pregnancy Units. 
 
Another systematic reviews (Chapter 7: a comparison of clinical officers with medical doctors 
on caesarean section outcomes) has contributed to the WHO’s recommendations 
‘Optimizing health worker roles to improve access to key maternal and newborn health 
interventions through task shifting’. The work of the thesis also complies with the WHOs 
objectives, in exploring the evidence base for effective delivery strategies of interventions, 
and increasing coverage of care for mothers and newborns. This in turn has should influence 
the guidance of professional bodies such as the federation of international gynaecology and 
obstetrics (FIGO), and the international confederation of midwives (ICM), and the allocation 
of budgets and resources within health systems, and inform funders of maternal health 
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projects. The ultimate beneficiaries however will be the mothers and babies that receive the 
care influenced by this evidence. 
 
The work of this thesis has contributed to publications in the Lancet (64) (Appendix 14), the 
British Medical Journal (65, 379)(Appendix 12 and 13), and the International Journal of 
Gynaecology and Obstetrics (380)(Appendix 15). Publication of evidence is key for 
dissemination of evidence, and increasing the evidence base for practice. This is particularly 
true for high ranking journals such as the Lancet and British Medical Journal, as not only do 
they have global reach, they are credible sources of information for practitioners and policy 
makers worldwide. These high ranking publications have also resulted in dissemination 
through presentation at prestigious conferences (FIGO: World congress of gynaecology and 
obstetrics; Royal College of Obstetrics and Gynaecology Blair Bell) and the Houses of 
Parliament. 
 
Expanding the evidence base for improving maternal and perinatal mortality complies with 
the objectives of the ‘countdown to 2015’ movement (381), a programme backed by the 
WHO, unicef, the department for international development and many other leading 
organisations. This programme focuses on the progress towards achieving MDGs 4 and 5, 
in the 75 countries in which 95% of maternal and child deaths occur. The programme 
emphasises the importance of gathering and synthesising evidence, the keys steps of this 
thesis.  
 
In addition to communicating research findings to academics and clinicians, engagement, 
interaction and dialogue with the public can be useful, particularly with seeking funding for 
projects. Public engagement and interaction can also be vital for support of maternal health 
improvements, as it can improve female advocacy and empowerment. It can also tackle 
cultural and societal taboos associated with maternal health. Dissemination of new evidence 
through academic journal publication is not always suitable for the lay public, so this often 
needs to be converted into a more accessible means.  
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The research conducted in this thesis has been used to inform and produce a maternal 
health resource pack as part of a funded project (at our mothers feet), which involved 
translation of the evidence into a format suitable for the lay public. The resource pack was 
distributed amongst charities and non-government organisations, to encourage focus and 
funding of maternal health projects (appendix 16). It also aimed to encourage investment 
into specific interventions that have been shown to be effective through the systematic 
reviews, as well as dispel the myth that costly interventions are the sole solution to 
addressing maternal mortality. 
The research contributing to this thesis has also informed discussions and debates on 
maternal health and maternal healthcare practices, with organisations interested in 
commencing maternal health projects (Ammalife, MADE in Europe, Islamic Relief, Muslim 
Hands, Muslim Charity), but also with community groups that were deterred from, or against 
supporting maternal health projects due to particular cultural or religious taboos. These took 
place in community centres and mosques; the evidence from this thesis has also informed 
workshops on maternal health with schools and youth groups. 
Through targeting an academic audience, a clinical audience, potential funders, and the 
public, and by disseminating information in a means accessible to the various audience 
types, the intention is to create the maximum possible support for reducing maternal 
mortality, hence creating the maximum possible impact. 
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Table 48 Interventions reviewed in the Thesis 
Question Population Intervention Comparison Outcome Finding MDGs 
Community Based Intervention 
Does training and 
supporting TBAs 
reduce maternal, 
neonatal and 
perinatal mortality 
rates in developing 
countries? 
Pregnant women 
seeking labour and 
delivery care in 
developing countries 
Training and 
Supporting TBAs 
Standard care Maternal, perinatal 
and neonatal 
mortality 
Strategies that incorporate the 
training and support of TBAs 
significantly reduces perinatal and 
neonatal deaths. 
Beneficial (suitable for 
implementation; no further 
research required) 
 
 
Do women’s groups 
practising 
participatory 
learning and action 
cycles improve 
maternal and 
neonatal outcomes 
in developing 
countries? 
Women  Participatory 
learning and 
action cycles 
Standard care Maternal and 
neonatal mortality 
Maternal and neonatal deaths are 
significantly reduced with women’s 
participatory action and learning 
groups. Women’s groups with at 
least 30% of pregnant women 
participating show greater 
reductions on neonatal and 
maternal mortality. 
Beneficial (suitable for 
implementation; no further 
research required) 
 
 
 
What are the 
barriers and 
facilitators of 
emergency 
transportation for 
pregnant women in 
developing 
countries? 
Pregnant women in 
developing  
countries seeking 
emergency 
transportation to 
access emergency 
obstetric care in  
Emergency 
transport 
None Experiences and 
opinions of 
pregnant women 
or stake holders. 
Barriers and 
facilitators of 
emergency 
transport of 
pregnant women. 
Individual themes should be 
appreciated within local context to 
provide illumination on local barriers 
and facilitators. Some potential 
solutions include motorcycle 
ambulance programme or 
collaboration with local minibus taxi 
services, community education and 
empowerment (raising awareness 
with women, partners, birth 
attendants and leaders), subsidies, 
insurance schemes and vehicle and 
road maintenance. 
Likely to be beneficial (may be 
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suitable for implementation with 
close monitoring of outcomes; 
further research may be required) 
Can motivational 
interviews reduce 
the unmet need for 
contraception in 
developing countries 
affected by conflict? 
Women of 
reproductive age in 
developing countries 
Motivational 
interviews 
Standard care Effective 
contraceptive use, 
subsequent 
pregnancy or birth  
Motivational interviews increase 
effective contraceptive use in a 
population at high risk of unintended 
pregnancy between zero to four 
months. This research complies 
with current global health research 
on improving family planning, 
however suitability to a developing 
world setting is questionable. 
Likely to be beneficial (may be 
suitable for implementation with 
close monitoring of outcomes; 
further research may be required) 
 
 
 
Task Sharing Interventions 
Are clinical officers 
as safe and effective 
as medical doctors 
at performing 
caesarean section? 
Pregnant women in 
developing countries 
requiring delivery by 
caesarean section 
Clinical officer 
performing the 
caesarean 
section 
Medical doctor 
performing 
caesarean 
section 
Maternal and 
neonatal mortality, 
wound infection 
and dehiscence 
Clinical officers and doctors did not 
differ significantly in key outcomes 
for caesarean section. There was 
an increase in wound infection and 
dehiscence with clinical officers. 
Beneficial (suitable for 
implementation; no further 
research required) 
 
 
Clinical Intervention 
Do prophylactic 
antibiotics reduce 
the incidence of 
infectious morbidity 
in surgical abortion 
and miscarriage 
surgery? 
Women having 
surgical abortion 
and women having 
miscarriage surgery 
Antibiotics Placebo or no 
drug 
Infectious 
morbidity 
Meta-analysis of RCTs showed an 
average reduction in infectious 
morbidity in cases of surgical 
abortion with prophylactic antibiotics 
by 41%.  
Beneficial (suitable for 
implementation; no further 
research required) 
Data on miscarriage was insufficient 
to draw inferences. High quality 
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research is needed. 
Unknown effectiveness (not for 
implementation; may be suitable 
for research if existing data 
indicative of benefits) 
Is cell salvage a 
safe alternative to 
homologous blood 
transfusion in 
caesarean section 
Women having 
caesarean section 
and blood 
transfusion 
Cell salvage Homologous 
blood 
transfusion 
Pre and post 
operative 
haemoglobin, 
blood loss, use of 
additional 
homologous blood, 
length of hospital 
stay, serious 
adverse effects 
Cell salvage could be suggested as 
beneficial in achieving normal 
haemoglobin levels for women that 
have undergone caesarean section, 
however further primary research of 
high quality is needed. 
Unknown effectiveness (not for 
implementation; may be suitable 
for research if existing data 
indicative of benefits) 
 
 
Is cell salvage a 
safe alternative to 
homologous blood 
transfusion in 
surgery for ruptured 
ectopic pregnancy 
Women having 
surgery for ruptured 
ectopic pregnancy 
and blood 
transfusion 
Cell salvage Homologous 
blood 
transfusion 
Pre and post 
operative 
haemoglobin, 
blood loss, use of 
additional 
homologous blood, 
length of hospital 
stay, serious 
adverse effects 
Simple cell salvage in ectopic 
pregnancy could be suggested to 
be an alternative treatment to donor 
transfusion. However high quality 
evidence is needed. 
Unknown effectiveness (not for 
implementation; may be suitable 
for research if existing data 
indicative of benefits) 
 
Is symphysiotomy a 
safe alternative to 
caesarean section in 
developing countries 
Women with 
obstructed labour 
Symphysiotomy Caesarean 
Section 
Maternal mortality, 
perinatal mortality, 
fistulae, 
haemorrhage, 
infection, pyrexia, 
incontinence 
Symphysiotomy could be suggested 
to be an alternative to caesarean 
section in developing countries 
where the risks associated with 
caesarean section are high. No 
additional long term complications 
are reported with symphysiotomy. 
High quality evidence is needed 
Trade off between benefits and 
harm (may be suitable for 
implementation according to 
local circumstances and 
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priorities. Implementation ideally 
carried out in the context of 
research; further research 
required 
Can the anti-shock 
garment improve 
outcomes for 
women with 
postpartum 
haemorrhage in 
developing countries 
Women with post-
partum 
haemorrhage 
requiring transfer to 
a place of care 
Anti-shock 
garment in 
addition to  
Standard care 
Standard care Maternal mortality, 
maternal morbidity,  
blood transfusion 
Anti-shock garment in addition to 
standard treatment could be 
suggested to reduce maternal 
mortality and morbidity from 
obstetric haemorrhage. High quality 
evidence is needed 
Unknown effectiveness (not for 
implementation; may be suitable 
for research if existing data 
indicative of benefits) 
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APPENDICES 
Appendix 1: Search terms for ‘Strategies that incorporate the training and 
supporting of traditional birth attendants reduce perinatal and neonatal deaths: 
A meta-analysis’ 
 
MEDLINE 
(((traditional birth attendant[All Fields] OR traditional birth attendant's[All Fields] OR traditional 
birth attendants[All Fields] OR traditional birth attendants[All Fields]) OR (birth attendance[All 
Fields] OR birth attendant[All Fields] OR birth attendants[All Fields] OR birth attendants[All 
Fields] OR birth attending[All Fields])) OR dias[All Fields]) OR comadronas[All Fields] 
EMBASE 
health care personnel/ or traditional birth attend*.mp.OR birth attend*.mp. OR dais.mp.OR 
comadronas.mp. 
AMED 
TX traditional birth attend* OR TX birth attend* OR TX dais OR comadronas 
BNI 
(traditional birth attend*) OR (birth attend*) OR (dais) OR (comadronas) 
Cochrane Library 
traditional birth attend:ti,ab,kw OR birth attend:ti,ab,kw  OR dais:ti,ab,kw OR 
comadronas:ti,ab,kw 
BIOMED central 
traditional birth attend* (All words) in All fields (full text) OR birth attend* (All words) in All fields 
(full text) OR dais (All words) in All fields (full text) OR comadronas (All words) in All fields (full 
text) 
CINAHL 
TX traditional birth attend* OR TX birth attend* OR TX dais OR TX comadronas  
PsycINFO 
traditional birth attend*.mp. OR birth attend*.mp. OR dais.mp. 
Science citation index 
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TS=traditional birth attend* OR TS=birth attend* OR TS=dais OR TS=comadronas 
Databases=SCI-EXPANDED Timespan=All Years 
African Index Medicus 
Traditional birth attend [Key Word] or birth attend [Key Word] or dais [Key Word] or comadronas 
[Key Word] 
Reproductive Health Library 
 Traditional birth attendant OR dais OR birth attendant OR comadronas 
LILACS 
Traditional OR birth OR attend$ OR dais OR Comadronas 
 
Appendix 2: Search terms for ‘Effect of women’s participatory learning and 
action groups on neonatal and maternal mortality: A systematic review and 
meta-analysis’ 
 
MEDLINE 
Community mobilisation.mp. OR Community participation.mp. OR Maternal Health Services/ or 
Health Knowledge, Attitudes, Practice/ OR participatory action.mp. OR Community-Based 
Participatory Research/ AND women* Group*.mp. OR participatory[All Fields] AND 
("women"[MeSH Terms] OR women's groups[Figure/Table Caption] OR women's 
groups[Section Title] OR women's groups[Body - All Words] OR women's groups[Title] women's 
groups[Abstract]) 
Embase  
Community mobilisation.mp. OR Community participation.mp. OR Maternal Health Services/ or 
Health Knowledge, Attitudes, Practice OR participatory action.mp. OR Community-Based 
Participatory Research OR women* Group*.mp. (MH "Action Research/ED/EV/OG") OR (MH 
"Group Exercise/ED/EV/MO/NU/OG/PF") OR (MH "Focus Groups/ED/EP/EV") 
Cochrane Collaboration 
Participatory action groups 
CINAHL 
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"participatory action groups" OR “women group" OR (MH "Group Exercise") OR (MH "Women's 
Health Services") OR (MH "Women's Rights") OR (MH "Women's Health")  (MH "Randomized 
Controlled Trials") OR (MH "Clinical Trials") OR (MH "Action Research") OR (MH "Group 
Exercise") OR (MH "Support Groups") 
ASSIA 
all(participatory action group) AND all(women) 
Science Citation Index 
Topic=(participatory action group*) AND Topic=(women*)  
African Index Medicus 
community mobilisation [Key Word] or community participation [Key Word] or women's groups 
[Key Word] participatory action [Key Word] or women’s groups [Key Word]  
 
Appendix 3: Search terms for ‘Maternal emergency transport in low and middle 
income countries: a systematic review and thematic synthesis of qualitative 
studies.’ 
 
MEDLINE 
(exp motorcycle/ AND exp ambulance) OR (exp ambulance AND exp bicycle/) OR (emergency/ 
AND patient referral/) OR (emergency/ AND Transport/) OR (emergency/ AND health care 
access/) OR (exp ambulance/ AND emergency/) OR (eranger.mp.) OR (exp Motorcycles AND 
Ambulances/) OR (bicycle.mp AND Ambulances/) OR (Emergencies/ AND “Referral and 
Consultation"/) OR (Emergencies/ AND access.mp) OR (Ambulances/ AND Emergencies/) AND 
(Qualitative Research OR exp Qualitative Research OR exp Interview OR Focus Groups/mt  
OR Focus Groups/ OR observational method/) 
Embase 
(exp motorcycle/ AND exp ambulance) OR (exp ambulance AND exp bicycle/) OR (emergency/ 
AND patient referral/) OR (emergency/ AND Transport/) OR (emergency/ AND health care 
access/) OR (exp ambulance/ AND emergency/) OR (eranger.mp.) OR (exp Motorcycles AND 
Ambulances/) OR (bicycle.mp AND Ambulances/) OR (Emergencies/ AND “Referral and 
Consultation"/) OR (Emergencies/ AND access.mp) OR (Ambulances/ AND Emergencies/) AND 
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(Qualitative Research OR exp Qualitative Research OR exp Interview OR Focus Groups/mt  
OR Focus Groups/ OR observational method/) 
African Index Medicus 
Emergency transport [Key Word] or bicycle ambulance [Key Word] or motorcycle ambulance 
[Key Word] or emergency referral [Key Word] or emergency access [Key Word] or ambulance 
[Key Word] or (emergency AND ambulance [Key Word]) 
CINAHL 
(TX motorcycle AND TX ambulance) OR (TX ambulance AND TX bicycle) OR (TX emergency 
AND TX patient referral) OR (TX emergency AND TX Transport) OR (TX emergency AND TX 
health care access) OR (TX ambulance AND TX emergency) OR (TX eranger) OR (TX 
Motorcycles AND TX Ambulances) OR (TX bicycle AND TX Ambulances) OR (TX Emergencies 
AND TX Referral and Consultation) OR (TX Emergencies AND TX access) OR (TX Ambulances 
AND TX Emergencies) AND (TX Qualitative Research OR TX Interview OR TX Focus Groups 
OR TX observational method) 
Science Citation Index 
Topic=( Emergency transport) OR Topic=( bicycle ambulance) AND Topic=( motorcycle 
ambulance) OR Topic=(emergency referral) OR Topic=( emergency access) OR Topic=( 
emergency AND ambulance) AND Topic=(Qualitative Research OR Topic= Interview OR 
Topic= Focus Groups OR Topic=observational method) 
Reproductive Health Library 
Emergency transport OR bicycle ambulance OR motorcycle ambulance OR emergency referral 
OR emergency access OR (emergency AND ambulance) AND (Qualitative Research OR 
Interview OR Focus Groups OR observational method) 
Cochrane library 
Emergency transport OR bicycle ambulance OR motorcycle ambulance OR emergency referral 
OR emergency access OR (emergency AND ambulance) AND (Qualitative Research OR 
Interview OR Focus Groups OR observational method) in title abstract keywords  
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ASSIA 
all((Emergency transport) OR all(bicycle ambulance) OR all(motorcycle ambulance) OR 
all(emergency referral) OR all(emergency access) OR all(emergency AND ambulance)) AND 
all((Qualitative Research) OR al(Interview) OR all(Focus Groups) OR all(observational method)) 
BNI 
all((Emergency transport) OR all(bicycle ambulance) OR all(motorcycle ambulance) OR 
all(emergency referral) OR all(emergency access) OR all(emergency AND ambulance)) AND 
all((Qualitative Research) OR al(Interview) OR all(Focus Groups) OR all(observational method)) 
QUALIDATA 
emergence AND transport OR bicycle AND ambulance OR motorcycle AND ambulance OR 
emergency referral OR emergency access OR emergency AND ambulance 
 
Appendix 4: Search terms for ‘Can motivational interviews improve 
contraceptive compliance and reduce unmet contraceptive need in post conflict 
zones: a systematic review.’ 
 
MEDLINE 
motivational[All Fields] AND ("interview"[All Fields] OR "interviews as topic"[MeSH Terms] OR 
"interview"[All Fields])) AND ((("contraception"[MeSH Terms] OR "contraception"[All Fields]) OR 
("family planning services"[MeSH Terms] OR ("family"[All Fields] AND "planning"[All Fields] AND 
"services"[All Fields]) OR "family planning services"[All Fields] OR ("family"[All Fields] AND 
"planning"[All Fields]) OR "family planning"[All Fields])) OR (("mothers"[MeSH Terms] OR 
"mothers"[All Fields] OR "maternal"[All Fields]) OR ("pregnancy"[MeSH Terms] OR 
"pregnancy"[All Fields]))) 
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CINAHL  
(MH "Motivational Interviewing") OR "Motivational interviewing"  AND (MH "Family Planning") 
OR (MH "Family Planning: Contraception (Iowa NIC)") OR (MH "Family Planning: Unplanned 
Pregnancy (Iowa NIC)")  
ASSIA 
all(motivational interviewing intervention) AND all((contraception OR family planning)) 
African Index Medicus  
contraception AND behavioural intervention, motivational AND interview, family planning AND 
behavioural intervention 
EMBASE 
motivation/ or motivational interview.mp. AND contraception.mp. or contraception/ OR family 
planning/ 
British Nursing Index 
all(motivational interview) AND (all(contraception) OR all(family planning)) 
Science Citation Index 
Topic=(contraception) OR Topic=(Family planning) AND Topic=(motivational interview)  
Reproductive Health Library 
Motivational interview contraception  
QUALIDATA 
Motivational interviews contraception 
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Appendix 5: Search terms for ‘A comparison of clinical officers with medical 
doctors on caesarean section outcomes in the developing world: A meta-
analysis of controlled studies’ 
 
MEDLINE 
(((((non-physician[All Fields] AND ("Clinician (Goa)"[Journal] OR "clinician"[All Fields])) OR non 
physician clinicians[All Fields]) OR medex[All Fields]) OR (("dental assistants"[MeSH Terms] 
OR ("dental"[All Fields] AND "assistants"[All Fields]) OR "dental assistants"[All Fields] OR 
"assistant"[All Fields]) AND ("Med Off"[Journal] OR ("medical"[All Fields] AND "officer"[All 
Fields]) OR "medical officer"[All Fields]))) OR ("Med Off"[Journal] OR ("medical"[All Fields] AND 
"officer"[All Fields]) OR "medical officer"[All Fields])) OR (clinical[All Fields] AND officer[All 
Fields]) 
Embase 
(clinical officer or medical officer or assistant medical officer or medex or non physician 
clinician* or non-physician clinician*).mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
CINAHL 
(TX non physician clinician OR TX medex OR TX non-physician clinician OR TX medical officer 
OR TX clinical officer OR TX assistant medical officer) 
Reproductive Health Library 
clinical officer OR medical officer OR assistant medical officer OR medex OR non physician 
clinicians 
Cochrane Collaboration 
'clinical officer OR medical officer OR assistant medical officer OR medex OR non physician 
clinicians in title abstract keywords in Cochrane Reviews' 
BIOMED Central 
clinical officer (All words) in All fields (full text) , and assistant medical officer (All words) in All 
fields (full text) , and medical officer (All words) in All fields (full text) , and non physician 
clinicians (All words) in All fields (full text) 
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Science Citation Index 
TS=clinical officer OR TS=medical officer OR TS=assistant medical officer OR TS=medex OR 
TS=non physician clinician OR TS=non-physician clinician 
Databases=SCI-EXPANDED Timespan=All Years 
 
Appendix 6: Search terms for ‘Prophylactic antibiotics for uterine evacuation: A 
systematic review and meta-analysis’ 
 
MEDLINE 
(abortion, spontaneous.mp. OR spontaneous.mp. OR miscarriage.mp. OR    abortion, tubal.mp. 
OR recurrent miscarriage.mp.OR pregnancy miscarriage.mp. OR miscarriage risk.mp. OR first 
trimester miscarriage.mp. OR    threatened miscarriage.mp. OR surgical evacuation of the 
uterus.mp. OR    evacuation of retained products of conception.mp. OR pregnancy loss.mp. OR    
incomplete miscarriage.mp. OR early pregnancy loss.mp. ORclinical spontaneous 
abortion.mp.OR complete miscarriage.mp.OR missed miscarriage.mp.) AND (sepsis.mp. OR 
therapy sepsis.mp.) OR (exp infection OR    (infection/ or infection.mp. OR infection rate.mp.) 
OR ( bacteremia.mp) OR (endotoxemia OR hemorrhagic septicemia) OR (fever OR 
pyrexia.mp).  OR   (postoperative infection OR post-operative infection.mp.) OR   (surgical 
infection) OR (blood poisoning.mp. OR bloodstream infection) OR  (septicemia.mp. OR blood 
infection.mp.) AND (abortion, incomplete.mp. OR septic abortion OR abortion, septic.mp. OR 
septic abortion.mp. OR  abortion, threatened.mp.OR embryo death OR embryo loss.mp) OR 
(induced abortion OR abortion, induced.mp. OR induced abortion.mp. OR spontaneous 
abortion.mp. OR abortion, missed.mp.OR  missed abortion.mp. OR medical abortion OR 
abortion, medical.mp.OR recurrent spontaneous abortion.mp. OR legal abortion OR abortion, 
legal.mp. OR eugenic abortion.mp. OR therapeutic abortion OR abortion, therapeutic.mp. OR 
abortion.mp.OR pregnancy termination OR termination of pregnancy.mp. OR  recurrent OR 
recurrent abortion.mp.OR illegal abortion OR exp imminent abortion OR legal abortion/ OR  
incomplete abortion OR second trimester abortion OR selective abortion/ OR surgical abortion 
OR fetus death) AND prophylactic.mp. AND (anti-bacterial agents.mp.OR anti bacterial 
agents.mp. OR anti bacterial.mp OR antiinfective agent/ OR exp antibiotic agent OR 
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antibiotic.mp. OR antibiotic therapy OR antibiotic treatment.mp. OR antibiotic agent.mp. OR 
antibiotic prophylaxis.mp. OR  prophylactic antibiotic.mp. OR prophylaxis, antibiotic.mp. 
AND (clinical trial OR randomized controlled trial OR  RCT OR   randomization OR 
randomization OR randomi?ed controlled trial$.tw. OR rct.tw. OR random allocation.tw.OR     
randomly allocated.tw. OR     allocated randomly.tw.OR (allocated adj2 random).tw.  
BIOMED Central 
(Spontaneous abortion OR miscarriage OR  tubal abortion OR recurrent miscarriage OR 
pregnancy miscarriage OR miscarriage risk OR first trimester miscarriage OR threatened 
miscarriage OR surgical evacuation of the uterus OR evacuation of retained products of 
pregnancy OR pregnancy loss OR incomplete miscarriage OR early pregnancy loss OR  
clinical spontaneous abortion OR complete miscarriage OR missed miscarriage) 
OR (incomplete abortion OR missed abortion OR septic abortion OR  threatened abortion 
OR embryo loss OR  induced abortion OR medical abortion OR recurrent spontaneous 
abortion OR  legal abortion OR therapeutic abortion OR abortion OR termination of 
pregnancy OR recurrent abortion OR illegal abortion) AND (Sepsis, OR therapy sepsis OR
  
infection:ab,ti OR bacteremia OR endotoxemia OR hemorrhagic septicaemia OR haemorrhagic 
septicaemia OR pyrexia OR postoperative infection OR post-operative infection OR post 
operative infection OR surgical infection OR blood poisoning  OR systemic inflammatory 
response syndrome OR septicaemia) AND prophylactic (anti-bacterial agents OR anti-bacterial 
OR antibiotic OR antibiotic therapy OR antibiotic treatment) OR prophylaxis OR  antibiotic 
agent OR antibiotic prophylaxis OR prophylactic antibiotic) 
Embase 
(abortion, spontaneous.mp. OR spontaneous.mp. OR miscarriage.mp. OR    abortion, tubal.mp. 
OR recurrent miscarriage.mp.OR pregnancy miscarriage.mp. OR miscarriage risk.mp. OR first 
trimester miscarriage.mp. OR    threatened miscarriage.mp. OR surgical evacuation of the 
uterus.mp. OR    evacuation of retained products of conception.mp. OR pregnancy loss.mp. OR    
incomplete miscarriage.mp. OR early pregnancy loss.mp. ORclinical spontaneous 
abortion.mp.OR complete miscarriage.mp.OR missed miscarriage.mp.) AND (sepsis.mp. OR 
therapy sepsis.mp.) OR (exp infection OR    (infection/ or infection.mp. OR infection rate.mp.) 
OR ( bacteremia.mp) OR (endotoxemia OR hemorrhagic septicemia) OR (fever OR 
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pyrexia.mp).  OR   (postoperative infection OR post-operative infection.mp.) OR   (surgical 
infection) OR (blood poisoning.mp. OR bloodstream infection) OR  (septicemia.mp. OR blood 
infection.mp.) AND (abortion, incomplete.mp. OR septic abortion OR abortion, septic.mp. OR 
septic abortion.mp. OR  abortion, threatened.mp.OR embryo death OR embryo loss.mp) OR 
(induced abortion OR abortion, induced.mp. OR induced abortion.mp. OR spontaneous 
abortion.mp. OR abortion, missed.mp.OR  missed abortion.mp. OR medical abortion OR 
abortion, medical.mp.OR recurrent spontaneous abortion.mp. OR legal abortion OR abortion, 
legal.mp. OR eugenic abortion.mp. OR therapeutic abortion OR abortion, therapeutic.mp. OR 
abortion.mp.OR pregnancy termination OR termination of pregnancy.mp. OR  recurrent OR 
recurrent abortion.mp.OR illegal abortion OR exp imminent abortion OR legal abortion/ OR  
incomplete abortion OR second trimester abortion OR selective abortion/ OR surgical abortion 
OR fetus death) AND prophylactic.mp. AND (anti-bacterial agents.mp.OR anti bacterial 
agents.mp. OR anti bacterial.mp OR antiinfective agent/ OR exp antibiotic agent OR 
antibiotic.mp. OR antibiotic therapy OR antibiotic treatment.mp. OR antibiotic agent.mp. OR 
antibiotic prophylaxis.mp. OR  prophylactic antibiotic.mp. OR prophylaxis, antibiotic.mp. AND 
(clinical trial OR randomized controlled trial OR  randomised controlled trial OR   randomization 
OR randomization OR randomi?ed controlled trial$.tw. OR rct.tw. OR random allocation.tw.OR     
randomly allocated.tw. OR     allocated randomly.tw.OR (allocated adj2 random).tw.  
PsychInfo 
(abortion, spontaneous.mp. OR spontaneous.mp. OR miscarriage.mp. OR    abortion, tubal.mp. 
OR recurrent miscarriage.mp.OR pregnancy miscarriage.mp. OR miscarriage risk.mp. OR first 
trimester miscarriage.mp. OR    threatened miscarriage.mp. OR surgical evacuation of the 
uterus.mp. OR    evacuation of retained products of conception.mp. OR pregnancy loss.mp. OR    
incomplete miscarriage.mp. OR early pregnancy loss.mp. ORclinical spontaneous 
abortion.mp.OR complete miscarriage.mp.OR missed miscarriage.mp.) AND (sepsis.mp. OR 
therapy sepsis.mp.) OR (exp infection OR    (infection/ or infection.mp. OR infection rate.mp.) 
OR ( bacteremia.mp) OR (endotoxemia OR hemorrhagic septicemia) OR (fever OR 
pyrexia.mp).  OR   (postoperative infection OR post-operative infection.mp.) OR (surgical 
infection) OR (blood poisoning.mp. OR bloodstream infection) OR  (septicemia.mp. OR blood 
infection.mp.) AND (abortion, incomplete.mp. OR septic abortion OR abortion, septic.mp. OR 
septic abortion.mp. OR  abortion, threatened.mp.OR embryo death OR embryo loss.mp) OR 
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(induced abortion OR abortion, induced.mp. OR induced abortion.mp. OR spontaneous 
abortion.mp. OR abortion, missed.mp.OR  missed abortion.mp. OR medical abortion OR 
abortion, medical.mp.OR recurrent spontaneous abortion.mp. OR legal abortion OR abortion, 
legal.mp. OR eugenic abortion.mp. OR therapeutic abortion OR abortion, therapeutic.mp. OR 
abortion.mp.OR pregnancy termination OR termination of pregnancy.mp. OR  recurrent OR 
recurrent abortion.mp.OR illegal abortion OR exp imminent abortion OR legal abortion/ OR  
incomplete abortion OR second trimester abortion OR selective abortion/ OR surgical abortion 
OR fetus death) AND prophylactic.mp. AND (anti-bacterial agents.mp.OR anti bacterial 
agents.mp. OR anti bacterial.mp OR antiinfective agent/ OR exp antibiotic agent OR 
antibiotic.mp. OR antibiotic therapy OR antibiotic treatment.mp. OR antibiotic agent.mp. OR 
antibiotic prophylaxis.mp. OR  prophylactic antibiotic.mp. OR prophylaxis, antibiotic.mp. 
WPRIM 
All:prophylactic or All:anti-bacterial agents or All:anti-bacterial or All:antibiotic or All:antibiotic 
therapy or All:antibiotic treatment or All:prophylaxis or All:antibiotic prophylaxis or 
All:prophylactic antibiotic 
All:abortion or All:threatened abortion or All:embryo loss or All:missed abortion or All:medical 
abortion or All:recurrent spontaneous abortion or All:induced abortion or All:termination of 
pregnancy or All:recurrent abortion or All:illegal abortion or All:imminent abortion or All:legal 
abortion or All:incomplete abortion or All:second trimester abortion or All:selective abortion or 
All:septic abortion or All:surgical abortion or All:therapeutic abortion or All:hormonal abortion or 
All:artifical abortion or All:habitual abortion or All:multiple abortion or All:premature exit of 
products of conception or All:elective abortion 
All:sepsis or All:therapy sepsis or All:infection or All:bacteremia or All:endotoxemia or 
All:hemorrhagic septicemia or All:pyrexia or All:postoperative infection or All:post-operative 
infection or All:surgical infection or All:blood poisoning or All:systemic inflammatory response 
syndrome or All:SIRS or All:blood stream infection or All:bloodstream infection or All:septicemia 
or All:blood infection 
All:spontaneous abortion or All:miscarriage or All:tubal abortion or All:recurrent miscarriage or 
All:pregnancy miscarriage or All:miscarriage risk or All:first trimester miscarriage or 
All:threatened miscarriage or All:surgical evacuation of uterus or All:evacuation of retained 
products of conception or All:pregnancy loss or All:incomplete miscarriage or All:early 
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pregnancy loss or All:clinical spontaneous abortion or All:complete miscarriage or All:missed 
miscarriage 
IMSEAR  
((abstract:abortion) OR (abstract:miscarriage))  
AIM 
abortion [Key Word] or miscarriage [Key Word] 
LILACS 
abortion or miscarriage [Words] and sepsis or infection or pyrexia or blood poisoning or 
septicemia [Words] abortion or miscarriage [Words] and anti-bacterial or antibiotic or 
prophylaxis [Words] 
IMEMR  
abortion or miscarriage [KeyWords] and anti-bacterial or antibiotic or prophylaxis 
[KeyWords] abortion or miscarriage [KeyWords] and sepsis or infection or pyrexia or blood 
poisoning or septicemia [KeyWords] 
PAHO  
abortion [Words] or miscarriage [Words]  
 
Appendix 7: Search terms for ‘Cell salvage in caesarean section: A systematic 
review and meta-analysis’ 
 
MEDLINE  
(cell AND salvage).ti,abOR (blood AND salvage).ti,ab(erythrocyte AND salvage).ti,ab OR 
(autologous AND transfusion).ti,ab OR autotransfusion.ti,ab AND (c*esarean section).ti,ab OR 
(obstetric*).ti,ab 
CINAHL 
(TX cell salvage OR TX blood salvage OR TX cell salver OR TX eythrocyte salvage OR TX 
autologous transfusion OR TX autotransfusion) AND (TX c*esarean section OR TX obstetric*) 
EMBASE 
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(blood transfusion/ or blood autotransfusion/ or erythrocyte transfusion/ or cell salvage.mp. OR 
blood salvage.mp. or blood autotransfusion/ or blood salvage/ or blood transfusion/ OR 
erythrocyte salvage.mp. OR blood autotransfusion/ or autologous transfusion.mp. OR 
autotransfusion.mp. or blood autotransfusion/ OR cell salver.mp) AND (c*esarean section.mp. 
OR obstetric*.mp.) 
Cochrane library 
'cell salvage OR blood salvage OR erythrocyte salvage OR autologous transfusion OR 
autotransfusion OR cell salver AND c*esarean section OR obstetric* in title abstract keywords’ 
African Index Medicus 
cell salvage [Key Word] or blood salvage [Key Word] or erythrocyte salvage [Key Word] or 
autologous transfusion [Key Word] or autotransfusion [Key Word] or cell salver [Key Word] 
LILACS 
cell OR salvage OR or OR blood OR salvage OR or OR erythrocyte OR salvage OR or OR auto
logous OR transfusion OR or OR autotransfusion OR or OR cell OR salver 
Reproductive Health Library 
cell salvage OR blood salvage OR erythrocyte salvage OR autologous transfusion OR 
autotransfusion  OR cell salver AND c*esarean section OR obstetric* 
Science Citation Index 
TS= cell salvage OR TS= blood salvage OR TS= erythrocyte salvage OR TS= erythrocyte 
salvage OR TS= autologous transfusion OR TS= autotransfusion OR TS= cell salver AND 
(TS=c*esarean section OR TS=obstetric*) Databases=SCI-EXPANDED Timespan=All Years 
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Appendix 8: Search terms for ‘Cell salvage in ectopic pregnancy: A systematic 
review’ 
 
MEDLINE  
(cell AND salvage).ti,abOR (blood AND salvage).ti,ab(erythrocyte AND salvage).ti,ab OR 
(autologous AND transfusion).ti,ab OR autotransfusion.ti,ab AND (ectopic AND pregnancy).ti,ab 
OR (tubal AND pregnancy).ti,ab 
CINAHL 
(TX cell salvage OR TX blood salvage OR TX cell salver OR TX eythrocyte salvage OR TX 
autologous transfusion OR TX autotransfusion) AND (TX tubal pregnancy OR TX ectopic 
pregnancy) 
EMBASE 
(blood transfusion/ or blood autotransfusion/ or erythrocyte transfusion/ or cell salvage.mp. OR 
blood salvage.mp. or blood autotransfusion/ or blood salvage/ or blood transfusion/ OR 
erythrocyte salvage.mp. OR blood autotransfusion/ or autologous transfusion.mp. OR 
autotransfusion.mp. or blood autotransfusion/ OR cell salver.mp) AND (tubal pregnancy.mp. or 
uterine tube pregnancy/ OR ectopic pregnancy.mp. or ectopic pregnancy/) 
Cochrane library 
'cell salvage OR blood salvage OR erythrocyte salvage OR autologous transfusion OR 
autotransfusion OR cell salver AND ectopic OR tubal pregnancy in title abstract keywords’ 
African Index Medicus 
cell salvage [Key Word] or blood salvage [Key Word] or erythrocyte salvage [Key Word] or 
autologous transfusion [Key Word] or autotransfusion [Key Word] or cell salver [Key Word] 
LILACS 
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cell OR salvage OR or OR blood OR salvage OR or OR erythrocyte OR salvage OR or OR auto
logous OR transfusion OR or OR autotransfusion OR or OR cell OR salver 
Reproductive Health Library 
cell salvage OR blood salvage OR erythrocyte salvage OR autologous transfusion OR 
autotransfusion  OR cell salver AND ectopic OR tubal pregnancy 
Science Citation Index 
TS= cell salvage OR TS= blood salvage OR TS= erythrocyte salvage OR TS= erythrocyte 
salvage OR TS= autologous transfusion OR TS= autotransfusion OR TS= cell salver AND 
(TS=ectopic OR TS=tubal pregnancy) 
Databases=SCI-EXPANDED Timespan=All Years 
 
Appendix 9: Search terms for ‘Symphysiotomy for obstructed labour in 
developing countries, an alternative to caesarean section: A systematic review 
and meta-analysis.’ 
 
PUBMED  
"symphysiotomy"[MeSH Terms] OR "symphysiotomy"[All Fields] OR “pubiotomy” [All Fields] 
Science Citation Index  
Topic=(symphysiotomy) OR Topic=(pubiotomy)  
Embase 
Symphysiotomy.mp. OR pubiotomy.mp. 
CINAHL 
"symphysiotomy OR pubiotomy"  
COCHRANE collaboration 
“symphysiotomy OR pubiotomy” 
African Index Medicus  
symphysiotomy OR pubiotomy 
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Reproductive Health Library  
symphysiotomy OR pubiotomy 
 
Appendix 10: Search terms for ‘Anti-shock garment for obstetric haemorrhage in 
developing countries: A systematic review and meta-analysis’ RHL: Gravity suit 
OR MAST suit OR Pneumatic suit OR NASG OR PASG OR G-suit OR Anti-shock 
trouser OR Anti-shock garment  
 
PUBMED 
((((((anti-shock[All Fields] AND ("clothing"[MeSH Terms] OR "clothing"[All Fields] OR 
"garment"[All Fields])) OR ("gravity suits"[MeSH Terms] OR ("gravity"[All Fields] AND "suits"[All 
Fields]) OR "gravity suits"[All Fields] OR ("anti"[All Fields] AND "shock"[All Fields] AND 
"trousers"[All Fields]) OR "anti shock trousers"[All Fields])) OR G-suit[All Fields]) OR (anti-
gravity[All Fields] AND suit[All Fields])) OR ("gravity suits"[MeSH Terms] OR ("gravity"[All 
Fields] AND "suits"[All Fields]) OR "gravity suits"[All Fields] OR ("pneumatic"[All Fields] AND 
"suit"[All Fields]) OR "pneumatic suit"[All Fields])) OR PASG[All Fields]) OR NASG[All Fields] 
AND obstetric 
AMED 
AB anti-shock garment OR AB anti shock trousers OR AB G-suit OR AB gravity suit OR AB 
pneumatic suit OR AB PASG OR AB NASG AND obstetric 
CINAHL 
AB anti-shock garment OR AB anti shock trousers OR AB G-suit OR AB gravity suit OR AB 
pneumatic suit OR AB PASG OR AB NASG AND obstetric 
Science Citation Index 
TS=anti-shock garment OR TS=anti shock trousers OR TS=G-suit OR TS=gravity suit OR 
TS=pneumatic suit OR TS=PASG OR TS=NASG AND TS=maternal (Databases=SCI-
EXPANDED Timespan=All Years) AND obstetric 
COCHRANE collaboration 
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anti-shock garment OR anti-shock trousers OR G-suit OR anti-gravity suit OR pneumatic suit 
OR PASG OR NASG AND obstetric 
Embase 
(Gravity suit or MAST suit or Pneumatic suit or NASG or PASG or G-suit or Anti-shock trouser 
or Anti-shock garment).mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword]  AND 
obstetric  
African Index Medicus 
anti-shock garment OR anti shock trousers OR G-suit OR gravity suit OR pneumatic suit OR 
PASG OR NASG AND obstetric 
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